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Synaesthesia is a hereditary, neurological condition in which common stimuli trigger
unexpected secondary sensations. For example, reading letters may result in the visual-
isation of colour, a variant known as grapheme-colour synaesthesia. While synaesthe-
sia is thought to confer a range of benefits such as improved memory, empathy, visual
search and creativity to the synaesthete, there is a small, yet growing, body of evidence
that suggests synaesthesia may also be associated with more clinical conditions. This
thesis investigates potential associations between synaesthesia and a range of clinical
conditions, identifying a set of cormorbidities, and exploring the possible genetic roots
of these associations. First, I identified an increased prevalence of multiple sclerosis
(MS) and its clinical precursor, radiologically isolated syndrome (RIS) in synaesthetes
self-referring for participation in scientific studies. Furthermore, I identified an in-
creased occurrence of anxiety disorder in randomly sampled synaesthetes. In addition,
I show that synaesthetes with anxiety disorder experience reduced luminance in their
synaesthetic colours. I also conducted an association study into the genetic origins of
synaesthesia and propose the immune hypothesis of synaesthesia, which provides a
theoretical basis for comorbidities (linked to the altered cortical connectivity thought
to underlie the development of synaesthesia). Finally, in phenotyping synaesthesia in
individuals, I also validated the most widely used online test for synaesthesia, and use
this test to provide a reliable prevalence of grapheme-colour synaesthesia in the general
population. Such baselines are important for establishing whether other (e.g., clinical)
populations are showing rates of synaesthesia higher than otherwise expected. I also
demonstrate there is no significant difference in grapheme-colour synaesthesia preva-




Many people have played a hugely significant role in this PhD. Firstly, I would like
to thank my supervisors Richard Shillcock and Stephen Lawrie and in particular, my
primary supervisor, Julia Simner for their excellent supervision, support and good hu-
mour throughout my PhD. I couldn’t have wished for better guidance and expertise,
and for that I am extremely grateful.
Research conducted at the Anne Rowling clinic would not have been possible with-
out the unfailing assistance and expertise of Belinda Weller, Anna Williams, Matt
Justin and Nicola MacLeod. I would also like to express my sincere thanks to col-
laborators Sarah Graham and Kate Kucera for their help in explaining the mysteries
of genetics. I would also like to express my gratitude to everyone who participated
in my research. It goes without saying none of this would be possible without your
participation.
A lot of people made academic life in Edinburgh interesting, fun and sociable. I
would like to thank the staff and my fellow students at the DTC for making the past
four years so enjoyable. A big thank you to Chris A. and Scotty for far-ranging whisky-
fuelled chats that often went long into the night.
I would like to express my heartfelt gratitude to my family and friends for always
being there, and for all the love and support you’ve given me over the years. Lastly,
I dedicate this thesis to Zoe and Fergus. Zoe, for all your love and support, without
which this thesis would never have been written and to Fergus for just being himself.
ii
Declaration
I declare that this thesis was composed by myself, that the work contained herein is
my own except where explicitly stated otherwise in the text, and that this work has not





1.1 An introduction to synaesthesia . . . . . . . . . . . . . . . . . . . . . 1
1.1.1 Neurology of synaesthesia . . . . . . . . . . . . . . . . . . . 2
1.1.2 Development and causes . . . . . . . . . . . . . . . . . . . . 5
1.2 Prevalence and objective testing of synaesthesia . . . . . . . . . . . . 8
1.2.1 Prevalence and sex bias . . . . . . . . . . . . . . . . . . . . . 8
1.2.2 Problems with synaesthesia testing . . . . . . . . . . . . . . . 10
1.2.3 Methodologies in testing for synaesthesia . . . . . . . . . . . 14
1.2.4 Thesis overview . . . . . . . . . . . . . . . . . . . . . . . . 17
2 A review of synaesthesia and comorbidity 20
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.2 Synaesthesia and comorbidity . . . . . . . . . . . . . . . . . . . . . 21
2.2.1 Synaesthesia and anxiety disorder . . . . . . . . . . . . . . . 21
2.2.2 Synaesthesia and autism spectrum disorders . . . . . . . . . . 23
2.2.3 Synaesthesia and epilepsy . . . . . . . . . . . . . . . . . . . 25
2.2.4 Synaesthesia and irritable bowel syndrome (IBS) . . . . . . . 27
2.2.5 Synaesthesia and migraine . . . . . . . . . . . . . . . . . . . 28
2.2.6 Synaesthesia and multiple sclerosis . . . . . . . . . . . . . . 30
2.2.7 Synaesthesia and schizophrenia . . . . . . . . . . . . . . . . 32
2.2.8 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
iv
3 Prevalence of multiple sclerosis in synaesthesia 37
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
3.1.1 Multiple Sclerosis . . . . . . . . . . . . . . . . . . . . . . . 38
3.1.2 Other syndromes linked to the development of MS . . . . . . 39
3.2 Why might synaesthesia and multiple sclerosis be linked? . . . . . . . 41
3.3 Experiment 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
3.3.1 Case-details of affected synaesthetes . . . . . . . . . . . . . . 44
3.3.2 Case-details of all synaesthetes with existing MRI scans . . . 48
3.3.3 Analysis of the prevalence of MS/RIS cases among scanned
synaesthetes against expected baselines . . . . . . . . . . . . 51
3.3.4 Baseline selection and results . . . . . . . . . . . . . . . . . 52
3.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
4 Genetics literature review 57
4.1 A brief introduction to genetics . . . . . . . . . . . . . . . . . . . . . 57
4.1.1 Inheritance and linkage . . . . . . . . . . . . . . . . . . . . . 58
4.1.2 Rationale for conducting genetic experiments . . . . . . . . . 59
4.1.3 Linkage and association methods . . . . . . . . . . . . . . . 60
4.2 The genetics of synaesthesia . . . . . . . . . . . . . . . . . . . . . . 64
4.2.1 Summary of the current position in the search for synaesthesia
genes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
4.2.2 Evaluation of the current position . . . . . . . . . . . . . . . 67
4.2.3 X chromosome . . . . . . . . . . . . . . . . . . . . . . . . . 69
4.3 Genetics of multiple sclerosis . . . . . . . . . . . . . . . . . . . . . . 70
4.3.1 The major histocompatibility complex . . . . . . . . . . . . . 71
4.4 Genetic overlap between multiple sclerosis and synaesthesia . . . . . 72
4.5 Chapter conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
v
5 The immune hypothesis of synaesthesia 75
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
5.2 Dual gene functionality: connectivity and immunity . . . . . . . . . . 77
5.3 Can the immune system influence the development of the brain? . . . 78
5.4 The immune hypothesis as a framework for synaesthesia and co-morbidity 80
5.5 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
6 Phenotyping synaesthesia: Validating the Synesthesia Battery’s short-term
test for synaesthesia 82
6.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
6.1.1 Prevalence and sex ratio . . . . . . . . . . . . . . . . . . . . 86
6.2 Experiment 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
6.2.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
6.2.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
6.2.3 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
7 The genetics of synaesthesia 99
7.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
7.1.1 Rationale for investigating genetics of synaesthesia . . . . . . 100
7.1.2 Selecting the region of the genome for analysis . . . . . . . . 101
7.1.3 Limiting the phenotype to grapheme-colour synaesthesia . . . 103
7.2 Experiment 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
7.2.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
7.2.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
7.2.3 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
8 Prevalence of synaesthesia in multiple sclerosis 115
8.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
8.2 Experiment 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
8.2.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
vi
8.2.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
8.3 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
9 Synaesthesia and other comorbidities: A health screening approach 129
9.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
9.2 Experiment 5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
9.2.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
9.2.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134
9.2.3 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
10 Conclusions and future directions 141
10.1 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
10.1.1 Synaesthesia and MS . . . . . . . . . . . . . . . . . . . . . . 143
10.1.2 Synaesthesia and anxiety disorder . . . . . . . . . . . . . . . 144
10.2 Methodological advances and limitations . . . . . . . . . . . . . . . . 146
10.2.1 Screen or recruit? The referral bias dilemma . . . . . . . . . 147
10.2.2 Focus on grapheme-colour synaesthesia . . . . . . . . . . . . 148
10.2.3 Comparing synaesthesia in healthy and clinical populations . 150
Appendix A Information sheet from MS prevalence study 153
Appendix B Consent form from MS prevalence study 159
Appendix C Questionnaire from MS prevalence study 162
Appendix D The genetics and inheritance of synesthesia 167
Appendix E The immune hypothesis of synesthesia 209
Appendix F Rates of white matter hyperintensities compatible with the ra-
diological profile of multiple sclerosis within self-referred synesthete pop-
ulations 213
vii
Appendix G Validating a standardised test battery for synesthesia: Does the
Synesthesia Battery reliably detect synesthesia? 224
Appendix H Colour fluctuations in grapheme-colour synaesthesia: The ef-
fect of clinical and nonclinical mood changes 236




3.1 MRI image showing white matter lesions from subject 1 . . . . . . . 46
3.2 MRI image showing white matter lesions from subject 2 . . . . . . . 47
3.3 MRI image showing white matter lesions from subject 3 . . . . . . . 48
6.1 Consistency test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
6.2 Variants of grapheme-colour synaesthesia . . . . . . . . . . . . . . . 92
9.1 Screenshot of the health questionnaire . . . . . . . . . . . . . . . . . 134
9.2 Prevalence of clinical conditions in synaesthetes . . . . . . . . . . . . 136
9.3 Anxiety disorder reduces luminance in synaesthetic graphemes . . . . 138
ix
List of Tables
3.1 Synaesthete case descriptions . . . . . . . . . . . . . . . . . . . . . . 45
3.2 MRI studies of synaesthete participants . . . . . . . . . . . . . . . . 50
7.1 Details of genetic control population . . . . . . . . . . . . . . . . . . 107
7.2 Genetic association analysis . . . . . . . . . . . . . . . . . . . . . . 110
8.1 Multiple sclerosis patients self reporting grapheme-colour synaesthesia 122
x
Six peer reviewed publications have arisen from this thesis
1. Simner, J. and Carmichael, D.A. (2015). Is synaesthesia a dominantly female
trait? Cognitive Neuroscience (in press)
2. Carmichael, D.A., Down, M.P., Shillcock, R.C., Eagleman, D.M. and Simner,
J. (2015) Validating a standardised test battery for synesthesia: Does the Synes-
thesia Battery reliably detect synesthesia? Consciousness and Cognition, 33
375-385.
3. Kay, C.L., Carmichael, D.A., Ruffell, H.E., and Simner J. (2014) Colour fluc-
tuations in grapheme-colour synaesthesia: The effect of mood. British Journal
of Psychology. doi: 10.1111/bjop.12102 .
4. *Simner, J., *Carmichael, D.A., Hubbard, E.M., Morris, M. and Lawrie, S.M.
(2014). Rates of white matter hyperintensities compatible with the radiological
profile of multiple sclerosis within self-referred synaesthete populations. Neuro-
case, (ahead-of-print), 1-9.
5. Carmichael, D. A. and Simner, J. (2013). The immune hypothesis of synesthe-
sia. Frontiers in human neuroscience, 7.
6. Asher, J.E. and Carmichael, D.A. (2013). The genetics and inheritance of
synesthesia, in Simner, J. and Hubbard, E.M. (eds) Oxford Handbook of Synes-





1.1 An introduction to synaesthesia
Synaesthesia is a hereditary, neurological condition in which common stimuli trig-
ger unexpected secondary sensations. For example, listening to music may result in
the visualisation of colour, in addition to the expected perception of sound, known
as music-colour synaesthesia (Ward et al., 2006), or the visualisation of colours may
be triggered by specific letters and/or numbers, a subtype known as grapheme-colour
synaesthesia (Ward et al., 2007). In this thesis, I will ask whether having synaesthesia
is also accompanied by other comorbid conditions. In this chapter, I will introduce the
genetics and neurology of synaesthesia, its prevalence and sex bias and discuss how
synaesthesia is empirically tested. This latter point is important for this thesis because
reliable tests for synaesthesia are a prerequisite to producing accurate prevalence esti-
mates, which is essential when comparing rates of synaesthesia in clinical and healthy
populations.
The synaesthetic experience as a whole is composed of two significant compo-
nents; the stimulus that triggers the secondary sensation, and the secondary sensation
itself. The former is known as the inducer, while the latter is known as the concurrent
(Grossenbacher and Lovelace, 2001). For example, in grapheme-colour synaesthesia,
1
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graphemes (i.e., letters and/or numbers) are the inducer that triggers the experience of
colour, which is the concurrent. In addition to the many forms of synaesthesia, there
are also two distinct types of synaesthete. The distinction is based on how the concur-
rent sensation is experienced. Synaesthetes who experience the concurrent sensation
projected outside their body are known as projectors, which synaesthetes who expe-
rience the concurrent internally, or in their “mind’s eye”, are known as associators
(Dixon et al., 2004).
Synaesthesia is a heterogeneous phenomenon, with between 60-150 distinct vari-
ants identified to date (Cytowic and Eagleman, 2009). A broad range of inducers are
found within these 60-150 variants, including such diverse stimuli as graphemes, food
tastes and even pain. The resulting concurrents are similarly diverse, ranging from
the experience of colour to tastes in the mouth, or the experience of emotions. While
data regarding the prevalence of synaesthesia are incomplete (see section 1.2.2 be-
low for more in-depth discussion), the most prevalent sub-type of synaesthesia is day-
colour synaesthesia, experienced by an estimated 2.8% of the population, followed by
grapheme-colour, with an estimated prevalence of 2% (Simner et al., 2006b)1.
1.1.1 Neurology of synaesthesia
Synaesthesia has a neurological basis. Recent research has shown that distinct struc-
tural and functional differences exist between the synaesthetic brain and the brains of
non-synaesthetes. Using a range of neuroimaging techniques, specific aspects of the
neurological profile of synaesthesia have been identified, and these are reviewed in
brief here.
1This estimate was generated by a study which excluded sequence-space synaesthesia, which may be
the most prevalent type of synaesthesia, found in approximately 10% of the population (Simner, 2009;
Sagiv et al., 2006) and this study also excluded mirror-touch synaesthesia, the prevalence of which is
also known to be approximately equal to that of grapheme-colour synaesthesia, at 1.6% (Banissy et al.,
2009a). Because the empirical work reported in this thesis was conducted primarily with grapheme-
colour synaesthetes, both of these subtypes will be excluded from discussions of synaesthesia prevalence
in this thesis
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Structural differences affecting white matter have been discovered. These differ-
ences have been identified using diffusion tensor imaging (DTI), an MRI technique
which provides information about the structural integrity of white matter fibres in the
brain. White matter connectivity in DTI is measured in terms of fractional anistropy
(FA). Simply put, FA measures the extent to which water molecules are free to diffuse
in white matter tracts in the brain, on a scale of zero to one. The lower the value, the
greater extent to which water molecules are free to diffuse in any direction. In healthy
white matter tracts, water molecules are constrained in the direction they may diffuse
by the structure of that tract. If the integrity of a tract is compromised (for example by
age or disease), water molecules have greater capacity for diffusion in multiple direc-
tions, which is reflected in a lower FA value. Thus, low FA values are linked to lower
integrity of white matter tracts in the brain (i.e., increases in FA indicate increases
in structural white matter connectivity). Research conducted using DTI has shown
localised increases in structural connectivity in the brains of synaesthetes. These in-
creases predominately centre around the fusiform gyrus and parietal lobe (Rouw and
Scholte, 2007), but have also been reported in the cingulate cortex, primary auditory
cortex, frontal cortex and cerebellum (Hänggi et al., 2008). Decreases in structural con-
nectivity have also been reported in the parietal lobe (Hänggi et al., 2008). The parietal
lobe is thought to play a key role in binding sensory input from different modalities
into a coherent whole picture.
Grey matter is also affected in synaesthesia. Evidence from structural MRI studies
looking at the properties of grey matter has shown a range of structural differences
in the same fusiform and intraparietal areas, including increased grey matter volume
(Weiss and Fink, 2009) and increased cortical thickness and increased cortical surface
area (Jäncke et al., 2009). In one study, both increases (in the left posterior fusiform
gyrus) and decreases in grey matter volume (in V5 and left anterior fusiform gyrus)
have been reported in the same group of synaesthetes (Banissy et al., 2012b).
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As well as structural differences, functional differences have been shown to exist
in the brains of synaesthetes. Evidence from functional magnetic resonance imaging
(MRI) - a technique which measures cortical activity based on changes in blood flow
- has shown that areas of the visual cortex that play a role in colour recognition -
for example, V4 - show activation when grapheme-colour synaesthetes are presented
with black-on-white graphemes (Hubbard et al., 2005; Nunn et al., 2002; Sperling
et al., 2006). This suggests that, on a neuronal level, the synaesthetic brain responds
to triggers to produce synaesthetically induced colour using the same mechanisms by
which actual colour is perceived (Rich et al., 2006) found that when synaesthetes and
non-synaesthetic controls were asked to imagine colours, both groups experienced in-
creased neural activity in the V4 in the right hemisphere. However, when synaes-
thetes were presented with graphemes which induced their synaesthetic colours, this
task activated the left medial lingual gyrus, activation which was not detected in non-
synaesthetic controls. This suggests that different neural mechanisms may underlie the
perception of colours in synaesthetes and non-synaesthetes. Further evidence that the
parietal lobe plays a role in synaesthesia has been shown by the use of transcranial
magnetic stimulation (TMS), an experimental technique which uses electric current to
temporarily stimulate localised areas of the brain. Stimulation of the right parietal
lobe has been shown to disrupt synaesthetic colour-shape binding (Esterman et al.,
2006) and also diminish interference in a synaesthetic Stroop test, implying that the
application of TMS diminished the influence of the participants’ synaesthetic colours
(Muggleton et al., 2007).
The conclusions from studies conducted in a range of imaging modalities provides
evidence firstly of localised structural differences in the synaesthetic cortex, manifest-
ing itself as altered white matter connectivity and altered grey matter volume in specific
locations. These regions appear to play important and specific roles in synaesthesia,
such as colour processing (e.g. V4) and binding (e.g. parietal lobe) (Rouw et al., 2011).
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While most research focusses on increased white matter coherence and grey matter
volume in these areas, it is important to note that decreases have also been reported
(Hänggi et al., 2008; Banissy et al., 2012b).These structural findings are corroborated
by evidence of differing levels of functional activation found in these same areas in
synaesthetes, in response to synaesthetic inducers. An interesting and open question
concerns the direction of causality. It is not clear whether the structural changes to
the cortex described above cause synaesthesia or arise as a result of synaesthesia (Ka-
dosh and Walsh, 2008; Bargary and Mitchell, 2008). While a coherent picture of the
neurological basis of synaesthesia appears to be emerging, it is important to point out
that imaging studies in synaesthesia remains a nascent field, and not all of the find-
ings discussed above have been replicated. For example, Jäncke et al. (2009) were not
able to fully replicate the FA differences in the fusiform gyrus previously reported by
Rouw and Scholte (2007). Furthermore, it has been suggested that current evidence
supporting the existence of a neurological basis for synaesthesia should be interpreted
with caution. Hupé and Dojat (2015) produced a comprehensive review of the MRI-
synaesthesia literature and propose the view that, due to methodological limitations
and low statistical power, studies in this area are yet to reliably identify any neural cor-
relates of synaesthesia. It is important to also consider what these differences in brain
structure and function may tell us about brain function in synaesthetes more broadly.
It is possible that such changes may result in more widespread differences in brain
function, in addition to the presence of synaesthesia. There is evidence to suggest that
a range of cognitive processes differ in synaesthetes, relative to the general population.
For example, synaesthetes have been shown to have improved performance in a range
of memory domains, which in turn, may indicate broader differences in the way in
which information is processed in the synaesthetic brain (Rothen et al., 2012). Sim-
ilarly, evidence suggests that synaesthetes exhibit enhanced sensory perception more
generally (Banissy et al., 2009b), which may arise as a result of general changes found
in the synaesthetic brain.
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1.1.2 Development and causes
This thesis looks at comorbidities in synaesthesia and therefore raises questions about
its aetiology. In this section, I therefore ask what causes synaesthesia and how does
synaesthesia develop? Recent research has shown synaesthesia to have a genetic basis
in addition to its distinct neurological profile. Synaesthesia is an inherited condition,
as first noted late in the 19th century (Galton, 1883a). Transmission from genera-
tion to generation is common, with approximately 40% of synaesthetes reporting a
first-degree relative who also experiences synaesthesia (Barnett et al., 2008), although
different forms of synaesthesia can occur in the same family (Ward et al., 2005). The
genetic basis of synaesthesia is attracting increasing interest from researchers in the
field. Currently however, research into the genetics of synaesthesia remains in its in-
fancy, with only a handful of studies conducted to date (Asher et al., 2009; Tomson
et al., 2011; Gregersen et al., 2013). These studies will be reviewed in greater detail
in Chapter 4, and in Chapter 7, where I present my own genetic analysis of grapheme-
colour synaesthesia. Until then, I point out that conclusions in the study of synaesthesia
genetics thus far are limited - these studies have identified areas of the genome poten-
tially linked to synaesthesia, but these areas contain several hundred possible candidate
genes. To date, no genes linked to the development of synaesthesia have yet been iden-
tified.
Beyond what we actually know about genetics, the actual causes of synaesthe-
sia remain undiscovered. There is evidence to suggest synaesthesia develops in early
childhood. The neonatal hypothesis of synaesthesia proposes that synaesthesia is an
experience common to all infants, gradually lost throughout development in the ma-
jority of people (Maurer, 1993; Spector and Maurer, 2009). According to this theory,
synaesthesia is retained in synaesthetic adults due to a failure to undergo the normal
pruning process. At birth, the human brain contains in the region of 100 billion neu-
rons and many more synaptic connections than are ultimately found in the mature adult
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cortex (Toga et al., 2006). During early development and into adolescence, many of
these synapses are removed (i.e., “pruned”) to leave a much less interconnected, but
functionally more streamlined, mature brain. It is this process of synaptic removal that
is proposed by the neonatal hypothesis to malfunction in synaesthetes, thus creating
brains with excess connectivity. The development of synaesthesia has not yet been
systematically traced through early life into adulthood. However, recent research into
synaesthesia in children aged 6-11 does show that the associations between inducer
and concurrent emerge slowly during childhood and strengthen over time (Simner and
Bain, 2013; Simner et al., 2009a).
The majority of synaesthesia cases are thought to be developmental in nature, aris-
ing in early childhood as discussed above. However, there are other ways in which
synaesthesia can occur. Temporary experiences of synaesthesia can result from tak-
ing hallucinogenic drugs such as LSD or mescaline (see Luke and Terhune, 2013 for
a review). Cases of synaesthesia have also been reported as a result of neuropatho-
logical insult, such as stroke (Fornazzari et al., 2012; Ro et al., 2007). It is not known
whether these acquired forms of synaesthesia are qualitatively comparable experiences
to developmental synaesthesia or arise via the same neurological mechanisms (Sinke
et al., 2012, but see Brogaard, 2013). There has been a suggestion that serotonin may
be a common link between developmental synaesthesia and synaesthesia experienced
during LSD consumption, because LSD activates a serotonin receptor (Brang and Ra-
machandran, 2008). In this thesis, I will only focus on developmental synaesthesia.
Two categories of model propose explanations for the creation of synaesthetic ex-
periences (see below), and additional recent models are a hybrid of both (Brang et al.,
2010). The cross-activation model (Ramachandran and Hubbard, 2001) suggests that
activation in one cortical area (e.g., visual cortex) can trigger activation in another (e.g.,
auditory cortex), and this is made possible by excess connectivity between functional
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areas of the cortex. The neurological evidence discussed above provides a degree of
support to this model, demonstrating that altered connectivity is indeed a feature of the
synaesthetic brain (e.g., Rouw and Scholte, 2007). Re-entrant and disinhibited feed-
back models propose that synaesthetic sensations are caused by disinhibited feedback
from higher cortical areas (e.g., in parietal lobe) failing to suppress non-relevant acti-
vation from lower cortical areas (Grossenbacher and Lovelace, 2001). In other words,
simultaneous activation arising from multiple lower sensory areas results in a synaes-
thetic experience. It has been suggested that this type of disinhibited feedback may re-
sult from excessive activity of excitatory neurons within the delicate balance between
both excitatory and inhibitory neurons in the brain (see Hubbard et al., 2011; Terhune
et al., 2011). Despite appearing superficially different, connectivity and feedback mod-
els need not be mutually exclusive. It is unlikely that altered feedback happens entirely
in the absence of changes in cortical connectivity, given the Hebbian principle that si-
multaneous activity strengthens interconnectivity between neurons. Therefore, these
two approaches might be considered somewhat unified in that connectivity models pro-
pose aberrant connectivity as the primary causal mechanism underlying synaesthesia
whereas feedback models might allow altered connectivity as an indirect consequence
of disinhibited feedback. While these models are now more than a decade old, expla-
nations of how these cortical characteristics might arise have proven elusive thus far
(but see Brang and Ramachandran, 2008; Mitchell, 2013).
1.2 Prevalence and objective testing of synaesthesia
In this section, I will provide a brief introduction to one area of particular interest in
synaesthesia research that will be relevant to this thesis. The main topic of this the-
sis is comorbidities in synaesthesia. In order to address this question, several types
of study were conducted; namely epidemiological research comparing the prevalence
of synaesthesia in people who have certain other conditions with its prevalence in the
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general population, as well as investigating the genetic make-up of verified grapheme-
colour synaesthetes. Central to this approach is the requirement to objectively test for
synaesthesia. Therefore the theory and practice behind this testing will itself become
a matter of focus. For this reason, I will begin by discussing how testing for synaes-
thesia is currently conducted and I will introduce some of the problems surrounding
the testing of synaesthesia. In addition, I will also describe what is known about the
prevalence of synaesthesia in the general (i.e. non-morbid) population.
1.2.1 Prevalence and sex bias
One of the first questions often asked about synaesthesia is “How common is it?”. A
number of studies investigating this question have been conducted, with prevalence
estimates that initially varied significantly. Early studies, relying exclusively on re-
cruitment via self-declaration, estimated prevalence to be in the region of 0.05-1% of
the population (Baron-Cohen et al., 1996; Barnett et al., 2008; Rich et al., 2005). By
self-declaration, we mean that the experimenter places an advert asking synaesthetes
to come forward, and a group of synaesthetes then self-declare in response. When par-
ticipants self-declare to take part in studies, this immediately differentiates them from
other members of the general public with respect to motivation to take part and their
interest in the topic. As a consequence, this can have a significant influence on the out-
come of scientific investigations (see below for further discussion). This problem was
first identified by Simner et al. (2006b), who instead ran their prevalence study using
random sampling techniques which relied less on the synaesthete’s self-motivation to
participate. They found the prevalence to be at least 4.4% of the population2 (Sim-
ner et al., 2006b). This study also provided reliable estimates of the most common
forms of synaesthesia, with the most prevalent sub-type of synaesthesia being day-
colour synaesthesia, experienced by an estimated 2.8% of the population, followed by
2This study tested 128 possible variants, but excluded sequence-space synaesthesia and mirror-touch
synaesthesia, now known to be common sub types (Sagiv et al., 2006; Banissy et al., 2009a)
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grapheme-colour, with a estimated prevalence of 2% (Simner et al., 2006b).
Investigations into the difference in prevalence of synaesthesia between the sexes
have also provided a somewhat varied picture. Initial studies reported very high num-
bers of female synaesthetes, (e.g. Cytowic, 1993), with ratios as high as 95% female in
some cases (Baron-Cohen et al., 1993). Subsequent early studies reported significantly
less skewed sex distributions, albeit with ratios that still indicate a majority of synaes-
thetes were female. These earlier estimates placed the sex ratio somewhere between
2:1 (Ward and Simner, 2005) and 6:1 (Baron-Cohen et al., 1996; Rich et al., 2005).
This bias towards females led to early speculation that transmission of synaesthesia
may be linked to the X-chromosome in some way (Baron-Cohen et al., 1996; Bailey
and Johnson, 1997; Ward and Simner, 2005), but recent evidence has shown this is
unlikely to be the case.
Studies showing strong female biases had again relied on self-referral, and Simner
et al. (2006b) pointed out that these differences likely arose or were exaggerated by
differences in self-disclosure Simner et al. (2006b). By using random sampling (rather
than self-declaration), Simner et al. (2006b) found an equal prevalence of synaesthesia
between men and women (1.1 females to every 1 male, a non-significant difference).
Furthermore, studies investigating the genetics of synaesthesia found no evidence of
linkage to the X-chromosome (Asher et al., 2009; Tomson et al., 2011). This evidence
will be reviewed in greater detail in Chapter 4.
Much of the discrepancy in prevalence estimates and the ratio of synaesthesia
prevalence between the sexes appears to have been introduced by the recruitment
methodology and definitional criteria used in the studies concerned. Both these issues
will be discussed in greater depth below.
Chapter 1. Introduction 11
1.2.2 Problems with synaesthesia testing
There are significant problems associated with the identification of synaesthesia in
people who claim to experience it. Below, I introduce some of the issues surrounding
the testing of synaesthesia that are pertinent to this thesis.
1.2.2.1 Recruitment bias
A diverse swathe of research, ranging from studies on alcohol abuse (Strohmetz et al.,
1990) to participation in physical exercise (Chinn et al., 2006), supports the hypothesis
that subjects volunteering to participate in scientific studies differ from the general
population from which they are drawn. In general, participants are more likely to
be female, well educated, intelligent and open to new experiences (a key personality
trait in the “Big Five” theory of personality), in comparison to the general population
(Rosenthal and Rosnow, 1975).
There is no reason to think the same bias would not affect synaesthesia research. In
other words, how participants are recruited is likely to significantly influence the results
of studies seeking to investigate the prevalence of synaesthesia. The less participants
have the opportunity to self-select, the more accurate the prevalence estimate is likely
to be. If the study relies on participants to volunteer, a range of other variables, such
as individual motivation and how aware of their synaesthesia the participant is, assume
greater significance.
Research into the prevalence of synaesthesia has undoubtedly been affected by
these issues. In order to reach a large number of participants, early prevalence studies
used print media as a recruitment tool, advertising for synaesthetes to volunteer to take
part, and thus calculated prevalence based upon circulation figures of the publication
in question (Baron-Cohen et al., 1996; Rich et al., 2005). For example, (Baron-Cohen
et al., 1996) found 22 synaesthetes by advertising in a newspaper with a circulation of
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44,000 readers, thus resulting in a prevalence estimate of 1 in 2000 (22/44,000). How-
ever, this method introduces a recruitment bias to the study, with only synaesthetes
who are sufficiently self-motivated to volunteer being recorded in the results. As such,
the results of these studies are undoubtedly underestimates. In contrast, the most reli-
able estimate of synaesthesia prevalence to date, Simner et al. (2006b), minimised this
self-referral bias by first selecting a large testing cohort and then individually assess-
ing every member of this group. With this improved method, Simner et al. (2006b)
found that only approximately 1 in 80 synaesthetes in the general population will self-
refer for synaesthesia studies and that these self-referrers (but not the population of
synaesthetes at large) will be skewed towards females.
Simner et al. (2006b) also compared prevalence estimates from two separate pop-
ulations; one consisting of university students and one recruited from visitors to a sci-
ence museum. This verified that the prevalence of one form of synaesthesia (grapheme-
colour) was equivalent across two samples and two testing methods (see below for a
discussion of how they diagnosed grapheme-colour synaesthesia in that study).
In summary, volunteer bias is likely to have significant consequences for the preva-
lence of synaesthesia and the ratio of synaesthesia prevalence between the sexes. In
this thesis, I will therefore test the prevalence of grapheme-colour synaesthesia, us-
ing a large sample of the population, recruited by random sampling. Volunteer bias
will therefore be minimised by establishing a testing cohort and inviting prospective
subjects to take part, without revealing purpose of the study beforehand (see Chapter
6).
1.2.2.2 Definitional criteria
Another reason different studies looking at synaesthesia prevalence arrived at differ-
ent findings is likely to be due to how synaesthesia was defined by the study. Testing
for all subtypes of synaesthesia is a logical solution to this scenario, but any study
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aiming to test for all types of synaesthesia will undoubtedly be constrained to some
extent by the “ease of testing” bias introduced below. Below, we shall see that some
forms of synaesthesia are very difficult to objectively test and are often omitted. Fur-
thermore, definitional criteria shift over time. For example, “sequence-personality”
synaesthesia (where graphemes trigger the notion of complex personality types; e.g.,
A = busy mother; Simner and Holenstein, 2007), is now widely recognised as a variant
of synaesthesia. However, this subtype was not included in the Simner et al. (2006b)
study, because it was not widely recognised at the time. Hence, studies testing all
synaesthesia subtypes can only reflect the current definition of synaesthesia at that
time, thus introducing another potential source of variability to estimates of prevalence
calculated at different times. Avoiding problems related to how synaesthesia is defined
is a key reason that this thesis focusses on the variant of grapheme-colour synaesthe-
sia, since this has been a clearly defined subtype for more than 100 years (see Jewanski
et al., 2009).
1.2.2.3 Ease of testing bias
In this thesis, I will focus in particular on one type of synaesthesia - grapheme-colour
synaesthesia - and I will briefly describe the reasons for this. As mentioned above,
there are a large number of synaesthesia subtypes (e.g., Day, 2010). With regard to
testing, not all subtypes have attracted equal interest. This in turn leads to certain
types of synaesthesia being better understood and therefore more frequently investi-
gated than others. The reasons are varied but are often pragmatic. Sometimes rarity
is a factor - it is often not possible to recruit sufficient synaesthetes of a specific type
to conduct empirical studies. This is particularly relevant to prevalence studies, which
are more susceptible to the recruitment biases discussed above and later in this thesis
(see Chapter 6 and Chapter 10).
Another significant reason for focussing on subtypes such as grapheme-colour
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synaesthesia are ethical considerations. University researchers are duty-bound to ad-
here to ethical codes of conduct ensuring no harm or discomfort can arise from their
experimental procedure. For this reason, synaesthesias which cause pain are seldom
investigated. A further, potentially more minor, factor concerns what information the
participant feels comfortable to disclose. For example, orgasm is a known synaesthetic
inducer but has not yet been empirically investigated and is possibly under-reported,
given its personal nature. All these reasons contribute to the heuristic that the eas-
ier a synaesthesia subtype is to test, the more it has been tested. This has significant
implications when the prevalence of synaesthesia is being discussed.
Why is this important? Because of the difficulty in objectively assessing some
forms of synaesthesia, it is problematic to calculate the prevalence of those subtypes.
Because of this, it is difficult to estimate the overall prevalence of synaesthesia as
a single phenomenon. Extrapolating the prevalence of synaesthesia as a whole by
looking at a subset of types may not present a truly accurate picture. This is especially
relevant given that it is currently unknown whether synaesthesia is best considered
a single phenomenon or an umbrella term for a collection of behaviourally similar
conditions that arise through different neurological or genetic mechanisms. I noted
above that in this thesis, I focus on the specific subtype grapheme-colour synaesthesia.
This subtype lends itself readily to testing, is behaviourally well understood and as a
consequence, is one of the most tested and best understood forms. Thus, the prevalence
measures obtained here can be readily compared to other studies in the literature.
In summary, testing for synaesthesia has certain inherent problems. Regardless of
these problems, a good objective test for synaesthesia is essential. How synaesthesia
is tested for is a central focus of this thesis and will be discussed in detail below.
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1.2.3 Methodologies in testing for synaesthesia
Investigating the central question in this thesis - synaesthesia and comorbidity - re-
quires reliable ways of distinguishing between synaesthetes and non-synaesthetes. As
a consequence, how synaesthesia is tested for and identified becomes important to con-
sider. The experience of a synaesthete is an inherently subjective one, personal to the
individual experiencing it - the same inducers do not result in the same concurrent
across all synaesthetes (Simner et al., 2005). For example, two different grapheme-
colour synaesthetes may experience different colours when presented with the same
letter. A significant challenge in demonstrating the genuineness of synaesthesia has
been the development of meaningful and practical means of objectively evaluating this
subjective experience. Such tests are of fundamental importance to synaesthesia re-
search. Without them, we lack the tools to establish how common synaesthesia is,
whether females are more affected by synaesthesia than males, and whether synaes-
thesia may be linked to other conditions.
Consistently describing the same concurrent as a result of perceiving the same in-
ducer is considered to be the behavioural hallmark of synaesthesia (Baron-Cohen et al.,
1987). For example, if a grapheme-colour synaesthete experiences the perception of
the colour red when viewing the letter ’a’, it is generally known that this association
will remain consistent over years, even decades (e.g., Simner and Logie, 2008). It is
this consistency that provided quantitative evidence to support the notion that synaes-
thesia is indeed a bona fide phenomenon, rather than the product of an exceptional
memory or perhaps an over-active imagination. As a consequence, the majority of
synaesthesia research aiming to verify the genuineness of synaesthesia relies on meth-
ods that show significant differences between the consistency of synaesthetes and non-
synaesthetic controls (for example see Baron-Cohen et al., 1996; Rich et al., 2005;
Simner et al., 2006b; Banissy et al., 2012b; Ward et al., 2010). Since this test of con-
sistency as a diagnostic for synaesthesia will be at the heart of my studies in this thesis,
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I briefly review its history below.
The first objective test of genuineness was designed and conducted by Baron-
Cohen et al. (1987), who assessed the consistency of a single synaesthete’s responses
for a variety of synaesthetic inducers across a 10 week interval. The participant expe-
rienced what the authors termed “chromatic-lexical” synaesthesia, which is the term
they used to describe experiencing colours induced by hearing words, names of people
and individual letters (now probably termed grapheme-colour synaesthesia). The se-
lected stimuli were 50 words, 7 days of the week, 20 Christian names and the 26 letters
of the alphabet, providing a total of 103 stimuli. The accuracy of recall of the synaes-
thete after a 10 week interval was 100%, and this was compared to a non-synaesthetic
control subject. This subject was asked to invent analogous associations and to then
recall them by memory alone. The control subject achieved only 17% accuracy, with
a much shorter test interval of 2 weeks. Furthermore, the retest of the synaesthete
was carried out without warning, whereas the control was informed upfront about the
subsequent retest.
From this starting point, an overwhelming majority of studies now verify the gen-
uineness of their participants’ synaesthesia by assessing consistency of synaesthetic re-
sponse over time (e.g., Baron-Cohen et al., 1993; Baron-Cohen et al., 1996; Mattingley
et al., 2001; Simner et al., 2006b) There has been, however, considerable differences
in how consistency testing has been implemented. This has introduced significant vari-
ation between studies, making direct comparisons problematic. The problems associ-
ated with testing for synaesthesia using consistency are discussed in greater detail in
the section below, because they will inform my methodology for verifying synaesthesia
in this thesis.
The majority of studies - earlier studies in particular - employed long term retest-
ing. This process involves recording a subject’s synaesthetic associations at two time
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points, and then comparing the consistency of response recorded on both those oc-
casions. Time intervals of between tests can vary significantly, which is another po-
tential source of difference between results. For example, Baron-Cohen et al. (1996)
used a time interval of at least one hour, whereas Simner et al. (2006b) used a mean
time interval of 6 months when testing synaesthetes (but only two weeks for con-
trol subjects, thus making the test more challenging for synaesthetes). In an effort to
introduce a standardised method for assessing the genuineness of synaesthesia, Eagle-
man et al. (2007) produced an online battery of tests - called The Synesthesia Battery
(www.synesthete.org) - that provided a way of testing consistency in a single test-
ing session (I refer to this as “short-term retesting” in this thesis). This consistency
test presents the relevant inducers (e.g. letters of the alphabet) three times each in a
randomised order and requires the subject to pick the matching concurrent from an
extensive online colour palette. The variation in colour chosen for each inducer is
then quantified and averaged, providing a consistency score for each test any given
subject completes. In Eagleman’s test, colour is measured in RGB colour space (a
colour model in which separate values for red, green and blue are combined to pro-
duce a wide range of colours, each with its own RGB vector value). The consistency
score produced by the Synesthesia Battery is a measure of distance in RGB space be-
tween colours chosen by participants. Lower scores indicate smaller distance between
colours in RGB space (i.e., more similar colours) and are therefore considered more
consistent and thus more synaesthetic. In this way, the final score can be considered a
“distance” score, with a low score meaning a small distance (in colour space) between
the three selections of colour for each grapheme (where small distance means highly
consistent responding). There are tests for a range of synaesthetic inducers including
graphemes, days of the week, months and musical notes and chords but the test is lim-
ited to subtypes of synaesthesia that have colour as the concurrent. One recent study
has built upon Eagleman’s work and speculated that the threshold in the Synesthesia
Battery perhaps should be raised. Rothen et al. (2013) have recently argued that a
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more appropriate cut-off may indeed be higher, and their argument relates to consider-
ations of colour space. Eagleman et al. (2007) evaluates consistency using distance in
RGB space but Rothen et al. (2013) suggest that alternative colour models (CIELUV
and CIELAB) might provide more sensitive measures. On this basis they proposed
a revised threshold within the existing Synesthesia Battery at < 1.43 for synaesthetes
(rather than < 1).
There are significant advantages to this short-term consistency approach. Firstly,
a quantitative consistency score is calculated, providing an objective, easily compa-
rable measure of consistency. Testing can be completed in a single session, resulting
in increased practicality and reducing the risk of participant drop out. The fact the
test is hosted entirely online allows participants to be tested remotely, greatly increas-
ing the scope for recruiting larger samples of subjects and potentially increasing the
opportunities for collaboration between researchers. In this thesis, I will use this con-
sistency methodology when assessing synaesthesia (both for epidemiological studies
and for phenotyping participants in a genetics study) and will tend to use the short
term approach unless particular constraints require a long-term approach (see Chapter
8). Furthermore, since the short-term consistency approach has never been evaluated
in comparison to the more traditional long-term consistency approach, I also dedicate
one of my empirical chapters to this aim. For a more in-depth explanation of this test
and my evaluation of it, please see Chapter 6.
1.2.4 Thesis overview
To conclude this chapter, I will summarise the contents of this thesis. The aim of
this thesis is to explore whether synaesthesia has any comorbidities. That is to say,
whether it co-occurs with any other conditions at greater levels than would be found
in the general population. I begin Chapter 2 by reviewing and summarising - for the
first time - all the existing literature on conditions that may (or may not) co-occur with
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synaesthesia.
In Chapter 3, I focus on one particular condition - multiple sclerosis - and present
data demonstrating that multiple sclerosis and its clinical precursor, radiologically iso-
lated syndrome appear to be more prevalent in synaesthetes self-referring to participate
in scientific studies than in the general population.
In Chapter 4, I consider the same question from a genetics viewpoint. I first pro-
vide a general introduction to genetics, a detailed review of the synaesthesia genetics
literature, and the genetics of multiple sclerosis, and I explore why the two conditions
may share common genetic origins.
In Chapter 5 I present my immune hypothesis of synaesthesia, as a theoretical
model to predict which conditions may co-occur in synaesthesia. This model explores
a theoretical framework explaining how the origins of synaesthesia may lie with genes
that play an important role in the development of the cortex in the first years of life,
and which have an immune function in the adult brain.
In Chapters 6 and 7 I present my own investigation into the genetics of synaes-
thesia which has the single aim of better understanding comorbidity by examining the
roots of synaesthesia, and several related threads. These involve first establishing (in
Chapter 6), a valid way to phenotype synaesthesia by evaluating an existing online
testing platform (The Synesthesia Battery; Eagleman et al., 2007). This validation in-
volves using the platform to generate the most accurate and large scale assessment of
the prevalence of grapheme-colour synaesthesia to date, and then comparing this to
a previous most widely accepted prevalence figure established from a well-validated
study using a different method (Simner et al., 2006b). This approach will also provide
the most accurate estimate of sex ratios within synaesthesia, which will itself be used
in my discussions of comorbidity (i.e., is synaesthesia more common in women? Is
a sex bias found in any other potential comorbidities?). In Chapter 7, I will use this
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(now validated) method of testing for synaesthesia to phenotype participants in my
own investigation into the genetics of synaesthesia.
In Chapter 8, I present data exploring the prevalence of grapheme-colour synaes-
thesia in a sample of patients with multiple sclerosis and in Chapter 9, I address a
different area of comorbidity by presenting empirical work showing that anxiety dis-
order is more prevalent in randomly sampled synaesthetes when compared to non-
synaesthetes. In Chapter 10, I discuss the conclusions reached by this thesis, and
explore future directions of research in this area.
Chapter 2
A review of synaesthesia and
comorbidity
2.1 Introduction
Synaesthesia is generally considered to be a benign alternative form of perception,
more often thought to confer cognitive benefits to the synaesthete, rather than negative
outcomes. A broad range of advantages have been suggested, including benefits in
memory (Rothen et al., 2012), empathy (Banissy and Ward, 2007), visual search and
creativity (Ramachandran and Hubbard, 2001). The traditional portrayal of synaes-
thesia in the scientific literature reflects this view. At time of writing, a simple litera-
ture search of “synaesthesia advantages” yields 7020 results in Google Scholar, while
“synaesthesia disadvantages” returns a mere 1530 hits.
However, there is a small, yet growing, body of literature that suggests synaesthesia
may be associated with more clinical conditions. Much of this evidence comes from
case studies of individual synaesthetes (e.g. Hänggi et al., 2008; Blakemore et al.,
2005) which makes it difficult to draw conclusions about both how synaesthesia and
other conditions might be linked, and if indeed any co-occurrence would be an indica-
tion of anything meaningful, such as a common neural or genetic mechanism. Recent
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research has become more broad, by moving from case studies of individuals to ex-
amining comorbidity in larger samples of synaesthetes and other patient groups. This
has been tackled thus far in one of two ways; either by examining the prevalence of
synaesthesia in a group of patients with a particular condition, or by examining the
prevalence of a particular condition in a group of synaesthetes.
The primary aim of this thesis is to investigate synaesthesia and its comorbidity
with other conditions. Prior to presenting any empirical work , this chapter summarises
all existing literature which suggests links between synaesthesia and any other clinical
conditions. I then explore whether directly comparing healthy and clinical populations
is a valid methodological approach. Below, I consider the following seven possible
comorbidities; anxiety disorder, autism (and autism spectrum disorders), epilepsy, ir-
ritable bowel syndrome (IBS), migraine, multiple sclerosis and schizophrenia. These
conditions are discussed in alphabetical order, rather than order of importance.
2.2 Synaesthesia and comorbidity
2.2.1 Synaesthesia and anxiety disorder
Anxiety disorder is a prevalent condition characterised by the experience of long term
generalised worry and anxiety (Evans et al., 2008). Commonly regarded as belonging
to a spectrum of mood related disorders, symptoms include feelings of threat, irri-
tability and tension, lifetime prevalence is estimated to be between 4.3-5.9% of the
population (Tyrer and Baldwin, 2006).
While conducting a questionnaire based study into the personality profile of synaes-
thetes, Banissy et al. (2012a) found higher rates of positive schizotypy, a personality
trait closely linked to problems with decision making and social anxiety. In their study,
30 participants were randomly selected from an existing database of synaesthetic sub-
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jects. These synaesthetes experienced colour as their concurrent sensation and had the
genuineness of their synaesthesia objectively assessed by completing the Synesthesia
Battery at www.synesthete.org (Eagleman et al., 2007). Participants were subsequently
given the Oxford-Liverpool Inventory of Feelings and Experiences, which can reliably
measure schizophrenia-like symptoms in the general population (Mason and Claridge,
2006). Given that anxiety is a key aspect of postive schizotypy (Debbané et al., 2009;
Lewandowski et al., 2006), their findings imply that synaesthetes may be more likely
to experience anxiety than non-synaesthetes. The authors conclude that the presence
of synaesthesia may be an indication of a broader phenotype, with synaesthetes ex-
hibiting atypical personality and cognitive profiles. The discovery of higher rates of
positive schizotypy in synaesthetes (Banissy et al., 2012a) and the link between pos-
itive schizotypy and anxiety, would imply that rates of anxiety disorder may also be
higher in synaesthetes. I investigate this empirically in Chapter 9.
Although participants were selected at random in the study by Banissy et al. (2012a),
subjects’ initial contact with the research team was via self-referral. It is therefore pos-
sible that synaesthetes who had the motivation to contact researchers and participate in
research studies may exhibit different personality traits from those who do not. How-
ever, if the control subjects were recruited by the same means, this bias could reason-
ably be expected to be controlled for. Despite this potential confound, their study is a
valuable first step in showing that synaesthetes may exhibit anxiety linked personality
differences that differ significantly from non-synaesthetes. Interestingly, Banissy et al.
(2012a) suggest that the presence of synaesthesia may be a marker for differences in
cognition that are not solely limited to the experience of synaesthesia. The authors
point out that both synaesthesia and positive schizotypy have both been linked to cre-
ativity and mental imagery vividness and point out that a disturbed balance of cortical
excitation and inhibition has been put forward as a potential mechanism underlying
both synaesthesia (Grossenbacher and Lovelace, 2001) and schizotypy (Grossberg,
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2000). In this thesis, I will measure the prevalence of anxiety disorder in a large,
random sample of the population and compare the prevalence of anxiety disorder in
synaesthetes and non-synaesthetes. Because self-referral bias will be minimised in my
own study, I will be able to ascertain whether anxiety disorder is more prevalent in
synaesthetes, without the possible confound of self-referral bias.
2.2.2 Synaesthesia and autism spectrum disorders
Autism spectrum disorders (ASDs) are a group of neurodevelopmental conditions
characterised by a high degree of aetiological and clinical heterogeneity, the behavioural
hallmarks of which are impaired social function, communication difficulties and pat-
terns of repetitive behaviours (e.g., Lauritsen, 2013).
Tentative suggestions that synaesthesia and autism may be linked have featured
sporadically in the academic literature for several decades (e.g., Wohlfarth, 1985; Cy-
towic, 1995). Initial investigations involving autism and synaesthesia focussed on case-
studies of individuals affected with both conditions (Baron-Cohen et al., 2007). For ex-
ample, several such studies have involved DT, a remarkable individual with synaesthe-
sia, Aspergers and savant abilities, who shows extreme numerical memory and ability
for mathematical calculation. Baron-Cohen et al. (2007) proposed that when synaes-
thesia and autism co-occur, the likelihood of savantism also being diagnosed increases
(also see Simner et al., 2009b; Bor et al., 2008).
Case studies such as DT had led to some speculation that synaesthesia and autism
may be related (Baron-Cohen et al., 2007). However, looking to case-studies for con-
vincing evidence of links between synaesthesia and other conditions is problematic.
There is a risk of falling prey to the illusory correlation, whereby a relationship is
perceived to exist between two rare variables which have coincidentally co-occurred,
when in fact no relationship exists at all (Chapman and Chapman, 1969).
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In 2013, the first empirical group studies investigating the prevalence of synaes-
thesia in ASD populations were conducted. In a study looking at the prevalence of
synaesthesia in autism, Baron-Cohen et al. (2013) report that the prevalence of self-
declared synaesthesia in a sample of 164 subjects with autism (a large majority hav-
ing Asperger syndrome; N=153) was significantly higher than in a group of matched
controls. This study relied predominantly on self-declaration (i.e., subjects coming
forward to declare they have synaesthesia) and the authors report having difficulty in
achieving compliance in tests of genuineness, indicating a lack of objective consistency
testing. Objectively verifying the genuineness of cases of self-declared synaesthesia is
an important step in the methodology of identifying synaesthetes. Given that the preva-
lence of synaesthesia can drop significantly once validation takes place (i.e., Simner
et al. (2006b) report finding 1 genuine synaesthete for every 6 subjects self-declaring
as experiencing synaesthesia), estimating prevalence based on self-declaration alone is
likely to be inaccurate.
In another study, Neufeld et al. (2013) assessed the prevalence of grapheme-colour
synaesthesia in a sample of Asperger syndrome patients. Although the sample of pa-
tients examined was small (N=21), the assessment of synaesthesia was rigorous, with
both objective tests of consistency and subject interviews conducted. To assess gen-
uineness of synaesthesia, the authors used their own version of The Synesthete Battery
(Eagleman et al., 2007). A questionnaire was then given to assess the participant’s sub-
jective experience of the consistency and vividness of their experience during the test
for genuineness. They found a significantly higher prevalence of grapheme-colour
synaesthesia in the sample of Asperger syndrome patients (5/21 tested subjects or
23.8%), in comparison to the rate in the general population of 2% reported by Sim-
ner et al. (2006b).
There is also evidence that does not lend support to the hypothesis of an associ-
ation between synaesthesia and autism. While a common behavioural characteristic
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of autism is a reduction in empathy (Baron-Cohen and Wheelwright, 2004), there is
no evidence to suggest empathy is reduced in synaesthetes. Banissy et al. (2013) con-
ducted an investigation into personality traits of grapheme-colour synaesthetes and
report that while synaesthetes may have atypical personality characteristics in some
domains (e.g., openness to experience), empathy scores appear consistent with those
found in demographically matched controls. Indeed, certain measures of empathy (the
emotional reactivity aspect of the empathy quotient questionnaire) has been shown to
be significantly higher in mirror-touch synaesthetes (who experience tactile sensation
on their body in response to seeing another person being touched), relative to control
subjects (Banissy and Ward, 2007).
Despite this discrepant finding regarding empathy, the study by Neufeld et al.
(2013) does appear to show evidence that synaesthesia and autism spectrum disorders
may be linked. If there is an association between synaesthesia and autism, it is possible
that the link may be mediated by, or connected to, other traits. Absolute pitch (AP) -
the ability to recognize the pitch of a musical note without a reference point (Deutsch,
2012) - may be one such potential trait, having been suggested as a potentially unusual
connection between autism and synaesthesia. Gregersen et al. (2013) report a genetic
overlap between absolute pitch and synaesthesia, and previous reports show absolute
pitch to be found more frequently in a sample of autism patients (DePape et al., 2012).
There is also evidence that patterns of connectivity are altered in AP, with hypercon-
nectivity in the superior temporal lobe reported by Loui et al. (2011). If an association
between AP, synaesthesia and autism can be convincingly demonstrated, it is possible
that isolating the genetic origins of a distinct cognitive trait such as absolute pitch may
help to identify the genetic origins of other conditions that are more phenotypically
heterogeneous.
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2.2.3 Synaesthesia and epilepsy
Epilepsy is a common neurological condition characterised by seizures which has an
estimated prevalence of 3.3-7.8 per 1000 people in Europe (Forsgren et al., 2005).
Head trauma, other brain conditions or pre-natal injury are known risk factors for
epilepsy but more than 50% of epilepsy cases have no known cause (Forsgren et al.,
2005). Evidence linking synaesthesia and epilepsy is currently sporadic and largely
anecdotal. Synaesthesia has been reported to be more common in patients with tem-
poral lobe epilepsy (Ramachandran and Hubbard, 2001) but this evidence is limited to
a small number of case studies in which the individuals concerned often exhibited a
complex range of other comorbid conditions, or have previously experienced signifi-
cant brain trauma. There is also the risk of illusory correlation in this situation where
single case studies are investigated - making the assumption that because two relatively
rare traits or diseases are present, they must be somehow related.
The majority of the comorbidity literature refers to synaesthetes who experience
developmental synaesthesia, meaning that synaesthesia is generally present in the indi-
vidual prior to the appearance of the comorbid condition. With respect to synaesthesia
and epilepsy, one of the few reported cases of individuals with both conditions refers to
the development of acquired synaesthesia after significant brain insult. Halligan et al.
(1996) report a case study of a patient who developed a phenomenon resembling touch
synaesthesia after having two major epileptic episodes subsequent to a stroke. The
subject was able to reliably detect the feeling of touch on his left arm and hand, but
only when able to see it. When vision was restricted, no feeling of touch was reported.
The authors themselves question whether the patient’s experience can be considered
synaesthesia in its truest sense. However, the intrinsic nature of the experience is cross-
modal, which warranted its inclusion here. It is important to draw attention to the fact
that in this case, the synaesthesia is acquired, rather than developmental. It remains an
open question how similar these phenomena are. Behaviourally, they appear closely
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related but their origins are obviously very different (see Sinke et al., 2012; Brogaard,
2013).
Jacome (1999) reports a case study of a patient who was diagnosed with both
epilepsy and multiple sclerosis, and experienced a range of unusual visual halluci-
nations. For example, the subject could voluntarily induce visual hallucinations of
people who spoke to her or objects that made noises. Although there is an element
of cross-modality to these experiences (sounds triggering visual experiences), and the
author uses the term synaesthesia to describe them, it doesn’t appear that they would
be considered synaesthesia as it is currently understood. This is because synaesthetic
associations are generally considered to occur automatically, rather be induced vol-
untarily, as was the case in this particular person. The subject (participant DT) of a
case study published by Baron-Cohen et al. (2007), which focussed on exploring a
potential link between synaesthesia, autism and savantism (see previous section) also
suffered from epilepsy at age 3. The fact that the subjects in all three of the case stud-
ies discussed in this section suffered from multiple comorbidities or had experienced
serious brain trauma highlights the difficulty in drawing conclusions about whether
synaesthesia may be linked to other conditions, or exactly how that might have arisen.
Further evidence that epilepsy and synaesthesia might perhaps be considered in in-
vestigations of comorbidity comes from a report that epilepsy medication has also been
shown to lessen synaesthetic experience in at least once instance (Cytowic, 1995). In
addition, Asher et al. (2009) conducted the first genome wide study into the genetics
of synaesthesia and put forward several genes linked to epilepsy as candidates wor-
thy of further investigation. These genes - previously known to be linked to epilepsy
(Escayg et al., 2000; Fujiwara et al., 2003) are located in the region of chromosome
2 identified by Asher and colleagues as most significantly linked to synaesthesia in
their investigation. However, the area of chromosome 2 implicated in this study are
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large and contain hundreds of genes, so no valid conclusions can be drawn linking the
genetics of synaesthesia and epilepsy from this investigation.
2.2.4 Synaesthesia and irritable bowel syndrome (IBS)
Irritable bowel syndrome is a functional disorder of the gastrointestinal tract, charac-
terised by symptoms such as abdominal bloating, constipation and diarrhoea (Thomp-
son et al., 1999). There is also evidence to suggest that IBS patients may experience
general hypersensitivity to a range of sensory stimuli (Carruthers et al., 2012).
To date, a single population based study has been conducted, and this reported a
higher prevalence of synaesthesia in IBS patients (Carruthers et al., 2012). The au-
thors limited their investigation to two forms of synaesthesia, grapheme-colour and
music-colour/shape synaesthesia, and found the self-declared prevalence of synaesthe-
sia in a group of 200 IBS patients was 13%, compared to 3% in a group of controls.
Once synaesthesia was verified using a longitudinal test of consistency with a 3 month
test-retest interval (i.e., completing the same test twice, three months apart), signifi-
cant differences between groups still remained. Using a consistency threshold of 50%
correct (reporting the same colour association with the same grapheme on both tests
for at least half the stimuli), the prevalence in the IBS group was reduced to 9.5% in
patients and unchanged from 3% in controls. When a stricter threshold of 75% ac-
curacy was used, prevalence dropped to 7.5% in the IBS group and 2.5% in controls.
In other words, when stricter thresholds of consistency were applied in order to verify
the genuineness of the synaesthesia (from an initial 50% correct to 75% correct), the
prevalence decreased by a greater degree in the patient group, whereas the prevalence
found in the control group remained relatively constant. This is noteworthy, and im-
plies that the IBS group were either more likely to report having synaesthesia when
they didn’t, their synaesthesia was less consistent than the control group or they ex-
perienced some difficulties in completing the test. The broader issue of comparing
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clinical populations with control groups is a significant one, and is discussed in greater
detail in the conclusion to this thesis (see Chapter 10).
2.2.5 Synaesthesia and migraine
Migraine is a neurological disorder characterised by unilateral throbbing headache
(Bashir et al., 2013) experienced by approximately 12% of the adult population in the
USA (Lipton et al., 2007). In common with the conditions discussed above, research
linking migraine and synaesthesia is largely limited to case studies of individuals, lim-
iting any conclusions that can be drawn regarding any generalised link between the two
conditions. Synaesthesia has been reported to occur as a symptom of migraine (Podoll
and Robinson, 2002) in a single individual, reported anecdotally to her general prac-
titioner. A second case study detailed an individual who reported synaesthetic experi-
ences which occurred sporadically during the aura phase of migraine. Approximately
40% of migraine sufferers experience this phase, a principal component of which are
visual disturbances such as the perception of flashes of light, loss of vision or visual
hallucination. In this particular case study, the synaesthetic experience took one of two
forms, either visual disturbances triggered by high pitch sounds, or a lemon taste trig-
gered by bright light (Alstadhaug and Benjaminsen, 2010). This case was complicated
by the presence of an additional co-morbidity in the form of bipolar disorder. The in-
teresting point about this example is the fact that it appears to be temporary acquired
synaesthesia - a relatively rare phenomenon. It is perhaps noteworthy to mention that
both cases reported here are of individuals whose professions involve working closely
with colour, namely art teacher and graphic designer respectively. Synaesthesia has
been shown to be more common in artistic groups, with Rothen and Meier (2010)
reporting a prevalence of grapheme-colour synaesthesia of 7% in art students, signif-
icantly higher than their baseline prevalence of 2% in a sample of matched controls.
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A population based study conducted in order to investigate neuropsychological
symptoms associated with migraine found significantly higher prevalence of self-declared
synaesthesia in migraine sufferers, with 19% prevalence versus 7% in controls (Jürgens
et al., 2014). Patients who experienced migraine with auras were particularly affected
when compared to migraine-without-aura sufferers, with 29% of this former group re-
porting synaesthesia, versus 15% of migraine-without-aura patients. This study was
entirely questionnaire based, the subtype of synaesthesia experienced was not reported
and no validation of the synaesthetic experience appears to have taken place. As noted
above, given that the prevalence of synaesthesia can drop significantly once validation
takes place (i.e., Simner et al. (2006b) report finding 1 genuine synaesthete for every 6
subjects self-declaring as experiencing synaesthesia), the absence of this critical step in
this study makes drawing firm conclusions more difficult. However, the sample taking
part in this study was large and considerable care had been taken to select a matched
control group (219 migraineurs and 161 age and sex matched controls). Furthermore,
the study examined a large number of traits that may be associated with migraine.
There was no a priori information provided to participants about links to synaesthe-
sia which would suggest the study would not be particularly attractive to synaesthetes.
Taken together, this provides good support for the hypothesis that migraine and synaes-
thesia may be linked. However, only a subset of 44% of those initially contacted re-
sponded with a completed questionnaire, introducing a response bias whereby only
participants who were particularly motivated to return questionnaires (i.e., perhaps the
synaesthetes themselves) were included in the study.
2.2.6 Synaesthesia and multiple sclerosis
Multiple sclerosis (MS) is a disease of the central nervous system (CNS), characterised
by demyelination, gliosis of white matter and axonal loss (Weiner, 2009). It is caused
by a complex interaction of environmental factors coupled with genetic susceptibility
(Compston and Coles, 2008). Comorbidity between multiple sclerosis and synaesthe-
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sia will be a particular focus of this thesis. I first review the literature for any prior
evidence of an association between synaesthesia and MS and show that prior to the
study conducted here, little research has been done in this area.
Synaesthesia-like phenomena are not unusual in cases where lesions or demyelina-
tion of the optic nerve are present, and so they are a common occurrence in a majority
of MS cases (Evangelou et al., 2001). Jacobs et al. (1981) reported a group of nine
patients who self-declared experiencing coloured phosphenes induced by sound, dur-
ing clinical interviews with their health care providers. All nine patients had white
mater lesions on the optic nerve, and three of the nine patients had a diagnosis of MS.
The authors propose these phosphenes occurred as a consequence of lesions to the
optic nerve. A previous investigation also reported cases of MS patients who expe-
rienced similar visual disturbances (Davis et al., 1976). Two patients initially volun-
teered the information they experienced phosphenes induced by eye movement. Seven
additional patients were subsequently questioned and were found to experience move-
ment induced phosphenes thought to arise as a result of damage to the optic nerve.
Unfortunately, no information was provided about MS patients who were questioned
and did not experience such phenomena. Taken together, these findings suggest that
the demyelination which is characteristic of the neurology of MS may increase the
likelihood of experiencing synaesthesia, or similar cross-modal sensations.
Sensory disturbances are a common symptom of MS (Compston and Coles, 2008).
For example, disturbances in the perception of vibration (Heijenbrok et al., 1991) and
temperature (Leocani et al., 2003) are often reported, and altered sensations such as
“pins and needles”, numbness and dysaesthesia are not unusual (Miller and Leary,
2007). Particularly common are visual disturbances, present at onset in approximately
25% of MS cases (Confavreux et al., 2003).
Since some studies have described synaesthesia (or at the very least used the term
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“synaesthesia”) to describe some of the sensory disturbances associated with Multiple
Sclerosis, it is important here to clarify two ways that synaesthesia and MS might
be linked. First of all, synaesthesia might be implicated as a consequence of MS:
i.e., that lesions caused by MS have knock-on effects in the sensory domain that can
come to resemble synaesthesia in some way. In this case, the synaesthesia would
be considered acquired. Alternatively, synaesthesia might be implicated as comorbid
with MS in that both would develop in parallel in some way, or at the very least, that
synaesthesia would exist prior to the onset of MS. In this case, the synaesthesia in
question would be the developmental variant. It is important to clarify henceforth that
this thesis is interested only in the latter type of comorbidity: it explores the possibility
that developmental synaesthesia may exist prior to MS.
Given the distinction in the paragraph above it is important to here clarify how we
would tell apart acquired and developmental synaesthesia, so we can consider only
the latter in combination with MS. It has been suggested that developmental and ac-
quired synaesthesia differ in the nature of their triggers: the former is triggered in the
overwhelming majority of cases by linguistic stimuli (Simner, 2007) while the latter
appears to be triggered more by low-level sensory stimuli. Therefore, by consider-
ing whether MS co-occurs with a prototypical linguistic synaesthesia (e.g., grapheme-
colour synaesthesia) we can establish whether it co-exists with a developmental vari-
ant. Put differently, we can attempt to rule out the possibility that the synaesthesia is
nothing more than a symptom of the MS, per se.
2.2.7 Synaesthesia and schizophrenia
Schizophrenia is a complex mental disorder, characterised by cognitive, emotional
and behavioural deficits, and has a lifetime prevalence of 4.0 per 1,000 people (Saha
et al., 2005). Cortical hyperconnectivity is hypothesised to play a significant role
in schizophrenia (Krishnadas et al., 2014; Ford et al., 2014), providing theoretical
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grounds to explore whether there might be an association with synaesthesia. Indeed,
in suggesting a model linking serotonin receptor 2a (S2a) to some types of synaes-
thesia, Brang and Ramachandran (2008) made the prediction that the prevalence of
synaesthesia would be higher in schizophrenia patients. In other words, if serotonin
receptors play a key role in synaesthesia, it is a reasonable prediction that conditions
also affecting serotonin might be more common in synaesthetes. Evidence that anti-
psychosis medications also act as serotonin receptor antagonists (Meltzer and Massey,
2011) provides further rationale to explore this hypothesis in greater depth.
Cross-modal experiences occurring in schizophrenic patients were first described in
the late 1950s (Chapman et al., 1959; Freeman and McGhie, 1957). These experiences
– catatonic episodes induced by auditory and visual stimulation – were interpreted by
the authors as synaesthetic in nature, given the production of a motor response (cata-
tonia) as a direct response to auditory and visual disturbance. Given the frequent clin-
ical presentation of auditory and visual hallucinations in schizophrenia (Bauer et al.,
2011), it is not difficult to imagine reports of synaesthetic experience being interpreted
as symptomatic of psychiatric illness. Indeed, early descriptions - now defunct - sug-
gested synaesthesia as being closely related to a range of psychiatric conditions and
to lie somewhere on a continuum between normal perception and hallucination (see
Ostwald, 1964 for discussion). Whether hallucinations could be considered similar to
synaesthesia at all is a matter of interpretation. On one hand, there is often a cross-
modal aspect to hallucinations that suggests the phenomena may be related. On the
other, hallucinations occur seemingly at random, whereas a synaesthetic experience
relies on a consistent inducer to act as stimulus (Fitzgibbon et al., 2012). Furthermore,
synaesthetes know the difference between their synaesthetic experiences and reality,
further emphasising the belief that synaesthesia should not be considered a psychiatric
condition or a hallucination (Ward, 2013).
More recently, Banissy et al. (2012a) conducted a questionnaire based study - as
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noted above - aimed at investigating the personality profile of synaesthetes. The instru-
ment used in the study - the Oxford-Liverpool Inventory of Feelings and Experiences -
measures sub-clinical schizophrenia-like symptoms in the general population (Mason
and Claridge, 2006). The authors report an increase in levels of positive and disor-
ganised schizotypy in people who experience forms of synaesthesia with colour as the
concurrent sensation, and conclude that having synaesthesia may be indicative of an
atypical personality profile, beyond the presence of synaesthesia itself. I discussed
positive schizotypy with reference to anxiety disorder, but because positive schizotypy
is associated with an elevated risk of developing schizophrenia (Barrantes-Vidal et al.,
2013), the increased prevalence of schizotypy in synaesthetes may suggest an associa-
tion between synaesthesia and schizophrenia.
With the aim of developing an experimental paradigm to test schizophrenic patients
for digit-colour associations, Sarhan et al. (2008) tested a group of 11 schizophrenia
sufferers, the majority of whom reported seeing coloured digits when in fact all pre-
sented digits were white. No repeat testing was conducted, so it is unclear whether
these associations were stable and consistent over time, as would be required for a full
synaesthesia diagnosis. The authors employed convenience sampling (i.e., testing pa-
tients who happened to be attending the clinic), and it is unclear whether participants
were informed whether the study was about synaesthesia prior to taking part. If so, this
may lead to the sort of self referral bias discussed elsewhere in this thesis (see Chapters
1, 6 and 10).
On account of the proposed similarity in altered connectivity found in schizophre-
nia and synaesthesia, Tomson et al. (2011) speculate that synaesthesia may be an ideal
proxy by which to study altered connectivity in pathological conditions. In an inves-
tigation into the genetics of synaesthesia, they report a region on chromosome 16 that
may be linked to synaesthesia and put forward a candidate protein, go-alpha (GNAO1)
in this area that is under-expressed in schizophrenia patients. Linking synaesthesia
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and schizophrenia via this mechanism is highly speculative, because the area of the
genome identified by Tomson et al. (2011) contains many hundreds of genes, and the
sample size is small for a study of this nature.
A recent case study involving a patient with an arachnoid cyst in the temporal lobe,
who experienced both ticker-tape synaesthesia (the automatic visualisation of words in
the style of subtitles or teleprompter; Chun and Hupé (2013)) and psychotic episodes,
leading to the conclusion that lesions in this area of the brain may be linked to the de-
velopment of both conditions in this patient (Bastiampillai et al., 2014). Interestingly,
the patient reported that the intensity of his synaesthesia increased over time, which
the authors speculate may be linked to the increasing growth of the cyst. However, the
patient recalled being aware of synaesthesia aged 6, but the cyst was not diagnosed
until the patient was sixteen years of age. It is likely therefore, that the presence of
synaesthesia in this patient pre-dated the development of the cyst. In any case, the use
of a single case study again raises the possibility of illusory correlation, and the group
study reported above (Sarhan et al., 2008) did not use a robust method of identifying
genuine synaesthesia.
2.2.8 Conclusions
In this chapter, I summarise the current research into synaesthesia and its comorbidities
and highlight some of the issues surrounding this nascent field. The suggestion that as-
sociations may exist between synaesthesia and a variety of other conditions has been a
feature of the synaesthesia literature for a considerable length of time, and there are oft-
repeated statements that synaesthesia is linked to a variety of conditions. To date, the
empirical evidence underlying such beliefs is often limited by a paucity of published
data, and is often speculative and anecdotal. Early studies almost exclusively focus on
case studies of individuals who have synaesthesia and one or more other conditions
(reports linking synaesthesia to autism, epilepsy, migraine and schizophrenia fall into
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this category). Predicting associations between conditions based on a small number
of case studies, makes falling prey to the notion of an illusory correlation a distinct
possibility. If an individual exhibits two traits that are rare in the general population,
it is tempting to assume they must be causally linked in some way whereas in reality,
their joint presence may be entirely coincidental or linked to a third factor.
Recent research has attempted to take a more empirical view and examine the pos-
sible relationships between synaesthesia and a broad range of other conditions on a
group level (group studies have been carried out linking synaesthesia to anxiety (indi-
rectly via positive schizotypy), autism, IBS, migraine, MS and schizophrenia). As the
first attempts at this kind of study show, the methodological difficulties associated with
this approach can be manifold. The prevalence of the conditions discussed above and
synaesthesia in the general population are typically low, making it a difficult and time
consuming process to recruit and test populations large enough to enable meaningful
statistical conclusions to be drawn. The question of how to make meaningful compar-
isons between groups of healthy synaesthetes and synaesthetes with clinical conditions
is also a significant one, which I discuss further in the conclusions to this thesis (see
Chapter 10).
How might this area of synaesthesia research be advanced? A solution to these
problems lies in conducting suitably sized, well designed group studies. In this the-
sis, I conduct one such study, examining the prevalence of synaesthesia in a sample
of multiple sclerosis patients (see Chapter 8). Prevalence studies alone are unlikely
to shed much light onto the underlying causes of synaesthesia. They are however, an
important step in the process, and insight into the origins of synaesthesia may emerge
if comorbidities are found with conditions for which the causes are already better un-
derstood. It is also worth placing the field of synaesthesia and comorbidity research
in a broader context. What are the implications of identifying associations between
synaesthesia and other conditions? Firstly, associations between conditions may help
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to shed light on the causal roots of the conditions under investigation. Secondly, it is
possible that the presence of synaesthesia in an individual may provide information
regarding their risk of developing conditions in later life, assuming that associations
between those conditions and synaesthesia prove to be robust. Because synaesthesia
is considered to be neurodevelopmental in nature and many of the conditions thought
to be associated with synaesthesia first occur at a later age, having synaesthesia may
assist in understanding whether a person has an increased risk of developing a certain
condition when they are older. Clearly, there are many factors which contribute to the
development of a disease, but the presence of synaesthesia may contribute additional
evidence regarding these risks.
In the next chapter, I examine the relationship between synaesthesia and multiple
sclerosis from a different perspective, by presenting data demonstrating that multiple
sclerosis and clinical precursor conditions, appear to be more prevalent in synaesthetes
self-referring to participate in scientific studies than in the general population.
Chapter 3
Prevalence of multiple sclerosis in
synaesthesia
3.1 Introduction
In chapter 1, I introduced synaesthesia and briefly discussed its development, its causes
and the issues surrounding the identification and testing of synaesthesia in the research
environment. In chapter 2, I reviewed the literature regarding synaesthesia and its po-
tential comorbidities. In this chapter, I discuss one possible comorbidity in particular:
multiple sclerosis (MS). First, I present a brief introduction to multiple sclerosis, and
its precursor syndromes; clinically isolated syndrome (CIS) and radiologically isolated
syndrome (RIS). I then introduce new data showing that the shared MRI profile of MS
and RIS is significantly over-represented in synaesthetes who had participated in neu-
roimaging research. I do this by investigating a group of synaesthetes, who have been
scanned for unrelated purposes and who have shown unusually high rates of white
matter hyperintensities indicative of MS and its related conditions. I present valida-
tion of the clinical and MRI status of these synaesthetes, and an analysis showing the
significant probability their unusual number of MS-related cases may not have arisen
by chance, given the prevalence of MS in the general population. I then review this
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finding in the context of the entire published literature of MRI studies of synaesthe-
sia to show that even when all cases of scanned synaesthetes are taken into account,
the number of MS-linked cases remain statistically unexpected. I then discuss how to
interpret significant data based on small case-numbers, and consider the implications
of my findings for synaesthesia’s clinical status. Sections of this chapter have been
published in the form of a journal article, as Simner et al. (2014) (see Appendix F).
3.1.1 Multiple Sclerosis
In Chapter 2, I gave a brief introduction to MS, but I now elaborate on this overview
further, given the central focus on MS in the current chapter. As noted above, MS
is an inflammatory, degenerative disease of the central nervous system thought to be
caused by exposure to environmental risk factors in persons with genetic susceptibil-
ity to the condition (Compston and Coles, 2008). It is strongly mediated by immune
system interaction (Trapp and Nave, 2008). The condition is characterised by demyeli-
nation, axonal loss and gliosis of white matter (Weiner, 2009; Milo and Kahana, 2010;
Noseworthy, 1999). The mechanisms controlling these processes are relatively poorly
understood (McFarland and Martin, 2007). MS symptoms are varied and can include a
range of motor, sensory and cognitive impairments that can occur independently of one
another (Chiaravalloti and DeLuca, 2008). Typical symptoms can include for example,
numbness, loss of sensation, pain, loss of vision, and memory deficits (Compston and
Coles, 2008).
Although MS is typically classified as a white matter disorder (and I explore this
in greater detail below), grey matter is also known to be affected (Geurts and Barkhof,
2008), with reduced volume common in several areas throughout the cortex of MS suf-
ferers (Ceccarelli et al., 2008). The causes of grey matter damage are unknown and it
is currently unclear whether white matter and grey matter damage occur independently
or whether they are related (Raz et al., 2010).
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3.1.1.1 Diagnosis of MS
In this chapter I will be considering rates of MS within populations of people with
synaesthesia. It will therefore be important to understand exactly how MS is diag-
nosed, so that we have a clear understanding of which participants are affected. The
MacDonald Criteria are a universally accepted “gold standard” set of criteria used for
the diagnosis of MS (Polman et al., 2011). According to these specifications, a number
of clinical criteria must be fulfilled in order for a diagnosis of MS to be given (Polman
et al., 2011). The patient must have experienced a minimum of two episode of be-
havioural symptoms (e.g., visual disturbances, paresthesia, or walking difficulties) or a
minimum of two white matter lesions in MS-typical areas of the central nervous system
(e.g., brain stem, periventricular regions, spinal cord) (Compston and Coles, 2008).
If the minimum criteria above are not fulfilled, “dissemination in either space
and/or time” must also be demonstrated. There are numerous ways in which these
criteria can be met. Dissemination in space means either multiple sites in the body
must be affected (e.g. white matter lesions in different parts of the body, such as spinal
cord and periventricular regions of the cortex, or clinical episodes affecting different
parts of the body, such as loss of vision and loss of limb sensation). Dissemination
in time is shown by the occurrence of distinct clinical events separated by a period of
time (e.g., the appearance of new white matter lesions in subsequent MRI scans, or
two clinical episodes weeks or months apart). In addition to the above, other clinical
diagnoses must also be excluded, such as other inflammatory disorders or infections
of the central nervous system (Polman et al., 2011). If the above criteria are met, a
diagnosis of multiple sclerosis is given.
3.1.2 Other syndromes linked to the development of MS
As noted above, two distinct syndromes which meet a subset of these criteria are recog-
nised as precursors to a clinical diagnosis of multiple sclerosis; clinically isolated syn-
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drome (CIS) and radiologically isolated syndrome (RIS). Because these conditions are
strongly linked to MS - most patients who eventually receive a diagnosis of MS will
first be diagnosed with one of these two syndromes - both RIS and CIS will be intro-
duced here for completeness, although it is the former in particular which arises within
the sample I will be investigating.
Clinically Isolated Syndrome (CIS) is a term used to describe the presentation of
the first episode of clinical symptoms indicative of a demyelinating disease such as
MS affecting the central nervous system (Miller et al., 2012). Because of the relapse-
remitting profile of MS (periods of illness interspersed with periods of recovery and
good health), the majority of patients who eventually become diagnosed with MS will
experience - and recover from - an initial clinically isolated syndrome (Confavreux
and Vukusic, 2006). Not every episode of CIS will result in progression to clinically
definite MS. However, between 30% and 70% of CIS patients will eventually be di-
agnosed with MS (Miller et al., 2005). Although a diagnosis of CIS can be given in
the presence or absence of MRI abnormalities, the presence of detectable white matter
lesions significantly increases the likelihood that the patient will develop MS (Fisniku
et al., 2008). Furthermore, the number of lesions correlates positively with the risk of
progression (Tintore et al., 2010).
Radiologically isolated syndrome (RIS) is defined as the discovery of incidental
MRI findings which are suggestive of MS (namely white matter lesions), but without
the person in question displaying any overt clinical symptoms (Okuda et al., 2009). It
is this condition (along with MS) that will be relevant to the current study (see further
below). From a radiological perspective, MRI scans of RIS and MS are indistinguish-
able, and it is only the presence of clinical symptoms (which appear in the latter only)
that differentiates between the two conditions. RIS is uncommon, with an estimated
prevalence in the general population of 0.05% (Morris et al., 2009). Because this study
presents an analysis of the prevalence of MS and RIS in synaesthetes, and because RIS
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is typically an incidental finding (i.e., unintentionally discovered as a result of a un-
related imaging investigation), it is important to know this prevalence of RIS in the
general population and to note its rarity. Evidence linking RIS and MS however, is
significant. Despite the lack of clinical symptoms, RIS patients demonstrate reduced
cognitive performance akin to those of MS patients (Lebrun et al., 2010). In addition,
approximately one third of patients with RIS develop symptoms characteristic of MS
within 2-5 years, and RIS has been described as “preclinical MS” (Granberg et al.,
2013).
3.2 Why might synaesthesia and multiple sclerosis be
linked?
In this chapter I will present data showing a statistical relationship between MS and
synaesthesia: I will show a higher than chance occurrence of MS/RIS in a group of
synaesthetes who had been scanned using MRI (for unrelated reasons). In this section
I therefore consider whether there are any other reasons to believe that MS/RIS and
synaesthesia may be linked, and I begin by looking at the neurological profiles of each
condition.
Synaesthesia is characterised by structural differences in white and grey matter
compared to the general population and this is also a feature of MS. As discussed in
Chapter 1, synaesthetes show both increases and decreases in grey matter volume and
increased cortical thickness in the fusiform gyrus, frontal cortex and parietal cortex
(specifically, the inferior and superior parietal lobules, anterior intraparietal sulcus and
posterior cingulate gyrus; Jäncke et al., 2009; Hänggi et al., 2008; Weiss and Fink,
2009; Rouw and Scholte, 2010). Altered coherence of white matter is also reported
(Rouw and Scholte, 2007; Hänggi et al., 2011; Jäncke et al., 2009), and is found in
regions implicated by the synaesthetic report, and also elsewhere. Specifically, synaes-
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thetes experiencing colour sensations show increased FA (i.e., increased white matter
connectivity) compared with controls in and adjacent to colour selective region V4
(Rouw and Scholte, 2007; Jäncke et al., 2009) but also show FA increases (Rouw and
Scholte, 2007) and decreases (Hänggi et al., 2008) in the parietal lobe. In addition to
this, altered white matter connectivity has been reported in frontal (Hänggi et al., 2008)
and temporal (Rouw and Scholte, 2007) regions. The cortical reorganisation of white
and grey matter in synaesthesia might call for comparison with MS/RIS, since I ask in
this chapter whether epidemiological or pathological links might exist between them.
Grey matter pathology in MS can be widespread and diffuse, potentially affecting
all areas of the brain (Geurts et al., 2012). White matter damage can also be widely
distributed in MS (Kutzelnigg et al., 2005). In particular, both grey and white matter,
pathology has been found in the frontal, parietal and temporal lobes (Bø et al., 2003;
Kutzelnigg et al., 2007; Sbardella et al., 2013) and these same lobes show changes
in synaesthesia too (see above; Hänggi et al., 2008; Jäncke et al., 2009; Rouw and
Scholte, 2007; Weiss and Fink, 2009). Given the widespread overlap of affected areas
in both MS and synaesthesia, it is possible therefore, to identify brain regions that are
implicated in both MS and synaesthesia. Specifically,there is evidence for changes in
both MS and synaesthesia in the following regions: fusiform gyrus (Datta et al., 2015;
Jäncke et al., 2009) and parietal lobe (Miller et al., 2003; Rouw and Scholte, 2010).
Superficially at least, it therefore seems as if the two conditions can involve similar
neurological profiles, when considered at this level.
I suggest here however that this level of comparison is probably unhelpful in any
attempt to link MS and synaesthesia. Although it is true that both conditions cause
white/grey matter changes, and although some of these changes can arise in the same
or neighbouring regions, I suggest that this alone is not sufficient to draw any strong
conclusions about comorbidities between the two conditions. One reason for this is
that similar profiles are also seen in a range of other conditions. For example, although
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grey matter volume changes in parietal lobe have been noted in synaesthesia, changes
in the parietal lobe have also been reported in a wide range of other conditions, such
as schizophrenia (Job et al., 2005), epilepsy (Bernasconi et al., 2004) and Parkinson’s
disease (Melzer et al., 2012). Similarly, altered coherence of white matter in the brain
regions implicated above in synaesthesia has been shown in a range of conditions, such
as autism (Mueller et al., 2013), schizophenia (Roalf et al., 2015) and anxiety (Baur
et al., 2011). For this reason we must be careful to not draw strong conclusions based
on this type of neurological similarity alone - although clearly having two conditions
that alter coherence in white and grey matter is a reasonable place to start for compar-
ison.
The key reason to draw a parallel between synaesthesia and MS is found in the data
I will present below. This question of an association between MS and synaesthesia is
motivated below by a finding of particularly high occurrence of MRI abnormalities
consistent with the neuroradiological profile of MS/RIS within synaesthetes who have
presented to our laboratories. I present these data below.
3.3 Experiment 1
In this study I consider three independent synaesthete cohorts tested in three different
countries (San Diego, USA; Paris, France; Edinburgh, UK). After these studies were
complete, my research group (Prof. Julia Simner and Dr. Ed Hubbard) opportunisti-
cally noticed there were three separate pathological cases among the 29 synaesthetes
scanned, and that all three cases were related to MS. Specifically, all three showed the
clinical and/or radiological indicators suggestive of MS in 1 in 6 synaesthetes (San
Diego; Hubbard et al., 2005), 1 in 10 synaesthetes (Paris; unpublished data) and 1 in
13 synaesthetes (Edinburgh; Simner et al., in review), respectively. In other words,
three affected participants were identified in a sample of 29 subjects in total. These
studies were not initiated with the intention of investigating the prevalence of MS/RIS,
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but these unexpected findings led us to further evaluate this post-hoc detection of white
matter abnormalities in these three participants. Because the participants recruited to
take part in these three studies were regarded as being in good general health, and be-
cause the association between MS and synaesthesia investigated by this study was not
yet identified at the time at which these participants were recruited, information about
presence of other conditions known to be comorbid with MS was not requested from
participants during the recruitment phase. Below, I will show that all three affected
cases met the McDonald (imaging) criteria for the diagnosis of MS, namely multiple
white matter hyperintensities spread throughout the cortex. At the time of writing this
thesis, Subject 1 (USA) has a full diagnosis of MS, while Subjects 2 (France) and 3
(UK) are currently free from clinical symptoms and therefore considered to have RIS.
Subjects 2 and 3 were initially flagged by routine protocols in these studies in which
neuroradiologists examine T2-weighted axial MRI scans for unanticipated pathology.
Subject 1’s diagnosis was first suggested by her GP several months after being tested
by Hubbard et al. (2005), because routine radiological checks were not part of that
study’s protocol. Below I give detailed case studies of each subject, which I have been
able to generate for the purpose of this thesis.
3.3.1 Case-details of affected synaesthetes
Synaesthesia Status: Table 3.1 shows the synaesthetic status and demographic back-
ground of the three synaesthete participants in whom radiological anomalies have been
identified. The table shows their synaesthesia phenotypes, and these comprise the fol-
lowing: grapheme-colour synaesthesia gives rise to coloured percepts triggered by
letters and/or digits (e.g., the letter A might be red; Asher et al., 2006); sequence-
personality synaesthesia gives rise to complex personifications triggered by the mem-
bers of linguistic sequences (e.g., Monday might be female, unfriendly; Simner and
Holenstein, 2007); number-space synaesthesia, letter-space synaesthesia and time-
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space synaesthesia are all variants of the broader category of sequence-space synaes-
thesia, in which linguistic sequences are perceived in spatial arrays (e.g., the letters
A-Z might extend in an undulating line from right-to-left across the visual field; see
Simner, 2009 for review).
Test Site Age Sex Nationality Synaesthesia Phenotype(s)* MS-RIS?
San Diego 26 female American grapheme-colour MS
Paris 25 female French number-space, time-space
(coloured), grapheme-colour
RIS






Table 3.1: Synaesthetic case descriptions. For each affected synaesthete, the table
shows the imaging lab testing site, the participant’s age at scanning, sex, country
of origin (nationality), verified synaesthesia phenotype(s), and the clinical status.
* As discussed in Chapter 1, verification of synaesthesia relies on the behavioural gold
standard test for synaesthesia, which assesses the consistency of the synaesthetic report over
time (e.g., Simner et al., 2006b; Eagleman et al., 2007). In this, participants are required to
first report their synaesthetic experiences for a list of provided stimuli (e.g., they report their
colours for a list of letters), and they are subsequently retested after some considerable time
(e.g., 6 months, for the case scanned in San Diego; see Hubbard et al., 2005 for methodologi-
cal details). Synaesthetes are identified as those who are significantly more consistent in their
reports over time, compared to a group of matched controls who invent/recall analogous asso-
ciations.
3.3.1.1 Clinical status of MS/RIS
In this section, I next evaluate our three cases of MS/RIS both qualitatively and quan-
titatively, beginning with a detailed clinical evaluation.
3.3.1.2 Subject 1 (San Diego, USA)
This subject was diagnosed with clinically definite relapsing-remitting MS several
months after taking part in a synaesthesia study in 2001. A diagnosis of MS was
first suggested by this participant’s GP because routine radiological checks were not
part of that study’s protocol. Subsequent neurological follow-up consisting of sagittal
and axial T1 FLAIR, axial T2 and axial and coronal T1 weighted MRI scans revealed
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extensive hyperintensities in both the brain and cervical spine, considered to be pathog-
nomonic for MS. These white matter lesions, in conjunction with a history of clinical
symptoms, confirmed this participant’s diagnosis of MS. This participant had a total
of 16 lesions, in both periventricular and juxtacortical white matter (see Figure 3.1).
Periventricular lesions were located in the corpus callosum and in occipital and pari-
etal areas. Juxtacortical lesions were found in the parietal region. Lesions were also
detected in the spinal cord. This subject was originally scanned for, but subsequently
excluded from, Hubbard et al. (2005) (see Table 3.2).
Figure 3.1: Axial T2-weighted image showing a left parietal ovoid periventricular
lesion (of 16 overall lesions), from Subject 1
3.3.1.3 Subject 2 (Paris, France)
This subject participated in synaesthesia research in 2006, where her axial T2 MRI
scan was reviewed as part of routine assessments for unanticipated pathology by a
consultant neuroradiologist. Initial examination of her resultant T2-weighted MRI scan
revealed white matter hyperintensities in the brain. A second, axial T2 FLAIR MRI,
obtained 2 years after the initial scan, confirmed the presence of white matter lesions,
judged to be consistent with the McDonald criteria (See Figure 3.2). Due to a lack
of progression, these lesions are considered stable and this participant has remained
free of clinical symptoms. This participant had more than 20 identified lesions in
periventricular and juxtacortical white matter. Periventricular lesions were in frontal
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and parietal areas, while juxtacortical lesions were distributed across frontal, parietal
and temporal regions. This subject was scanned for Hubbard et al., unpublished data
(see Table 3.2).
Figure 3.2: Axial T2-weighted FLAIR images showing (left) a left frontal periven-
tricular lesion and (right) multiple lesions; the right parietal lesion involves jux-
tacortical U fibres
3.3.1.4 Subject 3 (Edinburgh, UK)
This subject participated in synaesthesia research in 2008 and her resultant axial T2
MRI scan was also examined routinely by a consultant radiologist to detect unantici-
pated pathology. Initial examination revealed white matter hyperintensities in the brain
of this subject. This T2-weighted MRI scan was independently examined by a second
neuroradiologist who confirmed that the number and location of the white matter le-
sions met the McDonald imaging criteria for diagnosis of MS (see Figure 3.3). Again,
this participant has remained free of clinical symptoms since the initial presentation
of her abnormal scan. This participant had more than 20 lesions in periventricular
and juxtacortical white matter (see Figure 3.3). Periventricular lesions were found in
frontal, parietal, temporal and occipital areas. Juxtracortical lesions were identified in
temporal and parietal areas. Infratentorial lesions were also present. This subject was
scanned for, and subsequently excluded from, a study by Simner et al., in review (see
Table 3.2).
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Figure 3.3: Axial T2-weighted image showing multiple ovoid periventricular white
matter lesions, from Subject 3
3.3.2 Case-details of all synaesthetes with existing MRI scans
This finding of three cases of MS/RIS among 29 synaesthetes is suggestive of an un-
usually high rate. However, the possibility must be addressed that we inadvertently
focussed on just those studies where anomalies were found, rather than all synaesthe-
sia imaging studies to date. At the time this chapter was written, 29 published studies
(see table 3.2) had collectively scanned 211 synaesthetes (including 6 of our own 29
synaesthetes, described in Hubbard et al., 2005). Together with our research group’s
remaining unpublished cases (n=23), this gives 234 synaesthete scans in existence,
known to us. When conducting MRI scans for research purposes, the scan may be
examined by a clinical professional for any obvious signs of pathology. Whether this
procedure is followed or not depends on the policy of the research institution conduct-
ing the study. Because the 234 MRI scans I have identified were conducted in a wide
range of academic institutions in different countries (see table 3.2 for details), it was
not initially clear which scans had been checked and which had not. In order to ob-
tain this information, I contacted the authors of every study in which MRI scans of
synaesthetes had been recorded (see Table 3.2).
Outwith our cohort of 29 participants, I have been able to ascertain that 80 addi-
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tional synaesthetes MRI scans were checked with a similar radiologist protocol, and
none revealed anomalous findings of this type. A further 121 were scanned without
being checked by a clinical professional and the remaining four scans have an un-
known status (see Table 3.2). The most conservative approach is to assume no cases
of pathology in any of the 234 scanned cases, other than the three identified here.
The methodology below evaluates this occurrence of MS/RIS in synaesthetes against
appropriate baselines, calculated from known prevalence rates of MS and RIS. First, I
present a set of analyses which aim to establish the appropriate baselines against which
to compare our finding of 3 affected cases (1 MS; 2 RIS). Below that, I will evaluate
the rates of MS/RIS found in this sample statistically, both compared to the original
cohort of 29 subjects and again with reference to all identified synaesthetes listed in
Table 3.2. To anticipate the methodologies below, I take the most stringent standards
against which to compare our observations (given factors such as the geographic vari-
ability of MS, and the sampling method of our studies) and nonetheless find that the
number of affected cases is significantly higher than chance would predict.
Table 3.2 shows what is to the best of my knowledge all studies that have generated
MRI scans from synaesthete participants at the time of writing including all published
studies, plus our two unpublished samples. Published articles were retrieved from an
all-years search of PubMed using search terms syn*esthesia (UK/US spellings) and
MRI, and any additional details on participants shown below that were not available in
the literature were retrieved by contact with the authors of these studies.
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Table 3.2: MRI studies of synaesthete participants. Table shows Year (of publica-
tion; or year of report for unpublished studies), Authors, Total n (total participant
numbers), Status with respect to radiological anomalies (see key; unknown unless
otherwise stated), and Female n (number of female participants).
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3.3.3 Analysis of the prevalence of MS/RIS cases among scanned
synaesthetes against expected baselines
We have found three cases of MS/RIS in 234 synaesthetes who have self-referred for
brain scanning studies across the literature. In order to establish whether the number
of affected synaesthetes is statistically significant, I must compare the prevalence of
observed cases against a meaningful baseline. Since RIS and MS are indistinguishable
from a radiological perspective, I first consider all three cases as a unified phenomenon.
Then, since RIS and MS are different in a clinical/symptomatic sense, I additionally
consider the two cases of RIS as a distinct phenomenon. Methodologically speaking,
I will calculate the RIS baseline from a study by Morris et al. (2009), which is a
meta-analysis of the prevalence of RIS across all MRI scans described in the imaging
literature (and below I further describe the conservative nature of my approach in this
regard).
Next, I will take our MS baselines from rates reported in clinical prevalence stud-
ies. Since the prevalence of MS is sex-linked and geographically variable, I have
considered that the large majority of all scanned synaesthetes are female (86%) and
have come from studies conducted in Europe (94%). Accordingly, I took a female MS
prevalence figure for Europe. Again however, since a key aim was to be maximally
conservative (i.e., to compare our findings with the highest prevalence rates where
possible), I additionally re-analysed our data using the most stringent prevalence rate
according to the nationality of the three affected cases (American/French/English). In
other words, since the rate of MS is highest in England (vs. America or France), I used
this highest England baseline in a second analysis. Below, these baseline-selection pro-
cedures are described in more detail, along with the resultant statistical outcomes of
these analyses (showing whether MS/RIS is indeed significantly higher in self-referred
synaesthete samples).
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3.3.4 Baseline selection and results
My first analysis below will compare all three clinical cases as a single phenomenon.
Since there is no published combined prevalence of MS/RIS, I here calculate an ad-
ditive value from each separately. A recent meta-analysis (Morris et al., 2009) shows
a baseline of RIS in the general population of 57.8/100,000. This figure was based
on nine cases of unanticipated white matter hyperintensities (WMH) considered as
definite demyelination, which were found in 15,559 scans reported in the literature.
To be conservative here, I will also include three cases of possible demyelination in
that same meta-analysis, and furthermore, I will consider scans only from self-referred
volunteer research participants (giving a total of 12 RIS cases found in 8,441 research
scans; Proportion (P) =0.14%, 95% CI [0.08%, 0.25%]; Morris et al., 2009). I con-
sider only self-referred volunteers because this type of participant is similar to those
in this cohort of synaesthetes, and across the 234 scanned synaesthetes more widely.
It is important to consider this method of (self-)referral since it may have elevated the
number of RIS cases in our cohort. Specifically, self-referred/volunteer recruitment
in any brain imaging study may increase rates of neuropathology by over-recruitment
of participants who are seeking covert evaluation for undeclared neurological com-
plaints (Morris et al., 2009). In other words, the three affected synaesthetes may have
volunteered for our studies in order to assuage personal neurological concerns, and I
must therefore compare their number against a baseline that specifically takes this into
account.
In summary, all these considerations give us a comparative baseline for RIS in the
general population of 142/100,000. However, I point out that this baseline is likely
to be highly inflated since closer inspection of the data that contributed to the meta-
analysis of Morris et al. (2009) reveals that two-thirds of cases contributing to this
figure were found in a single study in which 90.0% of participants were former lead
workers with a mean age of 60.1 years (Alphs et al., 2006). Since the likelihood of
detecting white matter hyperintensities increases significantly with age (Smith et al.,
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2000) and with exposure to neurotoxicants such as lead (Stewart et al., 2006), the true
prevalence of white matter hyperintensities in the general population of self-referred
volunteers is likely to be substantially lower than the baseline we are selecting here.
Nonetheless, I use this baseline as a maximally conservative estimate (to combine with
a suitable estimate for MS prevalence below), for comparison with the synaesthete
sample.
The prevalence of MS in the general population is better understood, and known to
vary by geographic region (with particularly high rates in Scotland; Sutherland, 1956)
and by sex (females approximately 2:1; Pugliatti et al., 2006). This is of note given that
one of the testing sites where MS/RIS was found was in Edinburgh, Scotland (although
only four of 13 participants were Scottish; the remainder travelled from England), and
also the fact that the scanned synaesthesia population is skewed towards females (F=
201). Considering the sex and nationality of the 234 scanned synaesthetes (using the
location of testing centres as an indicator of nationality for cases unknown to us),
an appropriate baseline is the rate of MS in female Europeans (110/100,000 ) since
synaesthetes were virtually exclusively European (94%, n=220; including four Scots,
none of whom showed pathology). This we combined with the baseline for RIS to give
an additive RIS-MS baseline of 252/100,000.
Given the baseline above, I will now calculate the probability of obtaining our
observed number of MS/RIS cases within scanned synaesthetes, using the exact bi-
nomial test. Thus, I estimate the probability of three observations of MS/RIS among
234 self-referred synaesthetes (Proportion (P) =1.3%, 95% binomial CI [0.3%, 3.7%];
1282/100,000) given an expected population prevalence of 252/100,000. My statis-
tical test shows this rate among synaesthetes to be significantly higher than chance
would predict (p=.02). This difference remains significant (p=.04) even if I substitute
the female Europe MS rate and use instead the female England MS rate, which is the
most extremely conservative option given the demographics of our three affected cases
(American/French/English).
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Combining our three cases has allowed us to consider the shared MRI profile of
MS and RIS, and their related clinical progression (Granberg et al., 2013). However,
I might alternatively exclude our case of MS as a separate phenomenon, and consider
only the two observations of RIS against all 103 scans with protocols to check for
such anomaly (P=1.9%, 95% binomial CI [0.2%, 6.7%]. Taking again the highest RIS
baseline (142/100,000), this finding is also highly significant (p=.01). Indeed, taking
even the most extreme assumption of no other cases in any synaesthete scanned to date
– checked or unchecked – an observation of two cases in 234 (P=0.9%; binomial CI
[0.1%, 3.1%]) remains significant (p=.04).
3.4 Discussion
I initially observed three cases showing white-matter hyperintensities compatible with
the radiological profile of MS – one case of MS and two of RIS – in 29 synaesthetes
from three of our imaging labs across three different countries. I have taken the most
conservative approach in assuming no further cases in any synaesthetes scanned to
date, placing the prevalence at three affected cases in 234 synaesthetes (1,282/100,000,
compared to a population baseline estimate of 252/100,000). Two cases of RIS in 103
brain scans checked for pathologies would, if representative, place the prevalence of
RIS in synaesthetes at 1,942/100,000 (compared to a baseline of 142/100,000). These
rates are significantly higher than expected, even against our highly conservative base-
lines. I also specifically controlled for the possibility that our three affected cases
may have volunteered for our studies in order to assuage personal neurological con-
cerns. I did this by comparing our RIS cases to a baseline constructed only from
studies that included similar, self-referred, volunteer participants. In other words, I
compared our rates to studies likely to have just as many concerned self-referrers as
our own, rather than to studies using non-voluntary recruitment methods (e.g., work-
related health screening; Weber and Knopf, 2004).
It is important to clearly acknowledge that only a small number of affected cases
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are reported here, and on this basis, I do not claim that synaesthesia causes MS/RIS.
Indeed, our small sample size means it would be prudent to hold back from making
any strong claim whatsoever about links between these two conditions. There are many
environmental factors thought to contribute to the development of MS and RIS; the ev-
idence I present here suggests having synaesthesia may be one factor that could merit
further investigation. Indeed, I have chosen to present these data for two reasons. The
first is that the rates I have found are statistically significant; a considerably greater
sample size would usually be needed in order to detect the numbers we have found
although again our sample sizes are small. The second reason I present our data is a
practical one: cases of pathology are usually excluded from MRI study populations as
soon as they are detected. Therefore, they often do not appear in the literature and so
remain unknown outside the research group. I report these data because it is important
that other researchers working in this area are aware of these cases, so they do not
overlook future neurological abnormalities, should they ever be discovered. If a mean-
ingful link between synaesthesia and MS did exist, and as scanning of synaesthetes
for research purposes becomes more commonplace, further cases of this nature would
arise, and so I encourage researchers to make any cases known to the wider community
if they share similarities with our own.
As noted in Chapter 2, one explanation for a link between synaesthesia and MS
could be the occurrence of synaesthesia-like symptoms after the onset of MS. In other
words, it is possible that the degenerative neurological damage caused by MS might
give rise to sensory disorders that mimic synaesthesia, while having different causes.
We saw above that sensory disturbances do accompany MS (e.g., changes in colour
vision; Gregori et al., 2011) although this hypothesis would imply that the onset of
synaesthesia-like symptoms should be later in life – resulting from MS-related changes
in brain structure. However, I do not believe this account for the cases I present here,
and for two reasons. I pointed out above that later-acquired synaesthesias are qualita-
tively different to developmental variants (Ward, 2013) and do not reflect the synaes-
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thesias of our participants. Acquired variants of synaesthesia tend to involve low-level
sensory triggers (e.g., tones) rather than learned symbols such as graphemes (Ward,
2013) although it is precisely this latter type of trigger (graphemes etc.) that our own
cases possess here and which might therefore be considered a hallmark of develop-
mental synaesthesia. Furthermore, all three of our cases report life-long synaesthesia,
stemming back from early childhood, and being present for as long as they can remem-
ber.
In conclusion to this chapter, I have demonstrated a statistical link between MS/RIS
and synaesthesia. Overall, I have been conservative in this study in three ways: base-
lines were selected in an overly conservative way; I took additional measures to be
conservative when conducting my statistical analysis (e.g., assuming no anomalies in
scans not assessed by radiologists); and I am circumspect in the interpretation of these
findings. Because this study relies on a small number of cases - three only - I do not
claim that any causal link necessarily exists between synaesthesia and MS/RIS, and I
present these findings with this strong caveat. Nonetheless, if these epidemiological
findings are indeed later supported by additional evidence, this could invite a debate
about the clinical status of synaesthesia, which has previously been associated with
largely beneficial rather than unfavourable characteristics.
In the following chapters, I will further explore this possible link between synaes-
thesia and MS in two additional ways. In chapter 6, I will present a study of the genetics
of synaesthesia. For this, in chapter 4, I first provide a brief introduction to genetics
and the methodology of genetic studies. I then review and evaluate the literature of
synaesthesia genetics research, provide an overview of multiple sclerosis genetics and
raise the possibility that an association between synaesthesia and multiple sclerosis
may share common genetic origins. Subsequently, in Chapter 8, I will explore this po-
tential association from the opposing direction, namely by examining the prevalence
of synaesthesia in MS patients.
Chapter 4
Genetics literature review
In anticipation of my genetics investigation into links between synaesthesia, MS and
immunity (see Chapter 7), in this chapter, I provide an introduction to genetics in gen-
eral and an appraisal of possible approaches to conducting genetic experiments. I then
review the current understanding of synaesthesia genetics and provide an overview of
the genetics of MS. Finally, I put forward reasons why MS and synaesthesia may share
a genetic basis, and provide the rationale for the genetics work conducted for this the-
sis (see Chapter 7). Sections of this chapter have been published in the form of a book
chapter, as Asher and Carmichael (2013) (see Appendix D).
4.1 A brief introduction to genetics
The genome - the genetic code of an organism - is encoded by a complex molecule
called DNA, stored in the nucleus of almost every cell in our bodies. DNA is stored in
the form of chromosomes, which are large molecules of DNA, coiled around a specific
type of protein called histones that provide structure to the molecule. DNA consists
of nucleotides; each nucleotide consisting of a nitrogenous base, a dioxyribose sugar
and a phosphate group. DNA is made up of four different nitrogenous bases, cytosine
(denoted by the letter ’C’), guanine (G), adenine (A) and thymine (T). A molecule
of DNA consists of a long string of nucleotides joined together, the nomenclature of
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which is denoted by the corresponding base letter, such that a segment of DNA could
be portrayed as follows, for example: A-T-T-G-A-C-C-T-A-G-C-T-A-C. The entire
human genome is three billion bases in length and is approximately one metre long.
Genes are specific sequences of nucleotides that code for proteins, which in turn, carry
out virtually all the functions of the cell. There are approximately 21,000 genes in the
human genome, which makes up only about 2% of the total DNA. The remaining 98%
of the genome contains DNA which does not code for proteins but may fulfil a range
of other functions, such as indicating the start/end positions of genes and regulating
whether or not certain genes are expressed, or “switched on”.
4.1.1 Inheritance and linkage
Human cells contain 23 pairs of chromosomes, one inherited from each parent. The
process of sexual reproduction involves the fusion of two sex cells (called gametes),
an egg from the mother and a sperm cell from the father. Each gamete only contains
half the full complement of DNA (23 chromosomes). When fertilisation occurs, the
genetic material from both gametes combines and the newly created cell obtains its
full complement of 46 chromosomes. In this way, an individual inherits 50% of their
genetic material from each parent. Meiosis - a random shuffling of genetic material -
is a key phase in the process of forming gametes from diploid cells, meaning that no
egg or sperm cell is identical. This is a key source of genetic variation in organisms
that reproduce sexually. This critical stage means that any offspring will inherit many
of the same combinations of genes that their parents have but may also have novel
combinations that arise due to this recombination. In this way, a person may share
many similarities with their siblings and parents, but may also be quite different.
When the recombination outlined above occurs, the likely inheritance of each gene
is not a statistically independent event. The chances of genes being inherited together
or being separated during this random shuffling are influenced by physical proximity
to each other on the chromosome. Offspring possess two copies (known as alleles)
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of each gene, one from each parent. Genes that are located at adjacent loci have a
higher likelihood of being co-inherited, which leads to the formation of associations
between alleles in a population. This is known as linkage disequilibrium, or LD (Ardlie
et al., 2002). This notion that larger blocks of genes tend to be inherited together has
significant implications when designing studies aiming to find genes that cause disease
or other genetic traits, and these will be discussed in greater detail below.
In Mendelian terms, alleles can be viewed as dominant, recessive or co-dominant.
This quality effects how genetic traits and diseases can be inherited. Diseases that
are caused by mutations in single genes follow distinct patterns of inheritance. For
example, in order to develop a disease caused by a dominant allele (such as Huntington
disease, Walker, 2007), only one copy of the mutated gene is required. It therefore
follows that disorders that follow this pattern typically occur in every generation of
an affected family. Recessive conditions, where two copies of the mutated allele are
required for the disease phenotype to occur (e.g. cystic fibrosis, Bobadilla et al., 2002),
often result from individuals inheriting the recessive allele from each parent, who are
typically carriers of the recessive allele but who do not have the condition. It follows
therefore, that recessive conditions often skip generations. In co-dominant situations,
alleles have equal influence on the phenotype that emerges. For example, wavy hair
results from the possession of a curly hair allele in combination with a straight hair
allele - each allele exerts its influence on the final result and a mixture of the two traits
appears. Complex traits, involving the effects of multiple genes, do not necessarily
follow these patterns, therefore making the mode of inheritance harder to detect.
4.1.2 Rationale for conducting genetic experiments
In its simplest sense, a genetic experiment seeks to identify a gene which has a causal
influence on the phenotype that develops. The phenotype of an organism can be
thought of as the characteristics of that organism that develop from interaction be-
tween its genotype and environment. The basic hypothesis is that individuals with
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a particular trait or disease will have genetic differences to people who do not, and
these differences will confer a greater risk of developing the phenotype in question. A
genetic study seeks to identify those differences.
The optimal approach depends on numerous factors. Considerable influence over
the method of choice is exerted by the nature of the disease under investigation. Is
it a Mendelian condition caused by a single gene or a complex condition with effects
from multiple loci? The size and make-up of the population of affected individuals
available for testing (do you have access to extended families, siblings, unrelated indi-
viduals?), and also technical and financial considerations must also be factored in. An
in-depth discussion of these factors is beyond the scope of this thesis, but I will briefly
discuss both linkage approaches (because the existing synaesthesia studies are linkage
studies) and association methods (because the work conducted for this PhD used this
approach).
A study must have a set of identifiable markers which allow the differences be-
tween affected and non-affected individuals to be recognised and classified. Genetic
markers are sequences of DNA at known locations which can be compared to identify
differences between individuals or groups.The current marker of choice used in the
majority of studies is the single nucleotide polymorphism, or SNP. SNPs are locations
in the genome at which individuals differ by a single nucleotide in the string of nu-
cleotides that make up the molecule of DNA. For example, an individual may have a
‘G’ base at a particular location, when another person may have a ‘C’. On a population
level, these alleles can occur frequently (e.g., 40% of people may have a ‘G’ at a cer-
tain location and 60% may have a ‘C’) or they may be rare alleles (e.g., 2% of people
may have a ‘G’ at a given location).
4.1.3 Linkage and association methods
By analysing families with multiple cases, linkage studies aim to isolate areas of
the genome that co-segregate with the condition in question, by comparing the pres-
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ence/absence of genetic markers between affected and non-affected family members
(Ardlie et al., 2002). Linkage approaches work well in detecting the genes linked to
conditions that are monogenic (caused by one gene) and highly penetrant and perform
poorly when high levels of allelic heterogeneity are present, meaning many alleles at
a particular locus have an influence on disease state (Pritchard and Cox, 2002). Link-
age studies only tend to identify the loci exerting the strongest influence (Smith and
O’Brien, 2005), and candidate regions identified by linkage studies tend to be large
(Bailey-Wilson and Wilson, 2011). This means multiple loci exerting smaller amounts
of influence are often not detected and the subsequent identification of genes is made
difficult by the large size of the search area.
The extent of linkage disequilibrium (i.e. the co-inheritance of adjacent genes) is
a significant factor that can influence both major decisions in study design (such as
deciding between a linkage or association approach) or more minor decisions (e.g.,
SNP selection). The closer individuals are related to each each, the higher linkage
disequilibrium will be. For example, first degree relatives will have higher linkage
disequilibrium than more distant relatives who in turn, have greater linkage disequi-
librium than unrelated individuals. This is relevant because higher levels of linkage
disequilibrium allow larger areas of the genome to be investigated with fewer markers
(Cordell and Clayton, 2005). The advantage of using fewer markers means greater
statistical power, and it is technically less challenging and cheaper. The trade-off is
a difficulty in identifying the causal genetic variant (i.e. the gene contributing to the
cause of the disease) in the often large region of the genome in linkage disequilibrium.
Such areas can often contain several hundred genes. The converse applies in situa-
tions where linkage disequilibrium is lower. More markers are required to probe the
genome, which has implications for statistical power and sample size but the advantage
is that areas of association are generally smaller, meaning that causal variants may be
easier to isolate.
In practical terms, this means that because first degree family members inherit
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much of the same sections of the genome together, isolating the areas of the genome
that do not overlap between affected and non-affected members can be achieved with
smaller sample sizes than with unrelated individuals, but specifically because those in-
dividuals are related, the size of the genomic regions in common are likely to be larger.
The implication being that the nature of the the disease under investigation (one gene
or many?) dictates the best approach to study it. Conditions thought to be monogenic
are more easily identified with linkage studies whereas association approaches are best
placed to detect causal influence from multiple genetic variants.
In comparison to linkage studies, association studies work at the population level to
determine whether the presence of a particular allele at a polymorphic site correlates
with the presence of the condition under investigation (Oksenberg et al., 2008). In
other words, when comparing groups of affected individuals with groups of unaffected
individuals, is a particular allele more commonly found in that location? Associa-
tion approaches test for a relationship between the presence of disease and specific
genetic variations (Lewis and Knight, 2012). An increased frequency of a particular
genetic marker (usually a SNP) in a group of affected individuals implies that that
marker increases the likelihood of developing the disease in question. It is important
to acknowledge that a positive association is precisely that - just an association. A
SNP may fall in the coding region of a gene, in which case that SNP may provide
information about the causal mechanism underlying the disease, but more often than
not, a SNP may be located in a stretch of DNA that does not code for a gene, or in
a gene-poor region of the genome. In these cases, positive associations do not tell us
anything about the causal mechanism, but rather act as the drivers of new hypotheses
- namely, what genes are in the vicinity of the SNP that may be exerting an effect?
Association studies are particularly well suited to detecting common variants that con-
tribute modest risk effects (Risch et al., 1996), which given the current understanding
of synaesthesia genetics (see below), makes this approach valid for our own interests.
The characteristics of linkage disequilibrium can also be beneficially employed in the
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design of association studies. If it is known that certain areas of the genome are in
linkage disequilibrium, SNPs can be strategically selected to cover that whole region
(Stram, 2004). This ensures greater coverage of the genome for a smaller number of
SNPs, effectively increasing statistical power for a sample of a given size.
With regard to selecting SNPs for analysis, there are two broad approaches - a
candidate approach or a genome-wide approach. The candidate approach requires an a
priori hypothesis as to why that specific gene or region is likely to influence the pheno-
type under investigation. A genome wide association study, or GWAS - is hypothesis
free, and examines the whole genome in a predetermined degree of detail, as governed
by the number of markers used. One of the primary considerations in a genome-wide
association study is the balance between statistical power and sample size. In order
to have the required power to detect anything other than the most significant associa-
tions, samples of more than 1000 cases (and a greater number of controls) are required.
When the study in question aims to investigate a disease that is rare, recruiting such
a large sample becomes a significant challenge. For the experimental work presented
in this thesis, I adopt the former approach, and select a single SNP that may be linked
to synaesthesia (see Chapter 7). The end goal however, is to carry out the first GWAS
study in synaesthesia. I am working towards this goal with my collaborators (Julia
Simner and Simon Fisher and others), but this falls outwith the remit of this thesis.
A difference between linkage and association studies is that in association studies,
the same allele (or marker) is associated with the trait of interest across the whole pop-
ulation, whereas in linkage studies, different alleles (or areas of the genome) may be
associated with the same trait in different families (Cordell and Clayton, 2005). When
the genetic origins of a trait are unknown, as is currently the case with synaesthesia,
using both approaches is to be recommended. It is possible that the same genetic vari-
ants give rise to different subtypes, or different genetic variants give rise to the same
subtypes. To add further complexity, these possibilities are not mutually exclusive
- both are also possible. In the following section I will summarise and evaluate the
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synaesthesia genetics literature to date.
4.2 The genetics of synaesthesia
Seventy years after synaesthesia was first reported in the scientific literature by Sachs in
1812 (Jewanski et al., 2009), it was observed that this condition was found in multiple
members of the same families (Galton, 1883b). This led early researchers to suppose
that there was a shared genetic component to this condition which was in some part
responsible for the development of the synaesthetic phenotype. This component was
identified as being hereditary, enabling the transmission of synaesthesia from gener-
ation to generation in some families. Subsequent studies carried out in the modern
era place the proportion of synaesthetes that have a first-degree relative who also ex-
periences this phenomenon at approximately 40% (Baron-Cohen et al., 1996; Ward
and Simner, 2005; Barnett et al., 2008). Understanding the genetics of synaesthesia
offers an opportunity to gain insight into its aetiology and more broadly, may provide
a better understanding of how typical human perception develops. It may also help
understanding other conditions which might co-occur with synaesthesia, which is the
focus of this thesis.
In keeping with the general neglect of synaesthesia by the scientific community
in the early to mid 20th century (Lovelace, 2013), the genetic aspect of synaesthe-
sia remained unexplored for most of that time. For the majority of the last century,
the techniques required to investigate the potential role of individual genes in synaes-
thesia were either simply unavailable or too costly. As genetic techniques became
available, initial scientific resources were directed towards identifying genes associ-
ated with more clinical conditions. Towards the very end of the 20th century however,
the first attempts were made to investigate the purported hereditary nature of synaes-
thesia, and these are reviewed below.
The rebirth of modern synaesthesia research coincided with the development of
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suitably reliable methodologies which were able to phenotype the condition, (e.g. test
the consistency of the synaesthetic response over time, which is considered to be a
hallmark of authenticity, see Chapter 1). At this point, little empirical evidence was
available regarding either the prevalence of synaesthesia or the ratio in which it occurs
between the sexes. The importance of such information to understanding the inheri-
tance mechanisms of synaesthesia was swiftly realised, and as a consequence, initial
studies aimed to establish prevalence and sex ratio and used this evidence as a starting
point from which to explore the underlying genetics of this phenomenon (e.g., Baron-
Cohen et al., 1996; Simner et al., 2006b).
The first analyses of families with multiple synaesthetes provided evidence to sup-
port the idea that synaesthesia may be a penetrant Mendalian disorder with a dominant
mode of inheritance (Bailey and Johnson, 1997; Baron-Cohen et al., 1996). As noted
above, approximately 40% of synaesthetes report having a first- or second-degree rel-
ative with synaesthesia (Baron-Cohen et al., 1996; Ward and Simner, 2005) and there
is evidence to suggest this figure may yet be an under-estimation. Because differ-
ent forms of synaesthesia can co-occur in families (e.g., Ward and Simner, 2003),
the presence of a synaesthete with a different manifestation may not be immediately
apparent to other synaesthetes in that family. Indeed, systematic screening of first-
degree relatives of known probands has revealed that 11% of relatives identified as
non-synaesthetes by the proband were actually synaesthetes of a different type (Bar-
nett et al., 2008). Furthermore, when combined with the likelihood that a significant
number of people will not be aware that synaesthesia is an unusual phenomenon or
will not have discussed it with other family members, the reported recurrence rate of
40% is best interpreted as a minimum figure.
While detailed data for familial recurrence in synaesthesia are limited or non-
existent (e.g., recurrence rates for siblings and concordance rates for twins), this initial
picture indicates that synaesthesia is a reasonably heritable condition. By means of
comparison, the overall lifetime risk of developing multiple sclerosis if you have a first
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degree relative with the condition is only 2.9% (Nielsen et al., 2005).
4.2.1 Summary of the current position in the search for synaesthe-
sia genes
At present, the search for genes underpinning synaesthesia is in its infancy. Empir-
ical evidence linking specific areas of the genome to synaesthesia is limited to two
published studies1 (Asher et al., 2009; Tomson et al., 2011), both of which are fam-
ily based linkage studies. I review these studies below, and evaluate what they tell us
about the current understanding of synaesthesia genetics.
Asher et al. (2009) carried out the first whole-genome scan2 for possible synaes-
thesia genes using a sample of 196 individuals, consisting of 121 affected and 68 un-
affected individuals (7 phenotypes were unknown) from 43 multiplex families. The
authors of this study chose a phenotype of synaesthesia they called “auditory-visual”
synaesthesia, and which was defined as the experience of colour triggered by sounds
and/or spoken words. Today, this would be recognised as two or three distinct variants:
grapheme-colour, day-colour and music-colour synaesthesias. After initial analysis us-
ing microsatellite markers (short, repeating sequences of base pairs), fifteen potential
regions of interest were identified as being potentially linked to synaesthesia. After a
secondary analysis carried out at higher density using additional markers, this number
was subsequently reduced to four candidate regions. Significant linkage to chromo-
some 2q24 was found, and in addition, suggestive linkage to chromosomes 5q33, 6p12
and 12p12 was also reported. Because the mode of inheritance is unknown and be-
cause preliminary analysis revealed that parametric analysis was a poor fit to the data,
Asher et al. (2009) employed a non-parametric approach to analysis. In this context,
1An additional study by Gregersen et al. (2013) has been published exploring genetic links between
synaesthesia and absolute pitch, but this study used the same genetic data collected for Asher et al.
(2009)
2A linkage study that covers the whole genome is not the same as a genome wide association study
(GWAS). Linkage studies generally require the pedigrees of each participant to be known, so are usually
carried out with family groups. Association studies do not require the pedigrees of the subjects, so are
typically conducted with unrelated individuals
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a parametric analysis requires the specification of a genetic model prior to analysis,
whereas non-parametric analyses make no assumptions regarding the inheritance pat-
tern of the condition under investigation. This means that non-parametric analyses are
more sensitive to linkage detection than parametric techniques, but with the trade-off
being a reduction in specificity due to detected linkage peaks being typically larger
(Barrett and Teare, 2011).
Tomson et al. (2011) also conducted a linkage study, using a sample of 48 individu-
als from five multiplex families, in which they genotyped 24 affected and 24 unaffected
individuals. They choose a synaesthesia phenotype they defined as “colour sequence
synaesthesia” which includes coloured letters, numbers, weekdays and months. This
amalgamation of multiple subtypes had been suggested by Novich et al. (2011)’s find-
ing that certain subtypes of synaesthesia cluster together, so that if a person has a type
of synaesthesia that has colour as a concurrent (e.g., grapheme-colour synaesthesia)
they are more likely that members of the general population to have additional sub-
types that also have colour as a concurrent experience (e.g., day-colour synaesthesia)
(see below). Carrying out both parametric and non-parametric analyses, Tomson et al.
(2011) report linkage to chromosome 16 in two of the five families they tested. Given
that all five families were phenotyped as having ”colour sequence synaesthesia” but
three families showed no linkage to this region, this demonstrates that this locus is not
essential for the development of this form of synaesthesia and other loci are most likely
also involved. Furthermore, the sample size in this investigation is small, which limits
the strength of any conclusion to be drawn from these data.
4.2.2 Evaluation of the current position
Interpreting the findings of Asher et al. (2009) and Tomson et al. (2011) requires the
discussion of several potential confounding factors. It is currently unknown whether
synaesthesia is itself a single condition with common genetic roots or an umbrella
term for a collection of gentically distinct - yet phenotypically similar - conditions.
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Evidence that members of the same family can experience quite different forms of
synaesthesia point to a common genetic predisposition to develop synaesthesia in some
form. On the other hand, the study by Novich et al. (2011) described above, demon-
strated that various subtypes of synaesthesias occur in clusters. Subtypes in the same
cluster are statistically more likely to co-occur in an individual, while the probability
of experiencing a subtype across clusters remains at chance levels. Novich et al. (2011)
identified five independent clusters, which suggests that the development of different
types of synaesthesia may arise from distinct neural mechanisms, which may in turn
have their own genetic origins.
We have seen here that Asher et al. (2009) and Tomson et al. (2011) report linkage
to different regions of the genome. There are several reasons why this may be the case.
Each study chose to investigate synaesthetic phenotypes which only overlap in part.
Asher et al. (2009) included participants with auditory-visual synaesthesia, defined as
participants that experienced colour sensation induced by music and also colour in-
duced by spoken words. Participants in Tomson et al. (2011) experienced a “colour
sequence synaesthesia”, defined as experiencing colour from either letters, numbers,
days or months. It is possible the different regions reflect the differences in phenotype
selected by each investigation, and that as per Novich et al. (2011)’s suggestion, each
phenotype originates from independent genetic origins. It is unclear how much the
phenotypes overlap between studies and indeed how many of the synaesthetes tested
may experience multiple forms. Only Tomson et al. (2011) provide a rigorous justifi-
cation of their phenotype selection, taking Novich et al. (2011)’s findings into consid-
eration. Another difference across studies is that although in both studies, phenotypes
were validated by assessing consistency of response, methodological differences make
it more difficult to directly compare both investigations. Asher et al. (2009) used a
long-term consistency approach (Asher et al., 2006), in which subjects were given a
minimum one month interval between tests. In contrast, Tomson et al. (2011) used
short-term consistency in which participants were tested with a single test session (us-
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ing The Synesthete Battery). For a detailed comparison of single-session and long
interval consistency testing, see Chapter 1. Furthermore in Chapter 6, I will also make
a detailed empirical comparison of these different testing methods (see Chapter 6).
So in summary, what do these two genetics studies tell us? From the existing ev-
idence, drawing firm conclusions about the genetic origins of synaesthesia is not yet
possible. No genes have been discovered and the mode of inheritance has not yet been
elucidated. There are several possible reasons why multiple areas of the genome have
been identified as being linked to the development of synaesthesia. Independently, both
studies emphasise the idea that synaesthesia is most likely a heterogeneous condition.
It could therefore be a case of etiologic heterogeneity, whereby identical genes result
in different phenotypic outcomes, or the opposite, genetic heterogeneity, whereby dif-
ferent genes produce the same phenotype. The current evidence does support the idea
that synaesthesia is likely to have complex genetic origins, with significant genetic and
etiologic heterogeneity likely to be a feature of this phenomenon.
As with many complex genetic conditions, environment-gene interactions may also
play a significant role. It is not unreasonable to suggest some form of critical period
may exist, whereby exposure to relevant stimuli may influence the synaesthetic pheno-
type experienced by the individual. To provide a rather extreme example, grapheme-
colour synaesthesia is unlikely to develop without exposure to writing in early life.
It must also be acknowledged that synaesthesia may be both a “complex trait” and
“rare variant” condition. For example, while it is possible that a majority of synaes-
thesia cases may be caused by the combined influence of numerous genetic loci (i.e., a
complex trait), some others may arise as a result of rare or new mutations (i.e., a rare
variant). In terms of the phenotype, they may appear identical, despite having distinctly
different genetic origins. Although existing evidence may lean towards the former, this
does not preclude the possibility that a proportion of synaesthesia cases arise due to
rare and novel genetic variants. These unresolved issues in our understanding of the
genetics of synaesthesia is one motivation for my own genetics study to be presented
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in this thesis (see Chapter 7). Before then however, I address one final issue regarding
the genetics of synaesthesia and then move onto an overview of the genes known to be
implicated in MS.
4.2.3 X chromosome
A significant early hypothesis regarding the inheritance of synaesthesia concerned the
possible involvement of the X chromosome as a region of interest (Bailey and Johnson,
1997; Baron-Cohen et al., 1996). The X and Y chromosomes are the chromosomes
which determine sex of an individual; females carry two copies of the X chromosome
and males carry one copy of an X and one copy of a Y chromosome. Interest in the
X chromosome within synaesthesia research was initially sparked by an apparent lack
of father-to-son transmission of synaesthesia, and by early reports in the literature that
prevalence that was significantly skewed in favour of females (e.g., Cytowic, 1993).
Indeed, early studies reported prevalence ratios as high as 95% female in some cases
(Baron-Cohen et al., 1993; see Chapter 1). One possibility to explain this apparent lack
of male-to-male transmission and early female bias was that synaesthesia phenotype
may be linked to lethality in males in utero (Baron-Cohen et al., 1996). This hypoth-
esis was rejected by Ward and Simner (2005), who observed the ratio of male-female
relatives in the families of synaesthetes did not significantly differ from the expected
50:50 ratio.
Given that neither Asher et al. (2009) nor Tomson et al. (2011) report any asso-
ciation with the X chromosome and Asher et al. (2009) present hitherto unreported
cases of father-to-son transmission in their sample, it seems unlikely that the X chro-
mosome plays a major role in the genetics of synaesthesia. Recent studies report a
more equal sex ratio and provide evidence that previously reported skewed prevalence
findings are likely to be due in part to self-referral confounds. Work conducted in this
thesis also supports this finding (please see Chapter 7 for a full discussion of my study
investigating synaesthesia genetics).
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4.3 Genetics of multiple sclerosis
In comparison to synaesthesia, research into the genetics of multiple sclerosis is a
well established field stretching back several decades. Hundreds of studies have been
carried out, culminating in state of the art genome wide association studies involving
more than 10,000 affected individuals (e.g., Consortium et al., 2011, Consortium et al.,
2013). Our current understanding of MS points to a complex and heterogeneous con-
dition, the susceptibility to which is governed by a complicated interaction between
genes and multiple environmental factors such as nutrition and exposure to sunlight
(McElroy and Oksenberg, 2008). This interaction is neatly illustrated by the differ-
ence in concordance rates in monozygotic twins of 25-30% and dizygotic twins of
2-5% (Sadovnick et al., 1993), indicating that the genetic component of MS is strong
and environmental and epigenetic factors are also significant.
Excluding the influence of the environment on MS, the genetics of this disease
are themselves exceptionally complicated. Increased sample sizes, increased ability
to sequence the genome in greater detail, lower costs and greater technical capacity
for data analysis have led to an increasing number of causative loci being identified.
Furthermore, as the field matures, the increasing requirement for findings to be repli-
cated in independent studies before being accepted as bona fide has lead to greater
corroboration of existing and novel results. Loci that have a causative effect on the
development and aetiology of MS can be broadly divided into two areas, the Major
Histocompatibility Complex (MHC) (discussed in more detail below) and the rest of
the genome. First reported in 1972 (Bertrams and Kuwert, 1972; Naito et al., 1972),
the first, most replicated and most significant result in MS genetics was the discovery
of the involvement of the MHC locus (McElroy and Oksenberg, 2008). The effect this
region on chromosome 6p21 has on MS considerably dwarfs the contribution of the
rest of the genome (Consortium et al., 2005;Ramagopalan et al., 2009). Nonetheless,
there are many other regions which confer additional risk of developing MS or influ-
ence disease outcome in some capacity. To date, 110 causal variants in 108 separate
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loci have been identified (Consortium et al., 2013), with more likely to be found in
the foreseeable future. The current picture of MS genetics shows a condition charac-
terised by etiologic and genetic heterogeneity, with susceptibility and disease course
governed by a complex set of gene-gene and gene-environment interactions (McElroy
and Oksenberg, 2008).
4.3.1 The major histocompatibility complex
What is the major histocompatibility complex and why is it of interest in synaesthe-
sia research? The major histocompatibility complex (MHC) - also referred to as the
human leukocyte antigen (HLA) in homo sapiens - is a 3.5MB region located on chro-
mosome 6p21 (Muers, 2011). It is the most gene dense region of the human genome
and is heavily implicated in the immune system and autoimmune disease susceptibility,
with an estimated 22% of genes in this region serving an immunoregulatory function
(Fernando et al., 2008). One of the primary roles carried out by MHC proteins involves
the presentation of antigens to T-cells, allowing the immune system to differentiate be-
tween self and non-self cells and initiate an appropriate immune response (Janeway
et al., 2001). There are several characteristics of the MHC that make differentiating
causative effects of individual loci a significant challenge (Traherne et al., 2006). It is
a highly polymorphic region, meaning the genes in this region may exist in many com-
mon versions. If a gene linked to a disease or trait exists in many alleles, identifying
the specific allele responsible for that disease is more difficult than if the gene existed
only in 2 or 3 variants (Trowsdale and Knight, 2013). It is also a gene dense region
with high linkage disequilibrium, meaning actual causal genes are harder to differen-
tiate from the many genes close by that are likely to be inherited in concert with the
causal gene as a consequence of their proximity.
Given its functional focus on immunity, it is unsurprising that robust associations
between loci found at the MHC and a wide range of (auto)immune conditions have
been discovered, including irritable bowel syndrome (IBS), Celiac disease, Myasthenia
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gravis and Crohn’s disease to name but a few (de Bakker et al., 2006). Furthermore,
as we noted above, the oldest, most significant and most replicated genetic finding
for multiple sclerosis is also found within the MHC (Patsopoulos et al., 2013). As
noted, this region of the genome provides the most significant association with risk
of developing multiple sclerosis (Patsopoulos et al., 2013), accounting for between
17-62% of genetic susceptibility to MS (Haines et al., 1998). Within this locus, the
gene HLA-DRB1 has been repeatedly shown to have the strongest effect on multiple
sclerosis. Consequentially, if there is a genetic link between multiple sclerosis and
synaesthesia, examining the MHC is one of the most logical places to start looking.
In this thesis, I examine whether this specific area of the MHC locus, already strongly
implicated in MS, is also linked to the presence of grapheme-colour synaesthesia (see
Chapter 7).
4.4 Genetic overlap between multiple sclerosis and synaes-
thesia
In Chapter 3, I show that the radiological profile of MS is over-represented in synaes-
thetes participating in MRI studies of synaesthesia. What is the nature of this associa-
tion? If there is a causal link between these two conditions, investigating the possibility
of shared genetic aetiology is a highly worthwhile approach. From a methodological
perspective, the vastly more mature MS genetics literature offers a robust and well
researched starting point from which to identify areas of the genome that may be im-
plicated in the development of synaesthesia. Furthermore, some of the areas of the
genome reported by the studies of synaesthesia genetics discussed above also feature
in the MS literature. Specifically, an area of chromosome 2 (2q24) was reported by
Asher et al. (2009) and also Jakkula et al. (2010). Suggestive linkage to region 5q33
in synaesthesia was reported by Asher et al. (2009) and in MS by Consortium et al.
(2005). Similarly, region 12p12 has been linked to both synaesthesia (Asher et al.,
2009) and MS (Vitale et al., 2002). While this is encouraging, caution is also ad-
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vised. The maturity and scale of the MS genetics literature means that more than 100
locations in the genome have been reported as being linked to MS and often, many
of the effects are small. The regions of the genome listed here are also often quite
large, containing many genes. It is therefore possible that even if the same regions of
the chromosome are linked to synaesthesia and MS, different genes within that region
may be linked to each condition.
4.5 Chapter conclusions
Synaesthesia genetics is a field in its infancy. Existing evidence is limited and points
to a heterogeneous condition influenced by multiple loci. MS genetics is significantly
more advanced, confirming MS is an autoimmune condition, the majority of the ge-
netic association coming from a large and complex locus on chromosome 6, called the
major histocompatibility complex, which plays a fundamental role in immunity.
Given the strong association between the MHC and MS, as well as the compelling
evidence that MS is an autoimmune condition, I will take the following approach in the
chapters that follow. In Chapter 5, I will present a new model of synaesthesia in which
I consider whether it might be best considered under the rubric of autoimmune con-
ditions. In this immune hypothesis of synaesthesia, I discuss a theoretical framework
that might link the neurology and genetics of synaesthesia with the finding in Chapter
3 that MS was overly represented in synaesthetes.
Chapter 5
The immune hypothesis of
synaesthesia
5.1 Introduction
In this chapter, I introduce the immune hypothesis of synaesthesia, a novel hypothesis
which proposes the idea that genes which have a dual function - influencing connectiv-
ity in development and immune system function in adulthood - may play a causal role
in the development of the type of altered cortical connectivity thought to be present
in synaesthetes. Sections of this chapter have been published in the form of a journal
article, as Carmichael and Simner (2013) (see Appendix E).
We saw above (in Chapter 1) that current explanations of synaesthesia posit struc-
tural and/or functional differences in the synaesthete brain, and frame their models
in terms of excess cortical connectivity or altered cortical feedback. Yet, it is un-
clear how this altered connectivity may arise and which mechanisms might regulate
it in early development. In this chapter, I propose an immune hypothesis of synaes-
thesia, which supplements these existing models of synaesthesia by suggesting how
such altered connectivity may arise from a genetic standpoint. My hypothesis also
provides a theoretical framework by which to further understand possible associations
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between synaesthesia and comorbidities linked to immunity. For example, in Chapter
3, I present data showing an unexpectedly high prevalence of MS/RIS in synaesthetes.
Because MS is strongly mediated by the immune system (Trapp and Nave, 2008; Con-
sortium et al., 2011), it is plausible that any association between synaesthesia and MS
may originate from immune system impairments that are related. In this chapter, I
first review the dominant neurological models of synaesthesia introduced in Chapter
1. Next, I review the possible genetic bases of these neurological architectures in
synaesthesia. Finally, I show that the genes likely to be implicated in these types of
neurological architectures also have an additional function in the mature brain: one of
immunity.
In Chapter 1, I described the two categories of model that seek to explain the gen-
eration of synaesthetic experiences. The cross-activation model (Ramachandran and
Hubbard, 2001) suggests that excess connectivity between functional areas of the cor-
tex allows activation in one cortical area (e.g., auditory cortex) to directly trigger ac-
tivation in another (e.g., visual cortex). Evidence in support of this model comes for
example from diffusion tensor imaging (DTI) and shows that excessive connectivity is
indeed a feature of the synaesthetic brain (Rouw and Scholte, 2007). Re-entrant and
disinhibited feedback models propose that synaesthetic sensations are caused by dis-
inhibited feedback from higher cortical areas (e.g., in parietal lobe) failing to suppress
non-relevant activation from lower cortical areas (Grossenbacher and Lovelace, 2001).
This type of disinhibited feedback may result from excessive activity of excitatory
neurons within the delicate balance between both excitatory and inhibitory neurons in
the brain (Hubbard et al., 2011). Despite appearing superficially different, connectiv-
ity and feedback models need not be mutually exclusive. It is unlikely that altered
feedback happens entirely in the absence of changes in cortical connectivity, given
the Hebbian principle that simultaneous activity strengthens interconnectivity between
neurons. Therefore, these two approaches might be considered somewhat unified in
that connectivity models propose aberrant connectivity as the primary causal mecha-
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nism underlying synaesthesia whereas feedback models might allow altered connec-
tivity as an indirect consequence of disinhibited feedback.
While these models are now more than a decade old, explanations of how these
cortical characteristics might arise have proven elusive thus far (but see Brang and Ra-
machandran, 2008; Mitchell, 2013) and I explore this here. Synaesthesia is thought
to be primarily neurodevelopmental in nature (Spector and Maurer, 2009). Conse-
quentially, known processes of brain development are likely to be implicated in its
emergence. I propose that insight might be gained from examining the functionality
of genes that regulate the types of altered synaesthetic cortical connectivity assumed
in these models above (i.e., genes for axon guidance, synapse density). This is the
approach I follow below.
5.2 Dual gene functionality: connectivity and immu-
nity
As noted above in Chapter 1, current models link synaesthesia to altered structural con-
nectivity, misregulated feedback mechanisms, or a combination thereof. Explaining
how synaesthesia develops might therefore come from considering the genes known
to be responsible for the development of cortical connectivity. The key point I make
in the current chapter is that such genes - responsible for processes such as synaptic
pruning and axon guidance in early brain development - also tend to have a dual func-
tion. Crucially, this function is an immune one (for review, see Boulanger, 2009). I
therefore ask here whether a propensity to develop synaesthesia via atypical regulation
of synaptic pruning may be linked to the expression of genes also implicated in im-
munity in the CNS, since this expression can be conferred by genes with functions of
both immunity and cortical development. Put differently, I ask whether synaesthesia
may be linked not only to altered cortical connectivity but also to the expression of
immune genes. Many genes have been shown to have precisely the dual functionality
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described above (Boulanger, 2009). As well as their immunity function, such genes act
in cortical development, altering structural and/or functional connectivity by influenc-
ing the development of axonal guidance, synaptic connectivity, and synaptic pruning.
One outcome of these changes may therefore be the anomalous pattern of connectivity
proposed by the cross-activation theory in the development of synaesthesia. Alterna-
tively, the immune system could have a direct influence on excitatory neuronal activity,
leading to the outcomes proposed by disinhibited feedback models. This is because
the immune system plays an important role in the initial development and subsequent
plasticity of glutamatergic synapses, the primary excitatory transmission pathway in
the mammalian cortex (Fourgeaud and Boulanger, 2010). Below, I evaluate this novel
theory in more detail.
5.3 Can the immune system influence the development
of the brain?
Is it plausible to make a link between the immune system and regulation of the central
nervous system (CNS)? Isolated from the rest of the body by the blood-brain-barrier,
the CNS was once thought to barely interact with the immune system, leading to the
long held view that the CNS was “immune privileged” (McAllister and van de Water,
2009). However, research now shows a complex communication between the CNS
and immune system, with wide-reaching consequences for brain regulation and devel-
opment, both in health and disease (Elmer and McAllister, 2012). Immune proteins
are known to play a role at many stages in the developmental pathway. They are in-
tegral components of phases critical to brain development and plasticity, such as neu-
ronal guidance, synapse development, and synaptic remodeling (Boulanger, 2009). I
therefore hypothesize that CNS and immune system interaction may be the biological
mechanism which confers the predisposition to develop synaesthesia.
Which aspects of the immune system are known to exhibit the type of dual func-
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tionality under discussion in this chapter (i.e., functionality in both immunity and
cortical development)? Several areas of this extraordinarily complicated system are
worth highlighting. The complement system is one possible candidate, this being a
complex cascade of protein interactions involved in immunity which has also been
shown to play an important role in tagging of synapses to be eliminated by pruning
during development1 (Stephan et al., 2012). Another candidate relates to cytokines,
which are immune proteins that have also been shown to play significant roles in neu-
rogenesis and synaptic plasticity (Bauer et al., 2007). A third candidate relates to
major histocompatibility complex (MHC) proteins, described in the previous chapter.
MHC proteins are an integral part of the adaptive immune system found on the sur-
face of the majority of nucleated cells and widely expressed in neurons of the CNS
(Boulanger, 2004). In addition to fulfilling a crucial function in immune response,
MHC class I molecules and related components are thought to be involved in a range
of developmental processes, such as activity-dependent plasticity and synaptic refine-
ment (Boulanger, 2009), in other words, processes responsible for the development of
cortical connectivity. As noted in Chapter 4, the MHC locus contains several hundred
genes, and has also been widely implicated in a range of autoimmune conditions, such
as multiple sclerosis (MS), irritable bowel syndrome (IBS), and rheumatoid arthritis
(Fernando et al., 2008). While I have highlighted three specific areas of interest above,
I also point out that the immune system consists of many hundreds of individual factors
and processes. Given this, the specific suggestions of complement proteins, cytokines
and the MHC listed are by no means exhaustive. Nevertheless, I consider them to each
be plausible candidates for future investigation.
I end this section by asking whether existing studies into the genetics of synaes-
thesia would support my immunity hypothesis. In other words, have these studies
identified areas of the genome containing immune system genes? I noted above that
1A blog writer, C Wright, has written blog posts linking synaesthesia to the complement system.
She would like it acknowledged that her ideas were written prior to the publication of this thesis and the
article by Carmichael and Simner, 2013
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research into synaesthesia genetics is in its infancy and as yet, there are insufficient data
to draw firm conclusions. No synaesthesia genes have yet been identified and no firm
mode of inheritance has yet been elucidated. However, evidence from the two existing
studies on the genetics of synaesthesia (Asher et al., 2009; Tomson et al., 2011) have
identified several chromosomal regions of interest, and these regions do indeed contain
immune function genes. Asher et al. (2009) found significant linkage to chromosome
2q24 and possible linkage to areas on other chromosomes (5q33, 6p12, and 12p12),
while Tomson et al. (2011) identified a candidate region on chromosome 16q12.2-23.1.
The authors of both studies draw the conclusion that synaesthesia is likely to be a con-
dition influenced by a variety of genes in multiple loci. Nonetheless, the chromosomal
regions of interest highlighted in these two investigations do contain immune function
genes (e.g., interleukin-17, a cytokine protein found on chromosome 6p12), although
there are many other viable candidates that also lie outwith these regions. As such,
prior synaesthesia genetics studies may be suggestive of immunity-linked regions also
being linked to synaesthesia but the picture they paint is likely to be more complicated.
5.4 The immune hypothesis as a framework for synaes-
thesia and co-morbidity
An immune hypothesis of synaesthesia might additionally explain recent co-morbidity
data which suggests that having synaesthesia may be associated with increased risk
of other clinical conditions. In Chapter 2, we saw that Carruthers et al. (2012) report
an association between synaesthesia and IBS, having found an elevated prevalence of
synaesthesia in a population of IBS patients. Other researchers have raised the pos-
sibility that synaesthesia may also be found at elevated rates within populations with
autism (Baron-Cohen et al., 2007) or migraine (Alstadhaug and Benjaminsen, 2010).
I point out here that the immune system plays a prominent role in all of these condi-
tions (Collins, 2002; Bruno et al., 2007; Enstrom et al., 2009), suggesting that altered
immune system function may be a common causal link. If so, my immune model
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proposes a plausible framework by which to investigate comorbidity between synaes-
thesia and other conditions. If this hypothesis is correct, one might ask whether the
prevalence of synaesthesia is also higher in populations with other autoimmune con-
ditions. Indeed, the experiment I presented in Chapter 3 suggests that developmental
synaesthesia might occur more prevalently in people with MS/RIS, a demyelinating
disease of the human CNS, in which a maladaptive immune system is an undisputed
factor (Trapp and Nave, 2008), and in which the majority of genes implicated do have
an immune function (Gourraud et al., 2012). This statistical link between MS/RIS and
synaesthesia, along with a plausible immune hypothesis of synaesthesia, might there-
fore lead us to investigate whether synaesthesia and autoimmune conditions such as
MS could share overlapping genetic origins, and this is the aim of the two chapters
that follow.
5.5 Conclusions
In this chapter, I proposed a novel hypothesis that CNS/immune system interactions
during early life may play a role in the development of synaesthesia. I have asked
whether genes with dual functionality in both brain development and immunity may be
at the origin of existing models of synaesthesia, and whether this mechanism could pro-
vide a framework to investigate associations between synaesthesia and other immune-
related conditions. Identification of genes that contribute to the development of synaes-
thesia will make a significant contribution to the validity of this hypothesis, and whether
synaesthesia has one cause or many. Given this, I present a phenotypic and genotypic
analysis of synaesthesia in the following two chapters.
Chapter 6
Phenotyping synaesthesia: Validating
the Synesthesia Battery’s short-term
test for synaesthesia
6.1 Introduction
Previously, in Chapter 5, I presented the immune hypothesis of synaesthesia, outlining
a theoretical framework by which synaesthesia, immunity and immune related comor-
bid conditions (e.g., MS) may be linked by common genetic origins. In this and the
following chapter, I introduce empirical work relating to the phenotyping and the geno-
typing of synaesthesia. Phenotyping relates to how to identify genuine synaesthetes via
their behavioural traits, and is an essential step for accurate genotyping of synaesthesia
(i.e., looking for areas of the genome linked to synaesthesia).
In order to phenotype (identify genuine synaesthesia), reliable, validated tools are
essential. In this chapter, I report empirical work in which I assess what has become
the most widely used online test for synaesthesia: The Synesthete Battery (Eagleman
et al., 2007). In Chapter 1, we saw that this diagnostic test for synaesthesia relies
on assessing the consistency by which synaesthetes report their synaesthetic colours.
84
Chapter 6. Phenotyping synaesthesia: Validating the Synesthesia Battery’s short-term test for synaesthesia85
Below, I briefly review the nature of this assessment tool and then describe why a
validation of this tool would be highly useful before I use it to identify the synaesthetes
that will be genotyped in the following chapter. Sections of this current chapter have
been published in the form of two journal articles, Simner and Carmichael (2015) and
Carmichael et al. (2015) (see Appendices I and G).
Synaesthesia was initially an under-researched and poorly-understood area of cog-
nition until the last decades of the 20th century until the realisation emerged that
synaesthetes experiences could be verified behaviourally by the fact that they remain
conspicuously stable over time (Jordan, 1917; Baron-Cohen et al., 1987). Specifically,
synaesthetes tend to be highly consistent when reporting their synaesthetic sensations
for any given stimulus. For example, if the letter J triggers the colour pale blue for a
given synaesthete, the synaesthete will tend to repeat that J is pale blue (not green, not
yellow) when repeatedly tested over days, months and even years. Indeed, one study
was able to show that synaesthetic sensations had remained consistent over at least
three decades (Simner and Logie, 2008).
As discussed in Chapter 1, this stability of response over time is considered one
of the central features of synaesthesia and is routinely verified in almost every pub-
lication on the subject (e.g., Asher et al., 2006;Baron-Cohen et al., 1996;Rich et al.,
2005; Ward and Simner, 2003; but see Simner and Ludwig, 2012). In other words,
while a wide range of behavioural approaches have been employed to phenotype the
synaesthetic experience, experimental methodologies aiming to validate synaesthesia
have almost exclusively focussed on the feature of consistency. Researchers selecting
synaesthete participants for study first verify the genuineness of each case by requir-
ing their synaesthetes to demonstrate high levels of consistency over time compared
to non-synaesthete controls (e.g.,Asher et al., 2006; Baron-Cohen et al., 1996; Simner
et al., 2006b). Controls are tested on analogous associations (i.e., they invent colours
for the 26 letters, say, and then attempt to recall these later) and typically perform
significantly worse than synaesthetes.
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Although the majority of contemporary studies rely on this test of consistency for
genuineness, the particular instantiation of the test has varied widely. For example, a
wide range of methods have been used to elicit synaesthetic colours: participants have
indicated these by either giving verbal descriptions (e.g., Ward et al., 2005), written
descriptions (Simner et al., 2006a), using Pantone c© swatch colour charts (Asher et al.,
2006), electronic colour charts (Simner et al., 2009a) or even computerised colour
pickers offering extensive palettes of >16 million colours (e.g., Simner and Ludwig,
2012).
Despite this superficial variability, earlier tests of consistency nonetheless tended
to rely on one key shared feature: synaesthetes must outperform controls over fairly
lengthy re-test intervals. Consider, for example, the most widely cited large-scale
screening for synaesthesia (Simner et al., 2006b) in which a large sample of partic-
ipants were opportunistically recruited from the communities of Edinburgh and Glas-
gow Universities, and individually assessed for synaesthesia. Participants first indi-
cated by questionnaire whether they believed they experienced synaesthesia, and those
who reported in the affirmative were asked to provide their synaesthetic associations
(e.g., the colours of letters). These participants were then retraced after considerable
time had passed (on average 6.0 months, but up to several years) and were asked in a
surprise retest to re-state their associations. A group of controls without synaesthesia
performed an analogous task but were re-tested after only two weeks. Synaesthetes
were required to significantly out-perform controls even though much time had passed
and the deck was effectively stacked against them. Methodologies such as this allow
confident detection of genuine synaesthetes because the surprise retest over lengthy in-
tervals places the performance of synaesthetes beyond the usual abilities of the average
person. The drawback to this methodology, however, is that the task is extremely time-
intensive to perform, and risks a high drop-out rate if synaesthetes become untraceable
at retest.
Perhaps for this reason, one of the most important developments in the method-
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ology of synaesthesia validation came with the introduction in 2007 of an alternative
version of the test of genuineness. In place of classical long-term retests, Eagleman
and colleagues instead championed the short-term retest method. Eagleman et al.
(2007) introduced the Synesthesia Battery, a toolbox of online tests which provides
a test of consistency measured within a single test session lasting only approximately
10 minutes. Specifically, synaesthetes log on to the testing site (www.synesthete.org)
and specify which forms of synaesthesia they experience. The testing platform then
presents their triggering stimuli (e.g., the 26 letters) one by one in randomized or-
der, and participants are required to select their synaesthetic colour for each trigger.
Each stimulus (e.g., letter) is presented three times each, and a score is generated to
quantify the consistency of participant’s responses (e.g., did the participant choose the
same/similar colours each of the three times she saw a particular letter?) As described
in Chapter 1, this score represents the geometric distance in RGB (red, green, blue)
colour space, and this score is then normalized to lie between 0 and 1. If the mean over-
all score of colour-distance is less than 1, the participant is classified as a synaesthete;
if the score is 1 or higher, the degree of inconsistency serves to classify the participant
as a non-synaesthete. However, it remains an open question whether this limited retest
interval is sufficient to truly distinguish synaesthetes from non-synaesthetes.
In this chapter, I assessed the validity of the Synesthesia Battery by using it to test
almost 3,000 randomly sampled members of the general population for grapheme-
colour synaesthesia. The aim was to establish the prevalence of grapheme-colour
synaesthesia by this method. This will allow me to evaluate the Synesthesia Battery
by comparing this prevalence - obtained by assessments within a single test session -
to the most widely accepted previous estimate of the prevalence of grapheme-colour
synaesthesia based on the standard long-term retest method (Simner et al., 2006b). If
the Synesthesia Battery is as effective a method for detecting synaesthesia as the more
standard long-term retest method, I anticipate an equivalent prevalence of grapheme-
colour synaesthesia across both methods. For this study, I chose to evaluate grapheme-
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colour synaesthesia in particular for several reasons: it is one of the most common
forms of synaesthesia (Simner et al., 2006b), it is particularly well-understood in be-
havioural terms, it lends itself readily to online testing, and those who experience it
typically demonstrate the high levels of consistency expected from synaesthetes (com-
pared to other variants, whose more complex concurrents make them more difficult
to assess via consistency alone; see Simner et al., 2011 for discussion). My ultimate
aim in this pursuit is to establish whether The Synesthete Battery is an effective way
to phenotype grapheme-colour synaesthetes, and to subsequently identify a group of
randomly sampled grapheme-colour synaesthetes by this method. These synaesthetes
will be genotyped in Chapter 7.
6.1.1 Prevalence and sex ratio
In Chapter 1, I introduced two important questions in synaesthesia research; namely
its prevalence and the perceived difference in prevalence between the sexes. In addi-
tion to evaluating the Synesthesia Battery, the data generated in this chapter will also
provide an independent test of the prevalence of grapheme-colour synaesthesia and
explore whether synaesthesia is significantly more prevalent in females. The baseline
study to be used as comparison with the data I generate from The Synesthete Battery
will be the widely cited prevalence study of Simner et al. (2006b). This study found
the prevalence of grapheme-colour synaesthesia to be 1.4% (for synaesthetes with both
coloured letters and numbers) or 2% (for synaesthetes with either coloured letters or
numbers). This study was based on a sample of 500 individuals, and the prevalence
rate it generated was subsequently verified by a secondary method testing a further
1190 individuals (see Discussion for details of this second method). This current study
provides an opportunity to replicate these findings with a sample of almost 3000 addi-
tional individuals, individually assessed. The individuals in this study were randomly
sampled (see Methods for details) and did not rely on self-referral. As such, the current
study will provide the largest estimate of prevalence of grapheme-colour synaesthetes
to date, and thereby provide a worthy comparison to the previous study I will use as a
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baseline.
My investigation will also allow any potential difference in prevalence of synaes-
thesia between the sexes to be explored. Because self-referral bias during recruitment
will be reduced to a minimum in the current study (see Methods) these data will allow
me to test the hypothesis that any sex difference found in early studies (e.g., Baron-
Cohen et al., 1996) was likely the result of self-referral bias (where women are more
likely than men to self-refer). In our baseline study in contrast, Simner et al. (2006b)
reported no sex differences, with an overall prevalence of grapheme-colour synaesthe-
sia of 1.1%, with a female prevalence of 1.03% and a male prevalence of 1.15%. In
other words, when participants are randomly recruited, the sex difference in synaesthe-
sia is minimised. Using the same random recruitment methods here should therefore
also produce no sex difference in the prevalence of synaesthesia. Finally I point out
that clearly establishing whether there is or is not a skewed sex ratio in the prevalence
of synaesthesia will not only help us confirm whether The Synesthete Battery is a valid
way to phenotype synaesthesia, it will also be useful in its own right in my considera-
tion of synaesthesia’s genetic aetiology (see Chapter 7).
6.2 Experiment 2
The aim of this study is to assess a large sample of randomly recruited members of
the general population for grapheme-colour synaesthesia. This will provide us with a
prevalence estimate of grapheme-colour synaesthesia in the general population, which
I can then compare to the most widely accepted prevalence estimate in the literature
(Simner et al., 2006b). If these prevalence estimates match, we can conclude that the
short-term consistency testing of The Synesthete Battery is as an effective method for
phenotyping synaesthesia as classical long-term methods.
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6.2.1 Methods
6.2.1.1 Participants
Two thousand eight hundred and forty-seven participants took part in this study (1317
male, 1530 female; mean age 28.6, range 16-90, SD 14.3). Thirty-two further subjects
completed our study but had entered an obviously false date of birth (e.g., 2013). These
subjects did not enter our analysis, which was therefore based only on our N=2847.
Participants were recruited as part of a large-scale, centrally co-ordinated under-
graduate research project. Every student registered on the 2nd year of the Psychology
undergraduate course at the University of Edinburgh acted as a research assistant (RA),
and was required to each recruit 8 participants (4 male and 4 female) over 16 years of
age. The student RAs were not allowed to take part in the study themselves. In re-
cruiting the participants, I took a number of steps to ensure as random a sample as
possible. First, RAs were instructed not to deliberately seek out, nor to avoid, people
they knew to be synaesthetes. Furthermore, in order to avoid self-referral biases, RAs
were required to pre-select their sample, and then approach participants in a targeted
way (rather than send out an advert and accept self-referrals). Indeed, RAs were re-
quired to refrain from recruiting participants via any open calls at all, for example, they
could not post the testing URL on social media websites or internet forums. Finally,
RAs were also instructed not to a priori inform participants that the study involved
synaesthesia.
The study was carried out in two waves to maximise participation numbers: 1514
were tested in January 2013, and 1333 were tested in September 2013. Both used
identical methods, carried out by two consecutive intakes of 2nd year students. Data
from both rounds are pooled and presented together here.
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6.2.1.2 Materials/Procedure
My test was presented online and participants were sent an email directing them to
the url. The online test consisted of several sections. Participants first provided in-
formed consent via a checkbox and then gave demographic information such as age,
sex, handedness and native language. A second section consisted of a health ques-
tionnaire in which subjects were requested to indicate if they suffered from a range of
clinical conditions. These data were used to examine comorbidity in synaesthesia and
are reported in Chapter 9). After this page, the short-term consistency test of synaes-
thesia began. In this, we created a locally stored replica of the Synesthesia Battery,
and so all the methods hereafter pertain to this exact replica of that consistency test.
Participants were first asked whether they experienced grapheme-colour synaesthesia,
with the question “Do numbers or letters cause you to have a colour experience?”, This
was accompanied by an example, and then an option to accept separately according to
whether these colours are triggered automatically by numbers and/or digits. If par-
ticipants indicated that they saw neither letters nor numbers in colour, they advanced
to an exit page thanking them for their participation. However, those who answered
in the affirmative went on to complete the short-term consistency test, cloned identi-
cally from the Synesthete Battery. Note that the consistency test was presented only
to those who first self-declared having synaesthesia, and this is the established method
for identifying synaesthetes (e.g., Simner et al., 2006b).
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Figure 6.1: Screenshot from the consistency test
Participants who completed the short-term consistency test did so only for their
self-declared particular variant of grapheme-colour synaesthesia (for either digits, let-
ters, or both). This consisted of two parts, a colour consistency test and a speeded-
congruency task (see below). The colour consistency test was an identical clone of the
consistency test from the Synesthesia Battery (Eagleman et al., 2007). In this, partici-
pants were presented with each grapheme three times in random order (so 30 trials if
the subject reported coloured numbers only, 78 trials if letters only, and 108 trials if
both letters and numbers). For each trial, participants were required to select the colour
that “best matched” the grapheme presented (see Figure 5.1). Selections were made
from a palette of 256x256x256 colours. Once their selection was submitted, the screen
advanced to show the next grapheme.
The colour consistency test was followed by a speeded-congruency task. This
speeded congruency test is also a feature of the Synesthete Battery but it not used as the
primary diagnostic measure of synaesthesia. For this reason, as well as a programming
issue encountered here, this test will not be considered further.1
1After the current single session short-term test of consistency of coloured graphemes, participants
next immediately perform a second test of synaesthesia: a speeded-congruency verification task (Eagle-
man et al., 2007). In this section of the Synesthete Battery, participants are shown again the graphemes
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6.2.2 Results
The short-term consistency test generated a consistency colour-distance score. Here, I
follow the threshold implemented in Eagleman et al. (2007), meaning any participant
scoring < 1 on the short-term consistency test is considered to be a genuine synaes-
thete. For full details of website configuration and how the consistency colour-distance
score is calculated, see Eagleman et al. (2007). In my analysis below, I classified as
non-synaesthetes all those who were directed to the early-exit page (i.e., those who
said they did not experience coloured letters and/or digits) and all those who continued
but scored 1 or higher. The remainder were classified as synaesthetes (i.e., those who
scored < 1).
6.2.2.1 Synaesthesia prevalence
From this sample of 2847 participants, 140 subjects (55 male, 85 female, mean age
23.9, range 16-71, SD 9.5) self-reported grapheme-colour synaesthesia, giving a self-
reported prevalence of 4.9%. Of those 140 self-reported synaesthetes, 34 obtained a
they had just seen in the colour consistency test. This time they see each relevant grapheme twice, in
a random order, each flashed on screen for a maximum of 1 second or until the participant responds
(20 trials for just numbers, 52 trials for just letters or 72 trials for both letters and numbers). In 50%
of trials, graphemes are coloured congruently with the participant’s earlier specification, and in 50%
of trials they are coloured incongruently. Participants are required to indicate by mouse-click whether
each grapheme they saw either matched or didn’t match their previous colour pairing (as collected
during the consistency test; Figure 5.2). Their response mouse-click advanced the test to the next
grapheme, and the test continued until all graphemes had been shown. On completing this study we
discovered we had programmed minor methodological differences to Eagleman et al. (2007) in how
congruent and incongruently coloured graphemes were selected and presented. In this study , the first
presentation of graphemes included 50% that were randomly selected to be presented in their congruent
colour, taken from the participant’s first selection in the prior task. For the second presentation, 50%
of graphemes were again randomly selected to be congruently coloured, this time from the participant’s
second selection from the previous task. The incongruent colours were selected to be sufficiently distant
in RGB space from the congruent colours to prevent the two being confused. However, these incon-
gruent colours were randomly selected in RGB space, and were not taken from the participant’s earlier
palette. In Eagleman et al. (2007), each grapheme was presented twice in a fully randomised order once
congruently (always from the 1st selection given previously) and once incongruently. The incongruent
colour was chosen from the participant’s earlier palette of colours on the consistency test and verified
to be sufficiently distant in RGB space from the congruent colour. The details of this were not given
in the Eagleman paper.) Furthermore in this study, a response press advanced the display onto the next
grapheme, while in Eagleman et al. (2007) the grapheme was displayed for a constant 1s followed by
a fixed inter-stimulus interval. These differences mean I can no longer directly compare my data in
this section to those from Eagleman et al. (2007). Finally I point out that our central aim to assess the
consistency portion of the Synesthesia Battery is unaffected, because this omitted section is not widely
used for this purpose in any case.
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colour-distance score of < 1 on their consistency test (14 male, 20 female, mean age
24.9, range 17-51, SD 5.8), which is the criterion used by Eagleman et al. (2007) to
identify genuine synaesthesia. This places the prevalence of genuine grapheme-colour
synaesthesia at 1.2%.
Of the 140 self-reported synaesthetes, 55 reported experiencing coloured numbers
only, 58 reported experiencing both coloured numbers and letters and 27 subjects re-
ported experiencing coloured letters only (see Figure 6.2a).
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Letters and numbers Numbers only Letters only

























Numbers & letters Numbers only Letters only
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Figure 6.2: Variants of grapheme-colour synaesthesia reported by (a) all 140
participants who self-reported synaesthesia, and (b) the 34 participants con-
firmed as genuine synaesthetes (i.e., with colour-distance consistency scores of
< 1).
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Of the 34 participants that scored < 1 on the consistency test, 17 experienced
coloured numbers only, 14 experienced both coloured numbers and letters and 3 sub-
jects experienced coloured letters only (see Figure 5.3b). As an additional check, the
colour choices of the participants obtaining a consistency score of < 1 were examined
individually to allow us to confirm that none of these achieved their superior consis-
tency by entering the same colour for each grapheme, or by entering an obviously
non-synaesthetic pattern of colours throughout, e.g. red for R, green for G and blue for
B (see Simner et al., 2006b).
6.2.2.2 Comparing short and long-term consistency testing
The key aim of this study was to compare the prevalence of grapheme-colour synaes-
thesia generated by the Synesthesia Battery (a short-term, single-session test) to a more
conventional method based on long term (rather than single session) testing (Sim-
ner et al., 2006b). Using the Synesthesia Battery, the prevalence of grapheme-colour
synaesthesia in the general population was found to be 1.2% for those with coloured
letters or digits, compared to the previous estimate of 2% in conventional longer-term
testing (Simner et al., 2006b). These two estimates are not significantly different (χ2 =
2.1; df = 1; p = 0.14). However, if the prevalence for synaesthetes with both coloured
letters and digits is calculated, a value of 0.5% is found, which is significantly less than
the 1.4% found in conventional longer term retesting (Simner et al., 2006b; χ2 = 5.6;
df = 1; p = 0.02).
One recent study has also speculated that the threshold in the Synesthesia Battery
perhaps should be raised. Rothen et al. (2013) have recently argued that a more ap-
propriate cut-off may indeed be higher, and their argument relates to considerations
of colour space. Eagleman et al. (2007) evaluates consistency using distance in RGB
space but Rothen et al. (2013) suggest that alternative colour models (CIELUV and
CIELAB) might provide more sensitive measures. On this basis they proposed a
revised threshold within the existing Synesthesia Battery at < 1.43 for synaesthetes
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(rather than < 1). In this study, if prevalence is recalculated in this sample using
Rothen et al. (2013) suggested cut-off score of 1.43, our prevalence estimates are no
longer significantly lower than expected. With this revised threshold, I now find 70
genuine synaesthetes with coloured letters OR digits (2.5%; compared to 2% in Sim-
ner et al., 2006b; χ2 with Yates correction = 0.4; df =1; p = 0.53) and 31 synaesthetes
with coloured letters AND digits (1.1%; compared to 1.4% in Simner et al., 2006b;
χ2 with Yates correction = 0.143; df =1; p = 0.706). In other words, our results are
more in line with more conventional longer term evaluations of synaesthesia when the
threshold is shifted upwards according to the proposal of Rothen et al. (2013).
6.2.2.3 Sex ratio
In addition to using total prevalence as a proxy for evaluating the validity of the Synes-
thete Battery, comparing the prevalence of female and male synaesthetes is also a use-
ful additional benchmark. In this investigation, a total of 2847 participants were tested,
1530 female and 1317 male. From this sample, we identified a total of 34 grapheme-
colour synaesthetes, giving an overall prevalence of 1.2%. Of these 34 synaesthetes,
20 were female and 14 were male. Examining the synaesthesia prevalence of each sex
separately gives us a female prevalence of 1.3% and a male prevalence of 1.1%. The
difference in prevalence between males and females is not significant (χ2 = 0.358; df
= 1; p = 0.55).
These results corroborate the findings of our baseline comparison study. In the
museum part of their study (testing 1190 visitors to a science museum), Simner et al.
(2006b) reported an overall prevalence of grapheme-colour synaesthesia of 1.1%, with
a female prevalence of 1.03% and a male prevalence of 1.15%. Comparing the sex
ratio results from my current study with the results of Simner et al. (2006b) using a
Cochran-Mantel-Haenszel test reveals no significant difference (χ2MH = 2.14; df = 1; p
= 0.14). In other words, the difference in sex ratio in this investigation does not differ
significantly from the ratio found by Simner et al. (2006b).
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Examining these data acquired in my study from a Bayesian perspective corrobo-
rates the above statistical interpretation. By comparing the likelihood of two models
(in this case, the null and alternative hypotheses) as a ratio, Bayes factors allow us to
evaluate to what extent the data supports the hypothesis under investigation (Rouder
et al., 2009). Following Jeffreys (1961), a Bayes factor of less than 0.33 provides strong
support for the null hypothesis, a Bayes factor of greater than 3 provides support for
the alternative hypothesis and values in between indicate the data are insensitive and
no firm conclusions should be drawn. We calculated a Bayes factor of 0.012, indi-
cating that the sex of the person does not significantly alter the likelihood of having
grapheme-colour synaesthesia.
6.2.3 Discussion
In this study, I reproduced elements of the Synesthesia Battery (Eagleman et al., 2007)
which is a short-term online consistency test to diagnose (i.e. phenotype) grapheme-
colour synaesthesia. One aim of this chapter was to verify this as a valid method to
phenotype synaesthetes (in preparation for the subsequent genotyping of these synaes-
thetes in Chapter 7). I also used this method to estimate the prevalence of grapheme-
colour synaesthesia in a very large randomly recruited sample - indeed the largest sam-
ple for this purpose to date. I found the prevalence of grapheme-colour synaesthesia in
the general population to be 1.2% for those with coloured letters or digits, compared to
the previous estimate of 2% (Simner et al., 2006b). These two estimates are not signif-
icantly different (χ2 with Yates correction = 1.55; df = 1; p = 0.2131). However, if the
prevalence of synaesthetes with both coloured letters and digits is calculated, a value
of 0.5% is found, and this is significantly less than the 1.4% found in conventional
longer term retesting (Simner et al., 2006b; χ2 with Yates correction = 4.3; df = 1; p
= 0.04). Hence, the Synesthesia Battery numerically under-estimated the prevalence
of those with coloured letters and digits, compared to longer retesting methods. The
possible reasons for this are explored below.
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One explanation for an under-estimation of prevalence in the Synesthesia Battery
might stem from the way graphemes are presented to those who report more than one
variant: letters and digits are presented together, randomly ordered within the same
consistency test. In longer term retesting however, letters and digits were always pre-
sented in separate blocks (Simner et al., 2006b). It may therefore be that synaesthetes
are susceptible to interference when selecting colours for graphemes, and I raise this
possibility for future studies to consider.
One recent study has also speculated that the threshold in the Synesthesia Battery
perhaps should in fact be raised. Rothen et al. (2013) have recently argued that a
more appropriate cut-off may indeed be higher, and their argument relates to consider-
ations of colour space. Eagleman et al. (2007) evaluates consistency using distance in
RGB space but Rothen et al. (2013) suggest that alternative colour models (CIELUV
and CIELAB) might provide more sensitive measures. On this basis they proposed
a revised threshold within the existing Synesthesia Battery at < 1.43 for synaesthetes
(rather than < 1). The discussion above of where to set the cut-off threshold for con-
sistency in the Synaesthesia Battery might be considered part of a more fundamental
concern in synaesthesia research. In all kinds of consistency tests for synaesthesia -
and particularly obvious here - participants are divided into two groups by their score
on what is in fact an incremental continuum. It seems clear that someone who scores
1.05 on the consistency test is “more synaesthetic” than someone scoring 2.48, yet
according to the cut-off of < 1 (or indeed any cut-off), both would be considered
non-synaesthetes. Nonetheless, it is a particular strength of the Synesthesia Battery
that researchers are free to consider this score in its own right, rather than for cate-
gorical groupings alone. It is also worth highlighting that the age range of genuine
synaesthetes meeting the cut-off threshold of < 1 is narrower than the age range of
self-declared synaesthetes (16-51 years old for genuine synaesthetes, as opposed to
16-71 for the initial self-declared group). In other words, participants over the age of
51 who reported having synaesthesia, were not consistent enough to meet the consis-
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tency cut-off of < 1. This is perhaps additional evidence that the threshold should be
increased to the < 1.43 proposed by Rothen et al. (2013) in order to increase the sen-
sitivity of the test. Alternatively, this may be evidence that consistency of synaesthetic
response does decrease with age, as suggested by Meier et al. (2014).
An additional significant finding from this study is the lack of difference in grapheme-
colour synaesthesia prevalence between the sexes. Understanding the source of the
difference in numbers of female versus male synaesthetes is important in the context
of understanding more about the origins of synaesthesia. As discussed in Chapter
1, earlier findings in the literature suggested that synaesthesia was significantly more
common in females than males (e.g., Baron-Cohen et al., 1996). This finding led to the
logical conclusion that the development of synaesthesia may be linked to being female
in some way. Combining these early findings with evidence showing synaesthesia runs
in families and has a genetic component led to speculation that synaesthesia was either
not fully expressed in males or may be linked to the X-chromosome, possibly in a way
that causes lethality in males in utero (on account of having only one copy of the X-
chromosome) (Baron-Cohen et al., 1996). However, subsequent research has shown
this to be not the case, with families containing synaesthetes equally likely to produce
female or male offspring (Ward and Simner, 2005). Furthermore, confirmed cases
of male-to-male transmission (Asher et al., 2009) and one case of monozygotic male
twins who are discordant for synaesthesia have been reported Smilek et al. (2005).
In other words, a higher prevalence of synaesthesia in females might suggest the in-
volvement of the X chromosome in the development of synaesthesia. I do not find this
increased female prevalence in this study, therefore these data support later findings
that suggest the X chromosome is not involved in the development of synaesthesia.
In this chapter, I have evaluated whether single session tests of consistency are ef-
fective at identifying synaesthetes, compared to established longer retesting methods.
One previous study has also suggested that single session testing may indeed be valid.
Simner et al. (2006b) established the prevalence of synaesthesia both with long term
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testing (which I used here as our key comparison) but also by screening an additional
1190 people in a single session. Their method was more basic than that of Eagleman
et al. (2007) in that colour choices were made from a palette of just 13 colours, and only
absolute matches contributed to consistency scores. Nonetheless, this again produced
roughly comparable prevalence estimates as longer term testing (1.1% prevalence for
coloured letters and digits). Taken together with the current study, I therefore suggest
short-term, single session tests of consistency for synaesthetic associations do appear
to provide an appropriate method by which to phenotype synaesthetes. The widely
available nature of the Synesthesia Battery through its open-access online interface
makes it a particularly appealing version of the consistency test, as does its compre-
hensive colour palette, and its ability to give a calibrated estimate (i.e., continuous
consistency score) for synaesthesia status. Although researchers will want to consider
carefully the question of whether consistency captures every type of synaesthesia, or
indeed every type of synaesthete (see Simner, 2012 for discussion), it is clear from
this current study that the Synesthesia Battery provides a suitable tool for evaluating
synaesthetes along this dimension.
Chapter 7
The genetics of synaesthesia
7.1 Introduction
In chapter 3, I investigated a possible association between MS (a condition with strong
links to the immune system) and synaesthesia. In chapter 5, I proposed a theoreti-
cal link between synaesthesia and genes that play a dual role in cortical development
(potentially important for synaesthesia) and the immune system (important for MS).
In the previous chapter, I validated the most widely used online assessment of synaes-
thetic consistency - the Synesthete Battery (Eagleman et al., 2007) - and established the
suitability of this tool to phenotype synaesthetes. In this chapter, I present empirical
work investigating the potential genetic basis of an association between synaesthesia,
MS and immunity. I begin by briefly summarising the rationale for investigating the
genetics of synaesthesia and why I limited the phenotype of synaesthesia under in-
vestigation to grapheme-colour synaesthesia only. I then discuss the reasons why the
specific location of the genome I investigate in this study was chosen. I then explain
the phenotyping and genotyping process and present the results of my study. Finally, I
discuss the implications of these findings in the context of understanding the genetics
of synaesthesia.
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7.1.1 Rationale for investigating genetics of synaesthesia
In Chapters 3 and 4, I discussed neurological and genetic reasons why MS and synaes-
thesia may share common origins, and in Chapter 5, I put forward the hypothesis that
genes with the dual function of cortical development and immunity may play a role
in the development of synaesthesia. Understanding more about the genetic origins of
synaesthesia will help further knowledge of how synaesthesia develops and its neuro-
logical basis. Given the increased prevalence of MS-RIS in synaesthetes reported in
Chapter 3, investigating whether MS and synaesthesia share genetic origins is of spe-
cific interest. There are significant methodological advantages to using MS genetics
as a starting point for this investigation. The field of MS genetics is significantly more
mature than the synaesthesia genetics literature. Multiple, large scale genome-wide as-
sociation studies have been conducted, including many thousands of participants (Con-
sortium et al., 2011, 2013). The most significant results from these studies have been
replicated, and can therefore be considered reliable. In other words, much is already
known about the genetic origins of MS, and exploring genetic commonalities between
synaesthesia and MS should begin by taking the most robust associations from this
literature as starting points for investigation within synaesthesia.
As discussed in Chapter 4, an apparent high ratio of female synaesthetes and a
lack of male-male transmission of synaesthesia led to the hypothesis that the genetic
origins of synaesthesia may be found on the X chromosome. Because the observed
ratio of male-female relatives in the families of synaesthetes does not significantly
differ from the expected 50:50 ratio (Ward and Simner, 2005), and given that neither
of the previous studies into synaesthesia genetics (Asher et al., 2009; Tomson et al.,
2011) report any association with the X chromosome, empirical evidence in support of
this early hypothesis regarding involvement of the X chromosome is limited. For this
reason, the X chromosome was not considered to be a potential region of interest in this
study. Below, I discuss the rationale behind selecting the region chosen for analysis
here.
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7.1.2 Selecting the region of the genome for analysis
As first discussed in Chapter 4, SNPs are locations in the genome representing a single
nucleotide in the string of nucleotides that make up the molecule of DNA. In other
words, at the specific location in the genome denoted by that SNP, there is a single al-
lele; which could either be an ’A’, ’G’, ’C’, or ’T’. SNPs are used as markers in genetic
association studies, which is the type of study I will conduct here. The frequency of
the particular allele at a given SNP is measured in a sample of individuals who possess
the trait under investigation, and this frequency is compared with the frequency of that
allele in a control group. If the frequency of the alleles significantly differs, that SNP
is said to be associated with the trait under investigation.
First introduced in Chapter 4, the MHC region, located on chromosome 6, is a gene
dense area of the genome heavily implicated in both the immune system and autoim-
mune disease susceptibility. It also contains the most significant and most replicated
association with MS reported in the genome, namely allele HLA-DRB1*15:01 (Ra-
magopalan et al., 2009). Given the strength of its association to MS, investigating
whether this allele also has any association to synaesthesia is a logical starting point
from which to explore shared genetic links between MS and synaesthesia.
As noted above, genetic association studies (such as this study) use SNPs as mark-
ers via which to probe genetic differences at specific locations of the genome. A funda-
mental question when choosing a SNP to investigate for this study therefore becomes
which SNP can be best used as a proxy marker for the allele of interest. A specific
feature of the MHC can be used to assist this process of SNP selection. High levels of
linkage disequilibrium are found in this region of the genome. Linkage disequilibrium
(LD) refers to the non-random association of alleles throughout the genome (Slatkin,
2008). In other words, genes that are located at adjacent loci have a higher likeli-
hood of being co-inherited during the process of sexual reproduction, which leads to
the formation of associations between alleles in a population. When the likelihood of
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alleles being inherited together is high, linkage disequilibrium is said to be high. Be-
cause large areas of this region are inherited together (i.e., in linkage disequilibrium),
it is possible to identify a selection of SNPs, that are accurate and reliable surrogate
markers for larger areas of the MHC region. de Bakker et al. (2006) carried out a com-
prehensive mapping of SNPs in the MHC, and found certain SNPs can be used as ‘tag’
SNPs, reliably and accurately acting as proxy markers for larger areas of this area of
the genome. Specifically, they found that SNP rs3135388 is almost always in linkage
disequilibrium with the allele of interest. Therefore, this SNP represents a highly reli-
able surrogate marker for the allele under investigation in this study. In other words, if
the minor allele frequency at SNP rs3135388 is significantly higher in the synaesthete
sample, I can be sure that the frequency of allele HLA-DRB1*15:01 is also higher.
There are three scenarios in which association between a trait of interest and SNP
can arise (Cardon and Palmer, 2003). Firstly, a SNP may have a direct causative effect
on the trait in question. Second, it may be an indirect effect, arising because the SNP
of interest is in linkage disequilibrium with the actual causal variant. Lastly, any asso-
ciation could be spurious, or due to chance (Cardon and Palmer, 2003). Because SNP
rs3135388 is almost always in linkage disequilibrium with allele HLA-DRB1*15:01,
it is indirect association that would exist in this case (i.e., association to rs3135388 is
a surrogate marker for the proposed causal variant, allele HLA-DRB1*15:01).
At the location of the genome chosen for investigation in this study, SNP rs3135388,
the possible allele variants are either ’A’ or ’G’. In other words, every person either has
an ’A’ or a ’G’ allele at this specific location. The minor allele (i.e., the least common
allele) is ’A’. Globally, the frequency of the minor allele (the so called minor allele
frequency, or MAF at this SNP is 0.06. In other words, 6% of people have the ’A’
allele at this location. Below, I will discuss how the minor allele frequency varies by
geographic location (i.e, by continent continental region) and the implications of this
variation for the selection of a suitable control population (see Table 7.1 for the minor
allele frequencies in the control population chosen in this study).
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In summary, the most significant genetic association to MS is allele HLA-DRB1*15:01,
located in the MHC region, on chromosome 6. SNP rs3135388 was selected for analy-
sis in this study because it is the best proxy measure by which to measure the frequency
of this allele in the synaesthete sample (de Bakker et al., 2006).
7.1.3 Limiting the phenotype to grapheme-colour synaesthesia
Synaesthesia is a heterogeneous condition, with a wide range of variations having been
reported in the scientific literature. In this study, I took a conservative approach to
phenotype selection, limiting participant recruitment to grapheme-colour synaesthetes
only. Whereas acknowledging this limited my recruitment to a smaller group of avail-
able candidates, this decision was taken for the following reasons. Currently, it is not
known whether synaesthesia is a single condition or an umbrella term for a range of
different conditions that manifest themselves in behaviourally comparable outcomes.
It is feasible therefore, that different types of synaesthesia have different genetic ori-
gins or developmental mechanisms. If this is the case, recruiting subjects with differ-
ent synaesthesias could act as a confounding factor in the analysis. There is evidence
to suggest that various types of synaesthesia may indeed differ in their development
and origin. In a large scale analysis of self-report synaesthetes examining the co-
occurrence of different synaesthesia subtypes, Novich et al. (2011) found that different
forms of synaesthesia cluster in five separate groups, meaning that a synaesthete with a
particular type of synaesthesia was more likely to experience another type in that group
but had no greater likelihood of having a subtype from a different group than a control
subject. Novich et al. (2011) report that grapheme-colour synaesthesia clusters with
day- week- and month-colour synaesthesias, in a group they term “coloured sequence”
synaesthesias. This finding suggests that genetic or mechanistic differences may exist
between sub-groups and should be considered when conducting genetic analysis.
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7.2 Experiment 3
The aim of this experiment is to investigate the potential genetic basis of an association
between synaesthesia, MS and the immune system. To do this, a sample of grapheme-
colour synaesthetes was recruited, phenotyped to establish the genuineness of their
synaesthesia, and then genotyped. The result of this genotyping was then compared
to a previously genotyped control population, to ascertain whether the prevalence of




Participants for the genetic study were recruited from a range of sources. Grapheme-
colour synaesthetes from the Edinburgh-Sussex Database of synaesthete participants
were emailed and invited to take part. Online advertisements were placed on student
forums and mailing lists at the University of Edinburgh and invitations to participate
were included in a variety of media articles. Subjects were also recruited using word-
of-mouth and referrals from other researchers in the field. A total of 206 participants
were recruited who met the phenotyping criteria outlined below. These grapheme-
colour synaesthetes were subsequently genotyped and included in the study.
7.2.1.2 Phenotyping synaesthesia
The first stage in a genetics investigation is the identification of participants who ex-
hibit the trait of interest (also known as the “phenotype”). In Chapter 6, I showed
that the Synesthete Battery is a suitable tool with which to identify grapheme-colour
synaesthetes, and this methodology was employed here to phenotype participants in
the current study. Thus, all prospective participants were required to complete the on-
line synaesthesia assessment battery found at www.synesthete.org (Eagleman et al.,
2007). Those who met the required consistency criteria outlined below were included
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in the study.
The consistency score of < 1.0, used by Eagleman et al. (2007) as a threshold by
which to distinguish synaesthetes from non-synaesthetes, was also used as the primary
threshold by which to identify genuine synaesthetes in this investigation. However,
an additional consistency rule was also implemented, based on the following empiri-
cal findings reported in the synaesthesia literature. Firstly, as discussed in Chapter 6,
Rothen et al. (2013) recommend using a more lenient threshold of < 1.43 as a cut-off
to distinguish between synaesthetes and non-synaesthetes when using the Synesthete
Battery. They conclude that when using the Synesthete Battery, this higher threshold
offers greater sensitivity and specificity when distinguishing between synaesthetes and
non-synaesthetes. Furthermore, as noted above, Novich et al. (2011) reported that dif-
ferent forms of synaesthesia cluster together. In other words, if a participant were to
have grapheme-colour synaesthesia, they would be more likely to also experience an-
other form of synaesthesia from the same cluster (namely day-colour or month-colour
forms) but have no increased likelihood (relative to the general population) of experi-
encing a form from a different cluster (e.g., musical chords-colour).
Therefore, based on the original consistency threshold proposed by Eagleman et al.
(2007), and subsequent data from Rothen et al. (2013) and Novich et al. (2011), par-
ticipants in this study were required to meet a minimum of one of the following con-
sistency criteria:
1. Consistency score of < 1.0 for grapheme-colour synaesthesia (either letters and/or
numbers)
2. Consistency score of < 1.43 for grapheme-colour synaesthesia, with a consis-
tency score of < 1.0 for either day-colour or month-colour synaesthesia
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7.2.1.3 Genotyping synaesthesia
Once prospective participants had completed the online consistency test for grapheme-
colour synaesthesia and met the required inclusion criteria outlined above, a sample of
saliva was obtained from each participant. DNA for each participant was then extracted
from their saliva sample. Saliva samples were collected using Oragene DNA OG-500
kits (DNA Genotek, Ontario, Canada). To extract the DNA, samples were incubated
overnight at 50C and transferred to 15 ml screw-cap tubes. prepIT-L2P reagent (DNA
Genotek) was added to the samples (1/25th volume), mixed by vortexing, and incu-
bated on ice for 10 min to precipitate impurities. Samples were centrifuged at 12000
x g in a Sorvall RC6 superspeed centrifuge using a F13-14x50cy rotor with 15 µl tube
adaptors. The supernatant containing genomic DNA was transferred to a clean 15 ml
tube. Ethanol (1.2 volumes) was added, and the samples were mixed by inversion, and
incubated for 10 min at room temperature. The samples were centrifuged for 10 min
at 4800 x g in a Thermo Scientific SL40R bench-top centrifuge using a swing-bucket
rotor to pellet the DNA. The supernatant was removed and the DNA pellet was washed
with 1 µl of 70% ethanol. The DNA was dissolved in 10 mM Tris, pH 8.0, 1 µM
EDTA (typically 200-1000 µl, depending on the initial volume of the saliva sample).
The DNA concentration was measured using a Nanodrop 8000.
When DNA was extracted from all synaesthete participants, genotyping of the
rs3135388 SNP was conducted. In essence, the genotyping process records which
alleles are present at the SNP location for each participant. Briefly, this is done by
breaking down the DNA structure and washing the DNA over probes that are specifi-
cally prepared to be a complementary image of the fragment of DNA at that location.
The DNA segment of interest then sticks to this probe and is retained. Technical de-
tails of how the process was conducted in this study are as follows. Genotyping of SNP
rs3135388 was performed using KASP assay technology (LGC Genomics) and a Bio-
Rad CFX96 real-time PCR thermocycler. Each 10 µl reaction contained 0.14 µl of 72X
KASP primer mix, 5 l of 2X KASP master mix with standard ROX concentration, and
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2 µl of genomic DNA (diluted at 20 ng/µl). Thermocycling was performed as follows:
after an initial denaturation of 15 min at 94◦C, 10 cycles were run with 20s denatura-
tion at 94◦C followed by 45s of annealing/elongation starting at 61◦C and decreasing
by 0.6◦Cper cycle, followed by 30 cycles with 10s denaturation at 94◦C followed by
45s of annealing/elongation at 55◦C. If necessary, five further cycles were performed
using the same parameters as the final 30 cycles from the initial run. The assay was
validated by Sanger sequencing of randomly-selected samples of each genotype.
7.2.1.4 Control population
In order to make a meaningful analysis of the genetic information obtained from the
synaesthete participants in this study, statistical testing must make a comparison with
a suitable control sample. Control data for this study came from the 1000 Genomes
Project, a publicly available database of genotyped members of the general public.
This database contains data from a globally distributed sample of individuals, and is
organised into super-populations, based on geographical origin (African, mixed Amer-
ican, East Asian, European and South Asian). Because the majority of synaesthete
participants in this study were European in origin, data from the European super-
population were used as control population in the current study. The European popu-
lation from the 1000 Genomes Project consists of 379 individuals and is further bro-
ken down into sub-populations, which are as follows: British in England and Scotland
(GBR), Utah Residents with Northern and Western European Ancestry (CEU), Finnish
in Finland (FIN), Iberian Population in Spain (IBS) and Toscani in Italia (TSI) (see Ta-
ble 7.1, below)
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Total EUR 379 0.13
Table 7.1: Genetic control population. The table shows the sub-populations which
make up the European super-population, from the 1000 Genomes Project. The
numbers of subjects and the minor allele frequency are shown for each sub-group.
Genetic association studies rely on identifying significant differences in allele fre-
quency at specific locations throughout the genome (i.e., SNPs). The frequency of
allele variants at specific SNPs differs depending on the ethnic origin of the person un-
der investigation. In this study, I chose SNP rs3135388 for investigation and above, I
reported that the possible allele variants at this location are either ’A’ (least common) or
’G’ (most common). As shown in Table 7.1, the frequency of each allele variant differs
based on geographic origin of the sample under investigation, even within Europe. It is
therefore important to match the control sample to the experimental sample as closely
as possible, with respect to their geographic region of origin. This prevents differences
in allele frequency due to geographical origin confounding the analysis. Because the
majority of the participants in this study were recruited in northern Europe, a matching
sub-group of controls from this region was used in this analysis.
7.2.2 Results
A range of analyses were carried out, using a selection of models and a variety of
control sub-populations. Table 7.2 summarises the analyses conducted in this study.
Analyses were conducted using PLINK, the whole genome association analysis toolset
(Purcell et al., 2007).
Although it is assumed that synaesthesia has a genetic component, the actual un-
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derlying pattern of inheritance is unknown. In other words, it is unknown whether
the actual mode of inheritance is, for example, dominant or recessive. The mode of
inheritance affects the way in which the underlying genotype manifests itself as the
behavioural phenotype. For instance, if the mode of inheritance for synaesthesia was
dominant, then a person possessing a minimum of a single copy of the minor allele
(’A’) at the SNP rs3135388 would exhibit the phenotype of synaesthesia. In other
words, a person with ’AA’ or ’AG’ at this location would be synaesthetic, but a person
with two copies of ’G’ (the major allele in this case) would not have synaesthesia. If
the mode of inheritance was recessive, then the underlying genotype would result in a
different prevalence of the phenotype. Only people with two copies of the minor allele
(i.e., people with ’AA’ at location rs3135388) would exhibit the phenotype of synaes-
thesia; people with either AG or GG would not be synaesthetic. Because the mode of
inheritance is unknown, analyses were run under a number of models, each testing a
particular mode of inheritance (see Table 7.2).
As shown in Table 7.2, the four analyses were conducted: Fisher’s, genotypic,
dominant and recessive, and I explain each test in turn here. Because only four synaes-
thetes were homozygous for the minor allele (i.e., their genotype was ’AA’ at location
rs3135388), Fisher’s exact tests were used to compare allele frequencies. The Fisher’s
analysis is a Fisher’s exact test without any specific model of inheritance. This test
compares the total allele frequencies between cases and controls, irrespective of the
specific genotypic combination found in the participants tested. In other words, this
test compares the total frequencies of ’A’ and ’G’ in synaesthetes compared to con-
trols. The remaining three analyses use a Fisher’s exact test in combination with a
model that tests an assumption relating the underlying genotype found in the cases and
controls. Thus, the genotypic test compares the frequency of the three possible com-
binations of alleles against each other (i.e. AA versus AG versus GG). The dominant
model compares the genotypes ’AA’ and ’AG’ versus ’GG’, because under a dominant
model of inheritance, the genotypes ’AA’ and ’AG’ would result in the phenotype of
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synaesthesia but ’GG’ would not. Lastly, the recessive model tests ’AA’ versus ’AG’
and ’GG’, because under this model, only cases with two copies of the minor allele
(’AA’) would exhibit the phenotype of synaesthesia.
MODEL EUR GBR/CEU GBR/CEU/FIN
Fisher 0.065 0.423 0.364
Genotypic 0.020* 0.289 0.083
Dominant 0.017* 0.257 0.123
Recessive 0.591 0.738 0.287
Table 7.2: Genetic association analysis. The table shows the results from the ge-
netic association analyses. The type of model and the control population used are
shown. * signifies a p-value < 0.05.
As discussed above, selecting a suitably matched control population is of critical
importance when conducting a genetic association study. Here, I conducted the anal-
yses listed above with three different configurations of control population. First, I
used the total European super-population, which consists of individuals from British
(GBR), northern European (CEU), Finnish (FIN), Iberian (IBR) and Tuscan (TSI) ori-
gins. The advantage of using this entire group is the statistical power gained by the
larger number of controls (379 in total). The problem with using this group is that
the minor allele frequency is considerably lower in the Iberian and Tuscan group (0.11
and 0.08, respectively). As noted above, this difference in frequency can act as a con-
founding variable. Therefore, analyses were then conducted with control populations
that matched the ethic origins of the synaesthete test group more rigorously, controls
from British and northern European origin. Because the minor allele frequency is al-
most the same in the Finnish population, this group was also included, providing an
increase in statistical power.
In this study, significant differences in allele frequency were found between synaes-
thetes and non-synaesthetic controls when the genotypic and dominant models were
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tested using the total European control population (see Table 7.2). Because of the po-
tential confound introduced by the difference in allele frequency found in Iberian and
Tuscan controls, caution should be used when interpreting this outcome. The interpre-
tation of these results is discussed in greater detail below.
7.2.3 Discussion
The aim of this study was to investigate a potential genetic association between grapheme-
colour synaesthesia, MS and the immune system. To do this, I examined a single
SNP (rs3135388), which is a surrogate marker for allele HLA-DRB1*1501 (de Bakker
et al., 2006). This allele is located in the HLA region of chromosome 6, and has been
previously shown to be strongly associated with MS (Benešová et al., 2013; Schmidt
et al., 2007; Alcina et al., 2012). Despite strong links to MS, this SNP has not been
shown to have associations to other autoimmune conditions. To determine whether this
allele is linked to grapheme-colour synaesthesia, the allele frequency at this location
in the synaesthete sample was compared with the frequency in a control population.
A range of analyses was carried out in this study, using a variety of models and
a range of control population sub-groups. However, when an analysis was carried
out using a control population assumed to best fit my synaesthete sample, no signif-
icant association between the minor allele frequency and the presence of grapheme-
colour synaesthesia was found. Overall, the results of this study were inconclusive.
The outcome of the analyses varied considerably, depending on the model tested and
the control population used. The most conservative interpretation of these results is
that when a control group is used that best fits what we assume to be our test sam-
ple, no difference in allele frequency between the synaesthete and control sample was
found, and therefore, no association exists between SNP rs3135388 and the presence
of grapheme-colour synaesthesia. Because SNP rs3135388 is a very accurate proxy
for allele HLA-DRB1*1501 (the strongest association to MS reported thus far in the
genome), this study provides no evidence that grapheme-colour synaesthesia and MS
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share genetic origins.
There are however, several points that require highlighting to provide a fuller dis-
cussion of this null result. Firstly, as noted above, participant recruitment in this study
was limited to grapheme-colour synaesthetes only. One of the reasons for this decision
was the clustering of synaesthesias reported by Novich et al. (2011). The evidence
that different forms of synaesthesia cluster together suggests that the types in each
cluster differ in some (as yet) unknown way to types in other clusters. Genetic ori-
gins may be one such difference. For this reason, I limited recruitment in this study
to grapheme-colour synaesthetes only, to avoid the potential confound introduced by
including synaesthesia types with different genetic causes. Should it be the case that
different synaesthesia types have different genetic causes, then the possibility exists
that while grapheme-colour synaesthesia may not share genetic roots with MS, other
forms of synaesthesias might. The null result reported here does not preclude that pos-
sibility. Another possibility is that synaesthesia and MS may in fact share a genetic
association, but not at the location investigated in this study. Whereas the particular al-
lele in question here is the most strongly associated and most replicated genetic link to
MS (Ramagopalan et al., 2009), in total, 110 causal variants in 108 separate loci have
been linked to MS to date (Consortium et al., 2013). It is possible that any association
between synaesthesia and MS may originate at any of these other loci.
In addition to the above reasons, there is a methodological limitation in how the
results of this project can be interpreted. This is related to the available information
about the ethnicity of the participants and the subsequent matching of a suitable control
population. The purpose of this study is to establish whether SNP rs3135388, (which
acts as a surrogate marker for allele HLA-DRB1*1501) is associated with grapheme-
colour synaesthesia. To do this, the frequency of the minor allele in the synaesthete
population is compared to its frequency in a suitably matched control population. If
the frequency of the minor allele is significantly different between populations, this is
evidence that the SNP is associated with synaesthesia. The possible confounding factor
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is that the frequency of this minor allele varies by ethnicity. For example, in the British
population, the minor allele is found in 14% of the population, whereas in the Iberian
sample, its frequency is 8%. Unless the ethnicity of the synaesthete sample is known
in great detail, accurately matching a suitable control population to the synaesthete
sample relies on certain assumptions. It follows that unless the control population and
the sample are strictly matched, a proportion of any detected effect could arise due to
population stratification differences (i.e., differences in allele frequency as a result of
differing ethnicity), rather than due to the presence of synaesthesia. In other words,
mismatching test and control populations can result in a confound.
Because detailed ethnicity information is not available for the sample of synaes-
thetes recruited here, certain assumptions were made regarding the ethnicity of the
recruited synaesthete sample. In conducting the analyses above, I am making the as-
sumption that the genetic ethnicity of the synaesthete sample is a sufficiently accurate
match with where the participants were recruited (i.e., predominately in the UK and the
Netherlands). Making that assumption allows the use of a control sample that matches
that geographical location. Unfortunately, these assumptions may not be completely
reliable. For example, some participants may have been born and raised in the UK, but
have ethnic variation due to immigration in earlier generations (e.g. parents or grand-
parents). This introduces a degree of uncertainty to the interpretation of the results.
Because ethnicity information from the synaesthesia sample is only partially reliable,
it is unknown exactly how much population variation exists in this sample, and as a
consequence, how closely matched to the control population this sample is. Therefore,
some of the difference in minor allele frequency may be caused by differences in eth-
nicity between the test sample and control group, rather than entirely as a result of the
presence/absence of synaesthesia.
The study carried out in this chapter offered the opportunity to investigate poten-
tial genetic overlaps between MS, synaesthesia and a region of the immune system.
However, the ultimate goal of this work is to conduct the first genome wide associ-
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ation study (GWAS) into the genetics of synaesthesia. In genome-wide association
studies, the problem described above (population stratification arising from incom-
plete information regarding the ethnicity of the test sample) is overcome. Because
the whole genome is examined, specific markers that reveal the participants’ ethnicity
can be checked, thus enabling the ethnicity of the entire sample to be reliably estab-
lished, and rigorously matched to a suitable control population (Pritchard and Rosen-
berg, 1999). Conducting such a study requires the recruitment of a minimum of one
thousand synaesthetes, a scale of recruitment that is outwith the remit of a doctoral
thesis. In this chapter, I investigated whether SNP rs3135388, located in an area of
the genome with strong links to immunity and associated with MS, was linked to the
presence of grapheme-colour synaesthesia. No association was found and I discuss the
reasons for this above. In the following chapter, I present empirical data investigating
the prevalence of synaesthesia in a sample of MS patients.
Chapter 8
Prevalence of synaesthesia in multiple
sclerosis
8.1 Introduction
In chapter 3, I reported the results of an investigation into the prevalence of MS and
its clinical precursor, radiologically isolated syndrome (RIS) in synaesthetes volun-
teering to take part in MRI studies of synaesthesia. In that chapter, I show that the
prevalence of MS/RIS is higher in synaesthetes than would be expected in a random
sample of the population. In Chapter 7, I conducted a study exploring the genetic ba-
sis of synaesthesia to establish whether any links with MS could be found. However,
for methodological reasons discussed at the end of that chapter, a conclusive genetics
interpretation cannot yet be drawn. Therefore, in order to further investigate a possible
association between synaesthesia and MS, I report empirical work in the current chap-
ter that investigates the prevalence of synaesthesia in a sample of multiple sclerosis
(MS) patients. Given the findings reported in Chapter 3 in the reverse direction (i.e.,
an increased prevalence of MS/RIS in synaesthetes), a higher prevalence of synaes-
thesia in MS patients might also be expected. In the current chapter, three hundred
MS patients were recruited from local NHS clinics and all were given a questionnaire
that allowed them to self-declare any forms of synaesthesia they believed they had. All
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those who indicated they experienced grapheme-colour synaesthesia were given a con-
sistency test for synaesthesia. Those who passed this test were considered as genuine
grapheme-colour synaesthetes. Contrary to my hypothesis, the prevalence of synaes-
thesia in MS patients was not found to be higher than in the general population, and I
discuss scientific and methodological explanations for this null result at the end of the
chapter.
8.2 Experiment 4
In this study, I evaluate whether the prevalence of synaesthesia is higher in MS patients
versus the general population for one synaesthesia subtype - grapheme-colour synaes-
thesia. There are several reasons why tests were limited to this single subtype. First -
and as noted above - it is one of the most common subtypes (Simner et al., 2006b), and
it is behaviourally well understood. Second, it is relatively easy to reliably test for and
those who experience this form of synaesthesia typically demonstrate relatively high
levels of consistency (Simner et al., 2011). Lastly, a suitable baseline prevalence of
grapheme-colour synaesthesia was obtained in Chapter 6, allowing direct comparisons
of prevalence to be made between MS patients and healthy controls.
In the current study, I recruited a large sample of MS patients who were asked
to indicate in a questionnaire whether they had synaesthesia, and to indicate which
variants in particular from a list of 162 potential variants (see Methods). After this
initial screening, I then sought to verify grapheme-colour synaesthesia using a test of
consistency in all those who reported this particular variant. The methods and results
are given below.
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8.2.1 Methods
8.2.1.1 Participant recruitment
Participants were patients with MS who were opportunistically recruited from spe-
cialist neurology clinics run by the Department of Clinical Neuroscience within NHS
Lothian. Four clinics per week are run by NHS Lothian and I attended approximately
1-2 per week between October 2012 and August 2013. A total of 71 clinics were at-
tended. Due to stipulations required by the NHS ethics committee, participants were
initially approached by a member of their primary health care team; either a consultant
or a specialist MS nurse. At this point, prospective participants were asked whether
they would be interested in taking part in a study being run in the department. If they
expressed a willingness to take part, we were introduced. Subjects were given a written
information sheet about the study (see appendix A) and a verbal overview of what the
study would entail.
8.2.1.2 Power calculation
The aim of this study was to estimate the prevalence of grapheme-colour synaesthesia
in a sample of patients with MS. In order to ascertain the sample size of MS patients
required, a priori power calculations were carried out to establish how many MS pa-
tients should be tested to detect a higher prevalence of synaesthesia in MS, should this
exist. To do this, I first had to decide where to set any presumed estimate of synaes-
thesia prevalence in MS patients. Using the baseline prevalence of grapheme-colour
synaesthesia in the general population reported by Simner et al. (2006b) of 2% as a
starting point, in order to detect a presumed difference in prevalence within MS pa-
tients of - say - 5%, a sample of 307 participants would be required. In other words, if
the prevalence of grapheme-colour synaesthesia in multiple sclerosis patients is in the
region of 7%, a sample of 307 subjects would have sufficient statistical power (given
the convention of 80% power and 0.05 alpha) to reliably detect this difference. Note
that the prevalence baseline was taken from Simner et al. (2006b), rather than Chapter
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6 of this thesis, since the latter had not been generated at the time of testing. Nonethe-
less, both studies (Simner et al., 2006b and Chapter 6) produced largely equivalent
findings (see Chapter 6).
8.2.1.3 Participants
A total of 300 patients with a diagnosis of MS participated in the study (mean age =
41.1, SD = 11.9, range = 19.5-81.5; 74%female; 9.7% left handed, 1% ambidextrous).
A total of 37 additional patients were asked but declined to take part (75.6% female).
Reasons for non-participation were predominately a lack of time. A further 58 (69%
female) patients who were visiting the clinic for scheduled appointments during my
attendance were not approached to take part by the primary health care team. There
were a range of reasons behind the decision not to approach patients for participation.
Patients deemed too upset were not asked to take part and patients with cognitive or
physical impairment that would have obviously prevented the patient from either un-
derstanding the nature of the study or completing the questionnaire were also not asked
to participate. At the time participant recruitment was completed for this study, 1668
people had been diagnosed with multiple sclerosis in the Lothian region (1201, 72%
of whom were female).
8.2.1.4 Initial screening
Once the patient agreed to take part, he/she completed an initial screening stage of the
study during their appointment at the clinic. Initial screening consisted of the comple-
tion of a consent form (see appendix B) and the administration of a screening question-
naire (see appendix C), which aimed to identify participants who felt they experience
some form of synaesthesia. The questionnaire was an adapted version of the question-
naire used by Simner et al. (2006b), and it explained what synaesthesia is, provided
examples of synaesthesia and then asked subjects to indicate which forms of synaes-
thesia they experienced, if any. They did this by drawing lines between 18 triggers
and 9 experiences. For example, if they felt that letters triggered colour, they would
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draw a line between “letters” under triggers and “colour” under experiences (see ap-
pendix C for a full list of triggers and experiences). Participants were also given space
to indicate any other synaesthetic associations they may experience outwith the com-
mon inducers listed on the questionnaire. Eleven patients initially self-reported some
form of grapheme-colour synaesthesia (i.e., they linked the trigger “letter” or “num-
ber” with the experience “colour”). One subject was subsequently removed because
further questioning revealed she had misunderstood the purpose of the questionnaire
and in fact had no colours to report. This left 10 participants for further testing with a
consistency test.
8.2.1.5 Consistency testing
As noted previously in Chapter 1, verification of synaesthesia relies on the behavioural
gold standard test for synaesthesia, which assesses the consistency of the synaesthetic
report over time (e.g., Simner et al., 2006b; Eagleman et al., 2007). For example, in the
variant of interest here - grapheme-colour synaesthesia - the consistency test would first
elicit the synaesthete’s colours for each letter or digit, and then repeat this test a second
time, to compare how consistently the subject reports their colour associations. Each of
the 10 participants who indicated they experience grapheme-colour synaesthesia was
therefore recontacted with the aim of assessing whether the synaesthesia they initially
reported could be considered genuine, according to its consistency.
I assessed consistency in two ways: using either a short term or long term con-
sistency measure. The short-term consistency measure was the single session test de-
scribed in detail in Chapter 6, and this relied on the online assessment at www.synesthete.org,
known as the Synesthete Battery (Eagleman et al., 2007). This presents each grapheme
three times in a random order and requires subjects to select their synaesthetic colour
from an on-screen colour palette. The test then assesses how consistently colours are
selected for each grapheme (see Chapters and 6 for further details of this methodol-
ogy).
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The longer term retest was based on methods by Simner et al. (2006b) and was
carried out as follows. The self-declared grapheme-colour synaesthetes were given a
list of 26 letters and 10 digits in a blocked design and asked to report verbally or in
writing their synaesthetic colour for each grapheme (where possible, the grapheme-
colour associations for each participant were recorded at the time he/she completed
the initial screening, at the point I collected the questionnaire from them in the clinic).
Once a significant period of time had elapsed since completing the initial screening
questionnaire, typically a minimum of 3 months (M = 6.6 months, SD = 3.8 months),
the participant was recontacted without warning by telephone or email and asked to
report again their colour associations for each grapheme. If the occasion presented
itself to retest a participant on a subsequent appointment at the clinic (e.g., a six month
follow up appointment), this opportunity was taken.
In summary, some patients were given the short term retest (Eagleman et al., 2007)
and some the long term retest Simner et al. (2006b). The choice of retest method from
patient to patient was determined by a variety of factors. Some participants did not
have access to the internet or have a computer on which to carry out an online test,
thus precluding the short term test. An additional consideration was the physical and
cognitive condition of the participant. Multiple sclerosis is a heterogeneous condi-
tion that affects individuals in a wide range of different ways (see Chapter 3). Some
subjects experienced either physical or cognitive impairment to the extent that online
testing was not possible to conduct. Again, as a consequence, the long term test was
administered and again therefore, both retest methods were required for this popula-
tion. The results from Chapter 6 indicate that short term and long term testing produce
comparable outcomes, and can therefore be considered equivalent in the identification
of grapheme-colour synaesthesia.
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8.2.2 Results
8.2.2.1 Synaesthesia prevalence
In this section, I calculate the prevalence of synaesthesia in MS patients to compare
with the rates expected in the general population. Specifically, I calculate two measures
of prevalence. First I count synaesthetes as all those who self-declared the condition.
Then I count all those who were ultimately verified as genuine in a consistency test. I
report both these measures because they tend to differ significantly. For example, it has
previously been shown (Simner et al., 2006b) that for every six synaesthetes that self-
report having synaesthesia, only one is consistent enough to be considered a genuine
synaesthete. These two measures can therefore provide different baseline comparisons
and we shall see below that the usual types of consistency tests may not be equally
applied to healthy versus clinical populations (see general discussion in Chapter 10).
These prevalence rates were then compared with the baseline prevalence rates found
in the general population, screened via the online test reported in Chapter 6.
8.2.2.2 Self-reported prevalence
In the prevalence study carried out using a sample of the general population and re-
ported in Chapter 6, 4.9% of participants self-declared experiencing grapheme-colour
synaesthesia. In this study, 3.7% of MS patients self-declared experiencing grapheme-
colour synaesthesia. This difference is not significant (χ2 = 1.768; df = 1; p = 0.18). Of
the 111 MS patients (out of 300) who self-declared grapheme-colour synaesthesia, 9
were female, and their mean age overall was 47.5 years old (range 27-77, SD 14.4). Six
subjects reported experiencing colour with letters only, three subjects reported experi-
encing coloured numbers only and two subjects reported experiencing both coloured
letters and numbers. Details of all self-reported grapheme-colour synaesthetes are
shown in table 8.1 below.
1Here, I include the 11 participants initially self-declaring grapheme-colour synaesthesia, rather
than the 10 participants ultimately considered for consistency testing. This follows the methodology
employed by the baseline study of Simner et al. (2006b)
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Grapheme variant
Sex le�ers both numbers Test interval Retest method
F X
F 16/36 11 months Long-term
F X
F 17/26 4.25 months Long-term
F X
F 1.09 Short-term online
F X
F 10/11 4.5 months Long-term
F 0.51 Short-term online
F X
M X
Table 8.1: Details of MS patients self-reporting with grapheme-colour synaesthe-
sia. This table shows the variant of grapheme-colour synaesthesia experienced by
the subject and the consistency score obtained in the test. The consistency scores
are either the Eagleman consistency score (single number format, where a score of
< 1 = synaesthesia) or the number of correct graphemes obtained when retested
(out of 26 if letters only, 10 if numbers only and 36 if the subject reported experi-
encing both). The test method is indicated, and in cases where a test-retest method
was used, the interval between testing is given. An ’X’ denotes a participant who
was approached for retest but did not complete a test
8.2.2.3 Verified prevalence
As noted above, 10 of the 11 subjects who self-declared experiencing grapheme-colour
synaesthesia were considered for retesting to objectively assess the consistency of their
synaesthetic experience. Five participants successfully completed a test of consistency.
Two completed the online test at www.synesthete.org (Eagleman et al., 2007) and three
were tested using the test-retest methodology (Simner et al., 2006b).
Of the remaining five patients, one was unavailable to be contacted for retest, de-
spite repeated efforts to make contact. The other four participants were contacted for
retest but were unable to provide any colour associations at all at the time of their
retest. Their reasons were highly similar in that all reported not being able to recall
their colours anymore at the time of the retest. Colours were described as either too
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vague, too changeable or entirely forgotten. Of the five subjects who sucessfully did a
retest, two met the required consistency criteria to be considered genuine synaesthetes,
thus giving a verified prevalence of grapheme-colour synaesthesia in multiple sclero-
sis patients of 0.67%. This prevalence is not significantly different from the baseline
prevalence of 1.2% reported in Chapter 6 (Fisher’s exact test, p = 0.57).
8.2.2.4 Bayesian analysis
To further investigate whether our result provided evidence in support of the null hy-
pothesis (that having multiple sclerosis does not influence the likelihood of developing
synaesthesia), I calculated a Bayes factor. By comparing the likelihood of two models
(in this case, the null and alternative hypotheses) as a ratio, Bayes factors allow us to
evaluate to what extent the data supports the hypothesis under investigation (Rouder
et al., 2009). Following Jeffreys (1961), a Bayes factor of less than 0.33 provides strong
support for the null hypothesis, a Bayes factor of greater than 3 provides support for
the alternative hypothesis and values in between indicate the data are insensitive and
no firm conclusions should be drawn. I calculated a Bayes factor of 0.019, indicating
that having multiple sclerosis does not significantly increase the likelihood of having
grapheme-colour synaesthesia.
Modelling our experimental data allows us to gain further insight into the influ-
ence of multiple sclerosis on synaesthesia prevalence. Constructing a beta-binomial
model of our acquired data, we can show that there is an 30% chance that the MS
prevalence of synaesthesia is higher than the baseline prevalence. If I calculate a 95%
confidence interval of the difference in prevalence, this shows that any difference in
prevalence between MS patients and healthy controls is likely to fall in the range -
1.15% to 1.22%. To illustrate this with a theoretical example, if we were certain our
baseline prevalence of 1.2% was correct, we would be 95% sure that the true preva-
lence of grapheme-colour synaesthesia in MS patients would be in the range 0.05%
[1.2%-1.15%] to 2.42% [1.2%+1.22%].
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8.3 Conclusions
This study investigated the prevalence of synaesthesia in a population of multiple scle-
rosis patients. Limiting the subtypes of synaesthesia to the single subtype of grapheme-
colour synaesthesia, a prevalence of 0.7% was discovered. Contrary to my initial hy-
pothesis, this prevalence is not significantly higher than the rates of synaesthesia found
in a non-clinical sample of the general population, reported in the baseline prevalence
study conducted in Chapter 6. In addition to the possibility that there is indeed no
increased prevalence of synaesthesia in MS patients, there are several issues which
may have affected the result of this investigation. These are discussed in greater detail
below.
Throughout the synaesthesia literature, genuine synaesthetes are identified based
on the consistency of their associations (see Simner, 2012 for a review). Because this
method of identifying synaesthetes is so central to the literature, it was the logical
approach to follow in this study. However, the outcome of the current experiment
has highlighted one key problem with testing MS patients, namely that the cognitive
impairments that are symptomatic of this condition make it highly probable that this
patient group are unlikely to be as consistent as healthy members of the general popu-
lation, even if they are genuine synaesthetes. Normally when conducting experiments,
the experimenter tries to control all variables apart from the independent variable. Put
another way, the researcher aims to compare like with like, as much as possible. In this
study, I am comparing two samples that differ significantly in their clinical profiles and
as a consequence, are likely to differ in their ability to complete tests of consistency, as
we have now learned. For a variety of reasons, fewer than half of the participants who
initially reported experiencing grapheme-colour synaesthesia completed any form of
retest. Four of those failures resulted from memory problems, synaesthetic associa-
tions fading with age or changing with mood; problems that are likely to be due in part
to having multiple sclerosis. To summarise, the problem is that the majority of stud-
ies aiming to identify synasthetes use consistency of association between inducer and
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concurrent to do so. Clinical populations - such as those with MS in the current study
- often have significant cognitive impairments that make them likely to be less con-
sistent,whether they have synaesthesia or not. I will return to this issue in the general
discussion (see Chapter 10).
This discussion above raises a second issue: should this potential difference in
performance across populations have been identified in advance, and effectively pre-
cluded our particular choice of methodology? It is certainly true that the cognitive
limitations of MS patients are well documented in the literature. Cognitive impairment
is common in MS, experienced by approximately 50% of patients, in both early and
late stages of the disease (Benedict et al., 2006; Rao et al., 1991). Particularly affected
are processing speed, visual learning and memory, with upwards of 50% of patients
experiencing deficits in these specific domains (Chiaravalloti and DeLuca, 2008). It is
clear therefore, that MS patients experience significant cognitive impairment relative
to the general population. However, there are two arguments for nonetheless plan-
ning a consistency test in a study aiming to verify MS synaesthetes. The first is that
the burden of cognitive impairment experienced by MS patients can vary significantly.
MS is a highly heterogeneous condition and while some patients do experience more
cognitive problems, others experience more physical impairments, leaving them the-
oretically able to perform a consistency test like any other potential synaesthete (so
long as their interface is adaptable, as it was here). In addition, MS has a distinct
clinical profile, in that sufferers can experience clinical episodes that greatly impact
many aspects of their functioning during the episode, but then they recover and their
impairments dissipate. Again therefore, a consistency test might well have been suit-
able if our participants were able to complete it while in a recovery period (or if I
had been able to select patients that had physical rather than cognitive deficits only).
Nonetheless, the rarity of MS meant that I was ultimately forced to test all MS patients
that became available, and this therefore included a number that were in later chronic
stages, and or cognitively impaired. The later stages of MS result in a phase in which
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the relapse-remit profile of the illness earlier on is replaced by a more chronic stage,
in which the condition of the patient deteriorates without returning fully to their pre-
vious cognitive and/or physical capacity (Herndon, 2003). This fact will have made
a great difference in our participants capacity to complete the type of consistency test
described above. For all these reasons therefore, MS will have contributed to a signifi-
cantly reduced capacity for consistency of response, and this is perhaps attested to by
the fact that four out of 10 participants had cognitive difficulties that prevented them
from completing my retest for consistency.
A second consideration is that, at the time of testing, the prevailing literature sug-
gested that synaesthetic associations may be more similar to percepts rather than mem-
ories. If so, it would be reasonable to assume that cognitive losses (e.g., in memory)
might nonetheless allow for MS patients to perform a consistency test unimpeded. For
example, Kim and Blake (2013) describe a range of perceptual qualities to synaes-
thetic colours in their comprehensive review, and Simner and Logie (2008) presented
early evidence to suggest that synaesthetic sensations may be exempt from some of the
usual limitations of memory. However, it is unlikely that synaesthesia occurs in the
absence of input from memory and indeed, synaesthetes have been shown to demon-
strate improved memory in certain domains (Rothen et al., 2012). The responses of
our impaired population seem to add weight to the suggestion that memory is an im-
portant element in the generation of synaesthetic associations. Memory loss happens
gradually to some extent in the population in general, but MS patients are particularly
vulnerable to such memory impairments (Chiaravalloti and DeLuca, 2008). Because
of these factors, direct comparisons between MS patients and the general population
on measures of consistency are difficult to make if these involve memory recall - a
synaesthete with MS is perhaps simply likely to be less consistent than an unaffected
synaesthete.
Aside from MS, the samples tested from the general population (i.e., in Chapter 6)
and in the prevalence study conducted by Simner et al. (2006b) differed from those in
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this study in other ways too, and this might also have resulted in a lower prevalence of
synaesthesia in our sample of MS patients. The mean age of participants in Chapter
6 was 28.6 years, in Simner et al. (2006b) all the participants in one key study were
undergraduate students, so the mean age would almost certainly be in the low twen-
ties (age data are not reported). In contrast, the mean age in my current study was
41.1 years (of all participants) and 47.5 years (of self-declared synaesthetes). There
is evidence that the consistency of synaesthetic associations decreases with age. For
example, Meier et al. (2014) found age related changes in synaesthesia which sug-
gests consistency of colour associations might decrease with age. This age difference
across studies may also be a contributing factor to the lack of difference found between
healthy and MS samples. It is possible the prevalence of synaesthesia in a young (i.e.
matched to the baseline) sample of MS patients may be higher than in the older sample
tested here.
What possible solutions could be employed by researchers designing studies seek-
ing to compare synaesthesia prevalence in clinical and non-clinical populations? There
are several potential approaches that may be utilised for future studies. One option
might be to increase the accepted threshold for consistency when considering the clin-
ical group being tested. In other words, use a less stringent level of consistency when
assessing synaesthesia in the clinical sample. In Chapter 6, I replicated the most widely
used online test for synaesthesia, produced by Eagleman et al. (2007). This test pro-
duces a quantitative score of consistency, in which a participant scoring < 1 is con-
sidered to be a synaesthete. If there was a reliable way of establishing the burden of
cognitive impairment (e.g., by conducting a standard test of cognitive function) expe-
rienced by the participant at the time of their testing, the threshold at which they would
be considered consistent enough to be a synaesthete could be adjusted. Unfortunately,
there are several problems with this solution. Firstly, it requires the subject to com-
plete an additional test (i.e., tests of cognitive function), which increases the physical
and cognitive burden on the participant during testing. Secondly, there is no guarantee
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that a given reduction in cognitive capacity would translate exactly to a parallel loss
in consistency. For example, if it could be established that a potential synaesthete was
suffering a 15% impairment in cognitive function, there is no understanding if whether
this deficit would map to a corresponding 15% reduction in consistency. An additional
approach could be the recruitment of a test population that would be expected to have
an increased prevalence of synaesthesia relative to the general population. Given that
MS and synaesthesia are both hereditary to some degree, measuring the prevalence of
synaesthesia in first degree relatives of MS patients could be an alternative approach
to investigating this association, which would allow the recruitment of a larger sample
of participants. If the prevalence of synaesthesia was higher in this group, this could
provide evidence of a link between synaesthesia and MS.
In this chapter, I conducted an investigation into the prevalence of grapheme-colour
synaesthesia in a sample of patients with MS. The results of this investigation do not
provide evidence of any association between MS and synaesthesia. The prevalence
of grapheme-colour synaesthesia in this sample of MS patients was not significantly
different from the prevalence found in the general population, as reported in Chapter 6
and elsewhere (Simner et al., 2006b). Cognitive and physical impairments experienced
by the patients limited their ability to complete the tests required to objectively verify
the genuineness of their synaesthesia, making direct comparisons between these groups
difficult. I discuss the implications of this result in the context of this thesis as a whole
in Chapter 10. In the following chapter, I turn to other possible comorbidities with
synaesthesia, and present an empirical and theoretical link to one particular condition:
anxiety disorder.
Chapter 9
Synaesthesia and other comorbidities:
A health screening approach
9.1 Introduction
In Chapter 2, I provided an overview of the current research into synaesthesia and co-
morbidity. As this literature review shows, research into synaesthesia and potential
associations with clinical conditions is in its infancy. The majority of studies in the
literature report single case studies, with only a small number of investigations pro-
viding group level comparisons. In this chapter, I report empirical work in which a
large sample of the general population completed an online test for synaesthesia (as
first reported in Chapter 6) and also completed a health questionnaire. This generated
a cohort of randomly sampled synaesthetes, each giving a full description of the state
of their health. Within this sample, I examined four conditions in particular (anxiety
disorder, asthma, hay fever and irritable bowel syndrome) to evaluate whether their
prevalence was higher than would be expected in the general population see below for
why these conditions were tested in particular). My results show that the prevalence
of anxiety disorder is significantly higher in these randomly sampled synaesthetes in
comparison to the general population, and that being diagnosed with anxiety disor-
der can actually influence the nature of the synaesthetic experience. Specifically, it
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decreases the luminance of the synaesthetic colours perceived by the synaesthete. Sec-
tions of this chapter have been published in the form of a journal article, as Kay et al.
(2014) (see Appendix H).
As noted above, the key aim of this study is to record data on the prevalence of
a range of clinical conditions and ascertain whether any of them are more prevalent
in grapheme-colour synaesthetes. Previous work has shown an association between
synaesthesia and several conditions (see Chapter 2) and most relevant for the current
chapter is that these include a link between positive schizotypy (personality features
conferring increased risk of developing schizophrenia, as per Meehl, 1990) and synaes-
thesia (Banissy et al., 2012a). Because experiencing anxiety is strongly linked to the
expression of positive schizotypy (Debbané et al., 2009; Lewandowski et al., 2006),
the first hypothesis under investigation in the current chapter is that the prevalence of
anxiety disorder would be expected to be higher in synaesthetes.
In addition, my current study sought to further investigate possible links between
synaesthesia and immunity. In Chapter 5, I put forward the immune hypothesis of
synaesthesia. This hypothesis proposes that the altered cortical connectivity thought to
be a causal factor in the origins of synaesthesia arises as a result of genes that are known
to have immune system functionality in the adult brain but act upon the mechanisms
of cortical connectivity during development. As a consequence, clinical conditions
known to be linked to the immune system were of particular interest in this present
study. For this reason, a limited subsection of conditions listed on a health question-
naire completed by our testing population in the current chapter were selected a priori
for further analysis. These conditions were: anxiety disorder, hayfever, asthma and ir-
ritable bowel syndrome (IBS), the latter in particular because of a previously reported
finding in a group of IBS patients, by Carruthers et al., 2012. These immune linked
conditions - along with anxiety disorder - were compared between the synaesthete and
non-synaesthetes, identified by my wide-scale screening for synaesthesia.
Chapter 9. Synaesthesia and other comorbidities: A health screening approach 134
The third aim of my current study was to explore whether any of the conditions
found to be more prevalent in synaesthetes affected the synaesthetic experience in any
way. To do this, I compared the characteristics of the colours chosen by synaesthetes
with versus without the condition under investigation (e.g., I compared synaesthetes
with and without anxiety disorder to see whether their synaesthetic colours were af-
fected by this diagnosis). There are several reasons to think there might be such a dif-
ference. Although there is virtually no experimental evidence showing that health con-
ditions can affect the colours experienced by synaesthetes, there are sporadic anecdotal
reports in the literature pointing this way. For example, Day et al. (2013) describes
in detail how his synaesthesia temporarily faded after he experienced post-traumatic
stress disorder, and Cytowic (1995) discusses a case study in which a synaesthete with
epilepsy reported that taking her anti-epilepsy medication made her synaesthesia less
vivid. Finally, synaesthetes self-reporting for study in our lab have stated that their
colours paled or disappeared during treatment for cancer (Julia Simner, personal com-
munication) and other conditions such as MS (as reported in Chapter 8). For this
reason, it is possible that clinical conditions might affect the nature of synaesthetic
colours, and we explore this in the current chapter.
Finally, there are a priori reasons to think that anxiety disorder, in particular, may
affect synaesthetic colours in systematic ways. First, emotion is known to be a synaes-
thetic inducer in its own right (Ward, 2004) suggesting that it can play a role in me-
diating synaesthetic experiences. Second, Dael et al. (2013) have hypothesised that
negative mood states may diminish the intensity of synaesthetic experiences, even if
those experiences are not triggered by mood per se. In other words, it is possible
that synaesthetes with anxiety disorder may have notable changes to their synaesthetic
experience, even if that experience is triggered by non-mood related inducers (e.g.,
graphemes). Furthermore, it is possible that changes in mood and emotion can influ-
ence colours indirectly because they have an impact on cognitive processes such as at-
tention (Compton, 2003; Wadlinger and Isaacowitz, 2006). Attention has been shown
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to play a significant role in the modulation of the synaesthetic experience (Rich and
Mattingley, 2013), which may lead to mood affecting synaesthesia indirectly. There
is also evidence suggesting clinical conditions may influence the perception of colour
more directly. For example, Bubl et al. (2010) compared retinal activity in patients
with depression, and found that patients had reduced contrast perception, relative to
healthy control subjects. Taken together, this evidence suggests that the presence of
a clinical condition may exert some influence on how a synaesthete perceives their
synaesthetic colours.
9.2 Experiment 5
In this study, a large sample of randomly recruited participants completed a health
questionnaire and an online test, screening for grapheme-colour synaesthesia. From
these data, the health profile of the whole sample was obtained, and the randomly sam-
pled grapheme-colour synaesthetes within this sample were identified. Thus, the preva-




Participants took part in both the study described in Chapter 6 and the current study as
part of the same testing session, described previously (Chapter 6). As such, the same
2847 participants took part in this study (1317 male, 1530 female; mean age 28.6,
range 16-90, SD 14.3), and the recruitment method for this study is exactly the same
as described in Chapter 6.
9.2.1.2 Materials/Procedure
As described in Chapter 6, randomly recruited participants were sent to an online test-
ing site where they completed two tasks in sequence. The second of these tasks was
Chapter 9. Synaesthesia and other comorbidities: A health screening approach 136
a screening for grapheme-colour synaesthesia, and this was exactly as described in
Chapter 6. The first of these tasks, newly introduced here, was a health questionnaire.
This was a one-sheet online form which began “Have you ever been diagnosed with
any of the following conditions?” Subjects were asked to tick a box for any of the
24 conditions that applied to them (see figure 9.1 for these conditions). This yes/no
measure allowed point estimates of prevalence to be collected for each condition for all
participants, before they were required to give any information regarding whether they
experienced synaesthesia or not. The conditions were selected on the basis of being
prevalent in the general population and were laid out randomly in the questionnaire.
The four target conditions were anxiety disorder, asthma, hay fever and IBS. These
conditions were selected on the basis of being either previously linked to synaesthesia
in the literature (which was the case for anxiety disorder Banissy et al., 2012a and IBS
Carruthers et al., 2012) or by being prototypical immune conditions whose prevalence
is sufficiently high in the general population to obtain high numbers in a sample of the
size obtained in this study.
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Figure 9.1: Screenshot of the health questionnaire
9.2.2 Results
In this results section, I first briefly review the findings of the grapheme-colour screen-
ing test (i.e., how many participants were diagnosed with synaesthesia) and then I
relate this finding to the health questionnaire. In particular, I report the prevalence of
each of our target conditions (asthma, hay fever, anxiety disorder and IBS) within the
population of people diagnosed with synaesthesia, compared to the remaining non-
synaesthetes. Note that although there were 24 different conditions in the question-
naire, I report only the prevalence of four conditions, whose choice was scientifically
motived in advance (see materials/procedure). In order to correct for multiple com-
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parisons, I applied a Bonferroni correction, thus giving a 2-tail alpha level of 0.0125
(0.05/4).
As reported in Chapter 6, from the sample of 2847 participants, 34 subjects achieved
a score of < 1 on the consistency test, which is the criterion used by Eagleman et al.
(2007) to identify genuine synaesthesia. This places the prevalence of genuine grapheme-
colour synaesthesia at 1.2%. I now consider each of our target health conditions in turn,
since the first aim of this study was to ascertain whether the prevalence of any of the
clinical conditions listed in the health questionnaire was higher in synaesthetes.
9.2.2.1 Synaesthesia and anxiety disorder
Of the 34 genuine synaesthetes identified by the screening test for grapheme-colour
synaesthesia, 6 reported being diagnosed with anxiety disorder, giving a prevalence
of anxiety disorder in synaesthetes of 17.6%. From the subjects who were classed as
non-synaesthetes, 139 people reported a diagnosis of anxiety disorder, giving a preva-
lence of 4.9%, in line with previous estimates of between 4.3% and 5.9% found in
the general population (Tyrer and Baldwin, 2006). Finding prevalence estimates in
our non-synaesthete sample that are equivalent to accepted measures in the general
population indicates that the self-reporting methodology used is this study is valid.
The prevalence of anxiety disorder was significantly higher in synaesthetes when
compared to non-synaesthetes, using a two-tailed difference between independent pro-
portions test, (p = 0.0028, z = 2.993). This significance value survives the smaller
alpha specified by the Bonferroni correction. No significant difference in prevalence
was found in any of the other conditions of interest; hayfever (p = 0.067, z = 1.83),
asthma (p = 0.847, z = -0.193), and IBS (Fisher’s exact test, 2-tailed p = 1.0). The
prevalence of each condition across samples are shown in Figure 9.2, below.



























* p = <0.001
Figure 9.2: Prevalence of selected clinical conditions in randomly sampled synaes-
thetes. Error bars are 95% confidence intervals
9.2.2.2 Does anxiety disorder affect synaesthetic colours?
Above, I show that there are different prevalence rates of anxiety disorder in synaes-
thetes versus non-synaesthetes and I further explore this finding in the current section.
In this analysis, I compared the grapheme colours of synaesthetes with and without
anxiety disorder. As discussed in more depth in Chapter 6, the output of the on-
line screening test for synaesthesia include not only an indication of consistency (i.e.,
how consistently colours are reported for each grapheme, which is the yard-stick for
measuring genuine synaesthesia) but it also includes quantified information about the
colours of graphemes encoded as RGB (red, green, blue) vector values. For this anal-
ysis, I converted these values to their corresponding hue, saturation and luminance
values1 . The average luminance of all graphemes for each subject across all their re-
sponses was calculated (maximally, this was a mean across all three presentations of
1This was done using an online conversion tool, found at http://www.rapidtables.com
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each letter a-z and each digit 0-9, although participants were free to omit graphemes
that had no synaesthetic colour. In other words, firstly a mean value was calculated per
grapheme for each subject, then from those values, a single mean luminance value for
that subject was calculated). This process was repeated with saturation values to also
obtain mean saturation values for each participant. Note that I did not compare hue
values since this is a circular dimension and cannot be compared in the same way (see
Ward et al., 2006). Finally, I compared the mean luminance values for synaesthete par-
ticipants with and without anxiety disorder and then compared their mean saturation
values.
The saturation of synaesthetic colours was not significantly different for synaes-
thetes with anxiety disorder (mean = 209.4, SD = 12.6) compared to those without
(mean = 191.0, SD = 35.9; t=1.2, df = 32, p=.2). However, synaesthetes with anxiety
disorder had significantly darker (i.e, less luminant) colours (mean = 102.3, SD = 21.5)
than those without anxiety disorder (mean = 121.9, SD = 20.4; t=-2.1, df = 32, p=.04,
d=.89)2 . This difference is shown in Figure 9.3 below.
2In order to further investigate the interaction between the presence of anxiety and the luminance
and saturation of graphemes, a MANOVA was carried out. The result of this test was non-significant
(F(2,31) =1.9, p=.17; Wilk’s Λ = .89, partial η2 =.11)

























Figure 9.3: Synaesthetes with anxiety disorder have coloured graphemes with
lower luminance
9.2.3 Discussion
In this study, I screened a large sample of the population for grapheme-colour synaes-
thesia in order to identify the small number of genuine synaesthetes within this group.
As part of this online test, participants were also required to complete a health ques-
tionnaire in which subjects were asked to self-report having been diagnosed with a
wide variety of clinical conditions. I found that the prevalence of anxiety disorder (but
not asthma, hay fever or IBS) was significantly higher in synaesthetes in comparison
to non-synaesthetes. Given the strong link between anxiety disorder and schizotypy
(Debbané et al., 2009; Lewandowski et al., 2006), this finding supports previous work
showing a link between positive schizotypy and synaesthesia (Banissy et al., 2012a).
Furthermore, the colours chosen by synaesthetes with anxiety disorder were sig-
nificantly lower in luminance than those selected by synaesthetes without anxiety dis-
order. This finding supports existing evidence that mood and colour are related in
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non-synaesthetes (Bubl et al., 2010). It might also be the case that mood can affect
colour indirectly, by acting on cognitive processes such as attention (Compton, 2003;
Wadlinger and Isaacowitz, 2006). It should be noted that although the prevalence of
anxiety disorder in synaesthetes was high, the numbers of subjects with both synaes-
thesia and anxiety disorder are small, and as such, caution should be taken in the
interpretation of these results.
I did not find significantly higher numbers of synaesthetes with any of the other
autoimmune conditions selected for further analysis (asthma, hay fever or IBS). Pre-
vious studies in the literature have reported a higher prevalence of synaesthesia in IBS
patients (Carruthers et al., 2012), but my current study did not detect an increased
prevalence of IBS in synaesthetes. There are several reasons why this could be the
case. Firstly, our number of genuine synaesthetes was small, and as such, this sam-
ple may not have been large enough to provide an accurate representation of the true
prevalence of IBS in synaesthetes. The advantage of this study is that it avoided a
self-referral bias and used only randomly sampled synaesthetes. Nonetheless, a conse-
quent disadvantage was that the total number of synaesthetes was overall small. Given
this, the number of synaesthetes with any given condition was also small, making it
difficult to draw strong conclusions from null results. Nonetheless, I was able to show
a significant effect in the case of anxiety disorder, and then show the consequences of
having anxiety disorder on synaesthetic colours.
Another reason why I failed to replicate a link between synaesthesia and IBS (Car-
ruthers et al., 2012) may relate to the age of the sample in the current study. The mean
age of the sample participating in this study was 28.6 years old. Whereas the symp-
toms of IBS can occur at any age, patients usually present to a health care professional
with IBS symptoms for the first time between the ages of 30-50 (Quigley et al., 2009).
Indeed, the mean age of IBS patients in the study by Carruthers et al. (2012) was 43.1
years. Given the mean age of the sample in my study was under 30, a significant num-
ber who will ultimately be given a diagnosis of IBS at some stage in their life, will not
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yet have received this. Therefore, the overall prevalence of IBS in this sample is likely
to be lower than in the general population, which may have affected the number of IBS
patients in the synaesthete group.
A further reason for failing to replicate the IBS link reported by Carruthers et al.
(2012) may be the directionality of the association. Because Carruthers et al. (2012)
found an increased prevalence of synaesthetes in IBS patients, the assumption that the
association should hold in the opposing direction might not necessarily be true. This
also mirrors other findings in this thesis. In Chapter 3, I report a higher than expected
prevalence of MS-RIS in synaesthetes, but in Chapter 8, I did not find an increased
prevalence of synaesthesia in MS patients (i.e., the same conditions but opposing di-
rection of association). I discuss this further in the general discussion (see Chapter 10).
Chapter 10
Conclusions and future directions
10.1 Conclusions
In Chapter 1, I introduced the topic of synaesthesia, and discussed the neurology, de-
velopment and causes of synaesthesia. I also reviewed some of the research questions
pertinent to synaesthesia that have relevance for this thesis. Chapter 2 reviewed and
summarised - for the first time - all the existing literature on conditions that may (or
may not) co-occur with synaesthesia. In Chapter 3, I focussed on one particular condi-
tion, multiple sclerosis (MS) and presented data demonstrating that MS and its clinical
precursor, radiologically isolated syndrome (RIS) are statistically more prevalent in
synaesthetes self-referring to participate in scientific studies than in the general popu-
lation. In Chapter 4, I considered the same question from a genetics viewpoint. I first
provided a general introduction to the field of genetics,then a detailed review of the
synaesthesia genetics literature and the genetics of multiple sclerosis. Next I explored
why the two conditions may share common genetic origins. Chapter 5 presented my
immune hypothesis of synaesthesia, which explores a theoretical framework explain-
ing how the origins of synaesthesia may lie with genes that play an important role in the
development of the cortex in the first years of life, yet also have an immune function
in the adult brain.
In Chapters 6 and 7 I presented my own investigation into the genetics of synaes-
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thesia which had the single aim of better understanding comorbidity by examining the
roots of synaesthesia, and several related threads. These involved first establishing (in
Chapter 6), a valid way to phenotype synaesthesia by evaluating an existing online test-
ing platform (The Synesthesia Battery, Eagleman et al., 2007). This validation involved
using the testing platform to generate the most accurate and large scale assessment of
the prevalence of synaesthesia to date, and then comparing this to a previous, widely
accepted prevalence figure established from a well-validated study using a different
method (Simner et al., 2006b). My approach also provided the most accurate estimate
of any sex bias within synaesthesia, which itself was used in my discussions of synaes-
thesia’s aetiology and comorbidity (i.e., is synaesthesia more common in women? Is a
sex bias found in any other potential comorbidities). In Chapter 7, I used this method
of testing for synaesthesia to phenotype participants in my own investigation into the
genetics of synaesthesia.
In Chapter 8, I presented data exploring the prevalence of grapheme-colour synaes-
thesia in a sample of patients with MS and in Chapter 9, I addressed a different area
of comorbidity by presenting empirical work showing that anxiety disorder (but not
asthma, hayfever or IBS) is more prevalent in randomly sampled synaesthetes when
compared to non-synaesthetes. Finally, I showed a consequence of having both synaes-
thesia and anxiety disorder in that such synaesthetes experience less luminant colours
compared to their synaesthetic peers without anxiety disorder.
In this final chapter, I will now summarise and evaluate the findings of the research
conducted for this thesis, and I will discuss the strengths and weaknesses of my ap-
proach. The overall aim of this thesis was to explore comorbidity in synaesthesia, so
I draw conclusions by considering each comorbidity in turn. First, I discuss what this
work tells us about synaesthesia and MS, and second, what I have learned about the
association between synaesthesia and anxiety disorder. In addition, examining synaes-
thesia and comorbidity subsequently led to the investigation of several methodological
questions relating to synaesthesia research. I therefore also discuss these methodolog-
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ical issues and the resulting outcomes further below.
10.1.1 Synaesthesia and MS
Perhaps the key question raised by this thesis centres on the question of comorbid-
ity between synaesthesia and MS. When considering the findings across both my
MS/synaesthesia prevalence studies (Chapters 3 and 8), the question is raised of how
to interpret their combined findings. In other words, how do we interpret the fact that
an unusually high number of MS/RIS cases were found when looking within groups
of synaesthetes, but that synaesthesia was not found in high numbers when looking at
patients with MS, and furthermore, that my genetics study found no conclusive link
between the two conditions? One simple answer is that given the small sample of
synaesthetes scanned in MRI studies (to date, N=243), these high rates of MS I found
within the synaesthete population could have been a statistically spurious finding, de-
spite the conservative assumptions adopted during my study (e.g., the calculation of
conservatively established MS/RIS prevalence baselines). If this were the case, my
other two findings (in genetics and MS patients) would have been as expected.
Nonetheless, there is a second possible answer to this question, and this relates to a
methodological issue. In my conclusions to Chapter 8, I briefly discussed the difficul-
ties in using the same synaesthesia diagnostic test (a test of consistency) for both the
general population and for a clinical population of people with MS. I will elaborate on
this issue towards the end of this chapter where I further consider the methodological
challenges of this thesis. Until then, I remind the reader that the problem in particular
is that clinical populations may be a priori unable to perform well in a consistency test
- independent of whether they have synaesthesia or not. In other words, it is possible
that our test for synaesthesia in Chapter 8 within MS patients was simply unable to pro-
duce robust findings, even if these patients had had synaesthesia in high numbers. This
methodological consideration is all the more important when I consider the limitations
of current knowledge in genetics studies too. In Chapter 5, I discussed a plausible the-
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ory for why synaesthesia and MS may be related, based on the dual purpose of certain
genes, which not only play an important role in synaptic pruning and thus the for-
mation of cortical connections in early development (important for synaesthesia) but
also have later life autoimmune implications (important for MS). Nonetheless, when I
presented a genetic association study in Chapter 7, investigating whether genetic links
could be found between synaesthesia, MS and immunity, there were no significant re-
sults. However, I concluded that chapter by discussing the limitations of the particular
genetics approach I had used, specifically, the inability to control for population strat-
ification effects (see Chapter 7). Because these limitations are overcome by carrying
out a genome wide association study (GWAS), I conclude that genetic links between
these two conditions can only be fully investigated upon completion of such a study.
Although I and my collaborators are currently moving towards this goal (i.e., we are
currently collecting far larger numbers of synaesthete DNA, as required by the GWAS
approach), the GWAS study itself is outside the remit of this thesis. In summary, the
conclusion to be drawn from my MS investigations in Chapters 3,6, 7 and 8 are that
despite a plausible theoretical genetic link, and despite preliminary evidence that ap-
pears to show high rates of MS within synaesthetes, no other corroborating evidence
has yet been found. My future GWAS genetics study might yet shed further light on
this question.
10.1.2 Synaesthesia and anxiety disorder
In addition to investigating potential links between synaesthesia and MS, I also exam-
ined the prevalence of clinical conditions known to have either an association with im-
munity or which have been previously linked to synaesthesia in the literature; namely
hayfever, asthma, IBS and anxiety disorder (see Chapter 9). In my study, I recruited
randomly sampled synaesthetes in a large scale screening approach and then had all
subjects complete a health questionnaire. Two findings emerged from my data. First,
the prevalence of anxiety disorder (but not asthma, hayfever or IBS) was higher in
synaesthetes than in non-synaesthetes. Second, the luminance of reported synaesthetic
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colours was lower in synaesthetes with anxiety disorder when compared to synaes-
thetes without anxiety disorder. In other words, synaesthetes with anxiety disorder
experience synaesthetic colours that are generally darker than synaesthetes without
anxiety.
What conclusions can be drawn from these observations? In previous work link-
ing synaesthesia and positive schizotypy, Banissy et al. (2012a) suggest that increased
comorbidity with positive schizotypy points to the presence of synaesthesia as being
indicative of broad differences in cognitive function and personality. Given the strong
links between anxiety disorder and positive schizotypy (Lewandowski et al., 2006) and
links between anxiety disorder and personality traits more generally (Bienvenu et al.,
2004), my own findings lend support to that premise. With regards to comorbidity
more generally, this brings a key, much broader, question into focus, namely the nature
of the association between conditions. Is the link direct, or is the presence of synaes-
thesia and its comorbid condition both related to an additional, unidentified aspect of
cognition, development or neurology. In Chapter 5, I suggest associations between
synaesthesia and certain conditions such as MS may be related to genes responsible
for both cognitive development and immune system function. Prevalence studies may
not offer direct understanding into this aspect of comorbidity research but ultimately,
the outcome of genetic studies into synaesthesia (see Chapter 7) may provide insight
into the causal relationship between synaesthesia and its cormorbid conditions.
In Chapter 9, I showed that synaesthetes with anxiety disorder have less luminant
(i.e., darker) synaesthetic colours. Previous evidence shows that mood can alter the
perception of colour in non-synaesthetes. The mechanism by which this happens is
still a question of debate. The presence of a clinical condition may exert an effect on
the perception of colour directly, as has been shown in depression Bubl et al. (2010),
or the effect may be modulated by an alternative cognitive process, such as attention
(Compton, 2003; Wadlinger and Isaacowitz, 2006). The interesting point is that both
non-synaesthetic and synaesthetic colour perception can potentially be influenced by
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similar factors (i.e., the presence of anxiety disorder). This would therefore suggest
that both synaesthetic and non-synaesthetic colours are influenced by the same percep-
tual mechanisms and may therefore originate via the same neurological pathways.
None of the other conditions I examined in the health questionnaire (IBS, hayfever
or asthma) had an increased prevalence in the synaesthete sample. Several method-
ological differences that may have led to non-replication of the IBS finding are dis-
cussed in Chapter 9, but an additional point is worthy of further discussion here. Re-
peatedly, throughout this thesis, I refer to possible associations between synaesthesia
and other conditions but without giving consideration to the question of whether or not
that association would be bidirectional or not. For example, Carruthers et al. (2012) re-
port a greater than expected prevalence of synaesthesia in IBS patients. One would as-
sume that the association would hold in the opposing direction, namely that the preva-
lence of IBS should be higher in synaesthetes. My study in Chapter 9 did not find this
outcome. Lack of replication was also found in my studies looking into synaesthesia
and MS, but in the other direction (MS appears overrepresented in synaesthetes but not
synaesthesia in MS patients).
10.2 Methodological advances and limitations
In Chapter 6, I screened a large sample of the general population for grapheme-colour
synaesthesia. To do this, I replicated and evaluated the most commonly used online
test for synaesthesia, the Synesthete Battery (Eagleman et al., 2007). This test is based
on the behavioural gold standard diagnostic for synaesthesia: consistency (i.e., synaes-
thetes report their colours with greater consistency than non-synaesthetes). I showed
that using an online test which screens for synaesthesia using a short-term consis-
tency approach (i.e., in a single session) produces comparable results to studies (e.g.,
Simner et al., 2006b) that assess synaesthesia using long-term consistency (i.e., in
two testing sessions with a significant time interval in between). My study found a
grapheme-colour prevalence of 1.2% and no difference in the ratio of prevalence be-
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tween the sexes. By replicating the grapheme-colour prevalence reported by Simner
et al. (2006b), my result suggests that the single session methodology is a valid and
reliable way of phenotyping genuine synaesthetes.
Previous studies ((Baron-Cohen et al., 1996; Rich et al., 2005) relied upon self-
referral, and consequently found a large female skew of up to 6 female synaesthetes for
every male synaesthete. When conducting my own study, care was taken to minimise
self-referral bias. No-one could self-volunteer to take part in this investigation: all
participants were individually approached to take part and it was only revealed that
synaesthesia was the subject of the investigation once participants began the online test
(see Chapter 6 for methods). In light of this improved methodological approach, the
lack of difference in synaesthesia prevalence between the sexes indicates that previous
differences reported in the literature (e.g., by Baron-Cohen et al., 1996) likely resulted
from recruitment biases, rather than any other difference (such as sex-linked genetic
reasons). My finding can therefore hopefully assist future research into the causes of
synaesthesia by shifting focus from possible sex-based differences.
10.2.1 Screen or recruit? The referral bias dilemma
There is a methodological trade-off involved in the design of studies requiring the re-
cruitment of participants with one or more rare conditions, and this concerns sample
size versus self-referral bias. When dealing with (multiple) conditions that are rare
in the general population, finding suitable participants is a challenge for researchers.
Small samples can cause problems with statistical power, thus limiting the strength
of conclusions that can be drawn from the presented evidence. On the other hand,
because participants who go out of their way to volunteer to take part in research stud-
ies are a priori different from non-volunteers on numerous measures, such as level of
motivation, level of education and openness to new experience (Rosenthal and Ros-
now, 1975), we cannot be sure that a sample of participants who made the effort to
self-volunteer to take part in a study are representative of the general population.
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In Chapter 6 of this thesis, I took the approach of screening a large sample of
the general population in order to identify the small number of genuine synaesthetes
within that group, thus taking steps to minimise self-referral bias. Once this group
of synaesthetes (n=34) was identified, I could then investigate questions such as the
overall prevalence of grapheme-colour synaesthesia, its distribution between males
and females and the prevalence of certain clinical conditions in synaesthetes. As noted
above, the advantage of my study is that self-referral bias and (thus the confounding
differences between volunteers and non-volunteers) is minimised. The disadvantage is
that the number of synaesthetes is small. When considering issues such as the overall
prevalence of grapheme-colour synaesthesia, or the bias in prevalence between the
sexes, I consider my approach to be superior, in that it produced an accurate estimate
of prevalence overall. Above therefore, I proposed that limiting recruitment bias will
ultimately result in a more accurate prevalence estimate. An opposite viewpoint is also
possible. For example, it would have been possible to advertise for grapheme-colour
synaesthetes and recruit a larger sample than the one obtained here by screening the
general population. As evidenced by different estimates of prevalence and sex bias
in synaesthesia early in the literature (discussed in Chapter 1), the results would be
significantly different using this approach.
10.2.2 Focus on grapheme-colour synaesthesia
In this thesis, I focussed on a specific synaesthesia subtype; grapheme-colour synaes-
thesia. There are several advantages and potential disadvantages to this approach that
are worthy of discussion here. Grapheme-colour synaesthesia is one of the most com-
mon synaesthesia variants, with a prevalence of approximately 1.2% in the general
population (Simner et al., 2006b). It is also one of the best understood variants, and
is easy to test the consistency of grapheme-colour synaesthesia, relative to other sub-
types (Simner, 2012). Grapheme-colour synaesthesia lends itself especially well to
online testing that can be conducted remotely, which is a significant advantage when
aiming to screen large samples of the general population.
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The question remains however, can grapheme-colour synaesthesia be used as a
proxy for all other forms of synaesthesia? If this approach is optimal, grapheme-colour
synaesthesia should share the same neurological and genetic causes as other synaes-
thesia variants. Whether this is indeed the case remains an open question. In chapter
4, I refer to literature showing that certain subtypes co-occur in clusters (Novich et al.,
2011), which lends support to the hypothesis that subtypes occur in clusters according
to the inducer and/or concurrent in question. For example, synaesthesia subtypes with
ordinal sequences (i.e., days and months) or graphemes as inducers and colour as an
concurrent are statistically more likely to co-occur in the same person, whereas the
likelihood of a grapheme-colour synaesthete experiencing lexical-gustatory synaesthe-
sia is the same as that of a non-synaesthete (Novich et al., 2011).
It is possible that specific comorbidities may be more greatly associated with forms
of synaesthesia other than grapheme-colour. For example, it is not unreasonable to pro-
pose that the prevalence of anxiety disorder may be higher in people who experience
forms of synaesthesia linked to emotions, given the link between anxiety disorder and
the regulation of emotion (Hofmann et al., 2012). It is possible therefore, that in-
vestigating anxiety disorder in only grapheme-colour synaesthetes may not provide a
wholly representative picture of the prevalence of anxiety disorder in synaesthesia.
On balance however, I suggest the advantages gained from testing grapheme-colour
synaesthetes are greater than the potential disadvantages. The issue of whether grapheme-
synaesthesia is a suitable proxy for all synaesthesia subtypes only becomes relevant if
indeed synaesthesia is an umbrella term for a collection of behaviourally similar con-
ditions with different origins, and to date, this remains an open question. If this were
indeed to be the case, it would limit conclusions from this thesis to be drawn with
respect to grapheme-colour synaesthesia only, rather than allowing findings to be gen-
eralised to synaesthesia as a whole. The advantages however, are tangible. Grapheme-
colour synaesthesia is well understood behaviourally, it is straightforward to test for,
and lends itself well to online and remote testing. This enables large samples of the
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size used in this thesis (in the thousands) to be screened for synaesthesia.
10.2.3 Comparing synaesthesia in healthy and clinical populations
As discussed above and in Chapter 1, this gold standard behavioural test for synaes-
thesia relies on consistency of response, either assessed across a significant long-term
time interval or using short-term single session tests (e.g. Eagleman et al., 2007).
Nonetheless, an important additional issue with studies comparing the prevalence of
synaesthesia in clinical populations with the prevalence in groups of healthy individ-
uals concerns how a fair comparison of consistency between groups might be estab-
lished. In this thesis, I assessed the prevalence of synaesthesia in both healthy and
clinical populations. This question is therefore especially pertinent, so I address it
more fully below.
The fundamental question is this - do we expect the synaesthetes in either clinical
or non-clinical groups to be equally consistent? Is this a fair comparison? Is it possible
that synaesthetes with comorbidities may be a priori likely to be less consistent as
a result of their additional condition (e.g., MS)? If so, how should researchers deal
with this situation? The answer to this issue comes down to the question of why
synaesthetes are consistent. Of primary concern is the possibility that only healthy
synaesthetes may be fully consistent over time. Put differently, the test of consistency
might be less appropriate in clinical populations, because their clinical condition may
itself hinder consistency in reporting synaesthetic colours (or other sensations). This
would of course depend on the type of comorbidity under consideration. One would
imagine that when considering conditions without any significant impact on memory,
cognitive performance or executive function (e.g., asthma), comparisons of consistency
would be valid. It would however, be reasonable to assume that conditions with greater
clinical burden (e.g., MS) could potentially reduce consistency. The problem then
becomes a matter of interpretation. Does a low level of consistency mean the person
should be considered less synaesthetic or that a reduction in general cognitive function
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indirectly linked to synaesthesia is responsible? In other words, the presence of illness
if a potential confound when assessing the consistency of synaesthesia. Furthermore,
individual synaesthetes are likely to be impacted to varying degrees - for example, the
consistency of every synaesthete with schizophrenia is not going to be affected to the
same extent. Do we conclude that if the consistency of their synaesthetic responses
is affected by the additional condition they suffer from, their synaesthesia is any less
genuine? If it is the latter, the question of how this should be addressed is a significant
one.
Several of the studies discussed in Chapter 2 highlight the methodological difficul-
ties and potential discrepancies in results that may emerge when comparing clinical
and non-clinical populations. For example, Baron-Cohen et al. (2013) report difficul-
ties in getting autism patients to successfully complete tests of consistency, effectively
preventing objective comparisons of synaesthetic consistency to be made between pa-
tients and controls. Carruthers et al. (2012) found IBS patients were less likely to meet
increasing strict consistency thresholds relative to control subjects. When consistency
was measured using thresholds of 50% accuracy and 75% accuracy, the number of
IBS patient synaesthetes obtaining these levels of consistency dropped significantly,
whereas the number of controls did not. This could have two possible causes; either
IBS patients are somehow more likely to indicate they have synaesthesia when they do
not, or the reduced consistency of their responses may be perhaps related to their ill-
ness. In my own work investigating the prevalence of synaesthesia in multiple sclerosis
patients (Chapter 8), we saw that consistency of response in self-reported synaesthetes
varied significantly, as did the burden of cognitive impairment experienced by some
participants. I concluded that it was likely that cognitive problems contributed to a
significantly reduced capacity for consistency of response.
I conclude this thesis by pointing to one final issue in the domain of consistency
testing in synaesthesia research. While consistency has thus far been considered the
defining benchmark of the synaesthetic experience (Baron-Cohen et al., 1993, 1996;
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Mattingley et al., 2001; Rich et al., 2005; Simner et al., 2006b), recent evidence sug-
gests that the link between synaesthesia and consistency may not be as rigid as ex-
pected. Simner (2012), made the point that establishing consistency as a defining cri-
terion of synaesthesia leads to the identification of consistent synaesthetes only and the
rejection of the rest. She points out however, that there may be a significant number
of synaesthetes who genuinely experience automatic synaesthetic associations when
presented with inducers, but simply happen to be non-consistent over time. In other
words, Simner (2012) revises the possibility that consistency may be a false foun-
dation on which to define synaesthesia: many synaesthetes are consistent but some
may not be. One ideal step forward in the synaesthesia literature - and especially
the literature that seeks to find comorbidities - might be to find new ways to identify
synaesthetes, which may ultimately allow a fairer comparison across synaesthete and
non-synaesthete populations.
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Exploring the Connection between Synaesthesia and Multiple Sclerosis 
PARTICIPANT INFORMATION SHEET 
 
We would like to invite you to take part in a research study based at the University of 
Edinburgh and NHS Lothian. This study involves patients who have been diagnosed with 
Multiple Sclerosis (MS). Before you decide it is important for you to understand why this 
research is being done and what it will involve. Please ask us if there is anything that is not 
clear and take your time to decide whether or not you wish to take part. 
 
1) What is the purpose of the study? 
This project aims to investigate a potential link between synaesthesia and MS. Synaesthesia 
is a benign form of perception in which stimulation of one sense leads to automatic, 
involuntary experiences in a second sense. For example, perception of numbers and letters 
may be associated with the experience of colours or a musical note may be associated with 
a particular colour. The purpose of the study is to explore the connection between 
synaesthesia and MS, which may ultimately lead to a better understanding of the causes of 
both synaesthesia and MS. 
  
2) Who is organising and funding the research? 
The research is being organised by the University of Edinburgh. This project is being 
supervised by Dr Julia Simner and Professor Stephen Lawrie who work in academic research, 
in collaboration with the Department of Clinical Neurology, NHS Lothian.  
 
WHY HAVE I BEEN ASKED TO TAKE PART? 
This study requires the participation of MS patients and a group of healthy volunteers to act 
as control subjects. You have been approached either because you are an MS patient 
attending an MS clinic at the Western General Hospital or because you are accompanying a 
patient attending this clinic. 
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3) Do I have to take part? 
No, your participation in this study is entirely voluntary. You are free to decline to enter, or 
to withdraw from the study at any time without having to give a reason. Participation in this 
study will not affect your ongoing care.  
 
4) What will happen to me if I take part? 
Participation in this study involves completing a questionnaire and taking part in an online 
behavioural test for synaesthesia. The questionnaire should take less than 20 minutes and 
the online test should take approximately 45 minutes. Both tests are designed to establish if 
you have any form of synaesthesia. Only participants who report experiencing synaesthesia 
will be asked to complete the online test, which can be quite time consuming and require 
concentration to complete.  The online test requires access to a computer connected to the 
internet. This test maybe completed at home at a time convenient to you or alternatively, in 
the clinic, should you not have access to the internet at home. Completing the online test 
requires giving consent online and any data obtained will be stored on an external database 
any may be used in future by owners of the site. Should you be asked to complete the 
online test, you will be provided with an email address and login to allow this test to be 
completed anonymously. 
 
5) Are there any risks or disadvantages if I take part? 
There are no anticipated risks or disadvantages to taking part in this study.  
 
6) Will taking part interfere with my treatment? 
No, taking part will not affect your clinical care in any way. 
 
7) What about my medication? 
We would ask you to take your medication as normal. We are not testing a new treatment. 
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8) What are the potential benefits of taking part? 
We do not anticipate any direct benefits to you. However, we hope to gain a greater 
understanding of whether synaesthesia and MS are connected. In doing so, it is possible 
that a better understanding of the causes of MS might be obtained. 
 
9) What happens when the research study stops? 
When the study finishes, we will analyse the data and determine the results. The results will 
then hopefully be published in scientific journals. If you would like to hear about the final 
results of the study, please let us know and we will arrange this with you. We will also retain 
your details about you as described below. 
 
10) What information will be held about me? 
Data from the questionnaire and online test will be collected, along with your name and 
date of birth. Questionnaires will be anonymised and coded with a unique identification 
number. This information will be treated as strictly confidential and will only be used for the 
purposes of scientific research. The results of these tests will be stored on password 
protected computers and your personal details will be stored securely. When the results of 
the study are published or presented to a third party, all data will be in coded form to 
preserve anonymity. Any information that could link the data back to you (such as your 
name and address) will be completely removed. Anonymised data from this study will be 
made available to the research team. It is possible that relevant data may be used by other 
researchers working within the University of Edinburgh for other ethically approved 
research projects but only after approval from the chief investigator. Any publications 
arising from this study will be fully anonymised and will be made available to you upon 
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11) What if there is a problem? 
If you have a concern about any aspect of this study, you should speak to the researchers 
who will do their best to answer your questions. If you remain unhappy and wish to 
complain formally, you can do this via the NHS complaints procedure. Details can be 
obtained from Patient Advice and Liaison Service at any of the hospital sites involved. 
 
12) Does my GP need to be informed? 
Because synaesthesia is not considered a clinical condition and this study does not interfere 
with your health care in any way, we will not inform your GP about your participation in this 
study. 
 
13) What will happen if I do not want to carry on with the study? 
You may withdraw from the study at any point. 
 
14) Will I be followed up after the study? 
Participation in this study would not affect your ordinary care and follow up. 
 
16) Who has reviewed and approved the study? 
An NHS research ethics committee has reviewed and approved this study. This is an 
independent group of people who ensure that the dignity, rights and safety of participants 
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17) If you would like further information from an independent advisor, please call or write 
using the contact details below. 
Name:   Dr Anna Williams 
Job title:  Research Fellow and Honorary Consultant 
Work Address:  The Queen’s Medical Research Institute 
   47, Little France Crescent 
   Edinburgh 
   EH16 4TJ 
Daytime telephone: 01896 826 624 
Email:   annacwilliams@yahoo.co.uk 
 
18) If you would like more information or need to contact me after taking part, please call 
or write to me using the details below. 
 
Name:    Duncan Carmichael 
Job title:   PhD Researcher 
Work address:  room 3.34 Informatics Forum,  
10 Crichton Street,  
University of Edinburgh,  
EH8 9AB 
Daytime telephone:  0131 650 4415 
Email:    d.a.carmichael@sms.ed.ac.uk 
 
Many thanks for reading this information pack. Our research depends entirely on the 
goodwill of potential participants such as you. We realise that it may not answer all your 
questions. Please think about participation carefully and feel free to ask us anything you 
wish. 
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Exploring the Connection between Synaesthesia and Multiple Sclerosis 
PARTICIPANT CONSENT FORM 
 
Please confirm your personal details: 
Name:   __________________________ 
Date of birth:  __________________________ 
Address:  __________________________ 
Email:   __________________________ 
Contact number: __________________________ 
Participant ID: __________________________ 
 
PLEASE INITIAL THE RELEVANT BOXES REGARDING PARTICIPATION IN THIS STUDY: 
 
1. I confirm that I have read and understood the information sheet (version 1.2, 
23/05/2012) for the above study and have had an opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason. Should I withdraw, my medical care or legal 
rights are not affected. 
 
3. I understand that relevant sections of my medical notes and data collected during 
the study may be looked at by the study researchers and individuals from the 
Sponsor, regulatory authorities or from the NHS organisation, where it is relevant 
to my taking part in this research. I give permission for these individuals to have 
access to my records. 
 
4. I agree to storage of personal information in a secure, locked cabinet to which 
only the research members will have access to. 
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5. I understand that anonymised data will be stored securely and processed in the 
research department. If appropriate, this data may be reviewed by future 
researchers after the study has ended. 
 





Name of Participant:  __________________________ 
 
Signature of Participant: __________________________ 
 
Date:    __________________________ 
 
 
Name of Researcher:   __________________________ 
 
Signature of Researcher: __________________________ 
 
Date:    __________________________ 
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Prevalence Synaesthesia Questionnaire 
What is synaesthesia? 
 Synaesthesia is a benign form of perception in which there is a kind of ‘cross-over’ of the senses. So for 
example, for someone with synaesthesia, hearing music might give rise to the sensation of colour. There 
are many types of synaesthesia, and each one links some type of trigger (e.g., listening to music, reading 
numbers) with some type of crossed experience (e.g., a colour, a taste). Around 4% of people experience 
synaesthesia. People with synaesthesia very often do not realise that their experiences are different 
from other people – or they might view them as a simple eccentricity. For example, in one type of 
synaesthesia, people spontaneously associate letters of the alphabet with personality types or genders 
(e.g., A might be female, say, or untrustworthy). In another, they might feel that food tastes have 
different ‘shapes’ (e.g., chicken is pointed, banana is a small sphere). Other types of synaesthesia include 
letters triggering colour (r=dark red), words triggering food flavours (e.g., Philip = unripe oranges) or 
numbers, letters or time being ‘seen’ mapped out in space (e.g., months of the year in an oval shape). Of 
course, anybody could invent these types of association on the spot, but only people with synaesthesia 
will have had associations existing spontaneously, and before being asked in this questionnaire. These 
associations may date back since childhood or may have developed more recently.   
 
What is NOT synaesthesia? 
 Sensations triggering memories. E.g. a song reminding you of a person or place.  
 Learned associations. E.g. the word Christmas being linked to the colour red or the sound of carols; the 
colour green being associated with envy. 
 
The questionnaire below asks whether you any synaesthesia-like experiences. It also asks about other 
sensory experiences you might have. Please don’t worry about first guessing whether or not you have 
synaesthesia – just give any information as accurately as you can.   
 
SECTION 1: ABOUT YOURSELF 
Date of birth: ____________Sex:    Male   Female 
Handedness: Right-handed  Left-handed   Ambidextrous 
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SECTION 2: ABOUT YOUR EXPERIENCES 
2A. INSTRUCTIONS: Please use the space below to tell us about your experiences. Please link the triggers on 
the left with your experiences on the right by drawing a line(s) on the questionnaire. For instance, if numbers 
give you the impression of colours, draw a line between numbers (which is the trigger, on the left) and colours 
(which is the experience, on the right). You may have no associations, or you may have one or more than one. 
 
IMPORTANT: Please don’t connect the same things (e.g. colours-colours) as this is assumed true of 
everyone. We also assume (without you having to indicate) that letters/words etc. are experienced as 
shapes on a written page, and musical instruments/voices/spoken words as noise. 
 
TRIGGERS       EXPERIENCE 
 
Letters of the alphabet      Colours 
English words       Shapes/patterns 
Foreign words        Tastes 
People or People’s names     Smells 
Addresses/places      Pains/touches 
Numbers       Noises 
Days of the week      Flashes 
Months of the year      Music/sound 
Voices        Movement 
Pains/touches       personality/gender 
Movements/postures       
Music (instrumental)      
Noises       
Smells       
Tastes        
Colours       
Shapes/patterns      
Emotions      
Environmental sounds  
(e.g. a car engine, clapping hands) 
 
 






Some people experience sequences (e.g., numbers, days, months) in particular spatial patterns. For 
example, they might see months of the year in an oval shape, or a on a curved line. Does this apply to you? 
o No 
o Yes : Which sequences do you see? (please underline) 
o  
days       months       years       numbers       letters       temperature       height/weight       other___________ 
 
Please use the reverse side of this questionnaire to draw your spatial pattern(s). 
                                                                                                                           
                              
REF: 12/SS/0070 Synaesthesia Prevalence Questionnaire 1.2 Date: 06.09.2012  
 
2B. If you indicated any association in section 2A (e.g., letters-to-colours, sequences in space) please tick to 
tell us whether you recall having these experiences during your childhood. If some associations started in 
childhood and some started only later in life, please tick the ‘mixed’ box.  
o Yes (I’ve had all of them since childhood/early adolescence)         
o No (they all started later in life)   At what age?____________ 
o Mixed* (some started in childhood, some in adulthood; please use the space below to let us know 






*Please check that you have included ALL the associations you specified in section A. You can use the reverse 
if you need more room because we would like to understand when each one began. 
 
2c. Please tick whether you know of any family members who have similar experiences to those described 
in section 2A above. 
o No 
o Yes         Relationship to you:________________________________________________ 
                      Types of experiences they have: ______________________________________ 
 
2d. Since the onset of your multiple sclerosis have you experienced any sensory disturbances? 
o No 
o Yes, visual disturbances. Please describe: ______________________________________________ 
o Yes, taste disturbances. Please describe: _______________________________________________ 
o Yes, hearing disturbances. Please describe: _____________________________________________ 
o Yes, smell disturbances. Please describe: _______________________________________________ 
o  Yes, touch/tactile disturbances. Please describe: ________________________________________ 
 
 
Please use the space below if you would like to add further details about sensory disturbances or 






Please tell us how frequently you have these sensory disturbances by writing below which one(s) you have for 
each time-frame (e.g., Daily: visual disturbances and auditory disturbances)?  
o Daily: __________________________________________________________________________ 
o  Weekly: ________________________________________________________________________ 
o Monthly: _______________________________________________________________________ 
o Very infrequently (less than one per month): __________________________________________ 
o  




                                                                                                                           
                              










The genetics and inheritance of synaesthesia
Julian E. Asher and Duncan A. Carmichael
Early evidence for genetic transmission of synaesthesia: 
prevalence, sex bias, and familiality
Synaesthesia is a neurodevelopmental condition characterized by anomalous sensory 
perception and associated alterations in cognitive function due to interference from 
synaesthetic percepts. For synaesthetes, a stimulus (‘inducer’) in one modality triggers an
automatic, consistent sensation (‘concurrent’) in another modality. For example, in 
auditory-visual synaesthesia, sound triggers the perception of colour (Baron-Cohen, 
Wyke, and Binnie 1987; Ward, Huckstep, and Tsakanikos 2006). For many synaesthetes, 
the synaesthetic experience crosses modalities (e.g. sound-to-colour) while for other 
synaesthetes, the inducer and synaesthetic concurrent occur in different facets of the same
modality; in visual grapheme-colour synaesthesia, for example, reading black-on-white 
text triggers the perception of colour (Mattingley et al. 2001; Ramachandran and 
Hubbard 2001). While synaesthetic inducers vary widely (e.g. sounds, tastes, 
graphemes), the resulting percepts are almost always visual, most often in the form of 
colour although visually salient texture and movement have also been described (Asher 
et al. 2006; Baron-Cohen, Wyke, and Binnie  987; Simner et al. 2006).
The focus of this chapter is on the genetics of synaesthesia, which has important 
implications for its underlying aetiology. This aetiology can also be illuminated by 
examining the co-occurrence of synaesthesia with other cognitive phenotypes. Using 
neuroimaging techniques, alterations in white matter have been observed which could 
indicate the existence of overall increased connectivity in the brains of synaesthetes 
(Rouw and Scholte 2007). Studies also show that anomalous activation occurs in brain 
regions involved in colour processing when colour-experiencing synaesthetes are 
exposed to synaesthetic triggers (e.g. Nunn et al. 2002). Although many synaesthetes 
report their synaesthesia to be neutral or even pleasant, a growing body of evidence 
indicates that the simultaneous perception of normal and synaesthetic percepts can result 
in perceptual and cognitive dysfunction, with particularly strong effects on linguistic 
(Mattingley et al. 2001) and numerical (Green and Goswami, 2007) processing. 
Conversely, synaesthesia has also been implicated in ‘positive’ cognitive variation, 
including superior performance on certain perceptual tests (Ramachandran and Hubbard 
2001; see Kim and Blake, Chapter 15, this volume) and improved recall (Smilek et al. 
2002; see Meier and Rothen, Chapter 35, this volume). One of the most interesting 
connections is between synaesthesia and different forms of eidetic (‘photographic’) 
memory (Glicksohn, Steinbach, and Elimalach-Malmilyan 1999; Luria 1968), including 
absolute (‘perfect’) musical pitch (Rizzo and Eslinger 1989), and with heightened visual 
memory and imagery more generally (see Price, Chapter 37, this volume). Synaesthesia 
has also been implicated in cases of savantism (Baron-Cohen et al. 2007; Simner, Mayo, 
and Spiller e. 009; see Spiller and Jansari, Chapter 36, this volume). We shall return later 
to examine these findings in our discussion of candidate genes.
The tendency of synaesthesia to cluster in families was first reported in 1883 by 
Sir Francis Galton (Galton, 1883), 71 years after synaesthesia was first described in the 
scientific literature (by Sachs in 1812; see Jewanski, Day, and Ward 2009). Despite this 
early observation, the genetics of synaesthesia remained unexplored for most of the 
twentieth century. During the early part of the last century, the techniques required to 
investigate the role of genes were simply unavailable; then later, following the 
development of genetic techniques, scientific resources were initially focused on 
identifying genes associated with more pathological conditions. Towards the very end of 
the twentieth century, however, the first attempts were made to investigate the hereditary 
nature of synaesthesia.
The development of suitable diagnostic methodologies to verify genuine 
synaesthetes played a key role in enabling researchers to investigate the genetics of 
synaesthesia. These methodologies relied (and still rely to this day) on the consistency of 
synaesthetes’ reports about their percepts for any given trigger. Consistency is considered
to be a hallmark of authenticity because for synaesthetes, the particular concurrent 
triggered by a given inducer (e.g. the very specific shade of red triggered by the letter 
‘A’) tends to stay the same over time—even over very long time periods such as years 
and decades (e.g. Simner and Logie, 2008; see Johnson, Allison, and Baron-Cohen, 
Chapter 1, this volume, for review). In contrast, non-synaesthetes who invent analogous 
mappings by free association tend to be far less consistent over time, and this difference 
forms the basis of what has become known as the Test of Genuineness (TOG; Asher et al.
2006; Baron-Cohen, Wyke, and Binnie 1987; Baron-Cohen et al. 1993). The use of the 
TOG (or later versions; e.g. the Revised Test of Genuineness (TOG-R); Asher et al. 
2006) to identify synaesthetes remains central to the study of synaesthesia in general, and
to studies of its familiality.
At the birth of modern synaesthesia research in the final decades of the twentieth 
century, there was little empirical evidence regarding either the prevalence of 
synaesthesia or the ratio at which it occurs across the sexes, both of which are important 
for investigations of inheritance. Using the TOG, studies aimed to establish the 
prevalence and gender ratio as a starting point to explore the underlying genetics of the 
phenomenon. However, subsequent estimates of the prevalence of synaesthesia varied 
rather widely. Studies estimating prevalence by self-referral methods (i.e. asking 
synaesthetes to come forward through advertising media) estimated its prevalence at 
0.05% to 1% of the population (Barnett et al. 2008; Baron-Cohen et al. 1996; Simner et 
al. 2006), while studies directly testing samples of the population without relying on 
synaesthetes’ self-motivation found it to be as high as 4% (Simner et al. 2006; see 
Johnson Allison, and Baron-Cohen, Chapter 1, this volume, for an evaluation of previous 
prevalence methodologies). The use of different definitions of ‘synaesthesia’ for the 
various prevalence studies further complicated matters; many of the earlier studies (e.g. 
Baron-Cohen et al. 1996) focused on what was at the time the most well-known 
phenotype (auditory-visual synaesthesia, including music-colour synaesthesia which is 
now known to be a relatively uncommon phenotype) while the later studies included a 
much wider range of phenotypes (notably the most common variant, day-colour 
synaesthesia; e.g. Simner et al. 2006). Given recent evidence of clustering amongst 
synaesthetic phenotypes and, specifically, the evidence that that auditory-visual and day-
colour synaesthesia may be entirely separate phenomena (Novich, Cheng, and Eagleman 
2011), revisiting prevalence figures for different clusters of synaesthesia would now be 
warranted. However, while the prevalence of synaesthesia has been controversial (for 
review, see Johnson, Allison, and Baron-Cohen, Chapter 1, this volume) the results of 
modern familiality studies provided clear evidence for a strong genetic component in 
synaesthesia by showing greater than 40% prevalence amongst the first- or second-
degree relatives of known synaesthetes (Barnett et al. 2008; Baron-Cohen et al. 1996; 
Ward and Simner, 2005).1
Initial pedigree analyses of multiplex families (families containing multiple 
synaesthetes; Bailey and Johnson 1997; Baron-Cohen et al. 1996) supported the theory 
that synaesthesia may be a highly penetrant Mendelian disorder showing a major gene 
effect and a dominant mode of inheritance. By way of background, we provide here a 
brief overview of this terminology and then describe how such a theory was informed by 
early data on the relative proportion of female to male synaesthetes. Simply put, a 
1 The extent to which synaesthesia occurs in multiple family members may not be 
obvious because the condition can appear in different manifestations within the same 
family (e.g. a sister with coloured words may have a brother whose words trigger taste; 
e.g. Ward and Simner 2003). Indeed, data from a large-scale familiality study performed 
in Ireland with systematic screening of the first-degree relatives of synaesthetic probands 
revealed 11% of ‘non-synaesthete’ relatives to be synaesthetes of a different phenotype 
than the probands (Barnett et al. 2008). This means that reports from probands may 
underestimate the extent of familiality in synaesthesia if they focus on one variant only.
Mendelian disorder is a condition caused by a mutation in a single gene. Penetrance 
refers to the proportion of people possessing a particular variant of the gene in question 
who exhibit the phenotype (if the variant has a penetrance of 35%, only 35% of the 
people with that variant will show the phenotype). A condition is considered highly 
penetrant if a majority of people with that variant express the associated phenotype. To 
understand how these relate to inheritance and sex biases, we must also understand the 
inheritance of chromosomes.
Chromosomes are strings of nucleic acids and protein which carry genetic 
information in the form of genes. Humans possess 23 pairs of chromosomes, and inherit 
one chromosome per pair from each parent (for more information on this inheritance, see 
later in this chapter). As a consequence, we possess two copies (known as alleles) of the 
same gene, one on each chromosome—one inherited from our father, and one from our 
mother. In Mendelian terms, an allele can be dominant or recessive. If the possession of a
single allele is sufficient to cause the expression of a trait in the phenotype, that allele is 
dominant. A condition with a dominant mode of inheritance only requires one of the two 
alleles in a particular pair to cause the phenotype to be expressed, so in effect, only one 
parent needs to carry the allele and pass it on to their offspring. If a pair of alleles consists
of a dominant and a recessive copy, the dominant allele will mask the effect of the 
recessive allele in the phenotype. So for conditions that have a recessive mode of 
inheritance, the offspring must inherit a recessive copy from both parents before its effect
can be expressed in the resulting phenotype.
The inheritance of synaesthesia initially appeared to be linked to the X 
chromosome because more females seemed to be affected than males and there was a 
notable absence of confirmed cases of father-to-son (i.e. male-to-male) transmission. 
Females inherit two X chromosomes, while males inherit only one, this coming from 
their mother. Early studies suggested that there were six times more female synaesthetes 
than male synaesthetes (Baron-Cohen et al. 1996), and an initial meta-analysis performed
by Bailey and Johnson in 1997 concluded that the available data at that time best fitted an
X-linked dominant mode of inheritance. Because X-linked dominant inheritance alone 
cannot explain a female:male ratio greater than 3:1, the heavily skewed female presence 
was accounted for by suggesting that the putative ‘synaesthesia gene’ may be lethal in 
males causing death in utero (Bailey and Johnson 1997; Baron-Cohen et al. 1996). This 
could occur because males are hemizygous (meaning they possess only one copy of the X
chromosome) and if that single copy were defective it could result in lethality.
However, more recent prevalence studies using different methodologies, and 
meta-analyses with larger data sets (e.g. Simner et al. 2006; Ward and Simner 2005) 
indicate that the female:male ratio may be far lower than previously believed (perhaps as 
low as 2:1 or even 1:1), calling the X-linked mode of inheritance into question. 
Furthermore, Ward and Simner (2005) showed that the male/female make-up of 
synaesthetes within families does not support a model of male lethality: female 
synaesthetes are just as likely to give birth to a son as to a daughter, and there was no 
difference in their number of brothers/sisters, aunts/uncles, or female/male cousins (see 
also Barnett et al. 2008). It was also suggested that the mode of inheritance was likely to 
be more complex, with skipped generations indicating reduced penetrance (Barnett et al. 
2008; Simner et al. 2006; Ward and Simner 2005). Nonetheless, the enduring possibility 
of an elevated number of female synaesthetes in sex comparisons (if not 1:1, then 
anywhere between 2:1 and 6:1 depending on methodology; and we return to this later) 
and the historical failure to detect any confirmed cases of male-to-male transmission 
made it imperative to directly test for the involvement of the X chromosome.
At present, the search for genes underpinning synaesthesia is still in its infancy. 
Empirical evidence linking specific areas of the genome to synaesthesia has been limited 
to a small handful of recent papers. Since the relative paucity of empirical studies 
precludes an extensive literature review, this chapter will focus on an in-depth discussion 
of the current literature, with particular emphasis on the seminal paper by Asher et al. 
(2009), the first genome-wide scan examining the genetic basis of synaesthesia. We begin
with an overview of the genetic concepts that are relevant to the findings reviewed in 
these family linkage studies.
What is ‘linkage’ and why is it important?
The initial phase of sexual reproduction involves a stage called meiosis, which takes 
place in the ovaries and testes. The cells produced by meiosis are gametes (eggs or 
sperm). In meiosis, 23 pairs of chromosomes—half having originated from each parent—
exchange fragments of DNA and are recombined. This results in the formation of a new 
and unique set of chromosomes containing genes from both parents. Unlike normal cells, 
gametes have only half the usual number of chromosomes: only 23, rather than 46. 
(When sexual intercourse subsequently occurs, these combine with the gamete 
chromosomes from the sexual partner, and genes from both parties are then inherited by 
the resulting offspring. In this way, genes from all four grandparents are inherited by the 
child.) In meiosis, the proximity of genes to each other on a given chromosome governs 
the likelihood of whether those genes become separated or remain together during the 
process of recombination. The closer together genes are located, the more likely they are 
to remain together on the newly formed chromosome. This likelihood of being inherited 
together is referred to as ‘genetic linkage’.
In genetic studies, linkage is commonly measured as a ‘log of odds’ (LOD) ratio, 
which gives a statistical measure of the likelihood of genes remaining adjacent on the 
newly formed chromosome.2 For example, a LOD score of 2 would indicate odds of 
100:1 that linkage did not occur by chance and a LOD score of 3 would indicate odds of 
1000:1. Linkage can be used to identify particular locations on a chromosome which 
contain genes responsible for a particular phenotype. Microsatellites, short sequences of 
repeating base-pairs of DNA distributed throughout the genome, can be used as genetic 
markers in familial linkage studies. In the same way that different family members can 
possess different versions of certain gene alleles, versions of microsatellites will also vary
per family member. If we compare the microsatellites of affected versus non-affected 
family members, we can see which microsatellites are different and importantly, on 
2 As in any statistical analysis, it is necessary to ensure that the results obtained in a 
linkage study are not due to chance and the logarithm of the odds (LOD) score, 
introduced by Morton (1955), is a statistical measure of the evidence for linkage. LOD 
scores are calculated by comparing the likelihood of two alternative hypotheses: the 
likelihood of observing the genotypes obtained from the study at each meiosis under the 
hypothesis of linkage, to the likelihood of observing that genotype under the null 
hypothesis of no linkage, in a likelihood ratio. If the likelihood ratio (‘odds’) is greater 
than 1 it is said to support linkage. This is normally expressed as Z, the LOD score. The 
probability of linkage in a set of families can be calculated by summing the LOD scores 
across the sample.
which chromosomes these differences appear. Because of the principles governing 
genetic linkage, we can deduce that the locations at which the microsatellites differ are 
also likely to be the locations at which the genes causing the phenotype under 
investigation (e.g. synaesthesia) are found. The implication is that the genes responsible 
for producing the phenotype will be in close proximity to the particular microsatellite 
markers found in affected family members.
Family-based linkage studies
Evidence of linkage to chromosomes 2, 5, 6, and 12 (2q24, 5q33, 6p12,
and 12p12)
Asher et al. (2009) conducted the first whole-genome scan for susceptibility genes linked
to synaesthesia. This study was conducted in a sample of 196 individuals who experience
colour synaesthesia triggered by sounds and/or by spoken words (referred to henceforth 
as ‘auditory-visual synaesthesia’) from 43 multiplex families. Families were recruited in 
two waves, with 19 families recruited during the initial recruitment period (Wave 1), and 
24 families recruited during the second recruitment period (Wave 2). Of particular 
interest, the sample included two families reporting male-to-male transmission of 
synaesthesia (see Figure 2.1) and we return to this later in the chapter. Before starting the
genome scan, Asher et al. confirmed the power of this sample to detect a major gene 
effect via computer simulations (SLINK; Weeks, Ott, and Lathrop, 1990) using the best 
available data on prevalence and mode of inheritance.
The sample was phenotyped using the TOG or TOG-R (Asher et al. 2006; Baron-
Cohen et al. 1996 ). Phenotyping revealed 121 affected individuals and 68 unaffected 
individuals; seven individuals were treated as phenotype unknown (five children who 
were too young to undergo diagnostic testing and two reported synaesthetes who were 
not available for testing). Genomic DNA was extracted from blood samples (Wave 1) or 
buccal swabs (Wave 2). Following extraction, DNA samples underwent whole-genome 
amplification—the production of larger usable samples of DNA from minute quantities.
Four hundred and ten highly polymorphic microsatellite markers were used in the 
genome scan. Asher et al. conducted a multipoint non-parametric linkage (NPL) analysis 
which estimates allele-sharing among all affected family members. NPL analysis makes 
no assumptions about the mode of inheritance, which makes it more sensitive to linkage 
than parametric analysis (where a mode of inheritance must be specified) but it is less 
powerful as the candidate regions identified tend to be larger. The analysis detected 15 
potential candidate regions with a LOD score >1 on 11 chromosomes (see Figure 2.2). 
Single-point NPL LOD scores for the linkage peaks were calculated using the same set of
parameters. These regions were then fine mapped at higher density with additional 
microsatellites. Further NPL analysis of the fine-mapped regions identified four 
candidate regions with LOD >2. Suggestive linkage under the Lander and Kruglyak 
criteria (LOD >2.2; Lander and Kruglyak 1995) was detected at two of these regions, on 
chromosomes 5q33 (LOD = 2.3, p = 0.0006) and 6p12.3 (LOD = 2.37, p = 0.0005). All 
regions with LOD scores >2 were supported by single-point LOD scores >1 from a 
minimum of three markers.
In addition, Asher et al conducted a multipoint heterogeneity LOD (HLOD) score 
analysis using models derived from the best available estimates following pedigree 
analysis. HLOD analysis has greater power to detect linkage in the context of substantial 
genetic heterogeneity than either traditional parametric or NPL analyses. Given the lack 
of consensus regarding the prevalence of auditory-visual synaesthesia in published 
prevalence studies (Baron-Cohen et al. 1996; Simner et al. 2006) a conservative estimate 
(genotype frequency = 0.01) was used for disease allele frequency in the analysis. 
Pedigree analysis of the sample revealed a dominant inheritance pattern (see Figure 2.3); 
but because skipping of generations has been observed both in this sample and in 
previous prevalence studies, initial penetrance for the dominant model was set at a 
variety of levels (see Asher et al. 2009 for details). Three models provided the best fit: 
dominant (penetrance = 0.65), dominant (penetrance = 0.90), and recessive (penetrance =
0.75). HLOD analysis was conducted using fine-mapping data whenever this was 
available and data from the primary genome scan data for the remainder of the genome.
Genome-wide empirical p-values for the HLOD analysis were calculated, 
correcting for multiple testing by estimating the null distribution over all genetic models 
in each simulation. Under the null hypothesis of no linkage anywhere in the genome, 
1000 replicates were generated, retaining original pedigree structures and missing data 
patterns in order to reflect the real data. In accordance with the Lander and Kruglyak 
recommendation, thresholds were calculated for suggestive linkage (1000 LOD scores of 
equal or greater size in 1000 simulations), significant linkage (50 LOD scores of equal or 
greater size in 1000 simulations), and highly significant linkage (1 LOD score of equal or
greater size observed in 1000 simulations) across the entire marker set. These simulations
generated the following empirical genome-wide significance thresholds: 2.03 for 
suggestive linkage, 2.97 for significant linkage (p <0.05), and 5.70 for highly significant 
linkage (p <0.001). The empirical p-value for a peak in the analysis was set by counting 
how often a simulated unlinked LOD score of greater or equal value is seen in 1000 
simulations.
The HLOD analysis detected one region of significant linkage on chromosome 
2q24.1 (HLOD = 3.025, empirical genome-wide p = 0.047) and three regions of 
suggestive linkage on chromosomes 6p12.3 (HLOD = 2.272, empirical genome-wide p = 
0.275), 12p12.1 (HLOD = 2.849, empirical p = 0.073), and 9q33.1 (HLOD = 2.473, 
empirical p = 0.188). A total of 23 regions with HLOD >1 were detected, 12 of which 
were also detected by the NPL analysis (including the suggestive linkage peak on 
chromosome 6). The linkage results on chromosomes 2, 6, and 12 were supported by 
single-point HLOD scores based on the same parameters. The result on chromosome 9 
was only supported by a single marker in the single-point analysis, indicating a possible 
statistical artefact, and hence this locus was not considered a candidate region. Additional
support for the HLOD results came from an additional set of NPL analyses focusing on 
the subsets of families contributing to each HLOD peak (see Figure 2.4). This analysis 
reveals a significant LOD score increase over the initial NPL analysis, indicating that the 
presence of significant heterogeneity at these loci was likely to have diminished the 
linkage signal in these regions and providing strong support for the HLOD result.
In sum, Asher et al.’s pioneering genome-wide scan for susceptibility genes for 
auditory-visual synaesthesia identified four candidate regions, with significant linkage to 
chromosome 2q and suggestive linkage to chromosomes 5q, 6p, and 12p under the 
criteria proposed by Lander and Kruglyak (1995). Notably, the results failed to support 
previous suggestions of linkage to the X chromosome, and we discuss this in further 
detail later. While the resolution of this genome scan makes identifying potential 
candidate genes within the candidate regions challenging, the uncertainty about the 
aetiology of synaesthesia makes the genetic locations of these regions of particular 
interest. We review this next, following Asher et al. (2009).
The marker with the highest LOD score in the region of significant linkage on 
chromosome 2q (D2S142, with HLOD = 3.025) has previously been linked to autism 
(IMGSAC 2001). This is particularly interesting in light of the fact that sensory 
abnormalities are a significant feature of autism-spectrum disorders (ASD; Ashwin et al. 
2009; Belmonte et al. 2004), with synaesthesia itself sometimes reported as a symptom 
(Harrison and Hare 2004). Moreover, a recent study at the University of Cambridge 
indicates a possible increased prevalence of synaesthesia among people with ASD (S. 
Baron-Cohen, personal communication). Furthermore, neuroimaging studies have 
revealed that auditory stimuli trigger responses in both auditory and visual brain regions 
in both autistic individuals (Kemner et al. 1995) and auditory-visual synaesthetes (Nunn 
et al. 2002). Studies have also shown increased neural connectivity in the brains of 
people with ASD (Courchesne, t al. 2005), which is particularly notable given recent 
evidence for increased connectivity in the brains of synaesthetes (Rouw and Scholte 
2007; see Rouw, Chapter 25, this volume). Finally, recent studies also suggest that 
savantism, long connected with ASD, may in some cases result from the combination of 
ASD and synaesthesia together (Baron-Cohen et al. 2007; Simner, Mayo, and Spiller e. 
009; see Spiller and Jansari, Chapter 36, this volume).
There are a number of interesting candidate genes on chromosome 2. TBR1 
(MIM3 604616) induces the transcription of genes regulated by the T-box element that are
thought to be integral in embryo development (Bulfone et al. 1995; Hsueh et al. 2000; 
Smith 1999). These genes include reelin (RELN (MIM 600514)), which is central in the 
development of the cerebral cortex; the brains of tbr1 knockout mice develop 
abnormalities in laminar cortical organization, which could in theory play a role in the 
altered neural connectivity of synaesthetes (Hevner, Miyashita-Lin, and Rubenstein 
2002; Hevner et al. 2001). Another set of genes in this region, the sodium channel alpha 
subunit genes SCN1A (MIM 182389) and SCN2A (MIM 182390) encode voltage-gated 
sodium channels throughout the central nervous system (Whitaker et al. 2000, 2001). 
Defects in these genes have been linked to seizures (MIM 607745) (SCN2A) (Berkovic et
al. 2004; Herlenius et al. 2007) and epilepsy (MIM 604233) (SCN1A) (Escayg et al. 
2000; Wallace et al. 2001). This has implications for synaesthesia since epilepsy has been
traced to alterations in the excitability and connectivity of neural networks (McCormick 
and Contreras 2001) and the ‘disinhibition’ theory of synaesthesia posits lowered 
excitability thresholds leading to increased cross-talk between neurons. Finally, rare 
mutations of TBR1, SCN2A, and a nearby gene SCN3A have again been also observed in 
autism (Bacchelli et al. 2003; Weiss et al. 2003). Additional noteworthy candidate genes 
in this region also include ERMN (MIM 610072), an analogue of which is upregulated 
3 Information on specific genes can be found online in the Mendelian Inheritance in Man 
(MIM) database (<http://www.ncbi.nlm.nih.gov/omim>); the MIM numbers used here 
refer to the unique identifier each gene has been assigned in this database.
during the period of active myelination of central nervous system axons in rats 
(Brockschnieder, t al. 2006).
The region on chromosome 5q detected by the Asher et al analysis includes 
DPYSL3 (MIM 601168). This gene plays a role in axonal growth and guidance, and in 
neuronal differentiation (Quinn, Gray, and Hockfield 1999). The fact that DPYSL3 is 
highly expressed in the very early stages of development but not in the adult brain (Choi 
et al. 2005) makes it of potential interest in the context of previous hypotheses for 
‘neonatal synaesthesia’ (Maurer 1993). In the ‘neonatal synaesthesia’ theory (see Maurer,
Gibson, and Spector, Chapter 3, this volume) all babies are assumed to experience 
sensory input in an undifferentiated way. While this experience disappears over the 
course of normal development in most people, synaesthetes may retain some of these 
neonatal connections. The role of DPYSL3 in neuronal differentiation and neural 
architecture more generally is therefore compelling given the known alternations in 
neural architecture in synaesthetes.
The region on chromosome 6 detected in Asher et al.’s analyses has been strongly
linked to dyslexia (DYX2) and is specifically associated with problems in phonological 
and orthographic processing (Fisher et al. 2002; Kaplan et al. 2002). Candidate genes for 
dyslexia include two genes in this region, KIAA0319 (MIM 609269) (Paracchini et al. 
2006) and DCDC2 (MIM 605755) (Meng et al. 2005), which both play a role in neuronal
migration. This has interesting implications for synaesthesia given the altered neural 
architecture implicated in the disorder. It is also notable given that several of the most 
common synaesthetic phenotypes are triggered by language units, including the two most
common forms of synaesthesia (day-colour synaesthesia and grapheme-colour 
synaesthesia; Simner et al. 2006). It is also interesting given early clinical reports of an 
elevated prevalence of dyslexia among synaesthetes (S. Baron-Cohen, personal 
communication) although this is complicated by reports of superior orthographic abilities
in other synaesthetes (Linn et al. 2008). Finally, the region on chromosome 6 detected in 
our analyses has also been linked to juvenile myoclonic epilepsy (MIM 606904), and a 
causative gene involved in apoptosis has been found (EFHC1 (MIM 608815); Suzuki et 
al. 2004). In the neonatal theory of synaesthesia described earlier, the perseverance of 
early undifferentiated sensory experience into adulthood has been attributed to a possible 
failure in apoptosis (the normal process of cell death by which early hyper-connectivity 
becomes ‘pruned’ in development; see Maurer, Gibson, and Spector, Chapter 3, and 
Mitchell, Chapter 27, this volume). The mutation of these epilepsy-linked genes in 
chromosome 6 seen in epileptic families lowers the gene’s apoptotic effect causing 
problems in neuronal pruning in development; a similar effect in synaesthetes could 
contribute to the retention of early synaesthetic pathways.
The region identified on chromosome 12 contains GRIN2B (MIM 138252), the N-
methyl-D-aspartate (NMDA) receptor 2B subunit gene. NMDA receptors may play a 
central role in long-term potentiation and the consolidation of learning and memory 
(Shimizu et al. 2000), a finding of particular interest in light of studies which have shown
a connection between synaesthesia and improve recall. Over-expression of this gene in 
mice has resulted in enhanced learning and memory (Tang et al. 1999). GRIN2B has been
further linked to autism (McCauley et al. 2005), which is particularly notable given our 
earlier discussions of improved memory, savantism, and autism in synaesthesia.
Evidence of linkage to chromosome 16 (16q12.2–23.1)
Further research into the genetic basis of synaesthesia has highlighted a region of interest 
on chromosome 16. Tomson et al. (2011) conducted a family-based linkage study 
investigating a different form of synaesthesia, a phenotype they called coloured sequence
synaesthesia in which linguistic inducers that fall in sequences (e.g. days, letters, 
numbers, months) trigger the perception of colour. There is some potential phenotypic 
overlap with the Asher et al. (2009) study (e.g. synaesthetes with coloured letters; these 
often experience colour for spoken words—although spoken words can also be triggered 
by phonemes). Testing five families (n = 48), Tomson et al. discovered linkage to a 
region of chromosome 16 (16q12.2–23.1) in two of the five families. Within this region, 
six candidate genes were selected for further analysis on the basis of having functions 
that may play a role in the development of abnormal neural connectivity between regions 
of the cortex. However, further sequencing of these genes did not reveal any evidence to 
suggest that they contributed to the development of synaesthesia in this subgroup. While 
these results must be interpreted cautiously given the small size of the sample and hence 
the lack of statistical power, this result is certainly of interest.
The fact that separate familial linkage studies investigating different phenotypes 
of synaesthesia identified linkage on distinct regions of different chromosomes raises a 
broader issue worthy of further discussion. Is there a single synaesthesia genotype that 
lends itself to a general predisposition to developing synaesthesia, with differences in 
sensory input or other environmental factors contributing to the development of a 
particular phenotype? Or do specific genes contribute directly to the occurrence of 
particular synaesthesia phenotypes? It has been demonstrated that certain types of 
synaesthesias tend to co-occur more than others (Simner et al. 2006) and synaesthesia 
may be classified according to broader groupings (Novich, Cheng, and Eagleman 2011). 
Novich and colleagues considered the co-occurrence within individuals of 22 different 
types of synaesthesias in a group of 12,127 synaesthetes who had been verified using a 
type of TOG via the online interface at <http://www.synesthete.org> (Eagleman et al. 
2007). Novich, Cheng, and Eagleman (2011) reported five distinct clusters of 
synaesthesia forms, in that a person possessing more than one type of synaesthesia is 
more likely to have types within the same cluster, rather than across clusters. No 
Celabelled these five clusters coloured music synaesthesias, coloured sequence 
synaesthesias (see earlier), non-visual sequela synaesthesias (colours triggered by 
physical touch or some emotional component), spatial sequence synaesthesia (where 
sequenced units are experienced as having spatial locations), and coloured sensation 
synaesthesias (whose inducers are non-visual; e.g. taste).
The findings of this study suggest that what we think of as ‘synaesthesia’ may in 
fact encompass several distinct phenomena each with their own patterns of expression. 
This has important implications for our hypotheses about the genetic roots of 
synaesthesia which are more likely, therefore, to be multifaceted. Specifically, Novich, 
Cheng, and Eagleman (2011) suggest that each group of synaesthesias may have 
independent underlying neural pathways, the development of which may be driven by 
distinct sets of genes. Importantly then, although there was likely to have been a partial 
overlap in the populations of synaesthetes sampled by Tomson et al. (2011) and by Asher
et al. (2009), there was also a key difference, the importance of which is now magnified 
by the findings of Novich, Cheng, and Eagleman: Asher et al.’s sample included music-
colour synaesthetes, while Tomson et al.’s sample were solely triggered by language 
sequences. The findings by Novich and colleagues tell us that these may represent 
qualitatively and meaningfully different forms (in the terminology of Novich and 
colleagues, coloured music synaesthesia and coloured sequence synaesthesia), each with 
their own genetic mechanism. While further empirical evidence will be required before 
firm conclusions can be drawn, it is clear that the relationship between genotype and 
phenotype is unlikely to be straightforward.
Why doesn’t X mark the spot?
We end our chapter with a re-evaluation of what was perhaps the most important early 
hypothesis about the genetic roots of synaesthesia. Early studies had suggested that there 
may be a major locus on the X chromosome, due to an absence of confirmed male-to-
male transmission and a female:male ratio of up to 6:1. However, neither Asher et al. 
(2009) nor Tomson et al. (2011) found evidence for a major locus on the X chromosome 
and so these findings indicate a need to revisit our early understanding of the mode of 
inheritance of synaesthesia.
The early assumption about an absence of male-to-male transmission has been 
subsequently refuted by the verification of two cases of male-to-male transmission of 
synaesthesia in the study by Asher et al. (2009). While it is possible that these two 
families may carry a very rare autosomal mutation and that the majority of cases of 
synaesthesia are in fact X-linked, the results of the genome scan indicate that this is 
unlikely to be the case. It is also possible that the marker density was insufficient to 
detect significant linkage to a locus on the X chromosome; increased marker density (e.g.
with an approach known as single-nucleotide polymorphism (SNP)-based high-density 
genotyping) would indeed increase the amount of information obtained from the 
chromosome (Sawcer et al. 2004). However, studies directly comparing the results of 
microsatellite and SNP-based genome scans indicate that while the increased information
content may raise unremarkable LOD scores to the level of suggestive linkage, or 
suggestive scores to the level of genome-wide significance, it has not resulted in the 
detection of significant linkage in areas where the microsatellite scan failed to do so 
(Middleton et al. 2004; Sawcer et al. 2005). This suggests that increased marker density 
would be unlikely to reveal a major locus on the X chromosome, though it might reveal 
stronger linkage in the region where the maximum LOD score was obtained.
In the absence of evidence for a major locus on the X chromosome, an alternate 
explanation for earlier observed high female:male ratios must be found. We noted earlier 
that is possible that the female predominance observed in previous studies of 
synaesthesia does not in fact reflect the true ratio among affected persons (Simner et al. 
2006; Ward and Simner 2005). Simner and colleagues have suggested that an especially 
high female skew may emerge when synaesthetes are asked to self-refer for study (e.g. 
Baron-Cohen et al. 1996), since women have been shown to be more likely to come 
forward to report atypical behaviour (Dindia and Allen 1992). Furthermore, when 
prevalence was assessed without the potential for self-referral, there was a non-
significant difference across the sexes (Simner et al. 2006). However, the complete 
absence of female predominance seems highly unlikely given the consistency of a small 
but persistent female bias across multiple studies (Simner et al. 2009). Simner and 
colleagues have pointed out a repeated trend in the direction of a female bias of 
approximately 2:1 (e.g. Simner et al. 2006, 2009) and suggest that poor power alone in 
previous statistical tests makes it possible that a female bias (perhaps of around 2:1) may 
re-emerge in larger sample testing.4 Furthermore, referral bias usually accounts for only a
slight variation (10%) in response rates (Dindia and Allen 1992) again making it likely 
that high early estimates were at least pointing in the right direction.
Assuming a slight but significant female bias may yet be found in future large-
scale testing, a number of genetic factors could account for this. Synaesthesia may be a 
complex trait involving multiple genes with relatively small individual genetic effect, or 
it may be subject to multiple modes of inheritance or locus heterogeneity. If synaesthesia 
is an oligogenic or complex trait subject to a threshold of liability, the families with 
father-to-son transmission may represent cases in which threshold was reached without 
4 Studies showing an apparent female bias without self-referral have not, thus far, been 
entirely free of the potential for this confound. Barnett et al. (2008) report a female bias 
of approximately 6:1 in a study that looked at both self-referred probands, and their 
family members who were directly contacted by the researchers. However, Barnett and 
colleagues were only able to objectively assess all first-degree family members for 17 out
of 53 probands, which meant that 81 of their 92 synaesthetes were either objectively 
unconfirmed cases or self-referred (J. Simner, personal communication). A similarly high 
female bias of approximately 4:1 (based on the members of n = 5 families) reported in 
Tomson et al. (2011) has now been corrected by erratum to 2.7:1. This brings it in line 
with an earlier study by Ward and Simner (2005) who showed a female:male ratio of 2:1 
when they also attempted to eliminate a referral bias by looking within the families of 
synaesthetes (n = 85 families). However, Simner and colleagues point out that this type 
of ratio may yet be an overestimate from self-referral, since families with a lone 
synaesthete are less likely to come to the attention of researchers if that synaesthete is 
male (Simner et al. 2006).
any contributions from mutations on the X chromosome, whereas the other families 
represent cases in which a mutation or mutations on the X chromosome plays a role in 
reaching threshold. Greater prevalence of the X chromosome mutation(s) would account 
for the X-linked transmission pattern observed in the majority of synaesthetic families. 
Additionally, the threshold may differ between the sexes, with one sex requiring fewer 
disease-causing factors to display the phenotype (Carter 1976). In the context of a 
complex disorder, the findings on the X-chromosome could reflect the existence of a 
locus with limited effect. Finally, a specific hypothesis has been proposed by Mitchell 
(Chapter 27, this volume) who points to a priori sex differences in connectivity, with 
women’s brains showing greater overall connectivity across the entire brain. Mitchell 
suggests that a condition such as synaesthesia, which results from atypical hyper-
connectivity may certainly be expected to be greater in females than males.
Summary and future directions
The findings reviewed here have important implications for our overall understanding of 
synaesthesia, as they indicate that its genetic basis is rather more complex than originally 
believed. Separate linkage studies (Asher et al. 2009; Tomson et al. 2011) conclude that 
rather than being caused by a single gene at a single locus with a single mode of 
inheritance, synaesthesia is more likely to arise from the effects of multiple genes at 
multiple loci with different modes of inheritance. The discovery of multiple peaks with 
relatively small genetic effects combined with the detection of significant linkage on 
chromosome 2q and suggestive linkage to chromosomes 5q, 6p, and 12p (Asher et al. 
2009) is consistent with a complex disorder with considerable genetic heterogeneity. This
conclusion is further reinforced by the discovery of linkage to a region on chromosome 
16, found in participants exhibiting a different, yet possibly overlapping, phenotype 
(Tomson et al. 2011).This could potentially mean that there are a number of causative 
loci, with different loci producing the clinical phenotype in particular families. This 
would be consistent with findings in other neurodevelopmental disorders such as specific 
language impairment (MIM 606711) (Newbury, Bishop, and Monaco 2005) and dyslexia 
(MIM 127700) (Paracchini, Scerri, and Monaco 2007) where both gene–environment and
gene–gene (epistatic) interactions are believed to play an important role.
Given the evidence for substantial genetic heterogeneity, it is likely that the 
development of meaningful endophenotypes will play a key role in future research. A 
genetic endophenotype is a well-defined, quantifiable measure describing one 
subdimension of a complex disease phenotype. Increasing phenotypic homogeneity 
through the use of endophenotypes has been shown to increase the power to find 
susceptibility genes (Buxbaum et al. 2004; Shao et al. 2002). It will be necessary to 
revisit the phenotypic data to identify subdomains of the synaesthetic phenotype that may
serve as useful endophenotypes, ideally by providing quantitative measures. The amount 
of information generated by more recent tests of genuineness (e.g. the TOG-R; or the 
tests at <http://www.synesthete.org>) makes this test a logical candidate for use in 
endophenotyping. However, it is notable that while the use of endophenotypes can 
produce more statistically reliable data they do not necessarily have a simpler genetic 
architecture than the underlying disease, and that the genetic effect sizes observed with 
endophenotypes are not necessarily larger than those observed with the global disease 
phenotype (Flint and Munafo 2007); care will need to be taken to ensure adequate 
statistical power to detect genes of small effect.
Even with this additional data, it may not be possible to specify a single mode of 
inheritance for synaesthesia. The recent evidence from Novich and colleagues based on a 
large sample of synaesthetes has shown that types of synaesthesias can be clustered 
together in certain subtypes and different varieties of synaesthesias are more likely to co-
occur in affected individuals if they belong to the same subgroup (Novich, Cheng, and 
Eagleman 2011). This conclusion raises the possibility that multiple genotypes may be 
responsible for the expression of distinct groups of different phenotypes. Indeed, we 
cannot currently say for certain whether Asher et al. (2009) and Tomson et al. (2011) 
have identified different loci that contribute some proportion of genetic effect to an 
overarching ‘synaesthesia genotype’ or whether they are loci central to quite distinct 
subgenotypes. For this reason, further investigation into the subtleties of the relationship 
between phenotypes should prove to be a fruitful line of inquiry. The use of additional 
phenotyping methods, notably neuroimaging, to define subphenotypes within the 
synaesthetic population with greater precision would provide important additional 
information and facilitate the search for susceptibility genes.
Even if most cases are due to oligogenic inheritance, it is possible (even probable 
given what has been seen in other neurodevelopmental disorders) that there are individual
families (e.g. as in specific language impairment; Fisher et al. 1998) or subgroups of 
families (e.g. as in Tourette’s syndrome (MIM 137580;)Abelson et al. 2005);and ASD 
(MIM 209850; )artin and Ledbetter 2007)) which show Mendelian inheritance of a 
mutation although genome scans indicate that the overall inheritance of the disease is 
genetically complex. While they are likely to be considerably rarer than those showing 
more complex inheritance, the detailed analysis of families with known chromosomal 
abnormalities or detectable copy number variants may facilitate the identification of 
candidate genes and the delineation of pathways which play an important role in the 
aetiological process.
Scientific exploration of the role played by genes in human cognition has only 
recently begun. Formerly an obscure condition, synaesthesia has attracted growing 
interest for its potential to advance our understanding of both typical and atypical human 
cognition and perception. A greater understanding of the neural mechanisms underlying 
synaesthesia has important implications for other neurodevelopmental disorders, many of
which (e.g. ASD ( arrison and Hare 2004); Williams–-euren syndrome (MIM 194050; 
Levitin et al. 2005)) involve abnormal sensory perception. Moreover, as synaesthetic 
perception occurs in the absence of direct sensory stimulation, it may offer insight into 
how the human brain integrates sensory data into conscious perception, and may even 
illuminate the neural basis of consciousness (Gray et al. 2002; see Sagiv and Frith, 
Chapter 45, this volume). The eventual identification and functional characterization of 
susceptibility genes linked to synaesthesia will yield fundamental insights into the role of
genetics in human cognition and perception.
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Results of the whole-genome scan. Generated by NPL analysis using MERLIN 1.1a with 
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individuals are included for information only with phenotypes based on clinical 
interview, and were excluded from the analysis.
 Reprinted from The American Journal of Human Genetics, 84 (2), Julian E. Asher, 
Janine A. Lamb, Denise Brocklebank, Jean-Baptiste Cazier, Elena Maestrini, Laura 
Addis, Mallika Sen, Simon Baron-Cohen, Anthony P. Monaco, A Whole-Genome Scan 
and Fine-Mapping Linkage Study of Auditory-Visual Synesthesia Reveals Evidence of 
Linkage to Chromosomes 2q24, 5q33, 6p12, and 12p12, pp. 279–285, Copyright (2009), 
with permission from Elsevier.
Figure 2.4
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Synesthesia is a hereditary, neurological
condition in which a wide range of com-
mon stimuli (e.g., letters, sounds, flavors)
trigger unexpected secondary sensations,
for example, synesthetes listening to music
might see colors in addition to hearing
sounds (Ward et al., 2006; see Simner
and Hubbard, 2013, for review). Current
explanations of synesthesia posit struc-
tural and/or functional differences in the
synesthete brains, and frame their mod-
els in terms of excess cortical connectivity
or altered cortical feedback. Here, we pro-
pose an immune hypothesis of synesthe-
sia, which supplements existing models by
suggesting how such altered connectivity
may arise and how associations between
synesthesia and other conditions might be
explained.
Two categories of model seek to explain
the generation of synesthetic experiences,
and more recent models are a hybrid
of both (Brang et al., 2010). The cross-
activation model (Ramachandran and
Hubbard, 2001) suggests that excess con-
nectivity between functional areas of the
cortex allows activation in one cortical
area (e.g., auditory cortex) to directly
trigger activation in another (e.g., visual
cortex). Evidence in support of this model
comes for example from diffusion tensor
imaging (DTI) and shows that exces-
sive connectivity is indeed a feature of
the synesthetic brain (Rouw and Scholte,
2007). Re-entrant and disinhibited feedback
models propose that synesthetic sensations
are caused by disinhibited feedback from
higher cortical areas (e.g., in parietal lobe)
failing to suppress non-relevant activation
from lower cortical areas (Grossenbacher
and Lovelace, 2001). This type of disinhib-
ited feedback may result from excessive
activity of excitatory neurons within
the delicate balance between both exci-
tatory and inhibitory neurons in the
brain (Hubbard et al., 2011). Despite
appearing superficially different, con-
nectivity and feedback models need not
be mutually exclusive. It is unlikely that
altered feedback happens entirely in the
absence of changes in cortical connec-
tivity, given the Hebbian principle that
simultaneous activity strengthens inter-
connectivity between neurons. Therefore,
these two approaches might be considered
somewhat unified in that connectivity
models propose aberrant connectiv-
ity as the primary causal mechanism
underlying synesthesia whereas feedback
models might allow altered connectivity
as an indirect consequence of disinhibited
feedback.
While these models are now more than
a decade old, explanations of how these
cortical characteristics might arise have
proven elusive thus far (but see Brang
and Ramachandran, 2008; Mitchell, 2013)
and we explore this here. Synesthesia is
thought to be primarily neurodevelop-
mental in nature (Spector and Maurer,
2009). Consequentially, known processes
of brain development are likely to be
implicated in its emergence. We propose
that insight might be gained from examin-
ing the functionality of genes that regulate
the types of altered synesthetic corti-
cal connectivity assumed in these mod-
els above (i.e., genes for axon guidance,




Above, we saw that current models link
synesthesia to altered structural connec-
tivity, misregulated feedback mechanisms,
or a combination thereof. Explaining how
synesthesia develops might therefore come
from considering the developmental pro-
cesses responsible for cortical connectivity.
The immune system is known to play a sig-
nificant role in these processes (for review,
see Boulanger, 2009) and we ask here
whether a propensity to develop synes-
thesia may be linked to the expression of
immune proteins in the CNS, since this
expression can be conferred by genes with
functions of both immunity and corti-
cal development. Indeed, many genes have
been shown to have precisely this dual
functionality (Boulanger, 2009). As well as
their immunity function, such genes act
in cortical development, altering structural
and/or functional connectivity by influ-
encing the development of axonal guid-
ance, synaptic connectivity, and synaptic
pruning. One outcome of these changes
may therefore be the anomalous pattern
of connectivity proposed by the cross-
activation theory in the development of
synesthesia. Alternatively, the immune sys-
tem could have a direct influence on
excitatory neuronal activity, leading to the
outcomes proposed by disinhibited feed-
back models. This is because the immune
system plays an important role in the
initial development and subsequent plas-
ticity of glutamatergic synapses, the pri-
mary excitatory transmission pathway in
the mammalian cortex (Fourgeaud and
Boulanger, 2010).
CAN THE IMMUNE SYSTEM
INFLUENCE THE DEVELOPMENT OF
THE BRAIN?
Is it plausible to make a link between
the immune system and regulation
of the central nervous system (CNS)?
Isolated from the rest of the body by
Frontiers in Human Neuroscience www.frontiersin.org September 2013 | Volume 7 | Article 563 | 1
HUMAN NEUROSCIENCE
Carmichael and Simner The immune hypothesis of synesthesia
the blood-brain-barrier, the CNS was
once thought to barely interact with the
immune system, leading to the long held
view that the CNS was “immune priv-
ileged” (McAllister and van de Water,
2009). However, research now shows
a complex communication between
the CNS and immune system, with
wide-reaching consequences for brain
regulation and development, both in
health and disease (Elmer and McAllister,
2012). Immune proteins are known to
play a role at many stages in the devel-
opmental pathway. They are integral
components of phases critical to brain
development and plasticity, such as neu-
ronal guidance, synapse development, and
synaptic remodeling (Boulanger, 2009).
We therefore hypothesize that CNS and
immune system interaction may be the
biological mechanism which confers the
predisposition to develop synesthesia.
Which aspects of the immune sys-
tem are known to exhibit the type of
dual functionality under discussion in this
article (i.e., functionality in both immu-
nity and cortical development)? Several
areas of this extraordinarily complicated
system are worth highlighting. The com-
plement system is one possible candidate—
a complex cascade of protein interactions
involved in immunity which has also
been shown to play an important role
in tagging of synapses to be eliminated
by pruning during development (Stephan
et al., 2012). Another candidate relates to
cytokines, which are immune proteins that
have also been shown to play significant
roles in neurogenesis and synaptic plas-
ticity (Bauer et al., 2007). A third can-
didate relates to major histocompatibility
complex (MHC) proteins, which are an
integral part of the adaptive immune sys-
tem found on the surface of the majority
of nucleated cells and widely expressed in
neurons of the CNS (Boulanger, 2004).
In addition to fulfilling a crucial func-
tion in immune response, MHC class I
molecules and related components are
thought to be involved in a range of
developmental processes, such as activity-
dependent plasticity and synaptic refine-
ment (Boulanger, 2009). The MHC locus
contains several hundred genes, and has
also been widely implicated in a range of
autoimmune conditions, such as multiple
sclerosis (MS), irritable bowel syndrome
(IBS), and rheumatoid arthritis (Fernando
et al., 2008). We point out, however that
the immune system consists of many
hundreds of individual factors and pro-
cesses. Given this, our suggestions above
should be considered speculative and by
no means exhaustive. Nevertheless, we
consider them to each be plausible candi-
dates for future investigation.
We end this section by asking whether
existing studies into the genetics of synes-
thesia would support our immunity
hypothesis. In other words, have they
identified areas of the genome contain-
ing immune system genes? Research into
synesthesia genetics is in its infancy and
as yet, there are insufficient data to draw
firm conclusions. No synesthesia genes
have yet been identified and no firm
mode of inheritance has yet been eluci-
dated. However, evidence from the two
existing studies on the genetics of synes-
thesia (Asher et al., 2009; Tomson et al.,
2011) have identified several chromoso-
mal regions of interest, and these regions
do contain immune function genes. Asher
et al. (2009) found significant linkage to
chromosome 2q24 and possible linkage
to areas on other chromosomes (5q33,
6p12, and 12p12), while Tomson et al.
(2011) identified a candidate region on
chromosome 16q12.2-23.1. The authors
of both studies draw the conclusion that
synesthesia is likely to be a condition influ-
enced by a variety of genes in multiple loci.
Nonetheless, the chromosomal regions of
interest highlighted in these two investiga-
tions do contain immune function genes
(e.g., interleukin-17, a cytokine protein
found on chromosome 6p12), although
we wish to be clear that many other viable
candidates also lie outwith these regions.
THE IMMUNE HYPOTHESIS AS A
FRAMEWORK FOR THE STUDY OF
CO-MORBIDITIES
An immune hypothesis of synesthesia
might additionally explain recent co-
morbidity data which suggests that hav-
ing synesthesia may be associated with
increased risk of other clinical conditions.
Carruthers et al. (2012) report an associ-
ation between synesthesia and IBS, having
found an elevated prevalence of synesthe-
sia in a population of people with IBS.
Other researchers have raised the possi-
bility that synesthesia may also be found
at elevated rates within populations with
autism (Baron-Cohen et al., 2007) or
migraine (Alstadhaug and Benjaminsen,
2010). The immune system plays a promi-
nent role in all of these conditions (Collins,
2002; Bruno et al., 2007; Enstrom et al.,
2009), suggesting that altered immune sys-
tem function may be a common causal
link. If so, the immune model proposes
a plausible framework by which to inves-
tigate co-morbidity between synesthesia
and other conditions. If this hypothesis is
correct, we might ask whether the preva-
lence of synaesthesia is also higher in pop-
ulations with other autoimmune condi-
tions. Indeed, recent data from our lab has
led us to explore whether developmental
synaesthesia might occur more prevalently
in people with the radiological profile of
multiple sclerosis (MS), for example, a
demyelinating disease of the human CNS
(Simner et al., submitted). A maladaptive
immune system is an undisputed factor
in the pathogenesis of MS (Trapp and
Nave, 2008), and the majority of genes
implicated in MS have an immune func-
tion (Gourraud et al., 2012). The immune
hypothesis of synaesthesia might therefore
lead us to investigate whether synaesthesia
and autoimmune conditions such as MS
could share overlapping genetic origins in




We have proposed that CNS/immune sys-
tem interactions during early life may play
a role in the development of synesthe-
sia. We have asked whether genes with
dual functionality in brain development
and immunity may be at the origin of
existing models of synesthesia, and this
mechanism would provide a framework to
investigate associations between synesthe-
sia and other immune-related conditions.
We make our proposal here as a model
for developmental synesthesia, although
not all cases of synesthesia are develop-
mental in nature. Synesthesia may also
be acquired, for example as a result of
brain injury (Schweizer et al., 2013) or
induced by consumption of psychoactive
drugs such as Lysergic acid diethylamide
(LSD; e.g., Cytowic, 1989). Our hypothesis
does not speak directly to such cases, and
it is not yet known whether these different
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forms of synesthesia have the same neural
origins or mechanisms. It is interesting to
note however that immune system activity
is elevated after brain injury, and processes
such as apoptosis do become activated
(Griffiths et al., 2010). It is therefore at
least plausible to ask whether the immune
system might also play a role in the appear-
ance of non-developmental synesthesias.
Identification of genes that contribute to
the development of synesthesia will make
a significant contribution to the validity
of this hypothesis, and whether synesthesia
has one cause or many.
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Synesthesia is an inherited condition causing unusual secondary sensations (e.g, sounds might be experienced as both
auditory and visual percepts). The condition has been linked with cognitive and perceptual benefits and is considered a
benign alternative form of perception. Here, we investigate self-referred synesthete populations and their rates of radi-
ologically determined white matter hyperintensities (WMH) of a type compatible with the McDonald imaging criteria for
the diagnosis of multiple sclerosis (MS). MS is a chronic condition resulting in damage to myelination surrounding nerve
fibers of the central nervous system (CNS). Magnetic resonance imaging (MRI) features highly suggestive of MS without
overt clinical symptoms are termed radiologically isolated syndrome (RIS). We present data showing that the shared MRI
profile of MS and RIS has been significantly overrepresented in synesthetes who have participated in neuroimaging
research. We present validation of the clinical and MRI status of these synesthetes and an analysis showing the significant
probability their unusual numbers may not have arisen by chance. We discuss how to interpret significant data based on
small case numbers and consider the implications of our findings for synesthesia’s clinical status.
Keywords: synaesthesia; synesthesia; multiple sclerosis; radiologically isolated syndrome; comorbidity
For people with synesthesia, stimuli are experienced with
unusual secondary associations. For example, sound-color
synesthetes experience sound stimuli as accompanied by
both auditory and visual (i.e., color) percepts (Asher et al.,
2009). Synesthesia tends to be regarded in positive rather
than negative terms and has a range of cognitive and
perceptual benefits (e.g., for memory; Yaro & Ward,
2007). Here, we investigate an observation of unusually
high rates of white matter hyperintensities (WMH) in a
group of synesthetes. These hyperintensities are areas of
high intensity on T2-weighted magnetic resonance ima-
ging (MRI) scans of a type compatible with the McDonald
(imaging) criteria for the diagnosis of multiple sclerosis
(MS; Polman et al., 2011).
MS is an inflammatory disease of the central nervous
system (CNS) with a broad range of perceptual and motor
symptoms. It is thought to be caused by environmental
risk factors in combination with genetic susceptibility
(Compston & Coles, 2008). MS is characterized by
demyelination, axonal loss, and gliosis of white matter
(Weiner, 2009). Diffusion tensor imaging (DTI) shows
reduced fractional anisotropy (FA) scores in MS patients,
indicating reduced white matter integrity in lesion sites
and elsewhere (Roosendaal et al., 2009). Although MS is
typically classified as a white matter disorder, gray matter
is also affected, with reduced volume common in several
areas (Ceccarelli et al., 2008). If patients present with MRI
features suggestive of MS but without overt clinical symp-
toms, this is termed radiologically isolated syndrome
(RIS). From a radiological perspective, MRI scans of
RIS and MS are indistinguishable, and it is only the
presence of clinical symptoms that differentiates between
the two conditions. There is also a clinical relationship
between the conditions in that approximately one-third of
patients with RIS develop MS symptoms within 2–5 years
(Granberg, Martola, Kristoffersen-Wiberg, Aspelin, &
Fredrikson, 2013).
Structural differences in white and gray matter also
characterize the condition of synesthesia. Synesthetes
show both increases and decreases in gray matter volume
(Hänggi, Beeli, Oechslin, & Jäncke, 2008; Jäncke, Beeli,
Eulig, & Hänggi, 2009) and altered coherence of white
matter (Hänggi, Wotruba, & Jancke, 2011; Jäncke et al.,
2009; Rouw & Scholte, 2007). This altered white matter is
found in regions implicated by the synesthetic report and
also elsewhere. For example, synesthetes experiencing
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color sensations show increased FA compared with con-
trols near color selective region V4 (Rouw & Scholte,
2007) but also show FA increases (Rouw & Scholte,
2007) and decreases (Hänggi et al., 2008) in parietal
lobe. The cortical reorganization of white and gray matter
in synesthesia might call for comparison with MS-RIS,
and we discuss in this article whether epidemiological or
pathological links might exist between them.
Our question is motivated by a particularly high occur-
rence of MRI abnormalities consistent with the neurora-
diological profile of MS-RIS within synesthetes who have
presented to our laboratories for brain imaging studies. In
three independent synesthete cohorts across three countries
(San Diego, CA, United States; Paris, France; and
Edinburgh, United Kingdom), we have opportunistically
found clinical and radiological indicators suggestive of
MS in 1 in 6 synesthetes, 1 in 10 synesthetes, and 1 in
13 synesthetes, respectively. Our studies were not initiated
with the intention of investigating the prevalence of MS-
RIS, but our unexpected findings have led us to evaluate
the post hoc detection of white matter abnormalities in
these three participants. All three affected cases met the
McDonald (imaging) criteria for the diagnosis of MS.
Subject 1 (United States) has a full diagnosis of MS,
while Subjects 2 (France) and 3 (United Kingdom) are
currently free from clinical symptoms and therefore con-
sidered to have RIS. Subjects 2 and 3 were initially
flagged by routine protocols in our studies in which neu-
roradiologists examine T2-weighted axial MRI scans for
unanticipated pathology. Subject 1’s diagnosis was first
suggested by her general practitioner several months
after our study, because routine radiological checks were
not part of that study’s protocol.
Our finding of three cases of MS-RIS among 29
synesthetes is suggestive of an unusually high rate.
However, we must address the possibility that we have
inadvertently focused on just those studies where
anomalies were found, rather than all synesthesia imaging
studies to date. Collectively, 29 published studies (see
Table 2) have scanned 211 synesthetes (including 6 of
our own 29 synesthetes, described in Hubbard, Arman,
Ramachandran, & Boynton, 2005). Together with our
remaining unpublished cases (N = 23), this gives 234
synesthete scans in existence known to us. Outside our
cohort of 29 participants, we have been able to ascertain
that 80 additional synesthetes’ MRI scans were checked
with a similar radiologist protocol, and none revealed
anomalous findings of this type.1 A further 121 were
scanned without this protocol and the remaining four
scans have an unknown status. The most conservative
approach is to assume no cases of pathology in any of
the 234 scanned cases, other than the three identified here.
Our methodology discussed later is to evaluate this occur-
rence of MS-RIS in synesthetes against appropriate base-
lines. We first begin with full case descriptions of the three
affected synesthetes. This is followed by a set of analyses
that consider the appropriate baselines against which to
compare our finding of three affected cases (1 MS; 2 RIS).
To anticipate our methodologies discussed later, we take
the most stringent standards against which to compare our
observations (given factors such as the geographic varia-
bility of MS and the sampling method of our studies) and
nonetheless find that the number of affected cases is sig-
nificantly higher than chance would predict.
Empirical study
In this section, we evaluate our three cases of MS-RIS
both qualitatively and quantitatively, beginning with a
detailed clinical evaluation.
Case details of affected synesthetes
Synesthesia status
Table 1 shows the synesthetic status and demographic
background of the three synesthete participants in whom
radiological anomalies have been identified. The table
shows their synesthesia phenotypes, and these comprise
the following: grapheme-color synesthesia gives rise to
colored percepts triggered by letters or digits (e.g., the
letter A might be red; Asher et al., 2009); sequence-
Table 1. Synesthetic Case Descriptions.
Test site Age Sex Nationality Synesthesia phenotype(s)* MS-RIS?
San Diego 26 Female American Grapheme-color MS
Paris 25 Female French Number-space, time-space (colored), grapheme-color RIS
Edinburgh 31 Female British/English Sequence-personality, letter-space, numbers-space, time-space RIS
*Verification of synesthesia relies on the behavioral “gold standard” test for synesthesia, which assesses the consistency of the synesthetic report over time
(e.g., Eagleman, Kagan, Nelson, Sagaram, & Sarma, 2007; Simner et al., 2006). In this, participants are required to first report their synesthetic experiences for
a list of provided stimuli (e.g., they report their colors for a list of letters), and they are subsequently retested after some considerable time (e.g., 6 months, for
the case scanned in San Diego; see Hubbard et al., 2005 for methodological details). Synesthetes are identified as those who are significantly more consistent
in their reports over time, compared to a group of matched controls who invent/recall analogous associations.
Note: For each affected synesthete, the table shows the imaging lab testing site, the participant’s age at scanning, sex, country of origin, verified synesthesia




































personality synesthesia gives rise to complex personifica-
tions triggered by the members of linguistic sequences
(e.g., Monday might be “female, unfriendly”; Simner &
Holenstein, 2007); number-space synesthesia, letter-space
synesthesia and time-space synesthesia are all variants of
the broader category of sequence-space synesthesia, in
which linguistic sequences are perceived in spatial arrays
(e.g., the letters A–Z might extend in an undulating line
from right to left across the visual field; see Simner, 2009
for review).
Clinical status of MS-RIS
All three synesthete participants in question met the
McDonald (imaging) criteria for the diagnosis of MS. This
requires the presence of one or more T2-weighted high signal
lesions in at least two of the following four areas of the CNS:
periventricular, juxtacortical, infratentorial, or spinal cord. A
full diagnosis of MS has been given in the case of one
participant, while the other two subjects are currently free
from clinical symptoms and are therefore considered to have
RIS. The synesthetic status of each participant is shown in
Table 1 and their clinical status is described here.
Subject 1 (San Diego, CA, United States) was diag-
nosed with clinically definite relapsing-remitting MS sev-
eral months after taking part in a synesthesia study in
2001. A diagnosis of MS was first suggested by this
participant’s general practitioner because routine radiolo-
gical checks were not part of the study’s protocol.
Subsequent neurological follow-up consisting of sagittal
and axial T1-weighted FLAIR and axial T2-weighted and
axial and coronal T1-weighted MRI scans revealed exten-
sive hyperintensities in both the brain and cervical spine,
considered to be pathognomonic for MS. These white
matter lesions, in conjunction with history of clinical
symptoms, confirmed this participant’s diagnosis of MS.
This participant had a total of 16 lesions, in both periven-
tricular and juxtacortical white matter (see Figure 1).
Periventricular lesions were located in the corpus callosum
and in occipital and parietal areas. Juxtacortical lesions
were found in the parietal region. Lesions were also
detected in the spinal cord. This subject was originally
scanned for, but subsequently excluded from, Hubbard
et al. (2005) (see Table 2).
Subject 2 (Paris, France) participated in synesthesia
research in 2006, where her axial T2-weighted MRI scan
was reviewed as part of routine assessments for unantici-
pated pathology by a consultant neuroradiologist. Initial
examination of her resultant T2-weighted MRI scan
revealed WMH in the brain. A second, axial T2-weighted
FLAIR MRI scan, obtained 2 years after the initial scan,
confirmed the presence of white matter lesions, judged to
be consistent with McDonald criteria (see Figure 2). Due
to a lack of progression, these lesions are considered stable
and this participant has remained free of clinical
symptoms. This participant had more than 20 identified
lesions in periventricular and juxtacortical white matter.
Periventricular lesions were in frontal and parietal areas,
while juxtacortical lesions were distributed across frontal,
parietal, and temporal regions. This subject was scanned
for Hubbard et al. (unpublished data) (see Table 2).
Subject 3 (Edinburgh, United Kingdom) participated in
synesthesia research in 2008 and her resultant axial T2-
weighted MRI scan was also examined routinely by a
consultant radiologist to detect unanticipated pathology.
Initial examination revealed WMH in the brain of this
subject. This T2-weighted MRI scan was independently
examined by a second neuroradiologist who confirmed
that the number and location of the white matter lesions
met the McDonald imaging criteria for diagnosis of MS
(see Figure 3). Again, this participant has remained free of
clinical symptoms since the initial presentation of her
abnormal scan. This participant had more than 20 lesions
in periventricular and juxtacortical white matter (see
Figure 3). Periventricular lesions were found in frontal,
parietal, temporal, and occipital areas. Juxtacortical lesions
were identified in temporal and parietal areas.
Infratentorial lesions were also present. This subject was
scanned for, and subsequently excluded from, a study by
Rehme et al. (in review) (see Table 2).
Case details of all synesthetes with existing MRI scans
Table 2 shows what is to our knowledge all studies that
have generated MRI scans from synesthete participants at
the time of writing including all published studies, plus
our two unpublished samples. Published articles were
Figure 1. Axial T2-weighted image showing a left parietal ovoid
periventricular lesion (of 16 overall lesions), from subject 1.



































retrieved from an all-years search of PubMed using search
terms “syn*esthesia” (UK/US spellings) and “MRI”, and
any additional details on participants given in the follow-
ing discussion that were not available in the literature were
retrieved by contact with the authors of these studies.
Analysis of the prevalence of MS-RIS cases among
scanned synesthetes against expected baselines
We found three cases of MS-RIS in 234 synesthetes who
were self-referred for brain scanning studies across the
literature. To establish whether the number of affected
synesthetes is statistically significant, we must compare
the prevalence of observed cases against a meaningful
baseline. Since RIS and MS are indistinguishable, from a
radiological perspective, we first consider all three cases as
a unified phenomenon. Then, since RIS and MS are dif-
ferent in a clinical/symptomatic sense, we additionally
consider the two cases of RIS as a distinct phenomenon.
Methodologically speaking, we will take our RIS baseline
from a meta-analysis of the prevalence of RIS across all
MRI scans described in the imaging literature (and later
we describe our very conservative approach in this
regard). We will take our MS baselines from rates reported







2001 Aleman et al. 1 ¥ 1
2001 Weiss et al. 1 † 1
2005 Weiss et al. 9 † 6
2006 Hubbard et al. (unpublished data) 10 § 10
2006 Sperling et al. 4 4
2007 Rouw and Scholte 0* 0
2008 Hänggi et al. 1 ¥ 1
2009 Jäncke et al. 0* 0
2009 Weiss and Fink 16* † 15
2010 Rouw and Scholte 42 ¥ 42
2010 van Leeuwen et al. 21 ¥ 19
2011 Gaschler-Markefski et al. 7 ¥ 6
2011 Hänggi et al. 24 ¥ 20
2011 Specht and Laeng 2 †† 2
2011 van Leeuwen et al. 0* 0
2012 Dovern et al. 5* † 5
2012 Hupe et al. 10 ¥ 7
2012 Neufeld et al. 14 ¥ 9
UK studies
2002 Nunn et al. 13 †† 13
2005 Blakemore et al. 1 †† 1
2006 Gray et al. 2* †† 2
2007 Cohen Kadosh et al. 1 †† 0
2008 Bor et al. 1 †† 0
2008 Tang et al. 10 †† 8
2011 Jones et al. 2 †† ¶ 1
2012 Banissy et al 9 † 5
2013 Rehme et al. (under review) 13 § 13
N. American studies
2003 Elias et al. 1 ¥ 1
2005 Hubbard et al. 6 § 3
2012 Brogaard et al. 1 †† 0
Other studies
2006 Rich et al. 7 †† 6
Total 234 201
*Subject numbers have been adjusted to exclude duplicate participants already scanned in previous studies by the same group (shown
elsewhere in the table).
†Routine radiological checks for pathology performed by neurologist and no anomalies found.
††Routine radiological checks carried out by a neuroradiologist and no anomalies found.
§Members of our study cohort (i.e., studies directed in our labs); three anomalies in N = 29 scans.
¶A study directed by colleagues outside our labs, but JS coauthoring.
¥No routine radiological checks for pathology performed.




































in clinical prevalence studies. Since the prevalence of MS
is sex-linked and geographically variable, we have con-
sidered that the large majority of all scanned synesthetes
are female (86%) and have come from studies conducted
in Europe (94%). Accordingly, we took a female MS
prevalence figure for Europe. Again however, since a
key aim was to be maximally conservative (i.e., to com-
pare our findings with the highest prevalence rates where
possible), we additionally reanalyzed our data using the
most stringent prevalence rate according to the nationality
of the three affected cases (American/French/English). In
other words, since the rate of MS is highest in England
(vs. America or France), we used this highest England
baseline in a second analysis. In the following we describe
these baseline selection procedures in more detail and the
resultant statistical outcomes of our analyses (showing
whether MS-RIS is indeed significantly higher in self-
referred synesthete samples).
Baseline selection and results
There is no published combined prevalence of MS-RIS, so
we use an additive value from each separately. Our recent
meta-analysis (Morris et al., 2009) shows a baseline of
RIS in the general population of 57.8/100,000. This figure
was based on nine cases of unanticipated WMH consid-
ered as definite demyelination, which were found in
15,559 scans reported in the literature. To be conservative
here, we will also include three cases of possible demye-
lination in that meta-analysis, and furthermore, we will
consider scans only from self-referred volunteer research
participants (giving a total of 12 RIS cases found in 8,441
research scans; Proportion (P) = 0.14%, 95% CI [0.08%,
0.25%]; Morris et al., 2009). We consider only self-
referred volunteers because this type of participant is simi-
lar to those in our own cohort of synesthetes and across the
234 scanned synesthetes more widely. It is important to
consider this method of self-referral since it might increase
the number of RIS cases in our cohort. Specifically, self-
referred/volunteer recruitment in any brain imaging study
may increase rates of neuropathology by over-recruitment
of participants who are seeking covert evaluation for unde-
clared neurological complaints (Morris et al., 2009). In
other words, our three affected synesthetes may have
volunteered for our studies to assuage personal neurologi-
cal concerns, and we must therefore compare their number
against a baseline that specifically takes this into account.
In summary, all these considerations give us a comparative
baseline for RIS in the general population of 142/100,000.
However, we point out that this baseline is likely to be
highly inflated since closer inspection of the data that
contributed to our meta-analysis reveals that two-thirds
of cases contributing to this figure were found in a single
study in which 90.0% of participants were former lead
workers with a mean age of 60.1 years (Alphs, Schwartz,
Stewart, & Yousem, 2006). Since the likelihood of detect-
ing WMH increases significantly with age (Smith,
Snowdon, Wang, & Markesbery, 2000) and with exposure
to neurotoxicants such as lead (Stewart et al., 2006), the
true prevalence of WMH in the general population of self-
referred volunteers is likely to be substantially lower than
the baseline we are selecting here. Nonetheless, we use
this baseline as a maximally conservative estimate (to
combine with a suitable estimate for MS prevalence
below), for comparison with our synesthete sample.
The prevalence of MS in the general population is
better understood and known to vary by geographic region
(with particularly high rates in Scotland, Sutherland, 1956,
and by sex: females approximately 2:1; Pugliatti et al.,
2006). This is of note given our Edinburgh testing study
Figure 2. Axial T2-weighted FLAIR images showing (left) a
left frontal periventricular lesion and (right) multiple lesions; the
right parietal lesion involves juxtacortical U fibers. [To view this
figure in color, please see the online version of this Journal.]
Figure 3. Axial T2-weighted image showing multiple ovoid
periventricular white matter lesions, from subject 3.



































(in which 4 of 13 participants were Scottish; the remainder
traveled from England) and the fact that the scanned
synesthesia population is skewed towards females
(F = 201) – as potentially, is synesthesia in general (e.g.,
see Ward & Simner, 2005). Considering the sex and
nationality of the 234 scanned synesthetes (using the loca-
tion of testing centers as an indicator of nationality for
cases unknown to us), an appropriate baseline is the rate of
MS in female Europeans (110/100,0002) since synesthetes
were virtually exclusively European (94%, N = 220;
including four Scots, none of whom showed pathology).
This we combined with the baseline for RIS to give an
additive RIS-MS baseline of 252/100,000.
Using the exact binomial test, we calculated the prob-
ability of obtaining our observed number of MS-RIS cases
within scanned synesthetes, given the expected baseline
prevalence estimates generated earlier. Thus, we estimated
the probability of three observations of MS-RIS among
234 self-referred synesthetes (Proportion (P) = 1.3%, 95%
binomial CI [0.3%, 3.7%]; 1282/100,000) given an
expected population prevalence of 252/100,000. Our sta-
tistical test shows this rate among synesthetes to be sig-
nificantly higher than chance might predict (p = 0.02).
This difference remains significant (p = 0.04) even if we
substitute the female Europe MS rate and use instead the
female England MS rate,3 as the most extremely conser-
vative option given the demographics of our three affected
cases (American/French/English).
Combining our three cases has allowed us to consider
the shared MRI profile of MS and RIS and their related
clinical progression (Granberg et al., 2013). However, we
might alternatively exclude our case of MS as a separate
phenomenon and consider only our two observations of
RIS against all 103 scans with protocols to check for such
anomaly (P = 1.9%, 95% binomial CI [0.2%, 6.7%]).
Taking again our highest RIS baseline (142/100,000),
this finding is also highly significant (p = 0.01). Indeed,
taking even the most extreme assumption of no other cases
in any synesthete scanned to date – checked or unchecked
– an observation of two cases in 234 (P = 0.9%; binomial
CI [0.1%, 3.1%]) remains significant (p = 0.04).4
Discussion
We initially observed three cases showing WMH compa-
tible with the radiological profile of MS – one case of MS
and two of RIS – in 29 synesthetes from three of our
imaging labs across three different countries. We have
taken the most conservative approach in assuming no
further cases in any synesthetes scanned to date, placing
the prevalence at 3 affected cases in 234 synesthetes
(1,282/100,000, compared to a population baseline esti-
mate of 252/100,000). Two cases of RIS in 103 brain
scans checked for pathologies would, if representative,
place the prevalence of RIS in synesthetes at 1,942/
100,000 (compared to a baseline of 142/100,000). These
rates are significantly higher than expectation, even against
our highly conservative baselines. We also specifically
controlled for the possibility that our three affected cases
may have volunteered for our studies to assuage personal
neurological concerns. We did this by comparing our RIS
cases to a baseline constructed only from studies that
included similar, self-referred, volunteer participants. In
other words, we compared our rates to studies likely to
have just as many “concerned self-referrers” as our own,
rather than to studies using nonvoluntary recruitment
methods (e.g., work-related health screening; Weber &
Knopf, 2004).
We would like to very clearly acknowledge that we
report only a small number of affected cases, and we
evidently do not claim that synesthesia causes MS-RIS.
Indeed, our small sample size means we hold back from
making any strong claim whatsoever about links between
these two conditions. There are many environmental fac-
tors thought to contribute to the development of MS and
RIS; the evidence we present here suggests having
synesthesia may be one factor that could merit further
investigation. Indeed, we have chosen to present our data
for two reasons. The first is that the rates we have found
are statistically significant; a considerably greater sample
size would usually be needed to detect the numbers we
have found – although again our sample sizes are small.
The second reason we present our data is a practical one:
cases of pathology are usually excluded from MRI study
populations as soon as they are detected. Therefore, they
often do not appear in the literature and so remain
unknown outside the research group. We have published
our data because we judge it important that other research-
ers working in this area are aware of our cases, and so
might not overlook future neurological abnormalities,
should they ever be discovered. If a meaningful link
between synesthesia and MS did exist, and as scanning
of synesthetes for research purposes becomes more com-
monplace, further cases of this nature would arise, and so
we encourage researchers to make any cases known to the
wider community if they share similarities with our own.
One explanation for a link between synesthesia and
MS could be the occurrence of synesthesia-like symptoms
after the onset of MS. In other words, it is possible that the
degenerative neurological damage caused by MS might
give rise to sensory disorders that mimic synesthesia,
while having different causes. Sensory disturbances do
accompany MS (e.g., changes in color vision; Gregori,
Papazachariadis, Farruggia, & Accornero, 2011) although
this hypothesis would imply that the onset of synesthesia-
like symptoms should be later in life – resulting from MS-
related changes in brain structure. However, we do not
believe this accounts for the cases we present here and for
two reasons. Later-acquired synesthesias are qualitatively




































not reflect the synesthesias of our participants. Acquired
variants of synesthesia tend to involve low-level sensory
triggers (e.g., tones) rather than learned symbols such as
graphemes (Ward, 2013) although it is precisely this latter
type of trigger (graphemes etc.) that our own cases possess
– and which might therefore be considered a hallmark of
developmental synesthesia. Furthermore, all three of our
cases report life-long synesthesia, stemming back from
early childhood, and being present for as long as they
can remember.
Finally, we point out one recent finding that might be
considered alongside our own. Bashir, Lipton, Ashina, and
Ashina (2013) have shown white matter abnormalities in
people suffering migraine, especially those for whom the
migraine is accompanied by auras. Migraine has been
linked with synesthesia (e.g., Alstadhaug & Benjaminsen,
2010) and the auras associated with migraine are visual
disturbances that themselves might be considered as resem-
bling certain types of synesthetic sensations (e.g., colored
photisms). Future studies might therefore further explore
any possible links between synesthesia and migraine and
the types of visual disturbances they each engender.
In conclusion to the current study, we have demon-
strated an apparent statistical link between MS-RIS and
synesthesia. Overall, we have been conservative in our
study in three ways: we selected baselines in an overly
conservative way, we took additional measures to be con-
servative when conducting our statistical analysis (e.g.,
assuming no anomalies in scans not assessed by radiolo-
gists), and we are circumspect in the interpretation of our
findings. Because our study relies on a small number of
cases – three only – we do not claim that any causal link
exists between synesthesia and MS-RIS, and we present our
findings with this strong caveat. Nonetheless, we present
these significant data so that imaging researchers might
consider them when evaluating any anomalies that may
arise in future studies. If our epidemiological findings are
indeed later supported by additional evidence, this could
invite a debate about the clinical status of synesthesia,
which has previously been associated with largely benefi-
cial rather than unfavorable characteristics (but see
Carruthers, Miller, Tarrier, & Whorwell, 2012). To investi-
gate this hypothesis further, we are currently also exploring
whether developmental synesthesia is found in high num-
bers within populations of people with MS, which would
enable firmer conclusions to be drawn regarding the validity
or otherwise of the statistical associations we report here.
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Notes
1. Where MS-RIS anomalies were found, authorship was
invited for the current article and this would explain why
three cases were found in our own cohort but not elsewhere.
2. Calculation of the rate of female MS in Europeans: Pugliatti
et al. (2006) report that “the total estimated prevalence rate
of MS [in Europe] for the past three decades is 83 per 100
000 with … a female: male ratio around 2.0” (p. 700). On
this basis, and given the overall population sex ratio in the
European Union (0.96 males to each female; The World
Factbook, 2011, Washington, DC: Central Intelligence
Agency, 2011), we calculate the estimated European female
MS rate at 110/100,000.
3. Calculation of the rate of female MS in England: There was
no available data for female MS prevalence in England per
se and so we calculated this based on the rate of MS in
eastern England (153/100,000; the highest regional rate in
England reported by Compston et al., 2006) and the male:
female ratio of MS (2:1; Compston et al., 2006) in combina-
tion with the overall population prevalence of women versus
men in the United Kingdom (1.01:1; The World Factbook,
2011, Washington, DC: Central Intelligence Agency, 2011).
This gives an estimate of female MS in England at 204/
100,000.
4. Analyzing the RIS cases and MS case separately serves an
additional purpose. The MS case was the first reported case
and as such can be viewed as the observation that led to the
forming of our hypothesis. It could be argued that including
this case in subsequent analyses, especially given the small
numbers of cases involved, may lead to inappropriate con-
clusions being drawn. It is important to point out therefore
that when this initial case is excluded and the subsequent
two cases are analyzed, the outcome remains statistically
significant, adding further methodological rigor for this
hypothesis.
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a b s t r a c t
Synesthesia is a neurological condition that gives rise to unusual secondary sensations (e.g.,
reading letters might trigger the experience of colour). Testing the consistency of these
sensations over long time intervals is the behavioural gold standard assessment for detect-
ing synesthesia (e.g., Simner, Mulvenna et al., 2006). In 2007 however, Eagleman and col-
leagues presented an online ‘Synesthesia Battery’ of tests aimed at identifying synesthesia
by assessing consistency but within a single test session. This battery has been widely used
but has never been previously validated against conventional long-term retesting, and with
a randomly recruited sample from the general population. We recruited 2847 participants
to complete The Synesthesia Battery and found the prevalence of grapheme-colour synes-
thesia in the general population to be 1.2%. This prevalence was in line with previous con-
ventional prevalence estimates based on conventional long-term testing (e.g., Simner,
Mulvenna et al., 2006). This reproduction of similar prevalence rates suggests that the
Synesthesia Battery is indeed a valid methodology for assessing synesthesia.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Synesthesia is an inherited condition in which everyday stimuli trigger unusual secondary sensations. For example, synes-
thetes listening to music might see colours in addition to hearing sound (Ward, Huckstep, & Tsakanikos, 2006). One par-
ticularly well-studied variant is grapheme-colour synesthesia, in which synesthetes experience colours when reading,
hearing or thinking about letters and/or digits (e.g., Simner, Glover, & Mowat, 2006). Despite being first reported over
two hundred years ago (by Sachs, 1812; see Jewanski, Day, & Ward, 2009) synesthesia was initially an under-researched
and poorly-understood area of human experience until the last decades of the 20th century. A significant factor in the eleva-
tion of synesthesia as a tractable topic was the realisation – and subsequent empirical confirmation – that synesthetes’ expe-
riences could be verified behaviourally by the fact that they remain conspicuously stable over time (Baron-Cohen, Wyke, &
Binnie, 1987; Jordan, 1917). Specifically, synesthetes tend to be highly consistent when reporting their synesthetic sensa-
tions for any given stimulus. For example, if the letter J triggers the colour pale blue for a given synesthete, she will tend
to repeat that J is pale blue (not green, not yellow, etc.) when repeatedly tested over days, months and even years. Indeed,
http://dx.doi.org/10.1016/j.concog.2015.02.001
1053-8100/ 2015 The Authors. Published by Elsevier Inc.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
⇑ Corresponding author at: 3.34 Informatics Forum, University of Edinburgh, 10 Crichton St, Edinburgh EH8 9AB, UK.
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one study was able to show that synesthetic sensations had remained consistent over at least three decades (Simner & Logie,
2008).
This stability of responses over time is considered one of the central features of synesthesia and is routinely verified in
almost every publication on the subject (e.g., Asher, Aitken, Farooqi, Kurmani, & Baron-Cohen, 2006; Baron-Cohen, Burt,
Smith-Laittan, Harrison, & Bolton, 1996; Rich, Bradshaw, & Mattingley, 2005; Ward & Simner, 2003; but see Simner,
2012). In other words, while a wide range of behavioural approaches have been employed to assess the nature of the synes-
thetic experience, experimental methodologies aiming to validate synesthesia have almost exclusively focussed on the
feature of consistency. Hence, researchers selecting synesthete participants for study first verify the genuineness of each case
by requiring their synesthetes to demonstrate high levels of consistency over time compared to non-synesthete controls
(e.g., Asher et al., 2006; Baron-Cohen et al., 1996; Simner et al., 2006). Controls are tested on analogous associations (i.e., they
invent colours for the 26 letters, say, and then attempt to recall these colour associations later) and typically perform
significantly worse than synesthetes.
Although more than a hundred contemporary studies rely on this test of consistency for genuineness, the particular
instantiation of the test has varied widely. For example, a wide range of methods have been used to elicit synesthetic col-
ours: participants have indicated these by either giving verbal descriptions (e.g., Ward, Simner, & Auyeung, 2005), written
descriptions (Simner, Glover et al., 2006), using Pantone swatch colour charts (Asher et al., 2006), electronic colour charts
(Simner, Harrold, Creed, Monro, & Foulkes, 2009) or even computerised colour pickers offering extensive palettes of >16 mil-
lion colours (e.g., Simner & Ludwig, 2012). In this way, synesthesia research has used varying methods, which in turn might
raise difficulties for researchers when trying to meaningfully compare data.
Despite this superficial variability however, the test of genuineness has nonetheless tended to rely on one key shared fea-
ture: synesthetes must outperform controls over fairly lengthy re-test intervals. Consider, for example, the most widely cited
large-scale screening for synesthesia (Simner, Mulvenna et al., 2006) in which a large sample of participants were oppor-
tunistically recruited from the communities of Edinburgh and Glasgow Universities, and individually assessed for synesthe-
sia. Participants first indicated by questionnaire whether they believed they experienced synesthesia, and those who
reported in the affirmative were asked to provide their synesthetic associations (e.g., the colours of letters). These par-
ticipants were then retraced after considerable time had passed (on average 6.0 months) and were asked in a surprise retest
to re-state their associations. A group of controls without synesthesia performed an analogous task but were re-tested after
only two weeks. Synesthetes were able to significantly out-perform controls even though much time had passed and the
deck was effectively stacked against them. Methodologies such as this allow confident detection of genuine synesthetes
because the surprise retest over lengthy intervals places the performance of synesthetes beyond the usual abilities of the
average person. The drawback to this methodology, however, is that the task is extremely time-intensive to perform, and
risks a high drop-out rate if synesthetes become untraceable at retest.
Perhaps for this reason, one of the most important developments in the methodology of synesthesia validation came with
the introduction in 2007 of an alternative version of the test of genuineness. Eagleman and colleagues produced the
Synesthesia Battery, a toolbox of online tests which provides a standardised set of questions, tests and quantitative scores
to assess a range of synesthesias (Eagleman, Kagan, Nelson, Sagaram, & Sarma, 2007). This battery is again based on internal
consistency in that synesthetes are validated by high consistency within their own synesthetic associations, stated repeat-
edly. However, consistency is measured within a single test session lasting only approximately 10 min. Specifically, synes-
thetes log on to the testing site (www.synesthete.org) and specify which form(s) of synesthesia they experience. The testing
platform then presents their triggering stimuli (e.g., the 26 letters) one by one in randomized order, and participants are
required to select their synesthetic colour for each trigger. Each stimulus (e.g., letter) is presented three times each, and a
score is generated to quantify the consistency of participant’s responses (e.g., did the participant choose the same/similar
colours each of the three times she saw a particular letter?) This score represents the geometric distance in RGB (red, green,
blue) colour space, where R, G, and B values are all normalised to lie between 0 and 1. If the mean overall score of colour-
distance is less than 1, the participant is classified as a synesthete; if the score is 1 or higher, the degree of inconsistency
classifies the participant as a non-synesthete. However, it remains an open question whether this limited retest interval
is sufficient to truly distinguish synesthetes from non-synesthetes.
In the current study we assessed the validity of the Synesthesia Battery by using it to test almost 3000 randomly sampled
subjects for grapheme-colour synesthesia. Our aim was to establish the prevalence of grapheme-colour synesthesia by this
method. This will allow us to evaluate the Synesthesia Battery by comparing this prevalence – obtained by assessments
within in a single test session – to the most widely accepted previous estimate of the prevalence of grapheme-colour synes-
thesia based on the standard longitudinal test–retest method (Simner, Mulvenna et al., 2006). If the Synesthesia Battery is
just as effective a method for detecting synesthesia as the more standard long-term retest method, we anticipate an equiva-
lent prevalence of grapheme-colour synesthesia across both methods. In carrying out our study, we chose to evaluate
grapheme-colour synesthesia in particular for several reasons: it is one of the most common forms of synesthesia
(Simner, Mulvenna et al., 2006), it is particularly well-understood in behavioural terms, it lends itself readily to online test-
ing, and those who experience it typically demonstrate the high levels of consistency expected from synesthetes (compared
to other variants, whose more complex concurrents may make them more difficult to assess via consistency alone; see
Simner, Gäartner, & Taylor, 2011 for discussion). It was not our intention to change or try to improve upon the method made
available by Eagleman et al. at www.synesthete.org. Rather, we attempted to simply replicate their test and methodology
and then evaluate how it performs in comparison to a conventional longitudinal test–retest method.
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In evaluating the Synesthesia Battery, our data will also provide an independent test of the prevalence of synesthesia. Our
baseline study – the widely cited prevalence study of Simner, Mulvenna et al. (2006) – found the prevalence of grapheme-
colour synesthesia to be 1.4% (for synesthetes with both coloured letters and numbers) or 2% (for synesthetes with either
coloured letters or numbers). This study was based on a sample of 500 individuals, and the prevalence rate it generated
was subsequently verified by a secondary method testing a further 1190 individuals (see Section 4 for details of this second
method).
Two previous studies have also aimed to validate aspects of the Synesthesia Battery (Eagleman et al., 2007; Rothen, Seth,
Witzel, & Ward, 2013). Both studies used self-reported synesthetes who had self-referred for study, in comparison to a group of
controls declaring they were non-synesthetes. it is important to highlight the difference between self-referred and self-reported
synesthetes. Self-reported synesthetes are any individuals who claim they have synesthesia. Self-referred synesthetes are
those who have additionally made the effort to contact a university researcher to volunteer to take part in synesthesia studies.
All synesthetes tested by Eagleman, Rothen and colleagues were not only self-declared, but also, importantly, self-referred. In
comparison, none of the synesthetes tested here are self-referred. Instead, our approach is to screen the general population
(some of whom at a certain point during our test, will self-report having synesthesia when asked, but will not be self-referred).
There are likely to be significant differences between our own synesthetes, and the self-referred synesthetes of Eagleman,
Rothen and colleagues. These latter synesthetes not only know they have coloured letters, but also know this is called synes-
thesia, and furthermore, they have made the effort to contact a university researcher to volunteer to take part in synesthesia
studies. They therefore have an understanding of synesthesia and judge that the extent of their synesthesia is worthy of study
by researchers. In other words, it is at least possible that self-referrers have relatively ‘strong’ (or noticeable, or attention-
catching) synesthesia in some way and may not be entirely representative of the population of synesthetes at large.
In summary, because of the sampling methods of the two previous validations (Eagleman et al., 2007; Rothen et al., 2013)
their participant groups (synesthetes versus controls) may have had diametrically opposing synesthesia characteristics,
which might have therefore made them relatively easy to distinguish between. Indeed, both Eagleman et al. (2007) and
Rothen et al. (2013) obtained a bimodal distribution of scores when assessing the consistency of grapheme-colour asso-
ciations of their self-referred synesthetes compared to controls. Here however we individually assess a randomly recruited
sample of subjects, allowing our own study to extend the previous findings of Eagleman et al. and Rothen et al. and establish
how the Synesthete Battery performs when a distinction between synesthetes and non-synesthetes is perhaps more difficult
to achieve. Put differently, by testing a random sample of the population, we expect to capture a broader, more representa-
tive range of synesthetic experiences, and we are evaluating how the Synesthete Battery performs under these conditions. In
addition, our study will provide the largest estimate of the prevalence of grapheme-colour synesthetes to date, with almost
3000 randomly sampled members of the general population.1
Finally, our study also investigates a second aspect of the Synesthesia Battery. After the single session test of consistency
of coloured graphemes, participants next immediately perform a second test of synesthesia: a speeded congruency verification
task (Eagleman et al., 2007). In this, participants are presented with individual graphemes, but this time the graphemes are
coloured either to match the participant’s earlier colour selection (congruent), or to be a different colour (incongruent). Par-
ticipants must simply answer whether the letter-colour pairing matched their previous choices or not, and their accuracy
and speed is measured. Eagleman et al. (2007) report that synesthetes tend to score 90% or higher with a mean RT of
0.64 ± 0.78 s, while non-synesthetes score below 90% with mean RT of 0.91 ± 0.87 s (Eagleman et al., 2007). We will examine
the sensitivity of this type of test to determine whether it too has the diagnostic capability to distinguish between par-
ticipants who score below the consistency threshold score of <1 (i.e., synesthetes) and those who do not. In other words,
where Eagleman et al. (2007) compared self-referred synesthetes with non-synesthete controls, we will extend this type
of test to assess (a) randomly sampled participants, who are (b) self-declared synesthetes, but who are not self-referred
synesthetes, and who are also (c) either verified as genuine versus non-genuine. As such, we are evaluating whether this type
of speed-congruency test still holds up in what is likely to be a more sensitive comparison.
2. Methods
2.1. Participants
Two thousand eight hundred and forty-seven participants took part in our study (1317 male, 1530 female; mean age 28.6,
range 16–90, S.D. 14.3). We had additionally tested 32 further subjects who completed our study but had entered an
1 Early estimates of prevalence in the science literature had varied widely, at least partly because researchers were focussing on different sub-types or using
different definitional criteria (Ramachandran & Hubbard, 2001). Even in studies that aimed to report the prevalence of all forms, estimates range from 1 in 4
(Calkins, 1895; Domino, 1989; Uhlich, 1957), to 1 in 10 (Rose, 1909), 1 in 20 (Galton, 1883), 1 in 200 (Ramachandran & Hubbard, 2001), 1 in 2000 (Baron-Cohen
et al., 1996), and 1 in 25 000–100 000 (Cytowic, 1993, 1997). A number of these studies were simply ‘best guesses’, while others failed to use objective tests to
verify synesthetic reports (e.g., Calkins, 1895; Domino, 1989; Rose, 1909; Uhlich, 1957). Others still did use robust consistency methods to verify synesthesia,
but were subject to a recruitment bias: their subjects were recruited in response to adverts in newspapers, leaving open the possibility that low prevalence
rates (e.g., 0.05–1% of the population; Barnett, Finucane, Asher, Bargary, Corvin, Newell, & Mitchell, 2008; Baron-Cohen et al., 1996) were due simply to poor
rates of responding (see Baron-Cohen et al., 1996 for discussion). The estimate we use here (from Simner, Mulvenna et al., 2006) is a particularly robust
estimate since it avoided the problems of self-referral by individually questioning every member of a participant pool, and using an objective test of
genuineness (consistency over long-term retest).
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obviously false date of birth (e.g., 2013). These subjects did not enter our analysis, which was therefore based only on our
N = 2847.
Participants were recruited as part of a large-scale, centrally co-ordinated undergraduate research project. Every student
registered on the 2nd year of the Psychology undergraduate course at the University of Edinburgh acted as a research assis-
tant (RA), and was required to each recruit 8 participants (4 male and 4 female) over 16 years of age. Our student RAs were
not allowed to take part in the study themselves. In recruiting our participants, we took a number of steps to ensure as ran-
dom a sample as possible. First, RAs were instructed not to deliberately seek out, nor to avoid, people they knew to be synes-
thetes. Furthermore, in order to avoid self-referral biases, RAs were required to pre-select their sample, and then approach
participants in a targeted way (rather than send out an advert and accept self-referrals). Indeed, RAs were required to refrain
from recruiting participants via any open calls at all, for example, they could not post the testing URL on social media web-
sites or internet forums. Finally, RAs were also instructed not to a priori inform participants that the study involved synes-
thesia. The instructions given by the RAs to prospective participants were uniform, and clearly stated that participants were
only allowed to complete the test once; if they had previously been approached to complete the test by someone else, they
were to inform the recruiter and not proceed with the test.
Our study was carried out in two waves to maximise participation numbers: 1514 were tested in January 2013, and 1333
were tested in September 2013. Both used identical methods, carried out by two consecutive intakes of 2nd year students. In
both rounds, the study was carefully managed and co-ordinated by authors JS and DAC. Data from both rounds are pooled
and presented together here.
2.2. The online test
The online test consisted of several sections. Participants first provided informed consent via a checkbox and then gave
demographic information such as age, sex, handedness and native language. A second section consisted of a health question-
naire not relevant for the current study. (In this, subjects were requested to indicate if they suffered from a range of clinical
conditions, and this was for another project to be reported elsewhere.) After this page, our online synesthesia assessment
began with our locally stored replica of the Synesthesia Battery. In this replica – as in the original – participants were first
asked whether they experienced grapheme-colour synesthesia, with the question ‘‘Do numbers or letters cause you to have a
colour experience?’’ This was accompanied by an example, and then an option to accept separately according to whether
these colours are triggered automatically by numbers and/or digits. If participants indicated that they saw neither letters
nor numbers in colour, they advanced to an early-exit page thanking them for their participation.
The rest of the test was completed by participants who answered in the affirmative to having coloured letters/digits.
These participants completed two further tests tailored to the particular variant of grapheme-colour synesthesia they had
reported (i.e., for either digits, letters, or both). These two tests were a colour consistency test and a speeded congruency
task. The colour consistency test was again an identical clone of the consistency test from the Synesthesia Battery
(Eagleman et al., 2007). In this, participants were presented with each grapheme (a–z, 0–9) three times in random order
(so 30 trials if the subject reported coloured numbers only, 78 trials if letters only, and 108 trials if both letters and numbers).
For each trial, participants were required to select the colour that best matched the grapheme presented (see Fig. 1). Selec-
tions were made from a palette of 256  256  256 colours, exactly as in the original Synesthesia Battery. Once their selec-
tion was submitted, the screen advanced to show the next grapheme. The colour palette followed an HSL colour model, with
colours varying in lightness along the vertical axis and saturation along the horizontal access a separate, horizontal bar
allowed hue to be adjusted (see Fig. 1).
The colour consistency test was followed by a speeded congruency task. In this section, participants were shown again the
graphemes they had just seen in the colour consistency test. This time they saw each relevant grapheme twice, in a random
order, each flashed on screen for a maximum of 1 s or until the participant responded (20 trials for just numbers, 52 trials for
just letters or 72 trials for both letters and numbers). In 50% of trials, graphemes were coloured congruently with the par-
ticipant’s earlier specification, and in 50% of trials they were coloured incongruently. Participants were required to indicate
by mouse-click on the relevant on-screen button whether the each grapheme they saw either matched or did not match their
previous colour pairing (as collected during the consistency test; Fig. 2). Their response mouse-click advanced the test to the
next grapheme, and the test continued until all graphemes had been shown.2
2 On completing our study we discovered minor methodological differences to Eagleman et al. (2007) in how congruent and incongruently coloured
graphemes were selected and presented. In our study here, the first presentation of graphemes included 50% that were randomly selected to be presented in in
their congruent colour, taken from the participant’s 1st selection in the prior task. For the second presentation, 50% of graphemes were again randomly selected
to be congruently coloured, this time from the participant’s 2nd selection from the previous task. The incongruent colours were randomly selected in RGB
space, and were not taken from the participants’ earlier palette. In Eagleman et al. (2007), each grapheme was presented twice in a fully randomised order –
once congruently (always from the 1st selection given previously) and once incongruently. The incongruent colour was chosen from the participant’s earlier
palette of colours on the consistency test and verified to be sufficiently distant in RGB space from the congruent colour. The details of this were not given in the
Eagleman paper. Furthermore, in our own study a response press advanced the display onto the next grapheme, while in Eagleman et al. (2007) the grapheme
was displayed for a constant 1s followed by a fixed inter-stimulus interval. These differences mean we can no longer directly compare our data in this section to
that from Eagleman et al. (2007). Instead, our investigation here will serve to determine whether this type of study (i.e., a speeded congruency task) can be
validated on our new participant population and how responses in this type of test might relate to the consistency scores provided by the Synesthesia Battery.
Finally we point out that our central aim – to assess the consistency portion of the Synesthesia Battery – is unaffected.
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In summary, the colour consistency test generated a consistency colour-distance score, and the speeded congruency task
generated an accuracy score and a reaction time. For full details of website configuration and how the consistency colour-
distance score is calculated, see Eagleman et al. (2007).
3. Results
In our study, we classified as non-synesthetes all those who were directed to the early-exit page (i.e., those who said they
did not experience coloured letters and/or digits) and all those who continued but scored 1 or higher. The remainder were
classified as synesthetes (i.e., those who scored <1).
From our sample of 2847 participants, 140 subjects (55 male, 85 female, mean age 23.9, range 16–71, SD 9.5) self-report-
ed grapheme-colour synesthesia, giving a self-reported prevalence of 4.9%. Of those 140 self-reported synesthetes, 34
obtained a colour-distance score of <1 on their consistency test (14 male, 20 female, mean age 24.9, range 17–51, SD 5.8),
which is the criterion used by Eagleman et al. (2007) to identify genuine synesthesia. This places the prevalence of genuine
grapheme-colour synesthesia at 1.2% and we will return to this prevalence value further below.
Of the 140 self-reported synesthetes, 55 reported experiencing coloured numbers only, 58 reported experiencing both
coloured numbers and letters and 27 subjects reported experiencing coloured letters only (see Fig. 3a). Of the 34 participants
that scored <1 on the consistency test, 17 experienced coloured numbers only, 14 experienced both coloured numbers and
letters and 3 subjects experienced coloured letters only (see Fig. 3b). As an additional check, the colour choices of the par-
ticipants obtaining a consistency score of <1 were examined individually to allow us to confirm that none of these achieved
their superior consistency by entering the same colour for each grapheme, or by entering an obviously non-synesthetic pat-
tern of colours throughout, e.g. red for ‘R’, green for ‘G’ and blue for ‘B’ (following Simner, Mulvenna et al., 2006).
Next we analysed accuracy and RTs in the speeded congruency task. We first divided our sample of self-reported synes-
thetes into two groups, around to the consistency colour-distance threshold of <1. For clarity, we refer to those who scored
Fig. 1. Screenshot from the consistency test.
Fig. 2. Screenshot from the speeded congruency task.
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<1 as genuine synesthetes, and those who score P1 we refer to as malingerers3 (i.e., non-synesthetes who self-reported synes-
thesia but failed to achieve what is considered a synesthetic score in the colour consistency test). There were 34 genuine synes-
thetes, as noted above, and 90 malingerers. There were also 16 subjects who reported too few coloured graphemes to generate a
consistency colour-distance score at all. Following Eagleman et al., 2007, participants were required to enter a minimum of two
valid graphemes to obtain a consistency score, a valid grapheme being defined as one to which the subject entered a colour for
all three presentations. These 16 are omitted from all further analyses below. (Finally, we remind the reader that there are no
values for participants who declared themselves to be non-synesthetes from the start because these individuals did not progress
to the synesthesia assessment.)
(a)
(b)
Fig. 3. Variants of grapheme-colour synesthesia reported by (a) all 140 participants who self-reported synesthesia, and (b) the 34 participants confirmed as
genuine synesthetes (i.e., with colour-distance consistency scores of <1).
3 We use this term only for clarity but are in fact agnostic about the nature of these individuals. The prevailing view is that these are likely to be non-
synesthetes falsely reporting synesthesia and therefore failing the objective consistency test. However, we leave open the possibility that some genuine
synesthetes may not in fact be consistent over time, and refer to the reader to Simner, Mulvenna et al. (2006), Simner (2012), Eagleman (2012) and Cohen
Kadosh and Terhune (2012) for further discussion on this matter.
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Using an independent samples t-test, we calculated the mean accuracy in the speeded congruency task for each group:
genuine synesthetes versus malingerers. This mean was 84.4% (SD = 11.8) for synesthetes and 70.5% (SD = 14.9) for malin-
gerers, and this difference was significant (t(122) = 5.45, p < .0001, d = 1.03). There was no significant difference in mean
reaction times between groups (Synesthetes M = 1.93 s; SD = 0.77; Malingerers M = 1.76 s, SD = 0.73; t(122) = 1.13, p = .13,
d = 0.23) see Fig. 4a and b). Mean reaction time was calculated across all trials, irrespective of whether the participant
had answered correctly or incorrectly.4
In order to investigate whether this non-significant result provided evidence for the null hypothesis we calculated a Bayes
factor. By comparing the likelihood of two models (in this case, the null and alternative hypotheses) as a ratio, Bayes factors
allow the researcher to evaluate to what extent the data supports the null hypothesis (Rouder, Speckman, Sun, Morey, &
Iverson, 2009). Following Jeffreys (1961), a Bayes factor of less than 0.33 provides strong support for the null hypothesis,
a Bayes factor of greater than 3 provides support for the alternative hypothesis and values inbetween indicate the data
are insensitive and no firm conclusions should be drawn. Using the online calculator provided by Rouder et al. (2009), we
calculated a Bayes factor of 1.17, indicating that the data are not sensitive enough to enable a conclusion to be drawn.
Finally we explored how these two types of test (consistency and speeded congruency) work in tandem in their assess-
ments of synesthesia. If we take self-reported synesthetes as a single group (i.e., collapsing genuine synesthetes and malin-
gerers) there was a significant inverse correlation between the consistency colour-distance score, and the speeded
congruency accuracy score (r(122) = .71, p < .001; see Fig. 5). Remembering that low colour-distance scores and high accu-
racy scores are both indicative of synesthesia, this inverse correlation shows that those who performed like synesthetes in
the first sub-test were also more likely to perform like synesthetes in the second. However, when we calculate this correla-
tion for genuine synesthetes and malingerers separately, it becomes apparent that the effect comes from the malingerer
group only. The correlation between consistency colour distance score and speeded-congruency accuracy score for genuine
synesthetes is non-significant (r(32) = .07, p = .35) whereas for the malingerers, the correlation is highly significant
(r(88) = .73, p < .0001).
Finally, there was no significant correlation between consistency colour-distance score and reaction time (r(122) = .05,
p = .59), nor for accuracy score and reaction time (r(122) = .11, p = .22), and this also remained the case when correlations
for the synesthete and malingerer groups were calculated separately (synesthete consistency-RT = r(32) = .006, p = .49; mal-
inger consistency-RT = r(88) = .014, p = .45) (synesthete accuracy-RT = r(32) = .18, p = .14; malinger accuracy-
RT = r(88) = .09, p = .19).5
3.1. Prevalence comparison between studies: Comparing short versus long-term testing
The key aim of this study was to compare the prevalence of grapheme-colour synesthesia generated by the Synesthesia
Battery (a single-session test) to a more conventional method based on long term (rather than single session) testing
(Simner, Mulvenna et al., 2006). Using the Synesthesia Battery we found the prevalence of grapheme-colour synesthesia
in the general population to be 1.2% for those with coloured letters or digits, compared to the previous estimate of 2% in con-
ventional longer-term testing (Simner, Mulvenna et al., 2006). We can now evaluate that these two estimates are not sig-
nificantly different (chi square = 2.1; df = 1; p = .14). However, we also calculated prevalence for synesthetes with both
coloured letters and digits, finding a value here of 0.5%, and this is significantly less than the 1.4% found in conventional
longer term retesting (Simner, Mulvenna et al., 2006; chi square = 5.6; df = 1; p = .02).
4. Discussion
In our study, we reproduced elements of the Synesthesia Battery (Eagleman et al., 2007) which is a single-session online
test for grapheme-colour synesthesia. We used this method to estimate the prevalence of grapheme-colour synesthesia in a
very large randomly recruited sample – indeed the largest sample for this purpose to date. We found the prevalence of
grapheme-colour synesthesia in the general population to be 1.2% for those with coloured letters or digits, compared to
the previous estimate of 2% (Simner, Mulvenna et al., 2006), a difference which is not significantly different. However, we
also calculated prevalence of synesthetes with both coloured letters and digits, finding a value here of 0.5%, and this is sig-
nificantly less than the 1.4% found in conventional longer term retesting (Simner, Mulvenna et al., 2006). Hence, the Synes-
thesia Battery numerically under-estimated the prevalence of those with coloured letters and digits, compared to longer
retesting methods and we explore possible reasons for this below.
One explanation for an under-estimation of prevalence in the Synesthesia Battery might stem from the way graphemes
are presented to those who report more than one variant: letters and digits are presented together, randomly ordered within
4 We analysed both correct and incorrect trails was because our aim in this paper was to replicate Eagleman et al.’s (2007) methods as faithfully as possible.
However, when analysing reaction times in Stroop-like behavioural tasks, convention typically dictates that only correct trials are included in the analysis.
When only correct trials are analysed, the result does not change: there is no significant difference in reaction time between genuine synesthetes and
malingerers (p = .95), which – like before – remains contrary to Eagleman et al.’s original finding.
5 An anonymous reviewer has asked us to comment on the age of our subjects. The age range of all participants was 16–90 years. No genuine synesthetes
were found in the age range 52–90. Four participants in this age range reported having synesthesia but scored >1 in the colour distance consistency test, so
were classified as malingerers.
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the same consistency test. In the longer term retesting used as the baseline here however, letters and digits were always
presented in separate blocks (Simner, Mulvenna et al., 2006). It may therefore be that synesthetes are susceptible to inter-
ference when selecting colours for graphemes, and we raise this possibility for future studies to consider. A second possible
explanation for the lower prevalence found here is that immediate retests might be inherently more conservative, and this
might be suggested by the fact that prevalence estimates here were numerically lower across the board. Immediate retesting
might be conservative because the scores of non-synaethetes are likely to be better across shorter (versus longer) time inter-
vals. In other words, non-synesthetes in an immediate retest (e.g., over 10 min) should score higher than in a delayed retest
(e.g., over several weeks) even though synesthetes’ scores, in comparison, would be likely to remain relatively unchanged.
This would raise the control baseline for single session testing, and therefore allow a smaller range of synesthetes to be iden-
tified as significantly more consistent. If this is correct, we conclude that the threshold at which synesthetes are identified
(currently around the score of 1) might be usefully set marginally higher in the Synesthesia Battery of Eagleman et al. (2007).
One recent study has also speculated that the threshold in the Synesthesia Battery perhaps should be raised. Rothen et al.
(2013) have recently argued that for the combination of RGB colour space and city block distance used by Eagleman et al.
(2007) – and also in this study – a higher cut-off may indeed be more appropriate. In order to maximise sensitivity and speci-
ficity for this colour space/distance combination, they proposed a revised threshold within the existing Synesthesia Battery
(a)
(b)
Fig. 4. Results from the speeded congruency task showing that (a) genuine synesthetes (indicated as ‘‘consistency <1’’) were significantly more accurate
than malingerers (indicated as ‘‘consistency P1’’) and that (b) there was no significant difference in mean reaction time between these two groups. (Note
that there are no values for participants who declared themselves to be non-synesthetes from the start because these individuals did not progress to the
synesthesia assessment.)
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at <1.43 for synesthetes (rather than <1). In our own study, if we recalculate prevalence in our sample using Rothen et al’s
suggested cut-off score of 1.43, our prevalence estimates are no longer significantly lower than expected. With this revised
threshold, we now find 69 genuine synesthetes with coloured letters OR digits (2.4%; compared to 2% in Simner, Mulvenna
et al., 2006; chi square = 0.3; df = 1; p = .57) and 31 synesthetes with coloured letters AND digits (1.1%; compared to 1.4% in
Simner, Mulvenna et al., 2006; chi square = 0.367; df = 1; p = .5). In other words, our results are more in line with more con-
ventional longer term evaluations of synesthesia when the threshold is shifted upwards according to the proposal of Rothen
et al. (2013).6 Finally, we point out that Rothen and colleagues also suggest that using alternative colour models (CIELUV and
CIELAB) and Euclidean distance provide the best combination of sensitivity and specificity in distinguishing between synes-
thetes and non-synesthetes. However that change would be beyond the scope of this paper, where we are simply evaluating
the Eagleman data output as it stands.
Our discussion above of where to set the cut-off threshold for consistency in the Synesthesia Battery might be considered
part of a more fundamental concern in synesthesia research. In all kinds of consistency tests for synesthesia – and particular-
ly obvious here – participants are divided into two groups by their score on what is in fact an incremental continuum of pos-
sible scores. (Using this test, participants can, in theory, score any value between 0 and 4, even though the cut-off is
conventionally placed at the fixed value of 1). It seems clear that someone who scores 1.05 on the consistency test is ‘‘more
synesthetic’’ than someone scoring 2.48, yet according to the cut-off of <1, both would be considered non-synesthetes.
Nonetheless, it is a particular strength of the Synesthesia Battery that researchers are free to consider this score in its
own right, rather than for categorical groupings alone.
The second part of Eagleman et al’s test involved speeded congruency task in which graphemes are presented either in the
same colour previously selected (congruent) or a different colour (incongruent). Subjects must indicate whether the colour
they saw matched their earlier choice, and Eagleman et al. (2007) report significant differences in speed and accuracy
between a pre-selected group of 15 self-referred synesthetes, and a non-synesthete control group. In our current study,
when our randomly-sampled respondents were divided into genuine synesthetes versus malingerers (i.e., around the thresh-
old score of 1), genuine synesthetes were again significantly more accurate than malingerers. These data suggest that accu-
racy scores can not only distinguish between self-referred synesthetes and non-synesthetes (as in Eagleman et al., 2007) but
is also subtle enough to distinguish between groups of genuine synesthetes and those who claim to be so, but do not pass a
conventional consistency test.
Furthermore, considering all self-reported synesthetes irrespective of their consistency, there was a significant inverse
correlation between consistency and accuracy, indicating that more consistent (i.e., more ‘genuine’) synesthetes were also
more accurate. However, when this correlation was calculated separately for the each group (genuine synesthetes and mal-
ingers) it became apparent that the effect was driven by the malingerers only. We suggest this is because genuine synes-
thetes score highly on the accuracy test, irrespective of what consistency score they achieve. In other words, a synesthete
obtaining a consistency score of, say, 0.99 is likely to be highly accurate on the speeded-congruency test – as accurate as
Fig. 5. Scatterplot showing a significant association between colour-distance consistency score and accuracy score for self-reported synesthetes.
6 If we repeat our earlier analyses from the speeded-congruency test (looking at differences in mean accuracy score and reaction time) grouping synesthetes
and non-synesthetes according to the revised threshold of <1.43, neither result changes. Synesthetes remain significantly more accurate than non-synesthetes
(82.8% (SD = 10.3) versus 63.7% (SD = 14.3); (t(95.27) = 8.32, p < .0001, d = 1.53). There remains no significant difference in reaction times between synesthetes
and non-synesthetes (1.71 s (SD = 0.56) versus 1.58 s (SD = 0.81); (t(92.04) = 0.97, p < .17, d = 0.19).
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a synesthete scoring 0.4 on the consistency test. In contrast, a malingerer obtaining a consistency score of 1.5 is more likely
to be more accurate on the speeded-congruency test than a malingerer scoring 3.5 for consistency.
The speed accuracy congruency test presented here showed one notable difference in results compared to Eagleman et al.
(2007). Our own findings were that genuine synesthetes, although more accurate than malingerers, were no faster. Eagleman
and colleagues found genuine synesthetes to be more accurate and faster than controls. This difference to Eagleman et al.
(2007) may stem from differences in our control populations: Eagleman et al. (2007) compared synesthetes to self-declared
non-synesthetes, while we compared to ‘malingerer’ individuals claiming to have synesthesia. It is possible that some por-
tion of our controls were in fact synesthetic in some way, albeit with lower consistency, and perhaps this is why our genuine
synesthetes did not differ from them in their RTs (see above and Simner, 2012 for discussion). Alternatively, our lack of dif-
ference in RTs may be the result of the unanticipated variations we introduced in our version of this test. Our method of
selecting congruent and incongruent graphemes and the timing of grapheme presentation for this part of the test differed
slightly from Eagleman et al.’s original approach (see Section 2 for a full explanation). Our own version may have raised
the difficulty of the task (e.g., because graphemes were on-screen for a shorter time on average) and our RTs were certainly
longer and hence potentially more noisy. There is no way to distinguish between these two hypotheses in the current study
and so we leave this as an open question for future studies to address.
We have evaluated whether single session tests of consistency are effective at identifying synesthetes, compared to estab-
lished longer retesting methods. One previous study has also suggested that single session testing may indeed be valid.
Simner, Mulvenna et al. (2006) established the prevalence of synesthesia both with long term testing (which we used here
as our key comparison) but also by screening additional 1190 people in a single session. Their method was more basic than
that of Eagleman et al. (2007) in that colour choices were made from a palette of just 13 colours, and only absolute matches
contributed to consistency scores. Nonetheless, this again produced roughly comparable prevalence estimates as longer term
testing (1.1% prevalence for coloured letters and digits). Taken together with the current study, we therefore suggest single
session tests of consistency for synesthetic associations do appear to provide an appropriate method by which to identify
synesthetes. The widely available nature of the Synesthesia Battery through its open-access online interface makes it a par-
ticularly appealing version of this test, as does its comprehensive colour palette, and its ability to give a calibrated estimate
(i.e., continuous consistency score) for synesthesia status. Although researchers will want to consider carefully the question
of whether consistency testing can reliably identify every type of synesthesia, or indeed every type of synesthete (see Simner,
2012 for discussion), it is clear from our current study that the Synesthesia Battery provides a suitable tool for evaluating
synesthetes along this dimension.
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Synaesthesia is a condition that gives rise to unusual secondary sensations (e.g., colours
are perceived when listening to music). These unusual sensations tend to be reported as
being stable throughout adulthood (e.g., Simner&Logie, 2007,Neurocase, 13, 358) and the
consistency of these experiences over time is taken as the behavioural hallmark of
genuineness.Our study looked at the influence ofmood states on synaesthetic colours. In
Experiment 1, we recruited grapheme-colour synaesthetes (who experience colours
from letters/digits) and elicited their synaesthetic colours, as well as their mood and
depression states, in two different testing sessions. In each session, participants
completed the PANAS-X (Watson & Clark, 1999) and the BDI-II (Beck, Steer, & Brown,
1996, Manual for Beck Depression Inventory-II), and chose their synaesthetic colours for
letters A-Z from an interactive colour palette.We found that negative mood significantly
decreased the luminance of synaesthetic colours. In Experiment 2, we showed that
synaesthetic colours were also less luminant for synaesthetes with anxiety disorder,
versus those without. Additional evidence suggests that colour saturation, too, may
inversely correlate with depressive symptoms. These results show that fluctuations in
mood within both a normal and clinical range influence synaesthetic colours over time.
This has implications for our understanding about the longitudinal stability of synaesthetic
experiences, and of how mood may interact with the visual (imagery) systems.
Synaesthesia is an inherited condition that causes unusual secondary sensations. For
example, synaesthetes may see colours when smelling odours (Day, 2013), or they might
experience tastes when hearing words (Ward & Simner, 2003) or listening to musical
notes (Beeli, Esslen, & J€ancke, 2005). These experiences feel intrinsically normal to the
synaesthete, who will have experienced them since childhood (at least in the case of
developmental synaesthesia, the focus of the current article). Synaesthesia is found in at
least 4%of thepopulation (Simner et al., 2006), and two recent genome-wide studies have
identified genetic regions of interest on chromosomes 2, 5, 6, and 12 and 16 (Asher et al.,
2009; Tomson et al., 2011). Synaesthesia is a multi-phenotypic condition depending on
which modalities are merged (e.g., sound with colour, taste with shape etc.), but one of
themost common forms is grapheme-colour synaesthesia (Simner et al., 2006) in which
*Correspondence should be addressed to Julia Simner, School of Psychology, Pevensey Building, University of Sussex, Falmer BN1
9QH, UK (email: j.simner@sussex.ac.uk).
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colour experiences are triggered by reading, hearing or thinking about graphemes (letters
or numbers). In scientific parlance, (Grossenbacher & Lovelace, 2001) graphemes would
be the ‘inducer’ stimulus in this variant, and colour would be the ‘concurrent’, and we
shall use this terminology throughout our article. In this article, we will look at how
synaesthetic concurrents of colour can be influenced by the mood states of synaesthetes.
Since one person cannot access another’s perceptual experiences, synaesthesia
researchers rely on measuring the behaviour of synaesthetes, or their neurophysiological
responses, but they also elicit first person accounts. When adult synaesthetes report their
concurrent sensations for any given list of inducers, these tend to be highly consistent
over time. In other words, a given inducer (e.g., the letter A) tends to elicit the same
synaesthetic concurrent (e.g., the colour red) for any given synaesthete in repeated
testing. Indeed, synaesthetic sensations are often thought to be consistent by definition
throughout the adult lifespan and this consistency-over-time is taken as the behavioural
hallmark of synaesthesia in genuineness testing (see Johnson, Allison, & Baron-Cohen,
2013 for review, and Simner & Bain, 2013 for how this constancy develops in childhood).
In a typical ‘genuineness test’ of synaesthesia (e.g., Baron-Cohen, Wyke, & Binnie, 1987),
synaesthetes are required to report their synaesthetic associations for a stimulus list (e.g., a
list of letters), andmust be significantlymore consistent in a retest compared to a group of
non-synaesthete controls,who are asked to invent analogous associations (i.e., tomake-up
colours for the 26 letters and then recall these later). Synaesthetes tend to be highly
consistent and have been shown to out-perform controls evenwhen tested over far longer
time intervals, and even when controls are given monetary incentives to perform well
(e.g.,Ward, Simner, & Auyeung, 2005). For example, synaesthete EPwas 100% consistent
in her colours for a set ofwords across 1 year, compared to a non-synaesthete controlwho
was just 17% consistent over 2 weeks (Baron-Cohen et al., 1987).
Research into synaesthesia has relied heavily upon this consistency feature because it
is the standard bywhich synaesthetic status is traditionally verified. But although virtually
every synaesthete described in the literature has been shown to be significantly more
consistent than controls, they are not necessarily 100% consistent. Grapheme-colour
synaesthetes in a study by Simner et al. (2006), for example, had consistency scores that
ranged from 73% to 100%. All were considered synaesthetes because they were each
significantly more consistent than controls. Nonetheless, this variation in consistency
shows there can be a degree of impermanence in synaesthetic sensations, which is rarely
talked about (but see Simner, 2012; Cohen Kadosh & Terhune, 2012; Eagleman, 2012). In
this study, we askwhatmight account for variations in reported synaesthetic colours, and
we begin by briefly exploring several theoretical possibilities below.
We first point out that inconsistently reported synaesthetic associations might be due
to difficulties in reporting, rather than to inconsistency in the experience itself. For
example, a synaesthetic colour that lies on the border between the two colour categories
of, say, red and brown (i.e., a maroon-like colour) might be described as red on one
occasion but brown on another, making the association appear inconsistent when it is in
fact not. Alternatively, it might be difficult for the synaesthete to identify the sensation at
all. Lexical-gustatory synaesthete JIW, for example, (who experiences floods of taste in the
mouth when reading words) experiences tastes he cannot always identify, and this too
can lead to reporting discrepancies (e.g., one taste was reported as Sugar Puffs© breakfast
cereal on one occasion but Rice Krispies© breakfast cereal on another – even though the
taste itself had not changed; Ward & Simner, 2003). Inconsistencies in reporting might
also arise when a single inducer has more than one concurrent: grapheme-colour
synaesthete JM, for example, reports that her letter L is ‘both black and yellow. Not a mix
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of those two, it’s just both simultaneously’ (personal communication). Again thismight be
artificially lower consistency scores, if JM chooses to report yellow on one occasion but
black on another. Indeed, some synaesthetic concurrents are so highly complex that it is
almost inevitable for inconsistencies in reporting to arise. Consider synaesthete MJS, for
example, who has sequence-personality synaesthesia (in which letters, numbers and
other sequences are synaesthetically imbued with personality qualities; Simner, G€artner,
& Taylor, 2011). Since personality has many facets, personality concurrents are
necessarily complex, and this can cause misleading reports. MJS for example first
described the number 2 as ‘someone who gets things done’, but later as ‘a quiet type’
(Simner et al., 2011). This appeared inconsistent until shewas asked again 4 years later, at
which point she described the personality more fully as a ‘good quiet little sort, can be
counted on. Deals with it. Ideal employee’ (Simner et al., 2011; p. 293). Only then was it
clear that the concurrent itself never changed, even though selective reporting had made
it appear inconsistent. Finally, it is also possible that different facets of a concurrent are
more prominent at different times.
In all instances above, the nature of the synaesthetic concurrent was unchanged over
time but simply reported differently. It is possible, however, that concurrents themselves
do change over time. This issue has been almost entirely overlooked in the literature and is
poorly understood. In this article, we ask how synaesthetic colours might change from
day-to-day, particularly under the influence of mood. Human moods or emotional states
change across points in time, and it is therefore reasonable to ask whether these mood
changes influence synaesthesia in some way. There are several reasons to believe they
might. First, mood states can affect cognition, reasoning and attention (Blanchette &
Leese, 2011; Compton, 2003; Oaksford, Morris, Grainger, &Williams, 1996; Pessoa, 2008;
Wadlinger & Isaacowitz, 2006) so may indirectly influence synaesthesia simply because
attention on the inducer, for example, is necessary for synaesthetic colours to be triggered
(for review of attentional influences on synaesthesia, see Rich & Mattingley, 2013).
Alternatively, changes in mood might influence synaesthetic experiences more directly,
and if this is true, it could cause fairly regular fluctuations in synaesthetic experiences. If
mood state does influence synaesthetic concurrents, we ask what form this influence
might take.
To answer this, let us briefly review what is known about how mood and colour are
related, both in synaesthetes and non-synaesthetes. In synaesthesia, there have been a
small number of case reports of emotion as the direct inducer for a synaesthetic
experience. One historical account describes case E, for whom ‘experiences are
emotionally coloured in a literal sense’ (Cutsforth, 1925, p. 529). This descriptive account
suggests that E experienced a range of stimuli (odours, sounds, memories) in terms of the
colour of their emotional valence: pleasant stimuli were often blues, reds, and yellows,
while unpleasant stimuli were often greens and browns. In more detailed account in the
modern literature, Ward (2004) described GW, who reports synaesthetic colours on the
presentation of emotionally valent words. When presented with a list of names for
example, she experienced colours more for the names of people she knew (and therefore
had emotional connections with) than of people she did not know. Common nouns, too,
triggered colour according to their emotional value: words that were highly emotive such
as ‘love’ elicited synaesthetic colours more often than neutral stimuli, such as ‘chair’.
There was also an association between emotions and the nature of the synaesthetic
colour: positive emotivewords had a lighter andmore saturated colour, andmorenegative
words were darker and less saturated. Ward (2004) therefore concluded that GW’s
inducer had an emotional component distinct from lexical qualities of the words
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themselves, and that this linked high luminance and saturation to positive emotional
valence.
Mood and emotional state are also associatedwith colour qualities for even the general
population. Studies have shown that different colour qualities (i.e., of hue, saturation and
luminance) are linked to different mood states. Manav (2007) found that subjects
associated the colour yellow, for example, withmore negative emotional adjectiveswhen
its luminancewas lower (e.g., boring, anxious, depressive). Children too are already able
to express coherent shared emotional responses to colours at the age of 5–6 years. When
asked ‘How does this colour make you feel?’ they tend to give positive emotions to bright
colours (e.g., pink, blue, red) and more negative emotions to dark or achromatic colours
(e.g., brown, black, grey; Boyatzis &Varghese, 1994). A similar finding has been replicated
in the adult population (Hemphill, 1996).
One final set of studies suggests again that mood variances may influence colour
associations – this time for clinical mood states – and they can even influence the very
nature of colour perception itself. For example, Bubl, Kern, Ebert, Bach, and Tebartz van
Elst (2010) found that participants with major depression have altered perception of
luminance (see below). Major depression is a common mood disorder which affects
approximately 10% of the population at any one time (Office for National Statistics, 2000)
andwhose predominant symptom is persistent lowmood (Hammen, 1997) or a lack of joy
(Peters, Nicolson, Berkhof, Delespaul, & de Vries, 2003). In this sense, major depression
might be considered an extreme extension of sadness, and indeed, both involve
overlapping brain regions (in both instances, negative mood state is associated with
decreased activity in right prefrontal cortex and increased activity in the subgenual
cingulate;Mayburg et al., 1999). Given our interest inmood, it is relevant to consider how
depression or other clinicalmood statesmight also relate to different colour qualities. Bubl
et al. (2010) looked at vision in (non-synaesthete) participants with major depression by
assessing their contrast gain. Contrast gain refers to the ability to differentiate objects from
their surroundings based on their luminance contrast; an example of high contrast, for
example, is the appearance of black letters on white paper. Bubl et al. (2010) evaluated
the ophthalmologic response of the retinawhenhealthy or depressedparticipants viewed
stimuli of differing contrasts. They found significantly lower retinal contrast gain in
depressed patients, suggesting that when people are depressed, they are less able to
perceive luminance contrasts in the visual world. The same researchers also showed that
people with depression had lower contrast discrimination performance in a behavioural
task (Bubl, Tebartz vanElst, Gondan, Ebert, &Greenlee, 2009). Finally, Carruthers,Morris,
Tarrier, and Whorwell (2010) found that people in certain clinical mood states are also
drawn to different types of colours in a systematic way. They asked healthy participants,
anxious participants and participants with depression to select their colour preferences
from a colour palette. Both depressed and anxious individuals were more drawn to the
achromatic end of the spectrum – particularly to the colour grey. This suggests that low
clinical mood states may relate not only to changes in luminance detection but also to
lower saturation (i.e., ‘chroma’) in colour preferences.
The review above has shown that mood states are systematically linked to colour in
three different populations: healthy individuals, clinical population (with depression or
anxiety) and synaesthetes. Healthy individuals associated negative emotional moods with
low saturation and luminance, both as children and adults. Depressed and anxious
individuals are drawn to low saturated colours, and the former experience poor contrast
sensitivity to luminance. Finally, synaesthetes who are specifically triggered by mood
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states as inducers experience lower saturated/ luminant colours for negative valence
words.
This study
Above we reviewed the role of mood/emotion in synaesthesia and in colour associations
more generally. In this study, we explore whether it can also play a role in variations in
synaesthetic colours, even for a type of synaesthesia not generally linked to emotional
qualities. Grapheme-colour synaesthesia is considered on the whole to be (1) consistent
over time; and (2) devoid of emotional influences (at least in the triggering of colour; see
also Callejas, Acosta, & Lupia~nez, 2007 and Hochel et al., 2009 for a discussion of how
synaesthetes might appraise the un/pleasantness of their synaesthesia, once triggered).
Here we ask whether changes in mood state can nonetheless influence grapheme-colour
synaesthesia, to bring about subtle changes in synaesthetic concurrent colours over time.
In Experiment 1, we examine day-to-day changes in mood in a non-clinicial population of
synaesthetes. In addition, since transient sadness and major depression recruit similar
brain regions and have similar impact on the association of colourwithmood,wewill also
consider the role of non-clinical depressive traits (Experiment 1) and clinical anxiety
disorder (Experiment 2). From our review of colour in clinical/non-clinical mood states
above, we predict that positive mood states may be associated with more luminant/
saturated colours, while negative mood states may associate with darker/ less saturated
colours. Given these strong predictors for saturation and luminance, we focus on these
two features in the current article, to the exclusion of hue (but we are considering the
impact on hue in other analyses for future publication).
EXPERIMENT 1
In the study below, we elicited synaesthetic colours for letters from a group of
grapheme-colour synaesthetes. Each synaesthete selected their colours from an on-screen
colour palette, and did so twice, separated by a period of approximately 3 weeks.
Participants were instructed to enter each session only when in a naturalistically different
mood: positive on one occasion and negative on another.We confirmed their mood levels
using mood questionnaires, and then compared their synaesthetic colours across the two
states of mood, in terms of changes in saturation and/or luminance. We used
questionnaires to evaluate both non-clinical mood state, and depressive traits. We
predicted that the positive mood state would be associated with higher saturation and




Participants were 24 native English-speaking grapheme-colour synaesthetes who expe-
rience coloured letters (mean age: 45.8 years, SD = 13.0; 21 females). Participants were
recruited from the Sussex-Edinburgh Database of Synaesthete Participants, and had
previously been verified as genuine cases using the ‘gold standard’measure of consistency
over time (e.g., Baron-Cohen et al., 1987). In this previous verification stage, participants
were given synaesthetic triggers as stimuli (in this case, a list of 26 letters) and were
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required toverbally report their synaesthetic colours.Theywere retestedwithoutwarning
after approximately 2 months, and their mean consistency score was 91.7% (SD = 12.6).
This performance was significantly higher than non-synaesthete controls (n = 40; from
Simner et al., 2006) who were only 36.2% consistent (SD = 13.8; t = 16.1, df = 62,
p < .001). Synaesthete participantswerepaid£20 for their involvement in ourmain study,
whichwas given ethical approval by the local ethics board at the University of Edinburgh.
Since their genuineness was established as part of other studies, this took place sometime
before this study – in some cases, several years earlier – and so would not have influenced
performance in the current task (in which synaesthetic colours are also elicited).
Materials
To remove geographical restrictions on testing, our experiment was generated via an
online testing platform, created using a survey builderwebsite. The experiment had three
components: a test of mood (the Positive and Negative Affect Schedule - Expanded form;
PANAS-X; Watson & Clark, 1999), a test of depressive traits (the Beck Depression
Inventory – II (BDI-II; Beck, Steer, & Brown, 1996) and a test to elicit synaesthetic colours.
These are described in brief below.
PANAS-X
This mood test requires the participant to read 60 emotive words, such as ‘distressed’ or
‘enthusiastic’. Participantswere asked to rate how relevant eachwordwas to their current
mood state on a 5-point scale, ranging from ‘not at all’ to ‘extremely’, with one rating per
word. For this study,we focussed on the PANAS-X positive and negative affect scales. Each
scale is made up of 10 emotive words (e.g., enthusiastic and distressed, for positive and
negative affect respectively).1 Stimuli were presented in an order stipulated by PANAS-X,
which ensures that words are well distributed and not clustered into emotion subgroups.
BDI-II
The BDI-II (Beck et al., 1996) is designed to determine the presence and level of
depressive symptoms. In this test, participantswere presentedwith 21 sets of statements,
each set comprising four sentenceswhich are similar but represent a decline inwell-being
from the first statement to the last. For example:
 I do not feel sad
 I feel sad much of the time
 I am sad all the time
 I am so sad and unhappy that I can’t stand it
Synaesthetic letter-colour test
In this sub-test, participants were presented with each letter, one at a time in a random
order, and were required to select their synaesthetic colour from an accompanying
1 The words within the PANAS-X are also further divided into additional subgroups: four negative (fear, hostility, guilt, sadness)
three positive (joviality, self-assurance, attentiveness) and four neutral (shyness, fatigue, serenity, surprise). However, given
the small number of words in each sub-group, and our relatively small sample size, we do not consider these subgroupings for this
study.
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electronic colour palette. This palette showed colour graduations within a square frame,
where hue changes horizontally, and saturation changes vertically. Participants can select
a colour by clicking anywhere in the frame. Luminance was manipulated by a separate
‘luminance bar’ placed vertically to the right of thepalette,which could bedraggedup and
down using the mouse. The selected colour is displayed in a separate display below the
palette, and encoded numerically to quantify its hue, saturation and luminance.
Procedure
Participants were informed they would be taking part in an online study which theywere
to complete by visiting our website twice (i.e., at two separate times). Participants were
asked to log onto thewebsite to takepart in Session1, but inparticular, onlywhen they felt
in a specific mood state. Half the participants were asked to take part in the first session
when they felt in a positive mood and the other half when they felt in a negative mood.
This is the first time a mood manipulation of this type has been used when testing
synaesthetes. The participants were informed that the test would take approximately an
hour for each session, and that they were to complete all elements of the test during each
session. This was to ensure we had their colour responses for a given session time-linked
to their mood/depressive responses.
The first page of the survey informed participants of their ethical rights. Participants
then consented with a check box and provided their name, date of birth and date of
completing the survey before proceeding to the study. Participants first completed the
PANAS-X, then the BDI-II, then the colour palette test. The palette was accessed using a
link to an accompanying webpage. Participants selected their colours for letters and
transferred the numeric codes into the main survey screen. After this test was
completed, the session ended. Participants were contacted 3 days later with the link to
the second survey, asking them to be in the alternative mood state when entering it.
Therefore, those who had completed the first survey in a positive mood were asked to be
a negative mood, and those who had completed the first survey in a negative mood were
asked to complete the second survey in a positive mood. The second survey was
identical to the first survey.
Although the participantswere not explicitly informed thatmoodwas the factor under
investigation, they were asked to be in a particular mood state to complete each test.
During debriefing, participants reported they found this instruction straight-forward, and
we took this approach to profit from natural variances in mood states (rather than to
attempt to vary mood states artificially within the test itself – see discussion). On average,
participants’ two testing sessions were separated by 23.3 days (SD = 14.0).
Results
Coding
Each test was coded prior to data analysis as follows.
PANAS-X
Responses to each word (e.g., distressed) are coded 1 to 5, from ‘not at all’ and 5 to
‘extremely’. Our analyses are based on the positive and negative affect scales, each of
which contains 10 words. The score for each scale is calculated as the mean score across
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the words in each list, giving amaximumpossible score of 5.0 (with 1.0 as theminimum).
For example, a participant might achieve a total of 32 points by summing each Likert
response across the 10 words in the positive affect scale. Their mean final score for this
scale would therefore be 3.2.
BDI-II
The BDI-II is scored by first coding each answer according to the level of response: each
level is given a score of 0–3, with 0 being the neutral statement and 3 being the most
negative statement. The final score is generated by adding these sub-scores scores
together to get overall depression score, with a maximum possible score of 63 (with 0 as
the minimum).
Synaesthetic colour letter test
The participants’ colour choices generated a unique 6-digit alphanumeric code, which
represents its hue, saturation and luminance levels. The values for luminance were
averaged across all 26 letters, for each subject, and the same process was also used for
saturation data.
In our analyses below, we first examine whether we successfully manipulated mood
across our two sessions and then examine the influence of mood on synaesthetic colours,
first by luminance and then saturation. Prior to all analyses, we first checked the
distribution of data using a Kolmogov-Smirnov test, and used parametric and non-para-
metric analyses as required.
Analyses
Did we successfully manipulate mood?
We compared mean scores for negative affect and then positive affect across our two
conditions: Requested positive mood condition versus Requested negative mood
condition. Distribution curves show that negative but not positive affect scores were
non-normally distributed and so we use a Wilcoxon signed rank test and a paired sample
t-test, respectively. Table 1 shows that, as anticipated, the Requested negative mood
condition generated higher negative affect scores than the Requested Positive mood
condition (Z = 3.8; p < .001), as well as lower positive affect scores (t = 9.4, df = 23,
p < .001), and higher BDI-II depression scores (Z = 4.7; p < .001).
Since scores indicate participants were in the appropriate mood states within each
testing condition, we assume henceforth that differences across conditions in synaes-
thetic colour reflect changes in mood. (We therefore also henceforth refer to our
Table 1. Mean scores across testing conditions in negative/positive affect (from the PANAS-X test) and
in depressive traits (from theBDI-II test). Therewere two testing conditions: participantswere instructed
to take part when their mood was either low (requested negative mood condition) or high (requested
positive mood condition). BDI-II depression scores are ‘Minimal’ below 14, and ‘Mild’ at 14–19
Requested negative mood condition Requested positive mood condition
Mean negative affect 2.1 1.3
Mean positive affect 2.2 3.3
BDI-II 15.7 5.0
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Requested positive/negative mood conditions as simply our Positive/Negative mood
conditions).
Does mood influence synaesthetic colours?
Below we examine the synaesthetic colour chosen by participants in each mood
condition, first by saturation data then by luminance data. The mean saturation of
synaesthetic colours was 161.6 in the Positive mood condition (SD = 28.1) and 159.6 in
the Negative mood condition (SD = 30.1), showing no significant difference (t = .46,
df = 23, p = .7). However, the mean luminance of synaesthetic colours was 131.5 in the
Positive mood condition (SD = 21.4) and 127.4 in the Negative mood condition
(SD = 20.8; see Figure 1), and this difference was significant (t = 2.4, df = 23,
p = .0248; see Figure 1).
What element of mood causes changes in synaesthetic colours?
Having established that changes in synaesthetes’ moods affect their synaesthetic colours,
we sought to explore what elements of mood were responsible: positive affect, negative
affect, or depressive traits. For this we ran a simultaneous entry multiple regression
analysis using all three as predictor variables, with luminance as the outcome variable in
one model, and saturation in another. Our predictor and outcome variables were each
calculated for each subject as the mean across both their testing sessions. We point out
that our sample size is small for regression modelling and so our conclusions here are
presented as tentative.
Despite our group effect above, there was no significant model relating mood/
depression scores as predictors for our luminance data (F = 1.1, df = 2,p = .4). However,
for our saturation data, we found a near-significant model (F = 2.6, df = 2, p = .08).
Figure 1. Mean luminance of synaesthetic colours from grapheme-colour synaesthetes in positive
versus negative mood. The lower and upper box limits first and third quartiles, and bars delimiting lowest
and highest values.
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Within this model, only one predictor approached significance, and this was depression
scores from the BDI-II (ß = .60, t = 1.8, p = .08) which was negatively related to the
saturation of the synaesthetic colour. In other words, as depressive tendencies increase,
the synaesthesia’s saturation tended to decrease. We illustrate this relationship in the
scatterplot shown (see Figure 2) with best-fit line shown.
Discussion
Our study has shown that the synaesthetic colour experiences of grapheme-colour
synaesthetes are influenced by theirmood.We requested that participants completed our
tests in two different mood states, and confirmed those mood states with mood
questionnaires. We found that participants reported significantly less luminant synaes-
thetic colours in the negative mood state compared with the positive mood state.We also
found a suggestion that the saturation of synaesthetic colours might be influenced by
depressive traits: there was a trend towards lower saturation when depressive traits were
higher. In the study below,we extend this finding to a clinical mood disorder, andwe also
address a methodological concern arising from Experiment 1.
EXPERIMENT 2
Therewas amethodological concern arising from Experiment 1, whichwe aim to address
in a second study here. Our concern is to verify that we did not induce strategic effects in
our first study simply by having asked participants to be in a particular mood. Ourmethod













Figure 2. Scatterplot showing a near significant (p = .08) inverse correlation between the depressive
traits of grapheme-colour synaesthetes, and the saturation of their synaesthetic colours.Depressive traits
are scored on the Beck Depression Inventory – II. The graph also shows the best-fit line and 95%
confidence interval surrounding it.
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also may have alerted our participants to the nature of our investigation. In the study
below, therefore, we test the effect of mood without drawing attention to this feature. In
Experiment 2, we screened a large random sample of the population to identify the
synaesthetes among them, and we also had participants fill out a health questionnaire.
Embedded in the questionnaire was an option to indicate whether the participant was
suffering from anxiety disorder. Anxiety disorder is a condition in which sufferers
experience generalised worry and anxiety, not (necessarily) connected to recent events.
Commonly regarded as belonging to a spectrum of mood related disorders, symptoms
include feelings of threat, irritability and tension (Tyrer & Baldwin, 2006). In this studywe
will investigate whether synaesthetic colours are systematically different (e.g., less
luminant) for those with (vs. without) anxiety disorder.
Methodology
Participants
Our participants were 34 English-speaking grapheme-colour synaesthetes (mean
age = 21.9, SD = 5.8, 20 females), six of whom had (self-reported) anxiety disorder
(mean age: 20.8, SD: 2.8; 3 females) and the remaining 28 reported did not (mean age:
22.1 years, SD = 6.3; 17 females). Participants were recruited via a large-scale screening
of 2847members of the general population (mean age: 28.4, SD = 14.3; 1530 female) for
grapheme-colour synaesthesia (see Carmichael, Down, Shillcock, Eagleman, & Simner,
2014 for further information). Our subjects were verified as synaesthetes using the
objective test described below.
Materials and procedure
Our procedure allowed us to identify a group of randomly sampled synaesthetes, tested
objectively, and also to verifywhich of those synaesthetes had anxiety disorder andwhich
did not. Our procedure also allowed us to determine our synaesthetes’ grapheme-colours,
so thatwecould then compare these across individualswith andwithout anxiety disorder.
All 2847 participants (including the 34 synaesthetes that would ultimately be found
among them) were sent to an online testing website where they completed a 2-stage test.
The first stage was a health questionnaire in which participants indicated (inter alia)
whether they did, or did not suffer from anxiety disorder. This health questionnaire listed
24 conditions in total (e.g., anxiety disorder, asthma, migraine) meaning that our focus of
interest was sufficiently hidden.
The second stage of testing was a short questionnaire which described grapheme-
colour synaesthesia and asked whether participants thought they might experience this.
For those who responded in the affirmative, an objective test followed. As in Experiment
1, this objective test for synaesthesia was based on consistency-over-time as the
behavioural hallmark of synaesthesia. Also as stated earlier, synaesthetes were identified
as those who were significantly more consistent than non-synaesthete controls. Our
consistency test was this time performed via the online diagnostic site synesthete.org (see
Eagleman, Kagan, Nelson, Sagaram, & Sarma, 2007 for methods, also Carmichael et al.,
2014). This site not only verifies synaesthesia, but also gathers synaesthetic colours in a
way that can later be analysed according to saturation and luminance values. In this
battery, graphemes were presented three times each in a randomised order and
participants were required to select their synaesthetic colour for each grapheme from a
palette of 256 9 256 9 256 colours (see Eagleman et al., 2007 for details of this
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interface). In this battery, themean colour distance across the three presentations of each
grapheme is converted to a standardized score, where a score less than 1 represents a
distance small enough to indicate synaesthetic status (see Eagleman et al., 2007 for
details). All 34 synaesthetes achieved this required score of less than one.
Results
In our analyses we compared the grapheme colours of synaesthetes with and without
anxiety disorder. The output of the online testing site was the colours of graphemes
encoded as RGB (red, green, blue) vector values. We first converted these values to their
corresponding hue, saturation and luminance. We then averaged the luminance of all
graphemes for each subject across all their responses (maximally, this was a mean across
all three presentations of each letter a–z and each digit 0–9, although participants were
free to omit graphemes that had no synaesthetic colour). We then repeated this for the
saturation values, and finally compared both these types of means across participant
groups. The saturation of synaesthetic colours was not significantly different for
synaesthetes with anxiety disorder (M = 209.4, SD = 12.6) compared to those without
(M = 191.0, SD = 35.9; t = 1.2, df = 32, p = .2). However, synaesthetes with anxiety
disorder had significantly darker (i.e, less luminant) colours (M = 102.3, SD = 21.5) than
those without anxiety disorder (M = 121.9, SD = 20.4; t = 2.1, df = 32, p = .04). This
effect is illustrated in Figure 3.
Discussion
Our study has shown that the synaesthetic colour experiences of grapheme-colour
synaesthetes are different for those with and without anxiety disorder. Those
Figure 3. Mean luminance of synaesthetic colours from grapheme-colour synaesthetes with and
without anxiety disorder (shown as Syn + anxiety and Syn  anxiety, respectively). The lower and upper
box limits first and third quartiles, and bars delimiting lowest and highest values. Outliers are shown as
cases marked ‘q’.
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self-reporting this condition had significantly darker synaesthetic colours (i.e., lower in
luminance). We discuss the implications of our findings across both studies below.
GENERAL DISCUSSION
In our studies,we elicited synaesthetic colours for letters fromgroups of grapheme-colour
synaesthetes, using an on-screen colour palette and converting colour selections into
numeric values for hue, saturation, and luminance. In Experiment 1, synaesthetes selected
their colours twice, separated by a period of several weeks, and were instructed to enter
each session in a naturalistically different mood: positive on one occasion and negative on
another. In each session we confirmed their mood state using the PANAS-X (Watson &
Clark, 1999) and the BDI-II (Beck et al., 1996) which quantify both non-clinical mood
states and also depressive traits. Our questionnaire data confirmed that participants were
in a significantly more positive mood when this had been requested of them. We then
compared our participants’ synaesthetic colours across the two (positive vs. negative)
mood states in terms of changes in saturation and luminance. We found that synaesthetic
colours in the negative mood state were on average significantly less luminant than in the
positive mood state. A second, more speculative multiple regression analysis looked at
which features of mood might influence colour changes: positive affect, negative affect
(PANAS-X subscales thereof), and depressive traits (from the BDI-II scale). This analysis
suggested that saturation might also be influenced by depressive traits: there was a trend
towards lower saturation when depressive traits were higher. However, given that this
latter trend failed to reach significance at the conventional alpha level, we will not
consider it further here.
In Experiment 2 we extended this finding with another group of grapheme-colour
synaesthetes. We showed that mood can alter synaesthetic colours not only when it
fluctuates in non-clinical everyday life (Experiment 1), but also when it alters more
dramatically, in anxiety disorder (Experiment 2). We showed that synaesthetes with
self-reported anxiety disorder experience significantly darker synaesthetic colours
compared to synaesthetes not suffering from anxiety disorder. Second, we addressed a
methodological limitation from Experiment 1, where our request for participants to take
part in a givenmood statemay have alerted them to the aims of our study. In Experiment 2,
the aims of our study were sufficiently hidden by asking about mood (i.e., anxiety
disorder) among 23 othermedical conditions. In evaluating our findings,we first point out
that the colour changes that arose with mood/anxiety were not large: hence our
synaesthetes were still highly consistent over time, and significantly more consistent than
controls. Similarly in Experiment 1, colours for letters were overall still very similar across
the two testing sessions: their mean luminance changed by only 2 percentage points (i.e.,
4.0/255) and their mean saturation by only 0.8 percentage points (i.e., 2.0/255). Hence
although synaesthetic colours are influenced by mood states, they shift only marginally
when mood varies within a normal (i.e., non-clinical range). Nonetheless, these
differences were larger in Experiment 2, where the mood manipulation was more
extreme: the colours of synaesthetes reporting anxiety disorder were more than 7
percentage points (19.6/255) darker in luminance. In both experiments, these differences
were systematic and statistically significant, but the more extreme mood change caused
the more extreme difference in synaesthetic colour.
We point out that our findings fit with prior literature relating mood to colour in both
the general non-synaesthetic population, and in clinical non-synaesthetic populations.We
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saw above that healthy adults and children associate negative emotional moods with low
saturation and luminance (Boyatzis & Varghese, 1994; Hemphill, 1996; Manav, 2007) and
that depressed and anxious individuals are drawn to low saturated colours (Carruthers
et al., 2010). Our own findings reflect the same direction of effects in synaesthetic
colours. Our findings also fit with one previous study showing that an emotionally
mediated synaesthete experienced darker and less saturated colours from negatively
valent words (Ward, 2004). In all cases therefore, negative mood states were linked with
low luminance and/or saturation of colours. If we assume that our findings reflect similar
mood changes in grapheme-colour synaesthesia, what might be at the root of these
changes?One possibility is thatmoodmay be influencing synaesthetic colours via arousal.
Another possibility is that changes in synaesthetic colour by mood are mediated by
attention. It is known that attention broadens in positive mood states (Compton, 2003;
Wadlinger & Isaacowitz, 2006) so may indirectly influence synaesthesia simply because
attention on the inducer is in someway heightened. Rich andMattingley (2013) provide a
comprehensive review of how attention influences synaesthetic colours, and one
intriguing fact from our own data may speak to this issue: the PANAS has a subscale of
attention (comprising the itemsAlert;Attentive;Concentrating;Determined). Apost-hoc
correlation between luminance and attention reveals a near significant r value (r = 0.22,
p = 0.06). This seems to suggest that one aspect ofmood linked to changes in synaesthetic
colour may indeed be attentiveness.2 Nonetheless, this result is just a trend based only on
four items, and so we leave it to future studies to explore the link between attention and
synaesthetic colour variation in more detail.
We might also consider our findings in terms of the neurological bases for mood, and
also for synaesthesia. Mood and emotional processing has been localised to a number of
regions, most particularly the limbic system, including the hippocampus, septal nuclei,
amygdala, cingulate gyrus, mammillary bodies and hypothalamus (for review see Martin,
2006). The amygdala has been particularly implicated in processing the emotional
importance of stimuli, for example, in behavioural and cognitive response to stimuli that
induce fear (Adolphs, Tranel, Damasio, & Damasio, 1995; Davis, 1992). However, the
amygdala is also believed to be important for perception and attention (Anderson &
Phelps, 2001; Williams, McGlone, Abbott, & Mattingley, 2005). For example, Young,
Scannell, Burns, and Blakemore (1994) found that the amygdala has connections to
numerous cortical regions, including sensory regions. It is possible therefore that
differences in emotional processing induced by mood changes have direct influences on
visual, and other perceptual functions. Alternatively, we might consider instead one area
in particular in visual cortex, V4, which has been directly implicated in synaesthetic
colours (e.g., Hubbard, Arman, Ramachandran, & Boynton, 2005), but has also been
linked to the feature of contrast gain (Gardner et al., 2005). We saw above that contrast
gain is altered in depressive mood states (Bubl et al., 2009, 2010). It may be possible
therefore, that the same mood-linked processes that alter contrast gain may have
simultaneous effects on synaesthetic colour-selective regions in the brains of synaes-
thetes.
Following the completion of our own study, a related article has very recently
appeared in press which is strongly compatible with our own (Dael, Sierro, & Mohr,
2014). These authors, like us, have questioned the role of mood, emotion and affect in
2We did not conduct further analyses of PANAS subscales because we had no other a priori assumptions, and therefore chose to
avoid the corrections required by multiple comparisons, given also our small sample size.
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synaesthesia. Their article is an interesting opinion piece hypothesising that emotion
might hold sway in synaesthesia not only as an inducer or concurrent, but also as ‘neither
the inducer nor the direct concurrent, but a moderator or mediator of the synesthetic
coupling’ (Dael et al., 2014). We suggest that our own study now offers precisely the
empirical data to support this speculation. Our results show empirically that mood can
indeedmediate the synaesthetic experience, andwepoint the reader toDael et al. (2014)
for an excellent and comprehensive reviewofmood and emotion in both synaesthetic and
non-synaesthetic perception.
In evaluating our studywewould like to present two possible alternative explanations
of our findings, and evaluate these alternatives in the light of the data at hand. One key
finding to consider when interpreting our study is that prior research has shown mood
changes can influence perception itself (e.g., Bubl et al., 2009, 2010). Given this, an
alternative interpretation of our data might be that people with synaesthesia in fact have
rigidly consistent synaesthetic colours, but that mood changes alter their ability to
indicate those colours via our task. In otherwords, it may be that their interfacewith our
colour wheel was compromised by changes in real-world perception, but their
synaesthesia itself remained unchanged. A closer inspection of the direction of our data
appears to speak against this possibility, and we explain this below.
Bubl et al. (2009, 2010) found that individuals with depression had lower contrast
sensitivity, and although it is difficult to interpret this directly in terms of absolute
luminance perception, it may be that this represents a shift towards under-perceiving
lightness (i.e., perceiving lightness as being less light). This would certainly follow from
decision studies linking negative mood states with lower luminance (e.g., Boyatzis &
Varghese, 1994; Hemphill, 1996; Manav, 2007; see above). Furthermore, depressed
individuals do indeed explicitly report that light appears dimmer (Friberg & Borrero,
2000), and perceptual judgements of brightness are lessened following negative (vs.
positive) affect judgements (Meier, Robinson, Crawford, & Ahlvers, 2007). If we extend
this conclusion to this study,wemight thenwish to askwhether our findings could simply
be explained as our participants perceiving our screen colours as less brightwhen in a bad
mood. If so, our findings would be unrelated to changes in synaesthesia at all. However,
the direction of our findings argues against this, because we in fact found the opposite
effect: selected colours were lower in luminance, but should have been higher if the
screen simply appeared darker in a perceptual sense. In other words, if perception
rendered the screenperceptually darker, subjects should have selected higher (not lower)
levels of luminance in order to compensate. They did not: luminance fell in the negative
mood state suggesting this represented an accurate selection of an altered internal colour,
rather than an impaired real-world selection of an unchanged internal colour.
A second alternative interpretation of our findings is that ourmood caused changes not
in synaesthetic colour, but in participants’ positioning of the curser on our electronic
palette. An anonymous reviewer has pointed out that luminance in both studies was
manipulated vertically with lightness at the top. This leaves open the possibility that poor
mood state did not affect luminance, but that instead it affected the height selected on the
screen (via English spatial metaphors related to mood such as: ‘I feel down today’). We
investigated this possibility and found itwas not the case. From the samen = 2847 sample
of Experiment 2, we examined the data of all subjects who attempted our test for
synaesthesia but were ultimately not synaesthetes. Remembering that synaesthetes are
those with a standardized score in our objective consistency test of <1 (see Methods), we
now selected as a group of non-synaesthete controls all those who scored >2. By
coincidence, this group had the same make-up as our synaesthetes (n = 34, of whom six
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had anxiety disorder). These controls completed the identical task as synaesthetes, under
exactly the same testing conditions, with exactly the same instructions, and all were
recruited by exactly the same method. If anxiety/ negative mood state causes people to
place the cursor lower on our electronic palette wewould expect again to find that those
with anxiety disorder selected colours with a lower luminance. They do not: people both
with and without anxiety disorder placed the cursor at the same height (i.e., they choose
the same luminance) as each other. The mean luminance for those with and without
anxiety disorder was 110.2 [SD = 24.0] and 107.3 [SD = 12.8] respectively (t = 0.27,
df = 5.51, p = 0.8). Hence only for those with synaesthesia, does anxiety disorder lead to
lower luminant (synaesthetic) colours.
In conclusion, we have found that mood states influence concurrent colours in
grapheme-colour synaesthesia, and that negative states in particular give rise to colours
that are lower in luminance, either as part of everyday non-clinical fluctuations in mood
(Experiment 1), or as part of more extreme fluctuations of the type found in anxiety
disorder (Experiment 2). We also found a trend to suggest that higher depressive traits
within the non-clinical range may give rise to lower saturated synaesthetic colours. These
results have implications for research into synaesthesia not only because they provide
novel information about how mood alters internal perceptions, but because they
challenge the traditionally held view that adult synaesthetic colours are consistent over
time. We invite future researchers to explore further when and how synaesthetic colours
might vary over time, as a key to better understanding the limits of this unusual condition.
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Is synaesthesia a dominantly female trait?
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Synaesthesia is a familial condition that gives rise to unusual secondary percepts. We present a large-scale
prevalence study which informs our ideas on whether the condition is more prevalent in men or women. A
number of studies over the last 20 years have suggested the condition is found more commonly in women, with
up to six times more female synaesthetes than male. Other studies attributed this female bias to merely a
recruitment confound: women synaesthetes may be more likely to self-refer for study. We offer two pieces of
evidence that there is no extreme female bias in synaesthesia: first we re-analyse previous reports of very large
female biases to show again that they likely arose from self-referral or other methodological issues. Second, we
present the largest published prevalence study to date on grapheme→colour synaesthesia in which our prevalence
(1.39% of the population) replicates our earlier estimates (and in which we demonstrate no strong female bias
even with sufficient power to detect such a difference.
Keywords: Synaesthesia; Prevalence; Sex ratio; Synesthesia.
For people with synaesthesia, stimuli are experienced
with unusual secondary associations (e.g., hearing
sound triggers colours in the visual field; Ward,
Huckstep & Tsakanikos, 2006). Synaesthesia is a
multi-variant condition with an estimated 65 (Day,
2005) to 150 (Cytowic & Eagleman, 2009) known
sub-types, depending on which modalities are linked
(e.g., sound triggering colours, taste triggering touch
etc.). One key question is how common synaesthesia
is, and whether it affects men and women differently.
Early estimates described the condition as extremely
rare (e.g., 1 in 250,000) and very strongly female
dominant (with a 6:1 ratio; Baron-Cohen, Burt,
Smith-Laittan, Harrison & Bolton, 1996). Later
studies have called into question both these claims
and we examine these issues in the current paper.
Despite a relatively contentious history, the
question of synaesthesia’s prevalence appears to
now be reasonably well understood. Early estimates
of prevalence varied widely at least partly because
researchers were focussing on different sub-types or
using different definitional criteria (Ramachandran &
Hubbard, 2001). However, even in studies that aimed
to report the prevalence of all forms of synaesthesia,
estimates ranged from 1 in 4 (Calkins, 1895; Domino,
1989; Uhlich, 1957), to 1 in 10 (Rose, 1909), 1 in 20
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(Galton, 1883), 1 in 200 (Ramachandran & Hubbard,
2001), 1 in 2000 (Baron-Cohen et al., 1996), and 1 in
25,000–100,000 (Cytowic, 1993, 1997). One problem
was that many of these early estimates were
essentially ‘best guesses’. Nonetheless, these early
studies served the important purpose of stimulating
research on synaesthesia’s prevalence and inspired the
first empirical assessments which followed thereafter.
The first prevalence study of its kind in the modern
literature (Baron-Cohen et al., 1996) assessed the
occurrence of synaesthesia by placing adverts in two
local newspapers in Cambridge, UK, calling for
synaesthetes to come forward. The advert described
several types of synaesthesia (sound [including ling-
uistic sounds]→colour, touch/taste/smell→vision/
sound) and identified two types of synaesthesia in
respondents, now known commonly as grapheme-
colour synaesthesia (experiencing colours from letters
and/or digits) and music-colour synaesthesia
(experiencing colours from sounds such as music). By
comparing the number of synaesthetes who came
forward (and who were subsequently verified as
genuine using an objective test; see below) against the
circulation figures of the newspapers, Baron-Cohen and
colleagues concluded that synaesthesia was at least as
common as 1 in 2000 people (i.e., 0.05%). However,
their methods would have greatly underestimated the
true prevalence because they relied on synaesthetes
making the effort to come forward in response to a
newspaper advert. For this reason the authors of that
study were careful to point out that their figure was only
a lower estimate, although their data has almost always
been misrepresented in the following literature as an
absolute estimate. A small number of studies in the
historical literature had avoided the problems of self-
referral by individually questioning every member of a
participant pool, although they established prevalence
only subjectively (at 6.7–23.0%: Calkins, 1895;
Domino, 1989; Rose, 1909; Uhlich, 1957) by relying
on self-declaration only, which is an approach known to
over-estimate prevalence (Simner et al., 2006). Hence,
one set of studies tends towards a conservative estimate
and the others towards an overly-liberal one.
Our own study in 2006 addressed these limitations
by individually assessing a large number of people
(n = 16901) and verifying their self-declarations with
an objective test of genuineness (see below). These
improvements in methodology showed the condition
to be far more common than previously thought,
affecting 1 in 23 members of the general population
across the relatively wide range of synaesthesias
tested (Simner et al., 2006). The important element
in this study was that synaesthetes were not required
to make the effort to self-refer in response to an
advert. Instead, a large sample of the general
population was individually assessed to find the
synaesthetes from among them, and this gave a
prevalence of 4.4% of synaesthetes within the
general population, for the variants tested. Within
this figure, one particularly common form was
grapheme-colour synaesthesia, in which colours are
triggered by letters and/or digits (e.g., A might trigger
the experience of red, B yellow, and so on). The
prevalence of grapheme-colour synaesthesia was 2%
(counting those with coloured letters and/or digits; or
1.1–1.4% for those with both coloured letters and
digits). Since the time of this study, these estimates
for the prevalence of different forms of synaesthesia
have been widely accepted (e.g., Banissy et al., 2012;
Bor, Rothen, Schwartzman, Clayton & Seth, 2014;
Cohen Kadosh & Henik, 2007; Ward, 2013; Weiss
& Fink, 2009).
In contrast to prevalence estimates, the sex ratio of
female to male synaesthetes has caused perhaps greater
controversy. Several early studies proposed that there
was a very strong female bias in synaesthesia,
suggesting a possible X-linked dominant mode of
inheritance (e.g., Baron-Cohen et al., 1996; Smilek
et al., 2002). Indeed, the extent of this female bias in
some studies (e.g. 6:1; Baron-Cohen et al., 1996) led
researchers to believe that the trait may even be
associated with male lethality in utero (Bailey &
Johnson, 1997; Baron-Cohen et al., 1996). This
would in turn suggest that synaesthetes’ families
should contain more women than men. However,
both these claims were subsequently challenged by
later studies, and we describe this development below.
Until 2006, the most commonly cited synaesthesia
study on prevalence and sex-ratios (Baron-Cohen
et al., 1996) proposed a female: male ratio of 5.5:1,
and this was followed by a second study (Rich,
Bradshaw & Mattingley, 2005) proposing a female
bias of 6.2:1. However, both studies based their
estimates on the number of synaesthete who self-
referred in response to media advertisements (e.g.,
newspaper adverts). Not only will this method
underestimate the total number of synaesthetes in a
population (see above) but it is also likely to over-
estimate the females. This is because females are
known to be more likely than males to come
forward to report atypical experiences, and this is
1Specifically, 1190 individuals were assessed for grapheme-
colour synaesthesia, and a further 500 individuals were tested for
162 different synaesthesias, one also being grapheme-colour
synaesthesia. Since the estimates of prevalence for grapheme-
colour synaesthesia were approximately equivalent across both
populations, Simner et al. (2006) collapsed both population sizes
to give a grand total of 1690 people tested.



































seen across a range of domains (e.g., Dindia & Allen,
1992). Simner et al. (2006) therefore suggested that a
self-referral confound may be responsible for the
previously high rates of female synaesthetes in
prevalence studies. Indeed, when this potential
confound was directly avoided by Simner et al.
(2006), we found that earlier studies had indeed
apparently over-inflated the proportion of females.
As noted above, Simner et al. (2006) specifically did
not rely on self-referred recruitment in their
prevalence estimate, but instead, they individually
assessed every member of a large participant pool
and used an objective test to identify the
synaesthetes from among them. Using this improved
methodology we found that that there was no large
(e.g., 6:1) bias towards female synaesthetes. Instead,
we found a female: male ratio of 1.1:1 when
considering a wide range of synaesthesias in a
population of n = 500, and a female: male ratio of
0.9:1 when considering grapheme-colour
synaesthesia2 in a population of 1190. Neither of
these comparisons showed any significant sex bias.
On the basis of the above literature we might
conclude that synaesthesia affects around 1 in 23
individuals and has no very strong sex bias.
However, there have been three subsequent
challenges to our position. First, a small number of
studies continue to cite the prevalence and/or sex ratio
from Baron-Cohen et al. (1996) despite the self-
referral confound, and this has propagated in the
literature a low value of prevalence and a high
estimate of female synaesthetes. Second, one
subsequent study (Barnett, Newell, Finucane, Asher,
Corvin, Mitchell, 2008) has pointed out that the sex
differences identified in self-referral more generally
(Dindia & Allen, 1992) only account for a slight
variation (10%) in men and women’s responding,
making it possible that very high early estimates for
female synaesthetes were at least pointing in the right
direction. Third, that same study (Barnett et al., 2008)
presented data that were ostensibly free from the self-
referral confound, but which continued to show a
strong (6:1) ratio of female to male synaesthetes.
For these three reasons we return to the issue of sex
differences in synaesthesia in the current paper. The
position we take is to re-affirm that there is no strong
6:1 ratio of female to male synaesthetes when all self-
referral confounds are removed. We do this below by
presenting our own very large-scale study free of self-
referral, but before then, we also re-evaluate the
findings by Barnett et al. (2008). Their findings had
been reported as evidence of a strong (6:1) ratio of
female to male synaesthetes in data that were
presented as being apparently free from the self-
referral confounds. We re-evaluate this claim below.
Barnett and colleagues conducted a synaesthesia
study of the mode of inheritance, and prevalence of
synaesthesic sub-types within families. In their study
they looked not only at self-referred probands (i.e., 53
synaesthetes who self-referred to the university in
response to a media advert) but also a subset of
their family members who were questioned by the
proband and/or directly contacted by the researchers.
Since family members were tested as well as self-
referred probands, Barnett et al. claim their findings
are free of a self-referral confound, and they report
that “our total sample of 92 confirmed and
unconfirmed synaesthetes includes 78 females and
14 males, yielding a female to male ratio of 6:1 in
the Irish population” (pg. 877). Below we present
several responses to these claims.
First, in their calculations of the female: male ratio,
Barnett et al. appear to directly compare their 78
female synaesthetes against their 14 male
synaesthetes, concluding that a female: male ratio in
synaesthesia of 6:1 exists in the general population
(more precisely this would be: 78/14:
14/14 = 5.57:1).
However, Barnett et al. evaluated twice as many
females than males (118 vs. 61) if we include all 179
participants whose status was somehow appraised
during their study (i.e., excluding all those with an
unknown status). This factor would considerably
reduce the absolute proportion of female synaesthetes
to males in their estimate for the general population.
A second consideration comes in the claim that
Barnett et al.’s findings were not contaminated by a
self-referral bias, because they looked not only at self-
referred probands but also their families. However,
according to our reading of their report, Barnett and
colleagues were able to objectively verify the
synaesthesia of all their self-referred probands, but
only a small portion of their non-proband
synaesthetes. Indeed, 81 of their 92 synesthetes
overall were either objectively unconfirmed cases
(n = 28), or they self-referred in response to an
advert (n = 53) and were therefore likely to be a
priori female-skewed. Equally, when Barnett et al.
state there was “no difference… between the sex
ratio for probands (46 females and 7 males) and …
relatives who did not contact us directly (30 females
and 5 males)”, we point out that almost 70% of these
synaesthete relatives appear to have received no
objective test for synaesthesia. As such, almost
every member of their cohort were either
2This particular reported figure related to grapheme-colour
synaesthetes who experience both coloured letters and digits
(rather than coloured letters and/or digits).



































self-referred, or were not verified as synaesthetes by
the usual objective standard.
Finally, Barnett et al. (2008) report that 17 families
were fully explored as far as all first-degree relatives of
the proband and this still gave a “6:1” (pg 885) ratio of
female tomale synaesthetes (i.e., 45 female synaesthetes
and 8 male synaesthetes found within these 17 families).
We point out, as above, that 45 female vs. 8 male
synaesthetes cannot be interpreted as 6:1 prevalence in
the general population without first knowing the sex of
each family member tested in those 17 families as a
whole which was not provided. We also point out that
one third of the synaesthetes discovered within those 17
families (i.e., 17 of the 53 synaesthetes discovered)
would have been contaminated by a self-referral
confound that strongly skews towards females,
because these families centred around 17 synaesthete
probands, who self-referred for study. Importantly, 87%
of all (n = 53) probands were female, meaning that
approximately 87% of the 17 probands in the target
families would be females, from what we know is a
skewed sampling method. In summary, target families
were not selected in a way to be free of an a priori
recruitment confound because all contained a proband
recruited by self-referral (see alsoWard & Simner, 2005
for a similar problem). Finally, we point out, as above,
that approximately half of the 53 synaesthetes within the
17 target families did not receive an objective test (of
consistency) for synaesthesia.
In summary, we conclude that the 6:1 ratio towards
female synaesthetes found by Barnett et al. (2008) did not
take into account the total number of females categorised
overall, or a priori confounds in the recruitment of self-
referred synaesthetes, and it did not categorise
synaesthetes with objective testing throughout. For
these reason we conclude that their 6:1 bias towards
female synaesthetes was affected, at least to some
degree, by self-referral methodology or other issues.
(Nonetheless, we point out that the study by Barnett
and colleagues provided much robust data on a number
of other epidemiological and cognitive factors within
synaesthesia—e.g., transmission of different variants
within families, trends in synaesthetic colours. etc.—
and it therefore represents a valuable step towards
understanding how synaesthesia might manifest itself,
beyond this sex issue.) Below we test whether there is a
6:1 female bias empirically when self-referral is removed,
but we first conduct a power analysis to confirm the
numbers that would need to be tested in order to
determine whether such a difference were statistically
significant. This is important because previous
epidemiological studies of synaesthesia aiming to
remove the self-referral confound (e.g., Simner,
Harrold, Creed, Monro & Foulkes, 2009; Simner et al.,
2006) have tested too few people to provide sufficient
power for a statistical comparison of the sexes.
POWER ANALYSIS
The female bias in synaesthesia estimated by Baron-
Cohen et al. (1996) was 5.5:1, and by Rich et al.
(2005) it was 6.2:1, and by Barnett et al. (2008) it
was 5.6:1. These values, repeatedly circling around a
6:1 ratio of female to male synaesthetes, can be tested
empirically if there is sufficient power in the number
of individuals tested. In order to calculate this we first
need to estimate what the individual prevalences of
synaesthesia would be for males versus females,
given a hypothesised 6:1 difference.
The most robust and widely cited synaesthesia
prevalence study to date (Simner et al., 2006), report
an overall prevalence of synaesthesia of 4.4% of the
population, when testing for 162 different variants.
However, there are considerable challenges to
identifying so many different types of sub-variants
within a single study (see Simner et al., 2006 for
discussion) so we instead chose to test for just one
variant of synaesthesia in the current study. We chose
grapheme-colour synaesthesia since this variant is very
well understood, relatively prevalent, and can be tested
for using a single standardised computerised method
(see below). Below we therefore conduct a power
analysis to reveal the number of individuals required
for screening in order to identify any 6:1 bias of female
synaesthetes with grapheme-colour synaesthesia.
Simner et al. (2006) report the prevalence of
grapheme-colour synaesthesia to be 2% (where
“grapheme-colour synaesthetes” are those with either
coloured letters, coloured digits, or with both). With
an assumed sex ratio of 6 female synaesthetes to
every male synaesthete, we would expect to find
1.71 female synaesthetes and 0.29 male synaesthetes
if we tested 100 members of the population. If we
carry out a sample size calculation for a chi-squared
test, with standard levels of power at 0.80 and alpha
at 0.05, in order to detect a difference in proportion of
this magnitude (1.71% versus 0.29%, or proportions
of 0.0171 and 0.0029 respectively) a sample of 1810
participants is required for screening (905 females and
905 males). In our empirical study below, we meet—
and indeed exceed—this sample size.
EMPIRICAL ASSESSMENT
We individually assessed a very large number of
individuals from the general population for



































grapheme-colour synaesthesia, avoiding a self-referral
bias. Every person was assessed using the behavioural
“gold-standard” test which identifies synaesthetes by
detecting the most widely accepted core characteristic
of synaesthesia. This characteristic is the consistency
in the reporting of synaesthetic sensations over time.
In grapheme-colour synaesthesia for example, a given
letter tends to elicit a consistent synaesthetic colour
for any given synaesthete in repeated testing (e.g., A
might be consistently red, B consistently blue, etc.).
This consistency-over-time is taken as the behavioural
hallmark of synaesthesia in standard diagnostic tests
for synaesthesia (see Johnson, Allison & Baron-
Cohen, 2013 for review). The mostly widely used
version of this test for grapheme-colour synaesthesia
is available at an online interface known as the
Synesthesia Battery (Eagleman, Kagan, Nelson,
Sagaram & Sarma, 2007). In this test, participants
are required to repeatedly report their synaesthetic
associations for the letters A-Z and/or the digits 0–9,
each shown three times in a random order. In order
for people to be diagnosed as synaesthetes, they must
achieve high enough consistency in their colour-
choices to show they are significantly better than
non-synaesthete controls, who previously performed
the same test to provide a robust base-line. This task
was used in our own study, and more details are given
in Eagleman et al. (2007) and in our methods below.
Participants
We individually screened 3893 participants for
grapheme-colour synaesthesia using The Synesthesia
Battery (2135 female; 1758 male). Their mean age
was 28.3 years (SD = 14.2). A further 65 participants
were excluded from study because they had entered
an obviously false date of birth (e.g., 2013; n = 48) or
because they reported too few coloured graphemes for
their synaesthesia to be meaningfully evaluated
(n = 17; see Eagleman et al., 2007). Participants
were unpaid, and our study was approved by the
local university ethics board.
Participants were recruited as part of a large-scale,
centrally co-ordinated undergraduate research project,
described in detail in Carmichael, Down, Shillcock,
Eagleman and Simner (2015). In this, every student
registered on the 2nd year of the Psychology
undergraduate course at the University of Edinburgh
between September 2012 and May 2015 acted as a
research assistant (RA), each recruiting approximately
8 participants (4 male and 4 female) over 16 years of
age. In recruiting participants, we took a number of steps
to ensure as random a sample as possible: RAs were
required to pre-select their sample, and then approach
participants in a targeted way, rather than sending out an
advert for self-referrals. Indeed, RAs were required to
refrained from recruiting participants via any advert or
open calls at all. For example, they could not post the
testing URL on social media websites or internet
forums. Furthermore, RAs were instructed not to
deliberately seek out, nor to avoid, people they knew
to be synesthetes and were also instructed not to a priori
inform participants that the study investigated
synesthesia. Instead, they pre-selected their samples to
create a pre-determined, non-referred testing cohort, and
then individually tested every member of that cohort.
Methods
To screen for grapheme-colour synaesthesia, we used
the consistency test from the Synesthesia Battery on-
line interface (Eagleman et al., 2007), which we
cloned with permission from the authors (see
Carmichael et al., 2015 for details). Participants
were provided with the URL of our online interface
and completed the test in their own time.
Our replication of the Synesthesia Battery first
obtains consent for testing and then records
demographic information about participants including
age and sex. Participants are then asked whether they
experience grapheme-colour synesthesia with the
question “Do numbers or letters cause you to have a
colour experience?” A checkbox is provided for
participants to record separately whether these
colours are triggered automatically by numbers and/
or digits. If participants indicated that they saw neither
letters nor numbers in colour, they advanced to an exit
page thanking them for their participation.
The consistency test was completed by participants
who answered in the affirmative to having coloured
letters/digits. This test displays individually on-screen
the letters A-Z and/or the digits 0–9 (according to how
participants responded to the checkboxes described
above). Each grapheme is shown three times in a
random order, and on each display, participants must
indicate their synaesthetic colour by selecting it from an
on-screen palette of 256x256x256 colours. The program
compares the colour selected each time the same
grapheme was presented (e.g., it compares the three
colours for the letter A). It then produces a
standardised score to reflect how far away in colour
space those three colours were, averaged across all
graphemes. A small standardised score reflects
consistent colours (i.e., selections for the same
grapheme were close in colour-space). A score less
than 1 indicates the high level of consistency typical of



































a synaesthete and this is the diagnostic threshold in this
test. For full details regarding how this test is designed
and implemented, please refer to Eagleman et al. (2007).
Results
In our study, we classified as non-synaesthetes all
those who were directed to the early-exit page (i.e.,
those who said they did not experience coloured
letters and/or digits) and all those who continued but
scored 1 or higher. The remainder were classified as
synaesthetes (i.e., those who scored <1).
From 3893 participants, we identified 54 grapheme-
colour synaesthetes with coloured letters and/or digits
(n = 5 with coloured letters; n = 26 with coloured
digits; n = 23 with both coloured letters and digits),
giving an overall prevalence of 1.39%. Of these 54
synaesthetes, 33 were female and 21 were male.3
Calculating the overall prevalence of grapheme-
colour synaesthesia for each sex separately taking
into account the total number of men and women
tested (2135 and 1758 respectively) gives us a female
prevalence of 1.55% and a male prevalence of 1.19%,
producing a female: male ratio of 1.3:1. This difference
in the ratio of female versus male synaesthetes is not
significant (χ2 = 0.63, df = 1, p = 0.43).4
Bayesian analysis
To further investigate our null result, we performed
two types of Bayesian analyses below. Together these
suggest that our sufficiently powered investigation of
whether there is a 6:1 ratio gave strong support for the
null hypothesis. However, they also provide an
estimate of how small any possible female bias
might yet be.
First, our Bayes factors analysis allows us to evaluate
to what extent the data supports the hypothesis under
investigation against the null hypothesis (Rouder,
Speckman, Sun, Morey & Iverson, 2009). Following
Jeffreys (1961), a Bayes factor of less than 0.33 provides
strong support for the null hypothesis, a Bayes factor >3
provides support for the alternative hypothesis and
values in between indicate no firm conclusions should
be drawn. Our Bayes factor was 0.014, indicating strong
support for the null hypothesis that sex does not
significantly influence the prevalence of grapheme-
colour synaesthesia.
Exploring our data further, a second analysis suggests
that although there was no large significant difference
across the sexes, there may yet be small difference, and
we can calculate its size. We constructed a beta-binomial
model of our acquired data which shows that any
difference between the numbers of male and female
synaesthetes in the general population is likely to be
very small. Calculating a 95% confidence interval of
the difference in prevalence, we see any difference in
prevalence between females and males is likely to fall in
the range −0.4% to 1.1%. Theoretically speaking,
therefore, if we were confident that—say—our male
prevalence of 1.19% were correct, we would therefore
be 95% sure that the true female prevalence is in the small
range between 0.79% (1.19%–0.4%) to 2.29% (1.19%
+1.1%). Indeed, if there were a difference between men
and women, our beta-binomial model also shows there is
an 82% chance that the prevalence would be higher for
females—albeit to this very marginal degree.
Discussion
We investigated the prevalence of grapheme-colour
synaesthesia in males and females to challenge the
suggestion that there are six times more female
synaesthetes than male in the general population
(Barnett et al., 2008; Baron-Cohen et al., 1996; Rich
et al., 2005). First we pointed out that two previous
studies showing this level of strong bias reported that
their methodology relied on self-referral (e.g., Baron-
Cohen et al., 1996; Rich et al., 2005). This method
likely encouraged female synaesthetes to reply more
than males (Simner et al., 2006; following Dindia &
Allen, 1992). Second, we described how previous
studies not liable to this confound (e.g., Simner
et al., 2009, 2006) had not found a strong 6:1 bias
towards females, and indeed had found no significant
difference across the sexes at all. Third we examined
an additional study showing a 6:1 bias of females
which claimed not to rely on self-referral (Barnett
et al., 2008). Using their published data and
descriptions of study, we suggested that they may
not have taken into account the total number of
males/females tested overall or may not have used
objective tests to verify synaesthesia in all
3Of the 33 female synaesthetes, 12 reported both coloured
letters and digits, 5 reported experiencing coloured letters only
and 16 reported coloured digits only. Of the 21 male, 11 reported
both coloured letters and digits, 0 reported coloured letters only and
10 reported coloured digits only.
4If we examine the sex ratio for only synaesthetes who have
both coloured letters AND numbers (n = 23; 12 female) we find a
prevalence of 0.59%. Calculating the synaesthesia prevalence of
each sex separately gives us a female prevalence of 0.56% and a
male prevalence of 0.63%, and a ratio of 0.89: 1. Using a chi-
squared test, we again determined the difference in ratio of female
versus male synaesthetes is not significant (χ2 = 0.002, df = 1,
p = 0.962).



































participants, and that their methods did not appear to
be entirely free of the self-referral confound.
In our empirical investigation, we screened 3893
individuals for grapheme-colour synaesthesia following
a power analysis. We took care to avoid self-referral
confounds and we individually tested every member of
a pre-determined cohort with an objective test for
synaesthesia. We found that 33 out of the 2135 females
tested had grapheme-colour synaesthesia (for coloured
letters and/or digits; female prevalence 1.55%) as well as
21 out of 1758 males (male prevalence 1.19%). This
ratio of 1.3: 1, female to male synaesthetes, was non-
significant. Further Bayes analyses suggest support for
the null result in our data, but that there remains the
possibility of a very small sex differences, in the range
of −0.4% to 1.1%, with a female bias being more likely
than a male bias.
Our results largely corroborate the findings of our
previous comparison study, Simner et al. (2006)
which reported an overall prevalence of grapheme-
colour synaesthesia of 2%, compared to 1.39% in our
own study (and this difference is non-significant;
χ2 = 1.16, p = .28). This was for synaesthetes with
coloured letters and/or digits, but it is also possible to
directly compare our findings in the female: male
ratio if we consider synaesthetes with both coloured
letters and digits (since this is the type of sex data
reported in Simner et al., 2006). In this comparison
we find a female: male ratio of 0.9:1 in the current
study compared to an identical ratio (0.9:1) found in
Simner et al. (2006; their female prevalence was
1.03% and their male prevalence was 1.15%).
In our calculations we point out that we classified
participants as synaesthetes according to the
conventional cut-off, as stated within the test we used
by Eagleman et al. (2007). This conventional cut-off
for synaesthesia is a score <1. Two recent studies
however have suggested that a more accurate
approach might be a cut-off centred on 1.43 rather
than 1 (for details see Carmichael et al., 2015;
Rothen, Seth, Witzel & Ward, 2013). For this reason,
we also re-calculate our prevalence and female/male
ratio according to the 1.43 cut-off and find a yet-closer
female: male ratio in synaesthesia. For clarity to aid the
reader, we have presented this data along with our
other prevalence/ratios in Table 1.
Of course we point out that our findings relate only
to the sex ratio and prevalence of the population we
sampled, and the type of synaesthesia we
investigated. We note that our average sampled
participant was 28 years old, which is younger than
the national average (median = 40.5 years; Central
Intelligence Agency, 2014), and this might have
influenced the prevalence we generated.
Furthermore, we looked only at grapheme-colour
synaesthesia, which is just one of many variants of
the condition (see Cytowic & Eagleman, 2009; Day,
2005). A recent study of a very large number of self-
referred synaesthetes by Novich, Cheng and
Eagleman (2011) revealed that groups of variants
clusters into synaesthetic subtypes (e.g., people with
grapheme-colour synaesthesia are likely to have a
second form involving colour, but not taste). This
suggests there may be multiple forms of the
condition, and indicates in turn that what is true of
grapheme-colour synaesthesia (e.g., its sex ratio) may
not be representative of all synaesthesias.
One curiosity not yet understood is the apparent
extent of the female bias in self-referral studies for
synaesthesia. We have shown there are roughly
equivalent numbers of female to male grapheme-colour
synaesthesia in the general population—or at the very
most, that there are only 1.3 women for every man.
However, six times more female synaesthetes are
detected in self-referral studies (e.g., Baron-Cohen et al.
1996). We attribute this difference in part to the known
confound that promotes responses from women over
men in self-referral (e.g., Dindia & Allen, 1992;
TABLE 1
Shows the number of confirmed male (M) and female (F) grapheme-color synaesthetes found in our total sample of 3893 subjects
(F = 2135; M = 1758). The prevalences are shown in brackets, with the female: male ratio beneath. This is done twice according to
two different cut-off for synaesthesia (a score of 1 vs. 1.43 in The Synesthesia Battery) and twice according to two different
definitions of grapheme-color synaesthesia (having colored letters AND/OR digits, vs. colored letters AND digits).
Coloured triggers Sex & ratio Battery cut-off at 1 Battery cut-off at 1.43
Letters AND/OR digits F 33 (1.55%) 55 (2.58%)
M 21 (1.19%) 39 (2.22%
F + M =54 (1.39%) =94 (2.42%)
Ratio F:M 1.3:1 1.2:1
Letters AND digits F 12 (0.56%) 23 (1.08%)
M 11 (0.63%) 19 (1.08%)
F + M =23 (0.59%) =42 (1.08%)
Ratio F:M 0.89: 1 1:1



































Rosenthal & Rosnow, 1975). However, Barnett et al.
(2008) point out that this bias usually gives just a slight
variation of around 10% (Dindia & Allen, 1992). Why
then might the female bias be so exaggerated in studies
of synaesthesia—and indeed, why are the rates so
consistent across self-referral studies? It could be, for
example, that female synaesthetes—although not
greatly more common—have perhaps more intense
experiences or are more aware of their synaesthesia or
attend to it more in daily life. This might make them
more likely to self-refer. However, we have no data to
support any specific supposition in this area, so leave this
question for future investigations.
Understanding sex ratios are important in
understanding the origins of synaesthesia. Initial
findings that synaesthesia appeared more common in
females led to suggestions that synaesthesia was
either not fully expressed in males or that it was
linked to the X-chromosome in some way (Bailey &
Johnson, 1997; Baron-Cohen et al., 1996; Ward &
Simner, 2005). Indeed, the extent of the female bias
led researchers to propose that synaesthesia might
causes lethality in males in utero (Baron-Cohen
et al., 1996). Subsequent research, including our
own study here, suggests this is not the case. In
combination with previous studies from our own lab
and elsewhere, we conclude there no very strong
female bias (Simner et al., 2009, 2006), that families
containing synaesthetes are equally likely to produce
female or male offspring (Barnett et al., 2008; Ward
& Simner, 2005), that there are confirmed cases of
male-to-male transmission (Asher et al., 2009), and
one case of monozygotic male twins who are
discordant for synaesthesia (Smilek, Dixon &
Merikle, 2005). Finally, neither Asher et al. (2009)
nor Tomson et al. (2011) found evidence for a major
locus on the X chromosome in their genome-wide
studies.5 This suggests a need to revisit our early
understanding of the mode of inheritance of
synesthesia (see Asher & Carmichael, 2013, for
review) and we provide our data for future studies
to do so.
We finally point out that our own studies have
shown relatively flat distributions of synaesthesia in
men and women, with a slight male bias when
considering grapheme-colour synaesthetes with
coloured letters and digits (female: male ratio of 0.9:
1 both here and in Simner et al., 2006) and a slight
female bias when considering grapheme-colour
synaesthetes with coloured letters and/or digits
(here, female: male ratio of 1.3: 1). It may yet be
possible to estimate the numbers required to test this
much reduced difference across the sexes (e.g., power
analyses in the ratio of 1.3:1 suggest we would need
to screen 47516 participants) but for the current study
we have shown that there is no 6:1 ratio of female to
male synaesthetes, even with sufficient power to test
for such a difference.
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Association of hla-drb1* 1501 tagging rs3135388 gene polymorphism with multiple
sclerosis. Journal of neuroimmunology, 255(1):92–96.
Bernasconi, N., Duchesne, S., Janke, A., Lerch, J., Collins, D., and Bernasconi, A.
(2004). Whole-brain voxel-based statistical analysis of gray matter and white matter
in temporal lobe epilepsy. Neuroimage, 23(2):717–723.
Bibliography 273
Bertrams, J. and Kuwert, E. (1972). Hl-a antigen frequencies in multiple sclerosis.
European neurology, 7(1-2):74–78.
Bienvenu, O. J., Samuels, J. F., Costa, P. T., Reti, I. M., Eaton, W. W., and Nestadt,
G. (2004). Anxiety and depressive disorders and the five-factor model of personal-
ity: A higher-and lower-order personality trait investigation in a community sample.
Depression and anxiety, 20(2):92–97.
Blakemore, S.-J., Bristow, D., Bird, G., Frith, C., and Ward, J. (2005). Somatosensory
activations during the observation of touch and a case of vision–touch synaesthesia.
Brain, 128(7):1571–1583.
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., and Mørk, S. J. (2003). Sub-
pial demyelination in the cerebral cortex of multiple sclerosis patients. Journal of
Neuropathology & Experimental Neurology, 62(7):723–732.
Bobadilla, J. L., Macek, M., Fine, J. P., and Farrell, P. M. (2002). Cystic fibrosis: a
worldwide analysis of cftr mutationscorrelation with incidence data and application
to screening. Human mutation, 19(6):575–606.
Bor, D., Billington, J., and Baron-Cohen, S. (2008). Savant memory for digits in a
case of synaesthesia and asperger syndrome is related to hyperactivity in the lateral
prefrontal cortex. Neurocase, 13(5-6):311–319.
Boulanger, L. M. (2004). Mhc class i in activity-dependent structural and functional
plasticity. Neuron glia biology, 1(3):283.
Boulanger, L. M. (2009). Immune proteins in brain development and synaptic plastic-
ity. Neuron, 64(1):93–109.
Brang, D., Hubbard, E., Coulson, S., Huang, M., Ramachandran, V., et al. (2010).
Magnetoencephalography reveals early activation of v4 in grapheme-color synes-
thesia. Neuroimage, 53(1):268.
Bibliography 274
Brang, D. and Ramachandran, V. S. (2008). Psychopharmacology of synesthesia; the
role of serotonin s2a receptor activation. Medical hypotheses, 70(4):903–904.
Brogaard, B. (2013). Serotonergic hyperactivity as a potential factor in developmental,
acquired and drug-induced synesthesia. Frontiers in human neuroscience, 7.
Bruno, P., Carpino, F., Carpino, G., and Zicari, A. (2007). An overview on immune
system and migraine. European Review for Medical and Pharmacological Sciences,
11(4):245.
Bubl, E., Kern, E., Ebert, D., Bach, M., and Tebartz van Elst, L. (2010). Seeing
gray when feeling blue? depression can be measured in the eye of the diseased.
Biological psychiatry, 68(2):205–208.
Cardon, L. R. and Palmer, L. J. (2003). Population stratification and spurious allelic
association. The Lancet, 361(9357):598–604.
Carmichael, D., Down, M., Shillcock, R., Eagleman, D., and Simner, J. (2015). Vali-
dating a standardised test battery for synesthesia: Does the synesthesia battery reli-
ably detect synesthesia? Consciousness and Cognition, 33:375–385.
Carmichael, D. A. and Simner, J. (2013). The immune hypothesis of synesthesia.
Frontiers in human neuroscience, 7.
Carruthers, H. R., Miller, V., Tarrier, N., and Whorwell, P. J. (2012). Synesthesia,
pseudo-synesthesia, and irritable bowel syndrome. Digestive diseases and sciences,
57(6):1629–1635.
Ceccarelli, A., Rocca, M. A., Pagani, E., Colombo, B., Martinelli, V., Comi, G., and
Filippi, M. (2008). A voxel-based morphometry study of grey matter loss in ms
patients with different clinical phenotypes. Neuroimage, 42(1):315–322.
Chapman, J., Freeman, T., and McGhie, A. (1959). Clinical research in schizophre-
niathe psychotherapeutic approach. British Journal of Medical Psychology,
32(2):75–85.
Bibliography 275
Chapman, L. J. and Chapman, J. P. (1969). Illusory correlation as an obstacle to the
use of valid psychodiagnostic signs. Journal of abnormal psychology, 74(3):271.
Chiaravalloti, N. D. and DeLuca, J. (2008). Cognitive impairment in multiple sclerosis.
The Lancet Neurology, 7(12):1139–1151.
Chinn, D., White, M., Howel, D., Harland, J., and Drinkwater, C. (2006). Factors as-
sociated with non-participation in a physical activity promotion trial. Public health,
120(4):309–319.
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